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GENERAL INTRODuCTION
The unexpected diagnosis of an oral cleft before or after birth is a shocking and traumatic 
experience for parents and their social environment, generating anxiety as well as numerous 
questions. What is an oral cleft? Why didn’t our baby’s mouth fully develop? How is it caused 
and can it be prevented? How many babies are born with clefts? What can be done to help our 
baby? What is the risk of other congenital anomalies? What will be the prognosis and outcome 
later in life? 
Oral clefts
Oral clefts are heterogeneous often immediately recognizable congenital anomalies affecting 
the lip and oral cavity. They comprise a wide range of sub-phenotypes varying from mild types 
(subcutaneous or submucous clefts) to more severe incomplete or complete clefts of the lip, 
alveolus, hard palate, or soft palate including the uvula (Figure 1).1-4 While median cleft lip 
and atypical facial clefts are regularly also included in the phenotypic spectrum of oral clefts, 
these anomalies should be considered as craniofacial anomalies because of their different 
pathogenesis and associated defects.4-7 With regard to oral clefts, effects on feeding, speech, 
hearing, appearance, and cognition can lead to long-lasting adverse outcomes for health and 
social integration. Therefore, affected individuals need multidisciplinary care from birth until 
childhood, generally including surgery, dental treatment, speech and hearing therapy, genetic 
counseling, and psychosocial intervention.8 Although rehabilitation is possible in developed 
countries with good quality care, children with oral clefts have higher morbidity and mortality 
throughout life than do unaffected infants. They are frequently affected with other congenital 
anomalies, often as part of Mendelian, chromosomal, or teratogenic syndromes.1, 2, 8-10 If oral 
clefts occur as isolated entities with no other apparent structural anomalies, they are collec-
tively termed as non-syndromic oral clefts.
Until the late 1990s, clefts were predominantly detected after birth, during the immediate 
postnatal period or—in case of a mild cleft palate—later in infancy. However, due to advances 
in ultrasound technology and the international introduction of routine prenatal screening at 
18-22 weeks of gestation, structural congenital anomalies, including oral clefts, are diagnosed 
prenatally more frequently.11-14 As a consequence, there is an increasing need for information 
to aid in prenatal counseling and optimize prenatal care. Decisions taken by parents, especially 
with regard to termination of the pregnancy, seem to be mainly affected by the long-term 
prognosis of the malformed fetus.15 When informing parents about the prognosis of their child, 
accurate diagnosis of the cleft sub-phenotype as well as of associated congenital anomalies 
is vital. In particular the identification of an underlying chromosomal defect will influence 
counseling and management of the pregnancy significantly. However, the exact prevalence 
and risk factors for associated structural anomalies and chromosomal defects are not known as 
they vary significantly between studies.16 This has led to lack of consensus on when to perform 
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Figure 1. Wide variation of oral cleft sub-phenotypes.
I. Unilateral left submucous cleft lip (also known as forme fruste, congenital scar, and microform, 
subsurface, or subcutaneous cleft) showing a notch of the vermilion (a) with a normal alveolus (b). 
II. Unilateral left incomplete cleft lip (a) with an incomplete cleft alveolus (b).
III. Unilateral left complete cleft lip (a) with a complete cleft alveolus (extending to the incisive foramen) 
(b). 
IV. Unilateral left incomplete cleft lip (a) with a complete cleft alveolus and a complete cleft of the hard 
and soft palates (b). This sub-phenotype is also known as the Simonart’s band.
V. Unilateral right complete cleft lip with a complete cleft alveolus (a) and a complete cleft of the hard 
and soft palates (b).
VI. Bilateral complete cleft lip with a complete cleft alveolus (a,b).
VII. Bilateral complete cleft lip with a complete cleft alveolus (a) and a complete cleft of the hard and soft 
palates (b).
VIII. Complete cleft of the hard and soft palates (a,b).
IX. Incomplete cleft of the hard palate with a complete cleft of the soft palate.
X. Submucous cleft of the soft palate showing a median cleft of the palatal muscles with intact mucosa 
(arrow).
invasive prenatal diagnostics to identify these underlying chromosomal abnormalities.17 
Should these invasive tests be advised in all prenatally identified cleft cases, or should they 
be limited to specific phenotypes and associated anomalies? In order to allow well-informed 
decisions on these invasive diagnostics and be able to optimize prenatal counseling and care as 
well as improve the prevention, prognosis, and outcome of oral clefts, one should understand 
the underlying embryology, etiology, and epidemiology of these conditions.
Development and etiology
Oral clefts result from a failure of normal embryonic processes that lead to the formation of 
the nose and oral cavity. Understanding of these processes explains how a particular sub-
phenotype arises and why clefts occur in certain patterns. Normal development of the primary 
palate (presumptive lip and alveolus) and secondary palate (presumptive hard and soft palates 
including the uvula) entails a complex series of embryonic events that require close coordina-
tion of cell proliferation, apoptosis (programmed cell death), and cell differentiation,6, 7, 18-21 
regulated by many different genes during different time frames.1, 22 In short, palatogenesis 
can be subdivided into an early (4-7 weeks postconception) and late (7-12 weeks postconcep-
tion) embryonic period.6, 7, 19, 22 During the first period, the primary nasal cavity and primary 
palate are formed in an occipito-frontal direction by subsequent outgrowth, adherence, and 
fusion of the three facial swellings around each nasal placode at both sides of the face (Figure 
2:1-3).6, 7, 18-22 After the fusion process of the primary palate, the late embryonic period starts 
with differentiation of the primary palate and formation of the secondary palate. The lip and 
alveolus are formed by merging, outgrowth, and differentiation (into bone and musculature) of 
the mesenchymal cores of the fused swellings. Simultaneously, the secondary palate is formed 
in a fronto-occipital direction by subsequent outgrowth, elevation, adherence, and fusion of 
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the two palatine shelves. These shelves fuse with each other, the primary palate, and the nasal 
septum, and their mesenchyme differentiates into bone and musculature (Figure 2:3-6).6, 7, 19-22 
Derailments in any of these tightly regulated processes during different developmental peri-
ods may result in various cleft sub-phenotypes. Disturbing factors impacting on developmental 
events during the early embryonic period can cause failure of fusion between the facial swell-
ings, resulting in defects such as complete clefts of the lip/alveolus. By contrast, disturbances dur-
ing the late embryonic period may lead to failure of fusion between the palatal shelves causing 
complete or incomplete clefts of the palate.6, 7, 19, 22 Subsequent disruption of differentiation of the 
primary or secondary palates may result in incomplete or submucous clefts of the lip/alveolus or 
submucous clefts of the palate, respectively.7, 19 However, factors leading to these developmental 
disturbances are complex and largely unknown. Although there has been marked progress in 
identifying genetic and environmental triggers for syndromic clefts,2, 8-10 the etiopathogenesis 
of the more common non-syndromic forms remains poorly characterized. They are thought to 
result from a complex interplay of genetic and environmental factors. Findings of a variety of 
genetic approaches (including mouse models, linkage and association studies, cytogenetics, 
and gene-expression analyses in human and mouse embryonic tissue) have suggested vari-
ous candidate genes and pathways implicated in oral clefts.1, 2, 9, 10, 22 However, results remain 
inconsistent owing to the considerable genetic heterogeneity. 
With regard to environmental factors, maternal smoking during pregnancy has been linked 
with an increased cleft risk,2, 8 especially in interaction with certain genes,23, 24 such as MSX1.25 
The role of maternal alcohol use is less certain, although some positive associations have been 
reported.2, 8 In addition, there is increasing evidence that nutritional factors and their related 
genes are involved.8, 22 Research in this field has been mainly focused on the role of folic acid 
and multivitamins in the prevention of clefts. However, while numerous observational studies 
have suggested a beneficial role of periconceptional folic acid or multivitamin supplement use 
in decreasing cleft risk, the evidence remains largely inconclusive and their role in cleft etiology 
remains unresolved.26-28 Other factors that have been associated with increased cleft risk are 
specific teratogens including maternal anticonvulsant drugs, corticosteroids, organic solvents, 
and agricultural chemicals.8
One of the main problems hampering the identification of genetic and environmental 
causal factors might be that oral clefts are generally defined as qualitative traits (that is, 
affected or unaffected).1, 2 Given the wide range of phenotypic expressions of clefts, this too 
simplistic approach could potentially result in important information being lost. The pheno-
typing spectrum is more complex than previously realized and includes a variety of—less 
evident—subclinical features, such as subcutaneous cleft lip (also known as microform cleft or 
forme fruste lip),29-31 submcucous cleft palate, hypoplastic palate, or bifid uvula.2, 3, 32 As these are 
often treated as ‘unaffected’, these individuals may represent genetic or environmental features 
that are currently overlooked. Another important aspect is that the power to detect effects 
is weakened when heterogeneous groups are treated as a single entity. Therefore, accurate 
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phenotyping—including subclinical features—and subsequent adequate classification is cru-
cial not only for improving overall cleft management and prognosis, but also for furthering our 
understanding of the etiopathogenesis of clefts.1, 2, 29-31 To facilitate the ongoing search for risk 
factors, detailed description and registration of sub-phenotypes with standardized protocols 
and data-sharing between cleft centers are needed.1
Figure 2. Embryonic development in successive stages viewed from the oral side: the fusion processes of 
the primary palate (1-3) and secondary palate (3-6), and differentiation of the lip and alveolus (3-6). 
1. The nasal groove surrounded by the facial swellings (a-c) at five weeks; 
2. Outgrowth and fusion of two (a-b) of the three facial swellings in occipito-frontal direction forming 
the nasal tubes at six weeks; 
3. Further outgrowth and fusion of the three swellings (a-c), resulting in the formation of the primary 
palate at about seven weeks and the beginning of development of the lip (al + bl), alveolus (aa +ba) 
and the shelves of the secondary palate (bp); 
4. Outgrowth of the nasal septum (n) and palatal shelves in vertical direction, and outgrowth of the lip 
and alveolus in caudal direction forming the presumptive labial groove at eight weeks; 
5. Elevation and outgrowth of the palatal shelves in horizontal position and start of the fusion of the 
shelves with the primary palate at eight to nine weeks; 
6. Completed fusion of the shelves in fronto-occipital direction with the primary palate and nasal 
septum, as well as with each other, and completion of the lip, alveolus, and labial groove (lg) at 10-12 
weeks. 
Abbreviations: a,b,c = facial swellings; al = lip developed from a; bl = lip developed from b; aa = alveolus 
(premaxillae) developed from a; ba = alveolus (maxillae) developed from b; bp = palatal shelves 
developed from b; n = nasal septum; lg = labial groove.
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International epidemiology and registration
Although oral clefts are among the most widely known and common congenital anomalies, 
their prevalence is not known in every part of the world and varies widely across geographic 
origin, racial and ethnic groups, as well as socioeconomic status.8, 33-38 Our current knowledge 
on the birth prevalence and figures of clefts around the world reveals not only the apparent 
variation, but also significant differences in methods of data collection and birth defect regis-
tration.8, 16, 34, 38 
Overall, oral clefts affect approximately 1 in 700 live births,34 but reported rates from differ-
ent registries vary considerably from 4.8 to 28.6 per 10,000 live births and stillbirths (with or 
without terminations of pregnancy, TOP).39 Generally, the highest prevalence has been found 
in Asian and Native American populations, while European populations have intermediate rates 
and African-derived populations the lowest rates.2, 34 Within Europe, higher rates are reported 
from northern than southern countries.8, 34 The prevalence also differs by gender and lateral-
ity: clefts involving the lip/alveolus are most frequently seen in males and have a left-sided 
dominance, while clefts of the palate only are most typical in females. These sex ratios vary 
with factors such as cleft severity and presence of associated anomalies.8, 34, 40 Besides the cleft 
prevalence, the frequency and type of associated congenital anomalies vary also significantly 
between studies.16 However, in general, further defects seem to be more frequent for indi-
viduals with clefts of the palate only than for those with clefts involving the lip/alveolus.8 The 
most commonly reported anomalies include eye, brain, heart, limb, and neural tube defects 
as well as developmental retardation and deafness.16 Finally, compared with other congenital 
anomalies, oral clefts have a relatively high rate of familial recurrence, especially for those of 
the palate alone.1 Altogether, these differences suggest a stronger genetic basis and different 
etiopathogenesis for clefts of the palate alone than for clefts involving the lip/alveolus. Con-
sistent with these epidemiological patterns as well as with the distinct developmental origins, 
oral clefts are traditionally divided into two categories: cleft lip with or without cleft palate 
(CL±P) and cleft palate only (CP). However, recent epidemiological studies have emphasized 
further subdivision of CL±P into clefts involving the lip only (CL) and clefts involving both the 
lip and palate (CLP) because of their suggested unique etiologic features, including different 
strong genetic associations2, 41 as well as different associations with risk factors and additional 
congenital anomalies.40, 42 
The epidemiological approach to congenital anomalies has been the backbone of research 
into their causes and prevention. Hypotheses about possible causative agents may arise from 
many different sources, but epidemiological analyses are necessary to test these hypotheses. 
To enable such activities, adequate description and registration of the type and number of 
congenital anomalies and their related factors is needed. Worldwide, various registers for con-
genital anomalies—including oral clefts—were established after the thalidomide “epidemic” 
in the 1960s.37, 43 Most of them use coding systems based on the “International Statistical Clas-
sification of Diseases and Related Health Problems” (ICD) of the World Health Organization44 
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or its extensions, such as the “British Pediatric Association Classification of Diseases” (BPA).34, 
43 Using these classifications, oral clefts are not described, but interpreted and directly coded 
according to clinical diagnosis. Moreover, data are often presented for just two (CL±P and 
CP)37, 43 or three (CL, CLP, and CP)35, 36, 39 categories. As a consequence, important anatomical 
and morphological details are being lost. As interpretations of congenital anomalies change 
by increasing knowledge about their development and etiology, adjustment of previously 
recorded data to new insights—such as a new classification—is often impossible. Therefore, 
more specific systems have been developed to adequately describe and classify the more 
frequent cleft variations according to their anatomical45-49 as well as morphological appear-
ance.50-53 However, infrequent or subclinical features are often not included and none of them 
has been fully based on the embryological processes underlying oral clefts, thereby lacking 
information needed to gain more insight into their causes and prevention.
Epidemiology and registration in the Netherlands
Virtually all surviving children with oral clefts who reside in the Netherlands are treated by one 
of the fourteen Dutch cleft palate teams.3 These teams—housed within university as well as 
non-academic hospitals—offer multidisciplinary care and are united in the “Dutch Association 
for Cleft Palate and Craniofacial Anomalies” (NVSCA). 
Until the late 1990s, the precise prevalence of oral clefts in the Netherlands was not known. 
One of the first reports found a prevalence of 13.8-17.7 per 10,000 live births and stillbirths 
through evaluation of children born in Dutch hospitals during 1982 and 1983.54 A few years 
later, a prevalence of 17.3-19.9 per 10,000 live births was reported, estimated on the basis 
of questionnaires and medical records at the request of the National Health Department to 
aid in the planning of healthcare programs for Dutch children with clefts.55, 56 While national 
figures were scarcely available during that period, regional registration of oral clefts had already 
been established. The local register of Eurocat in the Northern Netherlands started in 1981. 
This population-based registry records congenital anomalies—including oral clefts—among 
live births and stillbirths (including TOP) using ICD/BPA codes,43, 57 and rates have mainly been 
provided for CL±P and CP.37, 58, 59 In addition, the combined National Obstetric and Neonatal 
registries (LVR/LNR) have recorded diagnoses of congenital anomalies as part of information 
on pregnancy, delivery, and neonatal care since 1996. However, national data regarding CL±P 
and CP were firstly published in 2001 and appeared not to have complete regional and national 
coverage.60-62 
Therefore, a new registry for oral clefts and craniofacial anomalies started in 1997 on behalf 
of the NVSCA with the following aims: a) to gain insight into the frequency and distribution 
of all categories and subgroups of oral clefts and craniofacial anomalies in the Netherlands; 
b) to detect changes in their frequency and distribution, thereby detecting and eliminating 
their influencing factors; c) to evaluate the effectiveness of prevention strategies; d) to aid in 
planning and quality surveillance of health services; and e) to facilitate research related to the 
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causes and prevention these anomalies as well as the treatment and care of affected children.63, 
64 The registry has been designed and coordinated by the Registration working group, housed 
in the Department of Plastic and Reconstructive Surgery, Erasmus MC. This group developed 
a unique descriptive recording form based on the embryology of the head and neck area to 
anticipate all conceivable craniofacial anomalies.3, 19 With regard to oral clefts, all individual 
anomalies that form the cleft can be described by recording the affected anatomical structure 
(lip, alveolus, hard palate, soft palate including uvula), morphology (complete, incomplete, sub-
mucous), and side (left, right, median). The rationale behind this approach is that clefts are not 
classified or coded, but described in detail, thereby allowing NVSCA data to be fitted into any 
existing classification and to be compared with other studies. Additionally, infant and parental 
characteristics as well as diagnoses of associated congenital anomalies can be recorded. The 
NVSCA is not an ongoing registry and no data from other sources are included. 
Since its establishment, the Dutch cleft palate teams have registered their anonymous live-
born patients with clefts (no age limit) during the first visit to the team, prior to cleft surgery. 
This has resulted in an extensive database with unique descriptive data on a wide range of 
cleft sub-phenotypes and craniofacial anomalies.3, 19, 63, 64 In order to provide a solid basis for 
research and clinical purposes and thus achieve the objectives of the NVSCA, it is crucial that 
the data provided by the database are accurate and complete. Previously, it was shown that 
the NVSCA’s case ascertainment is of rather high quality.62 However, it is unknown whether 
the individual case and cleft characteristics have also been adequately recorded in this system.
AIMS AND OuTLINE OF THE THESIS
This thesis is aimed at defining an approach and providing a solid basis to further understand 
the etiopathogenesis of oral clefts and optimize their prenatal and postnatal outcome and 
prognosis. 
The specific objectives are:
I. To validate the Dutch Oral Cleft Registry (NVSCA) investigating whether this system 
is complete and feasible in clinical practice and whether its data are reliable for further 
fundamental and clinical studies.
II. To investigate the prevalence of oral clefts in the Netherlands, including its differences 
between regions and registries, as well as its influencing factors. 
III. To test and further develop a new postnatal embryological classification of oral clefts pro-
viding subgroups related to specific time periods and underlying embryological processes 
in development. 
IV. To assess the effects of periconceptional folic acid supplement use on the risk of oral clefts 
in the Netherlands.
21General introduction and outline
V. To investigate the type and prevalence of associated structural anomalies and chromo-
somal defects in prenatal and postnatal oral cleft populations and develop a new prenatal 
ultrasound classification of clefts aiding in prenatal counseling and care.
Chapter 2 describes the study design and first results of a national validation project evaluat-
ing the quality of NVSCA registry data. Oral cleft data were evaluated broadly according to the 
three cleft categories that are most frequently used to study oral clefts (CL, CLP, and CP), thereby 
investigating the value and suitability of NVSCA data for comparison with other registries and 
studies. In addition, information on associated infant and parental characteristics was analyzed. 
In Chapter 3 the quality of NVSCA data was further evaluated by analyzing whether the 
specific features (topography and morphology) of the various sub-phenotypes are adequately 
recorded in clinical practice, thereby investigating the feasibility of this system and its addi-
tional value—compared to other systems—for fundamental and clinical research.
In Chapter 4 NVSCA data on congenital anomalies, syndromes, and chromosomal defects 
associated with oral clefts were validated. Through two-phased medical data review, we 
investigated whether these anomalies are accurately diagnosed and recorded during the first 
consultations with the cleft palate teams and whether reregistration at a later age is needed. 
The type and frequencies of associated anomalies are presented, and the sources of under-
reporting as well as their implications are discussed.
Chapter 5 presents the prevalence of oral cleft live births in the Netherlands from 1997 to 
2006. As time-trend analyses showed a decrease in prevalence, trends were stratified into CL±P 
and CP in order to gain more insight into their possible influencing factors. For example, we 
investigated whether the higher periconceptional use of folic acid supplements in the Neth-
erlands65, 66 and the greater prenatal detection of oral clefts and their associated anomalies11 
might have affected the live-birth prevalence of oral clefts during this period.
In Chapter 6 the prevalence of oral cleft live births from three Dutch registries (NVSCA, 
LVR/LNR, and Eurocat) are described and compared to confirm the declining prevalence in the 
NVSCA and rule out underreporting as a cause of this decline. As previous studies have shown 
a wide variation in oral cleft prevalence not only between, but also within countries,8, 33 and the 
region Northern Netherlands seems to have a relatively high prevalence compared to other 
European regions,36, 58 we also investigated whether the prevalence differs regionally within 
the Netherlands.
For furthering our knowledge of causal factors and understand why oral cleft anomalies 
occur in certain epidemiological patterns, it is essential to subdivide them according to their 
specific time periods and underlying processes in development, allowing to link them to 
specific genes and environmental factors that are expressed during these periods. However, 
none of the previously published oral cleft classifications have been fully based on human 
embryology of the nose and oral cavity.44-53 Therefore, a new postnatal classification based 
on the pathoembryology of the primary and secondary palates was proposed.19 In Chapter 7 
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this new approach and its embryological basis are described and tested on all sub-phenotypes 
among Dutch newborns registered in the NVSCA.
While the embryogenesis of the secondary palate has extensively been investigated result-
ing in general consensus on this topic,8 the developmental processes of the primary palate 
are complex and have been rather underexposed. As a consequence, several questions remain 
unanswered. First, several studies have proposed further morphological grading of incomplete 
clefts of the lip,50-53, 67, 68 but its clinical and embryological relevance is unknown. More specifi-
cally, it has not been described whether these morphological grades (severity) are related to 
those of the alveolus and thus have a predictive value. Second, it is indefinite which part of 
the alveolus—that formed by the premaxilla or maxilla—is deficient in alveolar deformities. 
In Chapter 8 the completeness and feasibility of our new embryological classification for all 
sub-phenotypes of the primary palate is investigated using adult unoperated patients from 
Indonesia. In addition, the questions regarding the clinical and embryological value of addi-
tional morphological grading, as well as regarding the deficient part in alveolar deformities are 
addressed.
After analyzing the feasibility and completeness of our new classification, its subgroups 
were applied in Chapter 9 to assess the effects of periconceptional folic acid supplements on 
the risk of oral clefts relative to other non-folate related congenital anomalies. By combining 
complementary data from the NVSCA and Eurocat databases, we performed a population-
based case-control study in the Northern Netherlands analyzing the type, timing, and duration 
of supplement use in relation to timing and processes underlying cleft development—an 
approach missing in earlier studies.26, 28 
The prenatal characteristics of oral clefts differ significantly to those of postnatal cleft 
populations. Although the quality of prenatal detection of anatomical and morphological 
cleft characteristics is increasing,69-73 the prenatal identification of subclinical features and 
involvement of the palate can still be challenging.13, 17 Furthermore, before the recent advances 
in ultrasound diagnostics, the cases that were more likely to be detected prenatally tended 
to be the more severe cases with associated anomalies, intrauterine growth retardation, or 
other prenatal complications,13 resulting in a different prognosis and outcome. As increasing 
numbers of isolated clefts are identified in utero nowadays, the epidemiological figures of 
previous prenatal studies are not representative of the current prenatal populations. To aid in 
optimal management of the pregnancy in terms of decisions on invasive diagnostics, antenatal 
counseling and care, referral for birth to required specialist level, and planning for the postnatal 
treatment of the child, adequate and up-to-date information is needed. Therefore, Chapter 
10 gives an overview of literature and complementary NVSCA data on the type and frequency 
of associated structural and chromosomal anomalies related to oral cleft category in prenatal 
and postnatal populations. In addition, an algorithm for prenatal invasive testing is given. 
Finally Chapter 11 presents a new prenatal ultrasound classification of oral and craniofacial 
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clefts—designed for modern ultrasound technologies—subdividing clefts according to their 
patho-embryological processes, epidemiology, and associated congenital anomalies.
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AbSTRACT
Objective: Since 1997 the Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA) 
has maintained a national registry of congenital craniofacial anomalies. This study validates 
data on three common oral cleft categories (cleft lip/alveolus = CL/A; cleft lip/alveolus and 
palate = CL/AP; and cleft palate = CP) and general items.
Design: Retrospective observational study.
Setting: All 15 Dutch cleft palate teams registered presurgery patients with common oral clefts 
(n = 2553) from 1997 to 2003.
Patients: A random sample of 250 cases was used; 13 cases were excluded.
Main Outcome Measures: The corresponding medical data were reviewed; these medical data 
served to validate the NVSCA registry data. Prevalence comparisons, 2 x 2 tables and validity 
measures were performed.
Results: The cleft categories most accurately recorded were CL/A and CP. Both categories had 
an observed agreement of 98%, kappa of 0.94, and a sensitivity and specificity of 97%. Cleft 
lip/alveolus and palate had an observed agreement of 95%, kappa of 0.89, a sensitivity of 90%, 
and a specificity of 99%. Regarding the general items, observed agreement and kappa were 
highest for adoption/foster child (99%; 0.76) and lowest for remarks about pregnancy (63%; 
0.20). Sensitivity ranged from 25% (consanguinity) to 97% (white mother) and specificity was 
high for all items (> 93%) except for white father and mother (approximately 35%).
Conclusions: The NVSCA registry is a valuable tool for quality improvement and research 
because validity on all three common oral cleft categories is very good. Validity on the general 
items is reasonable to satisfying and appears to be related to the type of information.
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INTRODuCTION
International registries
Oral clefts are one of the most common congenital anomalies in humans. Worldwide, the 
prevalence of oral clefts varies between 4.8 and 28.6 per 10,000 live births and stillbirths (with 
or without termination of pregnancy)1 with considerable variations associated with sex, ethnic-
ity, socioeconomic status, and geographic region.2-6 
In many studies on oral clefts, median cleft lip and atypical facial clefts are included. How-
ever, these clefts should be considered as different craniofacial anomalies because of their dif-
ferent pathogenesis.7, 8 Therefore, the term common oral clefts (OCs), which comprises cleft lip/
alveolus and/or cleft palate, is introduced in this paper. Common oral clefts are very complex 
and heterogeneous birth defects. During embryonic development of the head and neck area, 
many different cell biological mechanisms and genes are involved, related to different time 
frames. 7, 9 Disturbance of this complex developmental process can result in many different 
types of OCs with variable degree of severity on clinical presentation.8 Classically, OCs are 
divided into two categories: cleft lip with or without cleft palate (CL±P) and cleft palate only 
(CP) because of their embryologic and epidemiologic differences.3 However, some studies have 
recently emphasized grouping cleft lip only (CL) and cleft lip with cleft palate (CLP) into dif-
ferent conditions, because of differences concerning their prevalence, relation to sex, relation 
to consanguinity and laterality, and different associations with other congenital anomalies. 10, 
11 Although the etiopathogenesis has been widely studied, it is still poorly understood for all 
three categories of clefts. When considered as single defects, many genetic and environmental 
factors, such as nutrition and smoking, have been suggested.3, 9, 12, 13 To facilitate further genetic 
and etiopathological studies and to improve prevention, diagnostics, and treatment, detailed 
descriptions of OCs and other anomalies of the head and neck area are needed.
The importance of registering the type and number of congenital anomalies is long recog-
nized. Worldwide, several congenital anomaly registries were established after the thalidomide 
“epidemic” in the 1960s. 5, 14-19 Most registries use a coding system based on the International 
Statistical Classification of Diseases and Related Health Problems (ICD) published by the World 
Health Organization. Because the ICD is not sufficiently detailed for more specialized purposes 
some registries use extensions of its codes, for example the British Pediatric Association Clas-
sification of Diseases (BPA).4, 5, 15, 20 The ICD (10th revision) has a section entitled “Cleft lip and 
cleft palate” (Q35-37) to record oral clefts (median cleft lip included).21 These codes can give 
some information regarding the morphology and topography of the oral cleft, but not in great 
detail. Therefore, many registries do not supply the detailed information required for OCs as 
well as for other craniofacial congenital anomalies.
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National registries
In the Netherlands, theoretically all surviving children with OCs who stay in the country are 
treated by one of the 15 cleft palate teams.22 These teams offer multidisciplinary treatment to 
patients with OCs according to the team protocols. Members of the teams belong to the Dutch 
Association for Cleft Palate and Craniofacial Anomalies (NVSCA). Important goals of this asso-
ciation are: (1) description of the frequency and distribution of all categories and subgroups of 
OCs and other craniofacial anomalies, (2) promotion of clinically-related research on etiology, 
prevention, diagnostics, and treatment of oral clefts and other craniofacial anomalies, and (3) 
planning and quality surveillance.23, 24 In order to fulfill these goals, a new descriptive record-
ing form was developed based on the embryology of the head and neck area, describing the 
morphology and topography of the anomalies.7, 25, 26 Since 1997, the NVSCA has maintained 
a national registry of congenital craniofacial anomalies, including OCs. Reporting is done for 
all new presurgery patients with OCs by the cleft palate teams through the standard NVSCA 
recording form (Figure 1).22
Before 1997, precise national prevalence of OCs was not known in the Netherlands. Felix-
Schollaart et al.27 described an oral cleft prevalence of 13.8 to 17.7 per 10,000 live and stillbirths 
among children born in Dutch hospitals during 1982 and 1983. Hoeksma et al.28 reported in 
1989 an estimated oral cleft prevalence of 17.3 to 18.9 per 10,000 live births for a 1-year period, 
based on questionnaires and medical records. Since 1981, Eurocat Northern Netherlands (NNL) 
has maintained a congenital anomaly registry for the region Northern Netherlands. Recording 
is based on ICD/BPA codes and regional prevalence rates of CL±P and CP among live and still-
births (including termination of pregnancy) are provided.2, 20 In addition, the National Obstetric 
and Neonatal Registries (LVR/LNR) record diagnoses of several congenital anomalies among 
live births and stillbirths from 16 weeks of gestation and have provide data regarding CL±P and 
CP from 1996 that were first published in an annual report in 2001. 29 In 2005, the prevalence of 
OCs in the Netherlands was estimated based on the NVSCA registry and LVR/LNR. The estimated 
national prevalence was 19.2 per 10,000 live births and the ascertainment—the proportion of 
cases recorded in at least one of the two registries—of OCs in live births appeared to be high 
(96%).30
Validation of registries
Worldwide, medical information is routinely collected and ICD coded in a variety of medi-
cal registries. In the past two decades, these registry data have been widely used for health 
research.31 Because registry data can in practice only be used for research purposes when 
registries provide reasonably valid information, many registries have been validated. 18, 31-34 
Therefore, a validation project of the NVSCA registry that evaluates data quality is essential to 
avoid invalid conclusions. 
The NVSCA registry has a unique recording method, which is not based on a coding system 
but on the detailed description of the morphology and topography of each anatomic structure 
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of the anomalies of the head and neck area, e.g., lip, alveolus, and hard and soft palates includ-
ing the uvula.22, 26 These detailed recording data are collapsible to more general diagnoses or 
codes and allow classifying oral clefts in many different ways. For instance, NVSCA data can be 
compared with those of other Dutch registries, which include ICD/BPA codes (Eurocat NNL), or 
the categories CL±P and CP (LVR/LNR). Vice versa, data of these registries cannot be converted 
into the detailed information of the NVSCA registry. Even when the quality is good, data of 
these registries do not reflect the severity and specific characteristics of OCs; for example, no 
distinction is made between cleft lip and cleft alveolus.20, 29 Therefore, medical records were 
used as our gold standard to validate the detailed NVSCA data. 
The aim of this study was to provide a comprehensive profile on the validity of the NVSCA 
registry data for common oral clefts in the Netherlands. In view of the huge amount of data 
available, the present study describes the study design and results after evaluation of the 
first part of the NVSCA recording form; i.e., the general items and the three common oral cleft 
categories. The validity of more specific features (side, topography, and morphology) of the 
oral clefts and the associated additional congenital anomalies will be reported in future papers. 
METHODS
NVSCA recording form and registry
The NVSCA registry is an anonymous prospective case registry that is formally fixed in accor-
dance with the Dutch privacy law. All Dutch cleft palate teams record their live born presurgery 
patients on the standard NVSCA form, after careful examination by one of their consulting 
physicians. The form is subdivided into a general section (including infant/parental character-
istics, e.g., sex, consanguinity, and birth weight), a section for craniofacial anomalies including 
OCs, and a section for congenital anomalies of other parts of the body (Figure 1). All individual 
anomalies of the head and neck area can be fully described by checking options regarding side, 
topography, and morphology. In addition, the form gives space for verbatim descriptions of (1) 
craniofacial anomalies not appropriate by checking options, (2) (preliminary) diagnosis of cra-
niofacial anomalies, and (3) congenital anomalies of other organ systems.22, 25, 26 Furthermore, 
a manual is included (Figure 2). The form is usually completed in the postnatal period. When 
patients are adopted or the oral cleft is detected later in infancy, the form is completed (before 
surgery) at a later age.22 The completed forms are sent to the NVSCA registry, the working group 
“Registration” checks the forms, and the recorded information is subsequently transferred to 
the NVSCA registry database. At the end of each year, the cleft palate teams perform case-
ascertainment activities. Note that the NVSCA is not an ongoing registry and that no data from 
other sources are included.
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Figure 1. Recording form of the NVSCA registry.
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Figure 2. Manual for the NVSCA registration form.
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Subjects
The validation project of registry data reported over a 7-year period was initiated and carried 
out in all 15 cleft palate teams. Each team gave written permission for the review of patients’ 
medical data. Principles outlined in the Declaration of Helsinki were followed. Between January 
1, 1997, and December 31, 2003, 2553 patients with OCs (median cleft lip and atypical facial 
clefts excluded) with or without associated congenital anomalies were recorded in the NVSCA 
registry and transferred to the NVSCA database. From this database a random sample of 250 
cases was taken. 
Data collection and verification
The cleft palate teams supplied medical information for all relevant disciplines (Plastic Surgery, 
Orthodontics, Pediatrics, Clinical Genetics, Maxillofacial Surgery and Otorhinolaryngology). A 
single investigator (AMR) obtained relevant data of 250 cases by making an anonymized copy 
by digital camera of medical records (including information about clinic visits, consultations, 
diagnostic tests, and hospitalizations), color photographs, panoramic radiographs, and dental 
casts. To be considered adequate, the information had to include at least one medical record. 
For 241 cases (96.4%), medical information was available for inspection, and this criterion 
was met. Preoperative and/or postoperative color photographs were obtained for 193 cases 
(77.2%). Panoramic radiographs and dental casts were retrieved for 26 cases (10.4%) and 91 
cases (36.4%), respectively. Apart from the nine untraceable cases, one case with insufficient 
medical data and three cases that were operated on the oral cleft before registration were also 
excluded. Subsequently, a total of 237 cases remained in the study.
The same investigator, trained in recording principles and practice, performed data verifica-
tion. The medical data were examined blindly and each of the 237 cases was reregistered with 
use of the standard NVSCA recording form (Figure 1). The criteria used to define the type of 
OCs were established in collaboration with a second investigator (CVK) and in accordance with 
existing literature.7, 8 Guidance statements from the registry manual (Figure 2) were used to 
record present congenital anomalies. All cases with unclear clinical information were discussed 
with the second investigator. Subsequently, the recorded data were transferred to an indepen-
dent reregister database. This database was checked for nonexistent, inappropriate, and invalid 
data and corrected when necessary. 
Data analysis
In the present study the following variables were validated: the general information (clinical 
genetics consulted, adoption/foster child, white father and mother, consanguinity, congenital 
abnormalities among relatives, common oral clefts among relatives, birth weight, gestational 
age, and remarks about pregnancy) and the three common oral cleft categories (cleft lip/
alveolus = CL/A; cleft lip/alveolus and palate = CL/AP; and cleft palate = CP). These variables 
concern information at birth and obvious external defects, for which recording should be 
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virtually complete.4 To validate these items as being accurate as possible, all available medical 
information (i.e., the medical record) was used for comparison, since this medical record was 
the most complete available reflection of the cases’ characteristics. Consequently, the NVSCA 
database was compared with the reregister database for concordance of information. Note 
that one case could contribute to more than one difference between the databases. In case 
of disagreement between the NVSCA and medical record database on the common oral cleft 
category (n = 12), the second investigator reviewed the medical data blindly and recorded the 
oral cleft independently. Regarding all 12 cases, the findings of the second investigator agreed 
with those of the first investigator. 
Statistical analysis
Characteristics of the study population are presented as percentages or means ± 1 SD for the 
NVSCA database and medical record database. Comparisons were performed using the chi-
square test and Student’s paired t test. 
To assess whether the NVSCA database accurately reproduced what was recorded in the 
reregister database, the observed agreement was assessed for dichotomous variables using 
two by two tables. In addition, the kappa statistic (κ) was used to describe agreement beyond 
chance. Kappa avoids the assertion that the reregister database has to be considered as a refer-
ence standard, and it determines the extent to which the two databases identified the same 
cases, i.e., inter-database agreement. 32, 35 According to the criteria reported by Landis and 
Koch,36 and described by Quan et al.,31 a κ value ranging from 0 to 0.20 indicates poor agree-
ment; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial 
agreement; and 0.81 to 1, near-perfect agreement. Because the reregister database could be 
considered as the best reflection of the cases’ conditions, this database was designated as the 
gold standard to calculate sensitivity (the number of positive cases in the NVSCA database con-
firmed in the reregister database divided by the total number of positive cases in the reregister 
database), specificity (the number of NVSCA negatives confirmed by the reregister divided by 
the total number of negatives in the reregister), positive predictive value (the number of NVSCA 
positives that are confirmed by the reregister, divided by the total number of NVSCA positives), 
and negative predictive value (the number of NVSCA negatives confirmed by the reregister 
divided by the total number of NVSCA negatives). For continuous variables the differences 
between the databases were presented as medians and ranges, and Pearson correlation coef-
ficients were calculated.
For all outcome measures, 95% confidence intervals (95% CIs) were calculated by assuming 
a normal distribution around the point estimate. 
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RESuLTS
Characteristics of the study population are shown in Table 1. Distribution of sex, adoption/
foster child, consanguinity, birth weight, and common oral cleft categories were comparable 
between the databases. Although gestational age was similar on average between the data-
bases, there appeared to be a significant difference on case level (p = 0.043). Clinical Genetics 
consulted, congenital abnormalities among relatives, common oral clefts among relatives, 
and remarks about pregnancy were more often recorded in the reregister database (p < 0.05), 
whereas white father and mother were more often recorded in the NVSCA database (p < 0.001). 
Agreement between the NVSCA and reregister database on the dichotomous general 
variables is shown in Table 2. The highest observed agreement was found for adoption/foster 
child and consanguinity (over 97%), and the lowest observed agreement was found for remarks 
about pregnancy (62.6%). For the remaining variables the observed agreement ranged from 
73.4% (Clinical Genetics consulted) to 84.8% (common oral clefts among relatives). The κ value 
Table 1. Characteristics of the study population in the NVSCA database and reregister database
Characteristic NVSCA Reregister Comparison*
Valid Cases n Valid Cases n p Value
General Information
Sex, % boys† 57.4 237 57.4 237
Clinical Genetics consulted, % yes 26.2 237 51.1 237 <0.001
Adoption/foster child, % yes 3.0 237 2.5 237 0.779
White father, % yes 86.5 237 72.2 237 <0.001
White mother, % yes 88.6 237 71.7 237 <0.001
Consanguinity, % yes 1.7 237 1.7 237 1.0
Congenital abnormalities among 
relatives, % yes
23.2 237 40.5 237 <0.001
Common oral cleft among relatives, 
% yes
13.9 237 23.2 237 0.009
Birth weight in grams (mean ± SD) 3290 ± 718 218 3234 ± 699 208 0.600
Gestational age in weeks (mean ± SD) 39 ± 2.4 216 39 ± 2.3 197 0.043
Remarks about pregnancy, % yes‡ 16.1 174 43.9 174 <0.001
Common oral cleft 
Cleft lip/alveolus, % yes 31.6 237 30.0 237 0.691
Cleft lip/alveolus and palate, % yes 37.6 237 40.9 237 0.452
Cleft palate, % yes 30.8 237 29.1 237 0.688
* Chi Square test for proportions; paired Student’s t test for continuous variables.
† Gender information was given for medical data retrieval and therefore not compared between the 
databases.
‡ Introduced in 1999 on the NVSCA recording form and gradually filled in by the cleft palate teams.
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ranged from 0.20 (remarks about pregnancy) to 0.76 (adoption/foster child); one item was at 
the level of poor agreement, three were at the level of fair agreement, three were at the level 
of moderate agreement, and one at the level of substantial agreement. Sensitivity ranged from 
25.0% for consanguinity to 96.5% for white mother. Meanwhile, specificity was high for all items 
(over 92%), except for white father and mother (36.4% and 31.3%, respectively). Positive predic-
tive value was low for consanguinity (25.0%), but ranged for the other variables from 71.4% 
(adoption/foster child) to 96.8% (Clinical Genetics consulted). Negative predictive value ranged 
from 60.3% for remarks about pregnancy to 99.6% for adoption/foster child. 
Validation of birth weight and gestational age was based on 196 and 186 cases, respectively, 
because of missing values in the NVSCA and reregister database. Agreement on birth weight 
was observed for 151 cases. For the remaining 45 cases a median difference of 50 g was found 
with a range of 1 to 3010 g. The Pearson correlation coefficient was 0.93 (95% CI: 0.91 to 0.95). 
Gestational age corresponded for 143 cases between the databases and disagreed for 43 with 
a median difference of 1 week and a range of 1 to 10 weeks. A Pearson correlation coefficient of 
0.89 (95% CI: 0.86 to 0.92) was found.
Table 3 shows the agreement on the common oral cleft categories between the databases. 
The observed agreement was high for all three categories: 97.5% for both CL/A and CP and 
94.9% for CL/AP. The κ value was 0.94 for both CL/A and CP and 0.89 for CL/AP; all were at the 
level of near-perfect agreement. The sensitivity was 98.6% for both CL/A and CP, 89.7% for CL/
AP, and the specificity was over 97% for all categories. The positive and negative predictive 
values were over 93% for all three categories. 
DISCuSSION
Validity NVSCA registry 
This study assessed the accuracy and completeness of a part of the recording data of the 
NVSCA registry on OCs. The general information and oral cleft categories were validated using a 
reregister database based on all available medical data for comparison. The oral cleft categories 
(CL/A, CL/AP, and CP) were recorded most accurately and completely in the NVSCA registry. All 
categories were identified perfectly with validity measures of more than 89% and near-perfect 
agreement (Table 3). 
In contrast, regarding the general information data, quality varied by item (Table 2). Informa-
tion on consultation of Clinical Genetics was missing for about 50% of the cases. This is related 
to the fact that generally the patient is recorded in the postnatal period before the clinical 
geneticists are consulted. Regarding data on adoption/foster child and consanguinity, the 
quality was good. For these two items a “high agreement but low kappa” was found, which can 
be explained by the low prevalence of these items. This phenomenon was described by Fein-
stein and Cicchetti.35 They identified the following paradox: when the vertical and horizontal 
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marginal totals of the 2 x 2 tables are symmetrically unbalanced, high observed agreement 
values can be associated with low κ values. The items white father and mother were consider-
ably overestimated in the NVSCA database with more than 60% false positives. This may not be 
surprising because the distinction between the white race and other races may sometimes be 
too subtle for recorders. Regarding the occurrence of congenital abnormalities among relatives 
and common oral clefts among relatives there may be insufficient inquiry by the specialists, 
because approximately 50% of the information recorded in the reregister database was found 
in the NVSCA database. For the item remarks about pregnancy, 27% of the reregister infor-
mation was recorded in the NVSCA registry. This could be explained by the fact that “remarks 
about pregnancy” is a not well-defined item. As a result, it is not clear for the recorder what has 
to be recorded at this item. Birth weight and gestational age were underreported on the NVSCA 
recording form as well as in the medical records. Since both are available at birth, the only 
explanation for the degree of underreporting and disagreement is insufficient and inaccurate 
reporting and documentation. Overall, validity on the general items was expected to be higher 
because most of this information could be directly transcribed at admission. However, incom-
pleteness of data on certain registry key items (for example, gestational age) is also reported 
elsewhere.37
Publications on the evaluation of data quality of congenital anomaly registries are scarce,16, 
37 and few data are available on the validity of registration of oral clefts.18, 19 However, numer-
ous articles have described the operations and strategies for case ascertainment of congenital 
anomaly registries. These show that case ascertainment is often still a problem and varies 
by defect, region, and hospital.14, 16, 17 For example, according to Boyd et al.,17 in the United 
Kingdom the surveillance of congenital anomalies by the national register is currently inad-
equate. Nevertheless, the ascertainment for oral clefts appeared to be among the highest in 
this register, 83% for CL±P and 71% for CP. A Norwegian study18 reported an ascertainment of 
94% for CLP cases in a national birth registry and a lower ascertainment of 83% and 57% for 
CL and CP cases, respectively. In another Scandinavian study,19 the ascertainment of oral clefts 
was 78% (CL: 74%, CLP: 84%, and CP: 75%) for the Swedish Birth Defects Registry. As mentioned 
before, Anthony et al.30 estimated the total number of live birth cases with OCs during 2002 in 
the Netherlands based on two Dutch registries: the NVSCA and LVR/LNR. Eighty-seven percent 
of the total number of cases found in this study appeared to be reported to the NVSCA registry, 
which is rather comparable to the ascertainment of the studies already mentioned. Because 
cases with severe additional anomalies resulting in neonatal deaths may not reach the cleft 
palate teams, these are most often not included in the NVSCA registry. This might explain why 
the ascertainment was not 100%.
Problems with registry data
In general, problems with quality of registry data can be caused by incorrect data entry, lack 
of entry of available information, or the original information may be correctly entered into 
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the database but may not reflect the true condition or characteristics of the case.33 The latter 
can arise as a result of physicians’ misdiagnoses, incomplete documentation, or incomplete or 
incorrect recording of a condition.31 
As many congenital anomaly registries are based on (ICD) codes, they are affected by specific 
problems inherent in coding systems. Certainly, coding is essential for data management and 
retrieval in birth defects surveillance programs because they process large numbers of cases.4, 
5, 15 Furthermore, coding allows aggregation of similar cases. Thus, when collecting data on a 
large scale, the use of standard coding systems is necessary; however, it is also known that it 
brings structural limitations. Codes reduce the amount of clinical detail, and coders will differ 
with respect to definitions and their application.4, 14, 15, 32, 34 Moreover, coding is generally based 
on written medical data, and thus correct recording of a condition also depends on the quality 
of this information.34 
The NVSCA recording form is designed to prevent recording errors as much as possible. 
However, accurate and complete recording still depends on the knowledge and the willingness 
of physicians to record accurately. To prevent problems with interpretation of the recording 
form as much as possible, the NVSCA provides a registry manual (Figure 2).
Recently a digital NVSCA recording form was developed to make recording easier and to 
promote accurate and complete recording.24 This has many advantages: no paperwork has to 
be sent by mail, and it cannot be lost; data do not need to be transferred from a paper form to 
a digital database; and obligatory fields are used for items such as birth weight and gestational 
age.
Strengths and limitations
One of the strengths of this study is the national distribution of the sampling frame, including 
cleft palate teams of large urban teaching and specialist hospitals as well as of small regional 
ones. During the last decade the diagnostic strategy and management of patients with OCs 
have undergone important changes. For example, most cleft palate teams now use imaging 
procedures and digitalization, which is needed for multidisciplinary treatment and favors this 
retrospective study. The retrieval of medical records was successful; for almost all cases at least 
one medical record (96.4%) was obtained along with pre-/postoperative color photographs, 
panoramic radiographs, and/or dental casts (82.8%). 
Based on the strengths described above, the medical data were considered as the best 
available reflection of the cases’ conditions, and therefore information extracted from these 
data was accepted as the gold standard. However, the use of medical data to validate registry 
data also has limitations. Medical data can never be equal to the presentation of patients in the 
outpatient clinical setting. In the present study, the amount and quality of medical informa-
tion varied between the teams. For example, for some teams dental casts were lacking, and in 
some cases less extensive medical information was caused by death of the patient or change 
of the treating cleft palate team. Nevertheless, no systematic pattern regarding the quality of 
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medical data was found when analyzing case characteristics and the oral cleft categories could 
be recorded successfully for all 237 cases. Another limitation is that although review of medical 
data was particularly thorough, errors that occur when clinical information is documented in 
the medical records cannot be captured.31, 34 On the other hand, an advantage of our method 
is that practice activity was examined retrospectively, so staff were not alerted to the study 
beforehand and had no opportunity to change recording behavior. 
CONCLuSIONS
Despite the limitations and challenges described, this study provides useful information on 
the quality of the NVSCA registry data, which varies by type of information. Validity appears to 
be very good for the three common oral cleft categories and reasonable to satisfying for the 
general items. As a result of this study and other data quality measures,30 the quality level of the 
NVSCA registry appears to be high. To attain the goals of the NVSCA optimally, it is important to 
get more insight in the detailed data. Therefore, further analysis will be carried out of the spe-
cific common oral cleft features (side, topography, and morphology) and associated additional 
congenital anomalies.
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AbSTRACT
Objective: Since 1997, common oral clefts in the Netherlands have been recorded in the 
national oral cleft registry using a unique descriptive recording system. This study validates 
data on the topographic-anatomical structure, morphology, and side of individual anomalies 
of the primary palate and secondary palate that form the oral cleft.
Design: Validation study.
Setting: All 15 Dutch cleft palate teams reporting presurgery oral cleft patients to the national 
registry.
Patients: A random sample of 250 cases registered in the national database with oral clefts from 
1997 through 2003; of these, 13 cases were excluded.
Main Outcome Measures: By linking registry data with clinical data, we identified differential 
recording rates by comparing the prevalence, and we measured the degree of agreement by 
computing validity and reliability statistics.
Results: The topographic-anatomical structures (lip, alveolus, and hard and soft palates) of 
the anomalies had near-perfect inter-database agreement with a sensitivity of 88% to 99%. 
However, when analyzing the individual anomalies in detail (morphology and side), validity 
decreased and depended on morphological severity. This association was most evident for 
anomalies of the secondary palate. For example, sensitivity was higher for “complete cleft hard 
palate” (92%) than for “submucous cleft hard/soft palate” (69%). 
Conclusions: Overall, the validity of Dutch registry data on oral clefts is good, supporting the 
feasibility of this unique recording system. However, when analyzing oral cleft data in detail, 
the quality appears to be related to anatomical location and morphological severity. This might 
have implications for etiologic research based on registry data and for guidelines on neonatal 
examination.
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INTRODuCTION
Common oral clefts (OCs) are very complex and heterogeneous birth defects affecting the lip, 
alveolus, hard palate, soft palate, and uvula. In the embryonic development of the primary pal-
ate (the presumptive lip and alveolus) and secondary palate (the presumptive hard palate, soft 
palate, and uvula), many different cell-biological mechanisms and genes are involved, related 
to different time frames. During the formation of the primary and secondary palates, complex 
embryological processes—including outgrowth, fusion, and differentiation (into bone and 
musculature) of the facial swellings and of the palatine processes—take place.1-3 Disturbance 
of these developmental processes can result in many different cleft types with variable degrees 
of severity on clinical presentation.3-5
Although the etiopathogenesis of OCs has been widely studied, it is still poorly understood.6 
To facilitate further genetic and etiopathological studies and to improve prevention, diagnos-
tics, and treatment, it is of paramount importance that details of all OC types are described 
and recorded. Worldwide, many registration systems have been developed in order to record 
congenital anomalies, including OCs.7-12 These registries classify OCs according to the Inter-
national Classification of Diseases (ICD) or its extensions, thereby providing some information 
about topography, but not always complete information about morphological severity (e.g., 
completeness or incompleteness of the cleft).7, 10, 13 Because different cleft types, which have 
specific topographic and morphologic features, originate from different time frames and are 
related to specific genes and cell-biological mechanisms, detailed information on the topogra-
phy and morphology is essential for fundamental research on OCs. Therefore, a unique detailed 
recording system for OCs and other craniofacial anomalies has been developed on behalf of 
the Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA). This unique NVSCA 
system is based on the embryology of the head and neck area and records all the individual 
anomalies of the primary and/or secondary palate that form the OC. Besides the topographic-
anatomical structure and side, the morphology of each anomaly can be described to anticipate 
all conceivable anomalies. Since its establishment in 1997, virtually all new live-born presur-
gery patients with OCs in the Netherlands—an average of 351 patients per year—have been 
reported to the national NVSCA registry.5
The main purpose of the NVSCA registry is to provide a solid basis for epidemiological, 
clinical, and fundamental research. To serve this purpose, it is crucial to ensure that the data 
provided by the registry are of high quality. Sound description and complete reporting of OCs 
and their specific features are necessary to maintain high standards of data quality. Previously, 
it was shown that the case-ascertainment of OCs in the NVSCA registry is high.14 In addition, we 
found recently that the NVSCA registry has high-quality data on the three OC categories: cleft 
lip/alveolus; cleft lip/alveolus and palate; and cleft palate.15 As described by Luijsterburg and 
Vermeij-Keers),5 these three categories manifest very heterogeneous cleft types, composed of 
individual anomalies of the primary and/or secondary palate having specific features regarding 
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topographic-anatomical structure, morphology, and side. However, it is unknown whether 
the individual anomalies in OCs have been recorded completely and accurately in the NVSCA 
registry.
The aim of this study was to investigate the quality of the NVSCA data on the individual 
anomalies of the primary palate and secondary palate in OCs by validating the registry data 
on the specific features of the anomalies: topographic-anatomical structure, morphology, 
and side. By linking the NVSCA database with a new independent reregister database derived 
from medical data review, we were able to identify differential recording rates by comparing 
the prevalence and to measure the degree of agreement by computing validity and reliability 
statistics.
METHODS
NVSCA Registry
The methodology of the NVSCA registry is described in detail elsewhere5, 15 and is summarized 
here. The NVSCA registry is an anonymous registry that was formally established in accordance 
with Dutch privacy law. All Dutch cleft palate teams report their new live born patients with 
OCs—before these patients have an oral cleft operation—using the NVSCA recording form. 
This form is composed of three parts: a general section (infant/parent characteristics), a section 
for craniofacial anomalies including OCs, and a section for congenital anomalies of other organ 
systems; a manual is available.5, 15 The section for OCs consists of a two-dimensional table, in 
which the specific features of the individual anomalies that form the OC can be described. 
As shown in Figure 1, the x-axis shows the topographic-anatomical structures: lip, alveolus 
(embryologically developed from the premaxillae and maxillae), hard palate (palatum durum), 
soft palate (palatum molle), and uvula. The y-axis depicts the morphology (complete, incom-
plete, and submucous) and the check boxes represent the side (left, right, and median). 
The recording form is completed by the consulting physician during the first visit of the 
patient to the cleft palate team, and subsequently the form is sent to the NVSCA registry. The 
Registration working group checks the recorded data before these are transferred to the NVSCA 
database. In addition, the cleft palate teams perform case-ascertainment activities annually. 
Note that the NVSCA does not have active follow-up of patients and that no data from other 
sources are included. 
Subjects
This validation study was initiated and carried out in the 15 Dutch cleft palate teams; all gave 
written permission for review of patients’ medical data. Principles outlined in the Declaration 
of Helsinki were followed. During a 7-year period (1997 to 2003), a total of 2553 patients were 
registered in the national NVSCA database with an OC. Patients with median cleft lip/alveolus 
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or atypical facial clefts were excluded due to their different pathogenesis.1, 4 From this database, 
a study population of 250 cases was selected using a standard random-sampling technique in 
Statistical Package for the Social Sciences (SPSS) version 17.0 (SPSS Inc., Chicago, IL).
Data Collection and Verification
We used medical data to validate the NVSCA data on the specific features of the individual 
anomalies in OCs. The methods of medical data collection and verification were described in a 
previous paper by Rozendaal et al.15 and are summarized here. 
The relevant medical information, including medical records, color photographs, panoramic 
radiographs, and dental casts, was supplied by the cleft palate teams. For 241 of the 250 cases 
(96.4%), the minimum criterion for inclusion—the availability of at least one medical record—
was met. Apart from the nine untraceable cases, we excluded one case that had insufficient 
medical information to record the cleft, and three patients who had undergone oral cleft 
surgery before registration. This resulted in a total of 237 cases that remained in the study.
Using the medical information that was created before as well as after completion of the 
original NVSCA recording forms, a single investigator (AMR) recorded each case blindly on the 
Figure 1. Section of the NVSCA recording form for common oral clefts in which the specific features of 
the individual anomalies that form the oral cleft can be described. The X-axis shows the topographic-
anatomical structures: lip, alveolus (embryologically developing from the premaxillae and maxillae), 
hard palate (palatum durum), soft palate (palatum molle), and uvula; the Y-axis depicts the morphology: 
complete, incomplete, and submucous; and the checking boxes represent the side: left, right, and median. 
Abbreviations: Pre./Max. = premaxilla – maxilla; Pre. = premaxilla; Pal.dur. = palatum durum; Pal.mol. = 
palatum molle.
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standard NVSCA form.15 The criteria used to define the type of OC were established in accor-
dance with existing literature.1 If the medical information was insufficient to record a specific 
feature, for example, the morphology or side of the hard palate, the investigator noted this on 
the form. This was done to allow exclusion of the case at a later stage from the specific feature’s 
analysis. All the recorded data were then transferred to an independent reregister database, 
and finally, this database was checked for nonexistent, inappropriate, and invalid data.
Statistical Analysis
To get complete insight into the quality of the detailed registry data on the individual anoma-
lies of the primary palate and secondary palate, their specific features were validated step by 
step. First, we analyzed the topographic-anatomic structures (lip, alveolus, hard palate, and 
soft palate including the uvula), then the morphology of the topographic-anatomic structures 
(e.g., complete cleft lip), then the side of the topographic-anatomical structures (e.g., left cleft 
lip), and finally the morphology and side of the topographic anatomical structures (e.g., left 
complete cleft lip), that is, the complete reflection of the individual anomaly. Note that the side 
of the soft palate including the uvula was not analyzed because clefts of the soft palate and 
uvula always develop in the median.
The prevalence of the specific features in the individual OC anomalies was calculated for 
both the NVSCA and the reregister. In addition, the NVSCA database was compared with the 
reregister database for concordance of individual patient data. Note that one case may con-
tribute to more than one difference between the databases. In case of disagreement between 
the databases on a specific feature (n = 99), a second investigator (CVK) reviewed the medical 
data blindly and recorded the OC independently on a new NVSCA recording form. If the two 
investigators disagreed, there was discussion until consensus was reached (n = 21).
It is known that the “disease prevalence” can affect reliability and validity statistics,16-18 and 
that the confidence intervals in reliability and validity statistics reflect the precision of the 
outcome measures. We validated, therefore, only those anomalies individually that had (1) a 
prevalence of n ³ 10 in the NVSCA database; and (2) a sufficiently small 95% confidence interval 
(CI) for all reliability and validity measures (distance between the upper and lower limits of 
95% CI < 0.50 for kappa values and < 50% for sensitivity, specificity, positive predictive value, 
and negative predictive value). The anomalies not meeting these two criteria were grouped 
together with their embryologically related anomalies according to the classification of fusion 
and differentiation defects. The concept of this classification was described in detail previously3 
and is briefly explained here. This classification is based on the normal and abnormal develop-
ment of the primary and secondary palates. During the formation of these structures, fusion 
and differentiation processes are regulated in time and place. Disturbances of these complex 
processes can give rise to fusion and/or differentiation defects of the lip, alveolus, hard palate, 
and soft palate including the uvula. Theoretically, all individual anomalies of the primary palate 
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and secondary palate that form the OC can be classified as a fusion or differentiation defect. The 
template for deciding which anomaly is a fusion or differentiation defect is listed in Table 1.3
When analyzing the morphology and/or side of the topographic-anatomical structures, the 
following anomalies were grouped together. We grouped “submucous cleft lip” together with 
“incomplete cleft lip”, because both are differentiation defects of the lip. The differentiation 
defect “submucous cleft alveolus” was grouped together with “incomplete cleft alveolus”, which 
is—in combination with an “incomplete/submucous cleft lip”—also a differentiation defect of 
the alveolus. We grouped “submucous cleft hard palate” together with “submucous cleft soft 
palate” because both anomalies are late differentiation defects of the secondary palate. The 
new group “submucous cleft hard/soft palate”, which still had a 95% CI that was too wide, was 
not grouped further because other differentiation defects of the secondary palate do not exist. 
“Incomplete cleft soft palate” and “complete cleft soft palate” were grouped together, because 
both are fusion defects of the soft palate. The anomaly “right cleft hard palate” was grouped 
together with “left cleft hard palate” because both are unilateral fusion defects of the hard pal-
ate. Because the anomaly “right submucous cleft alveolus” had not been recorded in the NVSCA 
database, it was not validated. Finally, because practically all incomplete and submucous clefts 
of the hard palate present in the NVSCA database were median clefts, the side was not validated 
for these anomalies. 
Table 1. Classification of the individual cleft anomalies of the primary palate and secondary palate 
according to fusion and differentiation defects. Any combination of anomalies of the lip, alveolus, hard 
palate, and soft palate is allowed.
Fusion defects Primary palate Complete cleft lip
Complete cleft alveolus
Incomplete cleft alveolus (only if the lip is
normal or has a complete cleft)
Secondary palate Complete cleft hard palate
Incomplete cleft hard palate
Complete cleft soft palate including uvula
Incomplete cleft soft palate including uvula
Differentiation defects Primary palate Incomplete cleft lip
Submucous cleft lip
Incomplete cleft alveolus (only if the lip has an
incompleet or submucous cleft)
Submucous cleft alveolus
Hypoplastic lip/alveolus
Secondary palate Submucous cleft hard palate
Submucous cleft soft palate including uvula
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The prevalence data were presented as numbers and percentages. Prevalence comparisons 
between the databases were performed using the chi-square test. All p values of < 0.05 were 
considered statistically significant.
Although the comparison of prevalence rates indicates the extent to which the two data-
bases detected the specific features of the individual anomalies, it does not indicate whether 
they have identified the same patients, and whether the NVSCA database accurately repro-
duced what was recorded in the reregister. We therefore determined the extent to which the 
two databases identified the same cases (i.e., the inter-database agreement) by calculating the 
kappa value (κ), which describes the agreement beyond chance and avoids the assertion that 
the reregister database has to be considered as a reference standard.16, 19 According to criteria 
reported by Landis and Koch20 and described by Quan et al.,21 a kappa value ranging from 0 to 
0.20 indicates poor agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 
0.61 to 0.80, substantial agreement; and 0.81 to 1, near-perfect agreement. 
To assess whether the NVSCA database accurately reproduced what was recorded in the 
reregister, we used the reregister—the best available reflection of the cases’ conditions—as 
the criterion standard to calculate the sensitivity (number of NVSCA positives confirmed by the 
reregister, divided by the total number of reregister positives), specificity (number of NVSCA 
negatives confirmed by the reregister, divided by the total number of reregister negatives), 
positive predictive value (number of NVSCA positives confirmed by the reregister, divided 
by the total number of NVSCA positives), and negative predictive value (number of NVSCA 
negatives confirmed by the reregister, divided by the total number of NVSCA negatives). For all 
outcome measures, 95% CIs were calculated, assuming a normal distribution around the point 
estimate. Statistics were performed using two software packages (SPSS version 17.0 and Stata 
version 10.0, StataCorp L.P., College Station, TX).
RESuLTS
Prevalence of Specific Features of Individual Anomalies in Common Oral Clefts
Table 2 presents the prevalence of the specific features of the individual anomalies of the pri-
mary and secondary palates by database. The prevalence of the four topographic-anatomical 
structures (lip, alveolus, hard palate, and soft palate including the uvula) in the NVSCA database 
was similar to that in the reregister database. For the two structures of the primary palate (lip 
and alveolus), the distribution of the morphology, of the side, and of the morphology and side 
in the NVSCA was similar to that in the reregister. For one structure of the secondary palate 
(hard palate), however, three anomalies were underreported significantly in the NVSCA (incom-
plete cleft hard palate: p = 0.007; median cleft hard palate: p = 0.009; and median incomplete 
cleft hard palate: p = 0.006). Only one anomaly (left complete cleft hard palate) was significantly 
less frequent in the reregister than in the NVSCA (4.8% vs. 11.0%, p = 0.015). 
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Table 2. Prevalence of specific features of individual anomalies of the primary palate and secondary 
palate in common oral clefts (n = 237)
Specific Feature of Individual Anomaly NVSCA Reregister Cases with 
Information*
n % n % n p Value†
Topographic-anatomical structure
Primary palate
Cleft lip 164 69.2 164 69.2 237 1.000
Cleft alveolus 126 53.4 139 58.9 236 0.228
Secondary palate
Cleft hard palate 117 50.0 128 54.7 234 0.309
Cleft soft palate 160 67.5 166 70.0 237 0.552
Morphology of topographic-anatomical structure
Primary palate
Complete cleft lip 83 35.2 67 28.4 236 0.114
Incomplete cleft lip 85 36.0 102 43.2 236 0.110
Submucous cleft lip 5 2.1 13 5.5 236 0.055
Complete cleft alveolus 80 34.2 83 35.5 234 0.771
Incomplete cleft alveolus 46 19.7 57 24.4 234 0.220
Submucous cleft alveolus 2 0.9 0 0.0 234 0.156
Secondary palate
Complete cleft hard palate 94 40.9 83 36.1 230 0.292
Incomplete cleft hard palate 16 7.0 34 14.8 230 0.007
Submucous cleft hard palate 6 2.6 6 2.6 230 1.000
Complete cleft soft palate 151 64.8 154 66.1 233 0.770
Incomplete cleft soft palate 7 3.0 6 2.6 233 0.778
Submucous cleft soft palate 7 3.0 12 5.2 233 0.242
Side of topographic-anatomical structure
Primary palate
Left cleft lip 120 50.6 122 51.5 237 0.854
Right cleft lip 79 33.3 77 32.5 237 0.845
Left cleft alveolus 96 40.9 102 43.4 235 0.575
Right cleft alveolus 58 24.7 70 29.8 235 0.214
Secondary palate‡
Left cleft hard palate 24 10.6 13 5.7 227 0.059
Right cleft hard palate 15 6.6 7 3.1 227 0.080
Median cleft hard palate 73 32.2 100 44.1 227 0.009
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Agreement on Specific Features of Individual Anomalies in Common Oral Clefts
Table 3 shows the degree of agreement between the databases for the specific features of the 
individual anomalies of the primary and secondary palates. When analyzing the morphology 
and/or side of the topographic-anatomical structures, several anomalies did not meet the crite-
ria for validation (i.e., they had a prevalence of n < 10 in the NVSCA database and/or 95% CIs for 
reliability and validity measures that were too wide). These anomalies were therefore grouped 
together with their embryologically related anomalies as described in the “Methods” section. 
Table 2. (Continued)
Specific Feature of Individual Anomaly NVSCA Reregister Cases with 
Information*
n % n % n p Value†
Morphology and side of topographic-anatomical structure
Primary palate
Left complete cleft lip 57 24.2 47 19.9 236 0.267
Right complete cleft lip 45 19.1 37 15.7 236 0.331
Left incomplete cleft lip 60 25.4 70 29.7 236 0.303
Right incomplete cleft lip 32 13.6 38 16.1 236 0.437
Left submucous cleft lip 3 1.3 8 3.4 236 0.127
Right submucous cleft lip 2 0.8 5 2.1 236 0.253
Left complete cleft alveolus 60 25.6 56 23.9 234 0.668
Right complete cleft alveolus 43 18.4 46 19.7 234 0.724
Left incomplete cleft alveolus 34 14.5 42 17.9 234 0.316
Right incomplete cleft alveolus 14 6.0 19 8.1 234 0.367
Left submucous cleft alveolus 2 0.9 0 0.0 234 0.156
Right submucous cleft alveolus 0 0.0 0 0.0 234 1.000
Secondary palate‡
Left complete cleft hard palate 25 11.0 11 4.8 228 0.015
Right complete cleft hard palate 15 6.6 9 3.9 228 0.134
Median complete cleft hard palate 54 23.7 61 26.8 228 0.387
Left incomplete cleft hard palate 0 0.0 1 0.4 228 0.317
Right incomplete cleft hard palate 1 0.4 0 0.0 228 0.317
Median incomplete cleft hard palate 15 6.6 33 14.5 228 0.006
Left submucous cleft hard palate 0 0.0 0 0.0 228 1.000
Right submucous cleft hard palate 0 0.0 0 0.0 228 1.000
Median submucous cleft hard palate 6 2.6 6 2.6 228 1.000
*  Number of cases that had sufficient information to record the topographic-anatomical structure,  
morphology and/or side of the individual anomalies.
†  p value presents statistical significance level between the NVSCA and reregister database in prevalence    
of feature/anomaly; p <0.05 is used to determine statistical significance and is presented in bold format.
‡ Side of the soft palate was not analyzed because clefts of the soft palate always develop in the median.
61Validation NVSCA registry data on specific oral cleft features
Topographic-anatomical Structure
All four topographic-anatomical structures had near-perfect inter-database agreement (κ 
value: 0.82 to 0.98) with a sensitivity of 87.8% or more, a specificity and positive predictive value 
of more than 95%, and a negative predictive of 84.5% or more.
Morphology of Topographic-Anatomical Structure
After regrouping the anomalies, four anomalies of the primary palate remained. Table 3 shows 
that the κ values ranged from 0.67 to 0.84; one anomaly (incomplete/submucous cleft alveolus) 
was at the level of substantial agreement, and three were at near-perfect agreement. Sensitivity 
ranged from 68.4% for incomplete/submucous cleft alveolus to 97.0% for complete cleft lip. 
Positive predictive values ranged from 78.3% for complete cleft lip to 97.7% for incomplete/
submucous cleft lip. The specificity and negative predictive values were more than 87% for all 
four anomalies. 
For the remaining four anomalies of the secondary palate, the κ value ranged from 0.43 
to 0.91; one anomaly (incomplete cleft hard palate) was at the level of moderate agreement, 
two were at substantial agreement, and one (complete/incomplete cleft soft palate) was at 
near-perfect agreement. Sensitivity was 35.3% for incomplete cleft hard palate, 69.2% for 
submucous cleft hard/soft palate, and more than 91% for the other two anomalies. Positive 
predictive values ranged from 75.0% for incomplete cleft hard palate to 98.7% for complete/
incomplete cleft soft palate. The specificity and negative predictive values were more than 87% 
for all four anomalies.
Side of Topographic-Anatomical Structure
Table 3 shows that all four anomalies of the primary palate had near-perfect inter-database 
agreement (κ value: 0.84 to 0.95), with a sensitivity of 81.4% or more and a specificity, positive 
predictive value, and negative predictive value of more than 91%.
For the secondary palate, there were two remaining anomalies after regrouping. One 
anomaly (left/right cleft hard palate) had a κ value of 0.42 (moderate agreement), sensitivity 
of 73.7%, positive predictive value of 35.9%, and specificity and negative predictive value of 
88.0% and over. The other anomaly (median cleft hard palate) had a κ value of 0.62 (substantial 
agreement), sensitivity of 66.0%, specificity and positive predictive value of more than 90%, 
and negative predictive value of 77.9%.
Morphology and Side of Topographic-Anatomical Structure
For the eight anomalies of the primary palate that remained after regrouping, the κ values 
ranged from 0.64 for right incomplete cleft alveolus to 0.88 for right complete cleft alveolus; 
five anomalies were at the level of substantial agreement and three at near-perfect agreement. 
Sensitivity ranged from 57.9% for right incomplete cleft alveolus to 93.6% for left complete cleft 
lip. Positive predictive values ranged from 75.6% for right complete cleft lip to 95.2% for left 
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incomplete/submucous cleft lip. Meanwhile, specificity and negative predictive values were 
high for all eight anomalies (more than 91%).
For the secondary palate, two anomalies remained for validation. Left/right complete cleft 
hard palate had a κ value of 0.45 (moderate agreement), sensitivity of 78.9%, positive predictive 
value of 37.5%, and specificity and negative predictive value of 88.0% and more. The anomaly 
median complete cleft hard palate had a κ value of 0.49 (moderate agreement), sensitivity of 
57.4%, positive predictive value of 66.0%, and specificity and negative predictive value of more 
than 85%.
DISCuSSION
This continuation of the NVSCA validation study shows that the quality of the NVSCA data on 
the specific features of the individual anomalies in OCs varies by type of anomaly. By linking 
the NVSCA database with a new independent reregister database derived from medical data 
review, we found that validity of the registry data is related to anatomical location and morpho-
logical severity of the individual anomalies.
The following results illustrate the pattern of recording in the NVSCA. The topographic-
anatomical structures of the individual anomalies of the primary palate (lip and alveolus) and 
of the secondary palate (hard and soft palates) were identified perfectly in the NVSCA and had 
high validity measures (85% to 99%) with near-perfect inter-database agreement. However, 
when analyzing the anomalies more in detail (i.e., analyzing the morphology and/or side) the 
validity decreased and appeared to be related to the type of anomaly. First, anomalies of the 
primary palate were recorded better than anomalies of the secondary palate; the inter-database 
agreement was near-perfect for most primary palate anomalies, whereas, it was moderate to 
substantial for most secondary palate anomalies. This suggests better registration of externally 
visible anomalies (such as cleft lip/alveolus) than anomalies that require a diagnostic procedure 
(such as opening the mouth for inspection and palpating the palate). In addition, validity was 
related to morphological severity, given that severe anomalies were generally recorded bet-
ter than mild anomalies. This association applied to both the primary and secondary palates, 
but was most evident for the secondary palate. For example, 35% of the incomplete cleft hard 
palates and 69% of the submucous cleft hard/soft palates present in the reregister were also 
present in the NVSCA, compared with more than 91% of the complete cleft hard palates and 
complete/incomplete cleft soft palates. 
Although many registries record OCs, studies on the validity of OC data are scarce. There 
are some studies, however, that describe the case-ascertainment of OCs in medical registries.9, 
11, 12, 22 In one study, that of Kubon et al.,9 this was done in relation to the various cleft types 
within the three main OC categories. Similar to our study, they found that registration in the 
Norwegian medical birth registry was more complete for clefts of the primary palate than for 
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clefts of the secondary palate. They suggested that this could be explained by the delayed diag-
noses of clefts of the hard/soft palate and thus incomplete routine examination of newborns, 
which was also reported in other studies.22-24 Different from registries that receive information 
from birth admissions or hospital discharge records, the NVSCA receives the OC data directly 
from the cleft palate teams, which are expected to be focused on OCs and to examine patients 
carefully.15 Still, part of our findings may be explained by incomplete examination, because the 
number of patients—and probably the experience and routine of diagnostics—varies strongly 
among the 15 Dutch cleft palate teams. 
Delayed diagnosis of cleft palate might have several clinical implications. For example, the 
presence of a cleft palate is often associated with additional congenital anomalies and syn-
dromes.6 and the diagnosis of a cleft palate should therefore generate an even more extensive 
examination of the newborn. 
Additionally, our findings that the quality of recording increased with the morphological 
severity of the anomalies and that this association was most evident for the secondary palate 
are also consistent with the findings of Kubon et al.9 Perhaps more unexpectedly, both studies 
showed that besides morphologically mild clefts of the secondary palate, those of the primary 
palate, which are clearly visible and require surgery, also tended to be underreported. A pos-
sible explanation for these findings is that greater morphological severity of an anomaly might 
be a factor that encourages doctors to report better.
The under-representation of morphologically mild anomalies may have consequences for 
research on registry data. These anomalies develop during stages in embryological develop-
ment and can be related to cell-biological mechanisms and genes other than morphologically 
severe anomalies.1-3 Consequently, studies based on registry data examining environmental 
factors or genes that are associated with morphologically mild clefts might underestimate the 
importance of such factors and genes. 
The strength of this study is that all cleft palate teams gave permission to collect the medical 
data. The sampling frame thus had a national distribution, including cleft palate teams of large 
urban teaching and specialist hospitals as well as of small regional ones. Most of these treatment 
centers have carried out high-quality documentation needed for modern multidisciplinary 
treatment, which favors our retrospective detailed evaluation. However, the use of medical 
data to validate registry data also has its limitation. It can never be equal to the presentation of 
the patient in the outpatient clinical setting, and therefore it is never 100% accurate.17, 21 As we 
showed previously.15 the amount and quality of the medical data varied by cleft palate team. 
For some cases, the collected medical information was insufficient to evaluate certain specific 
features of the individual anomalies, and therefore these cases had to be excluded from the 
features’ analysis in this study. 
Another limitation is that, although we grouped anomalies having a sample prevalence of 
n < 10 together with their embryologically related anomalies, there were still considerable dif-
ferences in the prevalence rates of the evaluated anomalies; morphologically mild anomalies 
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were, for example, less prevalent in the study sample than morphologically severe anomalies. 
Because it is known that disease prevalence can affect the reliability (kappa) or validity statistics 
(sensitivity, specificity, and positive and negative predictive values)16-18 we used to measure the 
degree of agreement between the NVSCA and reregister, the differences in validity of registry 
data on morphologically severe and mild anomalies might partially be explained by the differ-
ences in prevalence.
Finally, the study sample was not large enough to examine all anomalies of the primary and 
secondary palates individually. Nevertheless, we were able to analyze most of the individual 
anomalies in OCs recorded over a 7-year period, thereby evaluating the feasibility of the unique 
descriptive NVSCA recording system for OCs.
CONCLuSIONS
Our study is the first that validates descriptive registry data on OCs. The unique NVSCA system 
records the individual anomalies of the primary palate and secondary palate that form the OC 
by describing the specific features (topographic-anatomical structure, morphology, and side) 
of each anomaly. This study shows that the quality of the NVSCA data on the specific features of 
the individual anomalies in OCs varies by type of anomaly and is related to anatomical location 
and morphological severity. Greater morphological severity of an anomaly might be a factor 
that encourages doctors to report better, but underreporting might also partly be explained by 
incomplete examination of the oral cleft. These factors might have implications for genetic and 
etiologic research based on registry data, for example, and for guidelines on neonatal examina-
tion by the cleft palate teams.
Despite the limitations and challenges described, this study shows together with other 
quality studies14, 15 that, overall, the data quality of the NVSCA registry on OCs is high, support-
ing the feasibility of the unique NVSCA recording system. However, data on morphologically 
severe clefts can be interpreted with higher confidence than those on morphologically mild 
clefts. In contrast to ICD-based registries, the NVSCA registry has valid detailed OC data that 
are collapsible to more general diagnoses or codes, which allows classifying OCs in many differ-
ent ways. This makes the NVSCA registry a very valuable tool for epidemiological, clinical, and 
fundamental research and for the improvement of OC care.
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AbSTRACT
Objective: Since 1997, the 15 Dutch cleft palate teams have reported their patients with oral 
clefts to the national oral cleft registry (NVSCA). During the first visit of the patient to the 
team—which is usually within the first year of life—the oral cleft and associated congenital 
anomalies are recorded through a unique recording form by a plastic surgeon/orthodontist/
pediatrician. In this study, we evaluated the quality of data on congenital anomalies associated 
with clefts. 
Methods: We drew a random sample of 250 cases registered in the national database with oral 
clefts from 1997 through 2003; of these, 13 were excluded. Using two independent reregisters 
derived from two-phased medical data review, we analyzed whether associated anomalies 
were correctly diagnosed and recorded. 
Results: The agreement on associated anomalies between the NVSCA and medical data ranged 
from moderate to poor (kappa 0.59 to 0). Seventy-seven percent of the craniofacial anomalies 
were underreported in the NVSCA: 30% due to delayed diagnosis and 47% due to deficient 
recording. Additionally, 80% of the associated anomalies of other organ systems were under-
reported: 52% due to delayed diagnosis and 28% due to deficient recording. The reporting of 
final diagnoses was somewhat better; however, 54% were still underreported (24% delayed 
diagnosis and 30% deficient recording). The rate of overreporting was 1.6% or lower. 
Conclusion: Congenital anomalies associated with clefts are underreported in the NVSCA 
because they are under diagnosed and deficiently recorded during the first consultations with 
the cleft palate teams. Our results emphasize the need of routine and thorough examination of 
patients with clefts. Team members should be more focused on co-occurring anomalies, and 
early genetic counseling seems warranted in most cases. Additionally, our findings underline 
the need for postnatal follow-up and ongoing registration of associated anomalies; reregistra-
tion in the NVSCA at a later age is recommended.
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INTRODuCTION
Oral clefts—one of the most common birth defects in humans—range from mild types to 
complete clefts affecting the lip/alveolus/palate. Although many genetic and environmental 
factors (e.g., smoking and nutrition) have been found to contribute to their development,1, 2 the 
etiopathogenesis of oral clefts is still poorly understood. Oral clefts are frequently associated 
with other congenital anomalies, often as part of a syndrome or chromosomal defect. However, 
the proportion of individuals with additional anomalies varies greatly between studies (3% to 
63%) and appears to be related to time of registration and how data have been collected.3 
It has also not conclusively been established whether oral clefts are related to specific types 
of associated anomalies and there are differences among reports concerning which organ 
systems are most commonly affected.4, 5 Given that children with oral clefts associated with 
other congenital anomalies have much higher morbidity and mortality throughout life than 
do individuals with isolated clefts,6-8 early and sound diagnosis of co-occurring anomalies is 
of paramount importance. Furthermore, complete and accurate data on oral clefts and their 
associated anomalies are needed to facilitate further genetic and etiopathological studies and 
prevention of clefts.1
Since 1997, the 15 multidisciplinary cleft palate teams in the Netherlands have reported 
their new presurgery patients with clefts to the national oral cleft registry, which is maintained 
by the Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA). These teams treat 
virtually all surviving children with clefts who reside in the Netherlands. Using a unique detailed 
recording form based on the embryology of the head and neck area, oral clefts and their associ-
ated congenital anomalies are recorded.9, 10 Depending on the team, the form is completed by 
a plastic surgeon (9 teams), orthodontist (3 teams), or pediatrician (3 teams) during the first visit 
of the patient to the team, which is usually within the first year of life. 
As the main purposes of the NVSCA are to optimize diagnostics, treatment, and preven-
tion of oral clefts and to provide a solid basis for clinical, epidemiological, and fundamental 
research, it is crucial that data provided by this registry are of high quality. Early and sound 
diagnosis and complete reporting of oral clefts and their associated anomalies are essential 
to maintain high standards of cleft care and data quality. Previously, it was shown that oral 
clefts—especially those types that are readily diagnosed at birth—are recorded completely 
and accurately in the NVSCA.10-12 It is not known, however, whether associated anomalies are 
also correctly recorded by the 15 cleft palate teams. Because not all associated anomalies are 
detectable at birth or in the neonatal period,3, 13 these anomalies might be underreported due 
to delayed diagnosis. Another factor that might cause underreporting of associated anomalies 
is deficient (incomplete/incorrect) recording by the consulting physicians.14
In this paper, the last of three articles validating the NVSCA registry,10, 11 we evaluated 
the quality of data on congenital anomalies associated with clefts by validating I) additional 
anomalies of the head and neck area, II) additional anomalies of other organ systems, and 
Chapter 476
III) final diagnoses (including syndromes and chromosomal defects). Using two independent 
reregisters derived from two-phased medical data review, we investigated whether these 
anomalies were diagnosed and recorded correctly during the first consultations with the Dutch 
cleft palate teams.
MATERIAL AND METHODS
NVSCA registry
The methodology by which the NVSCA registry was established is described in detail 
elsewhere9-11 and is summarized here. The NVSCA is an anonymous registry. All Dutch cleft 
palate teams report their new patients—before they have an oral cleft operation—through 
a standard NVSCA form; a manual is available.9, 10 The recording form is composed of three 
parts. The first is a general section for infant/parental characteristics. The second part consists 
of a two-dimensional table based on the embryology of the head and neck area, in which oral 
clefts and any associated craniofacial anomaly (e.g., mandibular hypoplasia or congenital ear 
anomalies) can be recorded in detail. As shown in Figure 1, the X-axis depicts the topographic-
anatomical structures, the Y-axis the morphologic features, and the checking boxes represent 
the side. The last (third) part gives space for verbatim descriptions of both major and minor 
congenital anomalies of other parts of the body and final diagnoses, including syndromes and 
chromosomal defects.
Note that the NVSCA does not have active follow-up of patients and that no data from other 
sources are included. To optimize data quality, recorded data are verified on a case-by-case 
basis and the cleft palate teams perform case-ascertainment activities annually. 
Subjects
This quality study was initiated and carried out in the 15 Dutch cleft palate teams; all gave 
written permission for review of patients’ medical data. During 1997-2003, the NVSCA database 
included 2553 patients with oral clefts with or without associated anomalies. Median cleft lip/
alveolus and atypical facial clefts were excluded due to their different pathogenesis.15, 16 From 
this database, we selected a study population of 250 cases using a standard random-sampling 
technique in SPSS version 17.0 (SPSS Inc., Chicago, IL).
Data collection and verification
To validate NVSCA data on associated anomalies, we used medical information provided by 
the cleft palate teams. The methods of medical data collection and verification have been 
described in detail elsewhere.10 Medical records with or without color photographs, panoramic 
radiographs, and dental casts were obtained for 241 of the 250 cases (96%); nine cases were 
untraceable (medical data were missing in different hospitals, reasons unknown due to 
77Delayed diagnosis and underreporting of associated congenital anomalies
confidentiality constraints). We also excluded one case that had insufficient medical data and 
three cases that had been operated before registration. This resulted in a total of 237 cases that 
remained in the study. 
The obtained medical data were reviewed in two steps by a single investigator (AMR). Firstly, 
the investigator reviewed only medical data created before and during the first visit of the 
patients to the teams in order to identify the associated anomalies that were diagnosed before 
and during those first consultations. The median age at referral was 0.6 months [interquartile 
range 0.3-1.8 months]. For each case, a standard NVSCA form10 was blindly completed, thereby 
creating reregister 1. Secondly, the investigator analyzed all medical data to identify the true 
types and frequencies of associated anomalies. The median period of follow-up was 5 years 
[interquartile range 3-7 years]. Again, an NVSCA form was blindly completed for each case, 
thereby creating reregister 2. The criteria used to define the type of anomaly were established 
in accordance with existing literature15-18 and the NVSCA recording manual.10 Note that any 
Figure 1. Section of the NVSCA recording form in which craniofacial congenital anomalies, including 
oral clefts, can be described in detail. The X-axis depicts the topographic-anatomical structures (mouth, 
ala nasi, septum nasi, calvaria/facial skull, orbita, eyes, eyelids, ears, and soft tissue), the Y-axis shows the 
morphology (cleft, agenesis, aplasia, hypoplasia, hyperplasia, synostosis, and non synostosis), and the 
checking boxes represent the side (left, right, and median). 
1 = absent; 2 = present, wrong shape; 3 = right shape, too small; 4 = right shape, too large.
* Pre./Max. = premaxilla – maxilla; Pre. = premaxilla; Pal.dur. = palatum durum; Pal.mol. = palatum molle; 
Ton. = tongue; Par. = os parietale; Occ. = os occipitale; Temp. = os temporale; Fro. = os frontale; Nas. = os 
nasale; Zyg. = zygoma; Max. = maxilla; Mand. = mandible; I.o.d. = interorbital distance; Soft tissue = soft 
tissue of the head and neck area.
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associated congenital anomaly was recorded, including minimal/minor defects (e.g., epicanthic 
folds or fetal pads), as they may be recognizable components of specific syndromes or chromo-
somal defects.3, 17-19 All recorded data were then transferred to two independent databases, 
which were subsequently checked for nonexistent, inappropriate, and invalid data. 
Statistical analysis
To get complete insight into the quality of NVSCA data, validation was performed in two steps. 
First, we compared the NVSCA with reregister 2 (based on all medical data) to analyze whether 
associated anomalies were recorded completely and accurately in the NVSCA. For both data-
bases, we calculated the prevalence of associated anomalies of the head and neck area, associ-
ated anomalies of other organ systems, and final diagnoses. Prevalence data were presented as 
numbers and percentages, and prevalence comparisons were performed using the chi-square 
test. All p values of 0.05 were considered statistically significant.
Although comparison of prevalence rates indicates the extent to which the two databases 
detected the anomalies, it does not indicate whether they have identified the same cases and 
whether the NVSCA accurately reproduced what was recorded in reregister 2. Therefore, the 
concordance of individual case data was also calculated. We calculated kappa statistics to 
determine the extent to which the two databases identified the same cases (i.e., inter-database 
agreement). Kappa describes the agreement beyond chance and avoids the assertion that 
reregister 2 has to be considered as a reference standard.20 To analyze whether the NVSCA 
accurately reproduced what was recorded in reregister 2, we calculated rates of sensitivity and 
specificity, assuming reregister 2 (i.e., the best available reflection of the cases’ conditions) to be 
the criterion standard. Sensitivity (“true positives”) was defined as the proportion of cases with 
a given anomaly according to reregister 2 that were correctly identified as having the anomaly 
by the NVSCA. Specificity (“true negatives”) was defined as the proportion of cases with no 
anomaly according to reregister 2 that were correctly identified as having no anomaly by the 
NVSCA. Note that the proportions underreporting and overreporting correspond to 1–sensitiv-
ity and 1–specificity, respectively.
During the second step of validation, we compared reregister 1 (based on medical data 
created before and during the first consultations with the teams) with reregister 2 to analyze 
whether anomalies were underreported due to delayed diagnosis or due to deficient record-
ing. Underreporting due to delayed diagnosis was defined as the proportion of cases with a 
given anomaly according to reregister 2 that were not identified as having the anomaly by 
reregister 1 as well as by the NVSCA. Underreporting due to deficient recording was defined as 
the proportion of cases with a given anomaly according to reregister 2 that were identified as 
having the anomaly by reregister 1, but not by the NVSCA. Statistics were performed using SPSS 
version 17.0 and Stata version 10.0 (StataCorp L.P., Texas, USA).
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RESuLTS
Prevalence and type of associated anomalies
Table 1 shows the prevalence and type of associated anomalies in cases with oral clefts for 
the NVSCA and reregister 2. The latter showed that 61% of the 237 cases had one or more 
associated anomalies, while the NVSCA showed a significant lower prevalence (19%, p = 0.000). 
For 47% of the 237 cases, reregister 2 showed one or more associated craniofacial anomalies. 
Defects of the facial skull (hypoplastic mandible or maxilla), eyelids (e.g., epicanthic folds or 
upslanting /downslanting palpebral fissures), and ears (e.g., misshapen or low set/rotated ears) 
were most frequently reported, while the NVSCA showed a significantly lower prevalence for all 
craniofacial structures, except for the interorbital distance. 
For 39% of the 237 cases, reregister 2 showed one or more associated anomalies of other 
organ systems. Anomalies of the central nervous system were most frequently recorded, fol-
lowed by anomalies of the skin, upper limbs, and lower limbs. The NVSCA, however, showed a 
significantly lower prevalence (8.4%, p = 0.000). Anomalies that were less frequently reported 
in the NVSCA included anomalies of the respiratory system, urogenital system, central nervous 
system, body wall, skin, upper limbs, and lower limbs.
Table 1. Prevalence of associated congenital anomalies in cases with oral clefts (n = 237)a
NVSCA Data Medical Data p Valueb
Associated anomaly 46 (19%)c 144 (61%)c 0.000
Head and Neck 28 (12%)c 112 (47%)c 0.000
Mouth 2 (0.8%) 9 (3.8%) 0.033
Tongue anomalies 1 8
Miscellaneous 1 1
Septum nasi 0 (0%) 7 (3.0%) 0.008
Hypoplasia 0 7
Calvaria 0 (0%) 18 (7.6%) 0.000
Aplasia 0 3
Hypoplasia (microcephaly) 0 3
Craniosynostosis/non synostosisd 0 9
Miscellaneous 0 3
Facial skull 15 (6.3%) 54 (23%)c 0.000
Hypoplastic maxilla 0 9
Hypoplastic mandible 15 46
Interorbital distance 2 (0.8%) 5 (2.1%) 0.253
Hyperplasia 0 4
Miscellaneous 2 1
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Table 1. (Continued)
NVSCA Data Medical Data p Valueb
Eyes  0 (0%) 9 (3.8%)c 0.002
Coloboma 0 3
Miscellaneous 0 9
Eyelids 3 (1.3%)c 52 (22%)c 0.000
Aplasia 4 48
Hypoplasia 0 6
Miscellaneous 0 1
Ears 7 (3.0%)c 43 (18%)c 0.000
Aplasia 9 32
Miscellaneous 2 27
Soft tissue 0 (0.0%) 6 (2.5%) 0.014
Aplasia 0 6
Other craniofacial anomaliese 2 (0.8%) 13 (5.5%) 0.004
Other organ systems 20 (8.4%)c 92 (39%)c 0.000
Circulatory system 9 (3.8%)c 19 (8.0%)c 0.051
Atrial or ventricular septum defects 6 17
Cardiac valve anomalies 1 4
Persistent ductus arteriosus 0 4
Vessel anomalies 3 8
Miscellaneous 1 2
Respiratory system 1 (0.4%) 7 (3.0%) 0.032
Infant Respiratory Distress Syndrome  1 3
Miscellaneous 0 4
Digestive system 2 (0.8%) 7 (3.0%) 0.092
Pyloric stenosis 0 3
Miscellaneous 2 4
Urogenital system 3 (1.3%) 19 (8.0%)c 0.000
Renal hypoplasia 1 4
Undescendent or retractile testis 1 4
Hypospadia 1 5
Miscellaneous 0 15
Central nervous system 3 (1.3%) 32 (14%)c 0.000
Ventriculomegaly 0 4
Epilepsy 0 7
Mental or psychomotor retardation 0 20
Hypotonia or hypertonia 0 14
Miscellaneous 4 14
Vertebral column 4 (1.7%) 10 (4.2%)c 0.104
Sacral dimple and/or spina bifida occulta 3 5
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Table 1. (Continued)
NVSCA Data Medical Data p Valueb
Miscellaneous 1 6
Body wall 2 (0.8%) 12 (5.1%)c 0.007
Chest wall anomalies 1 4
Inguinal or umbilical hernias 1 5
Miscellaneous 0 4
Skin 2 (0.8%) 23 (9.7%)c 0.000
Hemangiomas and vascular malformations 1 12
Hypopigmentation or depigmentation 0 3
Café au lait spots 0 3
Hypertrichosis 0 3
Miscellaneous 1 4
Upper limb 3 (1.3%)c 22 (9.3%)c 0.000
Hypoplasia or agenesis 3 4
Clinodactyly 0 4
Abnormal palmar crease 0 10
Miscellaneous 1 9
Lower limb 3 (1.3%) 24 (10%)c 0.000
Hip dysplasia 0 5
Clubfeet 1 6
Syndactyly 0 7
Miscellaneous 2 9
Final diagnosis 21 (8.9%) 46 (19%)c 0.001
Chromosomal defect 6 (2.5%) 14 (5.9%) 0.068
Deletion 4p (Wolf Hirschhorn) 1 2
Deletion 4q 1 1
Partial trisomy 8 0 1
Trisomy 13 0 1
Trisomy 14 0 1
Ring chromosome 18 0 1
Trisomy 21 (Down) 1 1
Deletion 22q11 (DiGeorge / VCF / Shprintzen) 1 1
46,XX, t(2;4) 0 1
46,XY,der(6)t(2;6) 0 1
46,XX,add(14)(q?) 0 1
46,X,t(X;15) 0 1
46,XY,der(18)t(16;18) 1 1
Nonchromosomal syndrome 15 (6.3%) 31 (13%) 0.013
Amniotic band 0 1
Branchio-oculo-facial 1 1
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Finally, 19% of the 237 cases had a chromosomal defect, non-chromosomal syndrome or 
other final diagnosis according to reregister 2. The prevalence of these final diagnoses was 
significantly lower in the NVSCA (8.9%, p = 0.001).
Agreement and under/overreporting of associated anomalies
The degree of agreement between the NVSCA and reregister 2 on associated anomalies is 
presented by craniofacial structure, organ system, and final diagnosis in Table 2.
By comparing reregister 1 with reregister 2, we analyzed whether anomalies were under-
reported in the NVSCA due to delayed diagnosis or due to deficient recording. Reregister 2 
showed 112 cases with associated anomalies of the head and neck area. Of these cases, 23% 
(n = 26) were recorded in the NVSCA as having one or more craniofacial anomalies, and 77% 
were underreported: 30% (n = 33) due to delayed diagnosis and 47% (n = 53) due to deficient 
recording. Of the 92 cases with associated anomalies of other organ systems, 20% (n = 18) were 
recorded in the NVSCA as having one or more anomalies, and 80% were underreported: 52% 
(n = 48) due to delayed diagnosis and 28% (n = 26) due to deficient recording. Finally, 46 cases 
had a final diagnosis according to reregister 2. Of these cases, 46% (n = 21) were recorded cor-
rectly in the NVSCA, and 54% were underreported: 24% (n = 11) due to delayed diagnosis and 
30% (n = 14) due to deficient recording. Figure 2 shows the quality of reporting by craniofacial 
structure, organ system, and final diagnosis.
Table 1. (Continued)
NVSCA Data Medical Data p Valueb
CHARGE 1 1
Ectrodactyly Cleft Palate 1 1
Hay-Wells / AEC 0 1
Pierre Robin sequence 11 24
Van der Woude 1 1
Waardenburg 0 1
Other diagnosis 0 (0.0%) 2 (0.8%) 0.156
Neonatal Abstinence Syndrome 0 1
Neurofibromatosis type I 0 1
a Agenesis = absent; aplasia = present, wrong shape; hypoplasia = right shape, too small; and hyperplasia 
= right shape, too large. Morphological features are based on the terminology used in the recording 
system of the NVSCA (Dutch Association for Cleft Palate and Craniofacial Anomalies).9-11
b p value presents statistical significance level in prevalence of associated anomaly between NVSCA data 
and medical data; p <0.05 is used to determine statistical significance and is presented in bold format.
c A patient can have more than one associated anomaly.
d This group included one case with a trigonocephaly associated with a chromosomal defect and one 
case with a metopic ridge associated with the Hay-Wells/AEC syndrome. The other seven patients 
showed a skull shape comparable with craniosynostosis but with open sutures (i.e., non synostosis).
e  These anomalies included anomalies of the ala nasi, orbita, and neck.
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Table 2. Agreement between the NVSCA and medical data (criterion standard) on congenital anomalies 
associated with oral clefts (n = 237)a
Congenital Anomaly Observed 
Agreement
kappa underreporting
(1-Sensitivity)
Over-reporting 
(1-Specificity)
% 95% CI % %
Head and Neckb 63 0.23 (0.14-0.31) 77 1.6
Mouth 96 0.17 (–0.13-0.47) 89 0.4
Septum nasi 97 0 100 0
Calvaria 92 0 100 0
Facial skull 84 0.37 (0.23-0.51) 72 0
Interorbital distance 98 0.28 (–0.16-0.72) 80 0.4
Eyes 96 0 100 0
Eyelids 78 0.05 (–0.03-0.13) 96 0.5
Ears 84 0.20 (0.06-0.34) 86 0.5
Soft tissue 97 0 100 0
Other craniofacial anomaliesc 95 0.12 (–0.11-0.35) 92 0.4
Other organ systemsb 68 0.21 (0.12-0.31) 80 1.4
Circulatory system 94 0.47 (0.24-0.70) 63 0.9
Respiratory system 97 0.21 (–0.15-0.57) 86 0.4
Digestive system 98 0.44 (0.03-0.84) 71 0
Urogenital system 93 0.26 (0.02-0.49) 84 0
Central nervous system 88 0.15 (0.00-0.31) 91 0
Vertebral column 97 0.56 (0.25-0.87) 60 0
Body wall 96 0.28 (–0.03-0.58) 83 0
Skin 90 0.01 (0.01-0.02) 100 0.5
Upper limb 92 0.22 (0.01-0.43) 86 0
Lower limb 91 0.20 (0.01-0.40) 88 0
Final diagnosis 89 0.58 (0.43-0.72) 54 0
Chromosomal defect 97 0.59 (0.33-0.84) 57 0
Nonchromosomal syndrome 92 0.57 (0.40-0.75) 55 0.5
Other diagnosis 99 0 100 0
a  NVSCA = Dutch Association for Cleft Palate and Craniofacial Anomalies; 95% CI = 95% confidence 
interval. A patient may contribute to more than one difference between the databases.
b A structure or system can have one ore more associated congenital anomalies.
c These anomalies included defects of the ala nasi, orbita, and neck.
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Figure 2. Distribution of cleft patients with associated anomalies (n = 144) according to quality of 
reporting of I) craniofacial structure, II) other organ systems, and III) final diagnoses. Note that a patient 
can have more than one associated anomaly.
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DISCuSSION
This validation study showed that the quality of NVSCA data on congenital anomalies associ-
ated with oral clefts is moderate to poor and varies by type of anomaly. Associated anomalies 
are underreported because they are not diagnosed during the first consultations with the cleft 
palate teams or because they are deficiently recorded by the consulting physicians.
Using the classification system developed by Landis and Koch,21 our kappa values showed 
moderate to poor agreement between the NVSCA and reregister 2. Seventy-seven percent of 
the defects in cases with associated craniofacial anomalies were underreported in the NVSCA 
(30% delayed diagnosis and 47% deficient recording). Additionally, 80% of the defects in cases 
with associated anomalies of other organ systems were underreported in the NVSCA (52% 
delayed diagnosis and 28% deficient recording). The reporting of final diagnoses was somewhat 
better; however, 54% were still underreported in the NVSCA (24% delayed diagnosis and 30% 
deficient recording). The rate of overreporting appeared to be negligible (just 1.6% or lower). 
Strengths and weaknesses
The main strength of this study is that its sampling frame had a national distribution; all Dutch 
cleft palate teams participated, including teams of large urban teaching and specialist hospitals 
as well as of small regional ones. Another strength is its focus on detailed dysmorphology and 
syndromology. Besides major anomalies, we also evaluated minimal/minor defects, such as 
epicanthic folds and ear pits. In and of themselves, these anomalies do not cause increased 
morbidity. However, as they may be recognizable components of specific syndromes or chro-
mosomal defects, characterization of both major and minor anomalies is essential to help arrive 
at correct diagnosis and improve clinical care and outcome of the patient.3 
Additionally, the postnatal follow-up of our study allowed us to include anomalies detected 
later in infancy. Consequently, our study showed a relatively high proportion (61%) of cases 
with associated anomalies compared with other studies (3% to 63%).3-6, 8 Anomalies of the 
head and neck area were most frequently diagnosed, followed by anomalies of the central 
nervous system, skin, upper limbs, and lower limbs. Unfortunately, comparison of our findings 
with those of others is restricted due to great differences in case definitions, inclusion/exclusion 
criteria, times of registration, ascertainment methods (active vs. passive), sample sizes, popula-
tion characteristics, and ever-increasing knowledge of cleft syndromes.3
We realize that the postnatal follow-up in our study also had its limitation. Because our cases 
were born from 1991 (recorded in 1997) through 2003, the follow-up, and thus the chance 
of detecting anomalies, varied by case. Another limitation of this study is that the medical 
information used for comparison can never be 100% accurate. Medical data are not equal to 
the presentation of patients in the outpatient clinical setting, and errors that occur when clini-
cal information is documented cannot be captured.14 Furthermore, the amount and quality of 
data varied by cleft palate team.10 On the other hand, all medical data were abstracted and 
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subsequently recorded by the same investigator, thereby minimizing the variability in selection 
of medical information in this study.
Possible explanations underreporting
As has previously been described,3, 13 early registration might underestimate the true frequency 
of associated anomalies, especially of those that require specific diagnostic procedures (e.g., 
chromosomal defects) and those that can only be detected later in infancy (e.g., epilepsy and 
mental or psychomotor retardation). Therefore, our high rates of delayed diagnosis may partly 
be explained by the fact that most patients were registered during the first months of life. This is 
in line with several other studies reporting similar rates of underreporting of congenital anoma-
lies during the neonatal period (37% to 86%),13, 22-25 while studies evaluating longer periods of 
follow-up reported considerably lower rates (7% to 21%).26-29 However, our study also showed 
that obvious external defects (e.g., craniofacial anomalies and defects of the upper/lower 
limbs) had also been missed during intake. This may be explained by the fact that cleft patients 
in the Netherlands are initially seen by plastic surgeons, orthodontists, or pediatricians, who are 
generally not fully trained in the principles of dysmorphology and syndromology. If patients are 
referred to a clinical geneticist, this usually takes place at a later stage. On the other hand, part 
of our findings—especially regarding minimal/minor defects, such as epicanthic folds—could 
also be explained in terms of greater vigilance in identifying anomalies by the investigator 
rather than through routine examination by any physician at the outpatient clinic.30 
We also found that anomalies were deficiently recorded, which may be explained by the 
following factors. Given that incorrect recording would have caused both underreporting and 
overreporting in the NVSCA, our low rates of overreporting suggest that data were simply not 
entered. According to Mackeprang et al.,22 this incomplete recording of anomalies may be a 
consequence of the desire to first confirm a diagnosis. Another explanation could be the lack of 
awareness, focus or willingness among physicians to record completely and accurately. 
Implications and recommendations
From a clinical perspective, timely and correct identification of all associated malformations, 
including major and minor defects, is essential for accurate diagnosis, prognosis, and counsel-
ing and to develop policies of healthcare.3 As a result of advances in ultrasound technology 
and its routine use in obstetric practice, oral clefts and their associated anomalies (including 
less obvious internal defects) are being diagnosed prenatally more frequently.31 However, our 
study showed that external as well as less obvious internal defects are missed during intake. 
This emphasizes the need for more thorough evaluation of children with clefts. Team members, 
including plastic surgeons, orthodontists, and pediatricians, should be more aware of prenatal 
findings and should focus on postnatal detection of co-occurring congenital anomalies, 
especially regarding cardiovascular or urogenital anomalies and Pierre Robin sequence. These 
anomalies are often missed during intake, and early accurate diagnosis of these anomalies 
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will change treatment policy and thus possibly the outcome of the patient. Additionally, early 
genetic counseling seems warranted in most cases, particularly to detect anomalies that 
should be diagnosed as soon as possible given their implications for treatment and progno-
sis. For example, early diagnosis of deletion 22q11.2 is important given the need to identify 
hypothyroidism, to check calcium preoperatively as well as postoperatively, and to evaluate the 
immune system before administering live vaccines. Furthermore, cytomegalovirus-negative 
irradiated blood products should be used for infant surgeries.32
The underrepresentation of associated anomalies in the NVSCA restricts its use for research 
purposes, such as genetic/etiological studies, since clefts with accompanying defects have 
epidemiological and etiological features different from isolated clefts.1, 8 On the other hand, as 
long as one remains cognizant of the limitations, NVSCA data can still be useful, for example 
in providing low-end estimates of rates of associated anomalies.24 To improve data quality, 
recording physicians should be educated in identifying and recording associated anomalies, 
and optimally, each cleft patient should be examined by a clinical geneticist or dysmorpholo-
gist before registration.1
Finally, registration at birth is the most reliable way to capture the complete population of 
cleft patients. However, our findings highlight the importance of postnatal follow-up and the 
ongoing accurate reporting of birth defects. According to Van der Veen et al. and Wyszynski 
et al.,3, 13 most associated anomalies are diagnosed before 4-6 years of age. Therefore, reregis-
tration after 6 years of age seems adequate to obtain complete and accurate information on 
associated anomalies in patients with oral clefts. 
CONCLuSIONS
This paper, the last of three articles validating the NVSCA registry,10, 11 showed that congenital 
anomalies associated with oral clefts are underreported due to delayed diagnosis and deficient 
recording. It emphasizes the need of early routine and thorough examination of patients 
with clefts. Timely diagnosis of anomalies like Pierre Robin sequence and cardiovascular or 
urogenital anomalies will change treatment policy and thus the outcome of the patient. Health 
professionals involved in the management of oral clefts should therefore be more focused on 
such anomalies, and a clinical geneticist as well as an obstetric specialist should be included in 
each multidisciplinary cleft team to maximize the ascertainment of these anomalies. 
Our findings underline the need for postnatal follow-up and ongoing reporting of congenital 
anomalies. Registration at birth is the most reliable way to capture the complete population of 
cleft patients, but to obtain complete and accurate data on associated anomalies these patients 
should be reregistered after the age of 4-6 years.
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AbSTRACT
Objectives: The number of new oral cleft patients has fallen in the Netherlands. This may be 
explained by two hypotheses: 1) greater prenatal detection of congenital anomalies has led to 
more pregnancy terminations, and 2) increased folic acid use has reduced the oral cleft risk. Both 
hypotheses would mainly apply to the category cleft lip/alveolus ± cleft palate (CL±P), since, 
unlike cleft palate only (CP), CL±P can be detected prenatally by 2D ultrasound and develops 
during the period recommended for folic acid use. We aimed to determine trends in prevalence 
over 1997-2006 and to evaluate the hypotheses by stratifying trends by cleft category. 
Methods: This study was a time-trend analysis of infants born alive with oral clefts in the 
Netherlands during 1997-2006 and registered in the national oral cleft registry. We calculated 
prevalence rates and the estimated annual percentage change (EAPC) for all oral clefts and the 
two categories. 
Results: In 1997-2006, 3308 infants out of 1,970,872 live births had oral clefts, an overall 
prevalence per 10,000 live births of 16.8 (CL±P: 11.3; CP: 5.5). Time-trend analysis showed that 
the prevalence of all oral clefts decreased (EAPC –1.8%; 95% CI –3.0% to –0.6%), as did the CL±P 
prevalence (EAPC –2.3%; 95% CI –3.8% to –0.9%). No significant trends were found for the CP 
prevalence.
Conclusions: Because the live-birth prevalence of CL±P decreased, that of all oral clefts 
decreased. These findings are in line with both hypotheses and may therefore have implica-
tions for prenatal counseling and folic acid policy.
97Decreasing prevalence of oral cleft live births
INTRODuCTION
Oral clefts—one of the most common birth defects in humans—range from mild types to 
complete clefts affecting the lip/alveolus/palate. They may either be isolated or be associated 
with other congenital anomalies, syndromes, or chromosomal defects. Although the etiopatho-
genesis of non-syndromic clefts has been widely studied, it is still poorly understood. Many 
genetic and environmental factors, such as nutrition and medication, have been suggested to 
contribute to their development.1-3 
Since 1997, the fifteen cleft palate teams in the Netherlands have reported their new live-
born presurgery patients with oral clefts to the national oral cleft registry, which is maintained 
by the Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA). These teams 
treat virtually all surviving children with clefts who reside in the Netherlands.4, 5 The annual 
reports of this registry show that the number of cleft patients referred to the teams has fallen 
since 2003.6 This decline may be explained by two hypotheses. Firstly, the performance of pre-
natal 2D ultrasound examinations has increased since the 1990s, resulting in greater prenatal 
detection of congenital anomalies, including oral clefts,7 which has led to more terminations 
of affected pregnancies. Secondly, the government-sponsored mass media-campaign in 1995 
and the proactive intervention by Dutch pharmacies in 2004 to promote the use of folic acid 
have increased the periconceptional use of this supplement,8 thereby reducing the risk of oral 
clefts. To investigate these hypotheses, oral clefts have to be divided into two categories: cleft 
lip/alveolus with or without cleft palate (CL±P); and cleft palate only (CP). These categories dif-
fer embryologically and epidemiologically,2 and, unlike CP, the category CL±P can be detected 
prenatally using 2D ultrasound.9 This means that if pregnancies were terminated because of 
the presence of an oral cleft with or without associated anomalies, the CL±P prevalence would 
have been affected most. Additionally, most types of CL±P develop during weeks 4-7 post-
conception,3, 10 which is during the recommended period for folic acid use (four weeks before 
conception to eight weeks after it). CP, however, develops during weeks 8-12 postconception,3, 
10 and may therefore be less influenced by a higher use of folic acid during the recommended 
gestational period in the population. 
To investigate whether the prevalence of oral clefts among live births in the Netherlands 
decreased over the 1997-2006 period, we used data from the NVSCA to establish the rates of 
oral clefts. By stratifying trends by cleft category, we were able to investigate whether the oral 
cleft prevalence may have been affected by the greater prenatal detection of CL±P with or 
without associated anomalies, and/or by the higher periconceptional use of folic acid. 
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METHODS
The methodology by which the NVSCA registry was established is described elsewhere 4, 11 and 
is summarized here.
The NVSCA registry includes anonymous presurgery patients with oral clefts (no age limit) 
reported by the Dutch cleft palate teams. Using a unique recording system, detailed information 
on the topography and morphology of each anatomical structure of the head and neck area 
(e.g. lip, alveolus, and hard/soft palate) is recorded. Additionally, general information concern-
ing the infant/parents and diagnoses of associated anomalies are included. Note that the form 
is completed during the first visit of the patient to the team, which is usually in the immediate 
postnatal period, and that there is no active follow-up of patients. To optimize data quality, 
data are verified on a case-by-case basis and the cleft palate teams perform case-ascertainment 
activities. Furthermore, the registry has been systematically validated.11
The study population included all infants born alive in the Netherlands from 1997 to 2006 
who had been registered in the NVSCA database with an oral cleft (with or without associated 
anomalies). We excluded median and atypical facial clefts because of their different pathogen-
esis.12, 13 
The descriptive data of the study population (infant/maternal characteristics and informa-
tion on associated anomalies) were presented as percentages, medians with interquartile range 
[IQR], or means ± 1 standard deviation (SD).
We performed time-trend analyses to estimate the change in live-birth prevalence of all 
clefts and of the two categories (CL±P and CP) over the period 1997-2006. The prevalence was 
determined annually as the number of registered live-born infants with a cleft per 10,000 live 
births in the Netherlands for the same year. The annual numbers of live births in the Nether-
lands were retrieved from Statistics Netherlands.14 
We used Poisson regression, modeling counts against year, to calculate the estimated 
annual percentage change (EAPC) in prevalence; this method has been previously described 
by De Vries and colleagues.15 The EAPC, presented with its 95% confidence interval [95% CI], 
represents an estimate of the year-to-year change in rate; negative values represent declining 
rates and positive values represent increasing rates. Statistics were performed using the SPSS v 
17.0® software package.
RESuLTS
During the study period, 3308 infants were born alive with an oral cleft and were registered in 
the national database. The descriptive data of the study population are presented in Table 1. 
The median age at cleft palate team admission was 0.6 months. Most infants were born to Cau-
casian parents (approximately 88%), after a normal gestational age of 39 weeks, and the mean 
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birth weight was 3299 grams. Almost 28% of the infants had a family history of congenital 
anomalies, about 11% had congenital anomalies of the head and neck area other than clefts, 
and 13% had accompanying defects of other organ systems. In 10%, the oral cleft was part of a 
syndrome and/or chromosomal defect.
Between 1997 and 2006, there were 1,970,872 live births in the Netherlands; the average 
oral cleft prevalence was 16.8 per 10,000 live births. Figure 1 displays the prevalence over time. 
The annual prevalence of all clefts ranged from 14.5 to 18.6 per 10,000 live births (IQR: 15.8-
17.7). Time-trend analysis showed that over the 1997-2006 period, the oral cleft prevalence 
decreased significantly by –1.8% per year (95% CI: –3.0% to –0.6%). 
Infants with CL±P accounted for 67% of the study population (2218 infants), corresponding 
to an average prevalence of 11.3 per 10,000 live births. The prevalence of CP was 5.5 per 10,000 
live births. The annual CL±P prevalence ranged from 9.6 to 12.9 per 10,000 live births (IQR: 
10.5-12.0), and the annual CP prevalence ranged from 4.7 to 6.3 per 10,000 live births (IQR: 
5.0-6.2). Time-trend analysis for CL±P showed a trend similar to that observed for all clefts; per 
year, the prevalence decreased by a significant –2.3% (95% CI: –3.8% to –0.9%). By contrast, for 
CP there was no evidence of a significant trend over time (EAPC –0.8%; 95% CI: –2.9% to +1.2%). 
Table 1. Characteristics of the study population, the Netherlands 1997-2006.* Values are numbers (percentages) 
unless stated differently
No of patients: 3308
General information:
Boys 1935 (58.5)
Median referral age in months [IQR] 0.6 [0.3-1.8]
Caucasian father 2885 (87.2)
Caucasian mother 2930 (88.6)
Consanguinity 74 (2.2)
Mean gestational age in weeks ± SD 39 ± 2.2
Mean birth weight in grams ± SD 3299 ± 654
Congenital anomalies among relatives 915 (27.7)
Oral clefts among relatives 642 (19.4)
Oral clefts:
Cleft lip/alveolus with or without cleft palate 2218 (67.0)
Cleft palate only 1090 (33.0)
Associated anomalies:
Other craniofacial anomalies 352 (10.6)
Anomalies other organ systems 430 (13.0)
Syndrome and/or chromosomal defect 327 (9.9)
* Based on data of the NVSCA registry.
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DISCuSSION
Our study shows that the live-birth prevalence of oral clefts in the Netherlands decreased 
significantly during 1997-2006. By stratifying this trend by cleft category, we found a trend 
for CL±P similar to that observed for all clefts, while there was no significant trend for CP. This 
specific decrease in CL±P supports the hypothesis that the live-birth prevalence of oral clefts 
was affected by the greater prenatal detection of CL±P (with or without associated anomalies), 
and/or by the higher periconceptional use of folic acid. 
Strengths and weaknesses
While the use of the NVSCA database was the main strength of our study—it allowed us to 
collect detailed national data on oral clefts among live births—it also had some limitations. The 
first is that registry databases are known to be prone to underreporting and misclassification. 
Our findings are nonetheless unlikely to be explained by underreporting or misclassification, 
because case-ascertainment is performed annually, and extra control activities were performed 
after the decline in newly recorded patients. Furthermore, quality studies showed that the 
Figure 1. Time trends in prevalence of all oral clefts and the two categories (CL±P and CP) per 10,000 
live births in the Netherlands from 1997 to 2006. Time trends estimated by Poison regression with year 
of birth as independent variable. Estimated Annual Percentage Change (EAPC) calculated by fitting the 
regression line to the natural logarithm of the prevalence rates.
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NVSCA registry has a high case-ascertainment and contains high quality data for both CL±P 
and CP.5, 11 
Another limitation is that the national database records only patients who are treated by 
the cleft palate teams. Stillbirths are therefore not included, and infants with severe associ-
ated anomalies who die during the first weeks of life might also not be captured. A change in 
perinatal/neonatal mortality could thus have affected our rates. Although we cannot rule out 
the impact of this factor, we suspect it is of minor importance given that the Dutch perinatal/
neonatal mortality decreased during the study period.14 Besides, a change in these mortalities 
should have mainly affected the CP prevalence, since further anomalies are more frequently 
associated with CP than with CL±P.1 
Finally, the database does not provide complete and reliable data on associated anomalies 
(Unpublished data, Rozendaal et al. 2010). The NVSCA has no active follow-up of patients, and 
therefore, associated anomalies detected later in infancy are often not included.16, 17 For this 
reason, trends according to whether clefts were isolated or associated with other anomalies 
could not be given to further support that the increased prenatal detection accounted for the 
decline in prevalence.
Another source for Dutch oral cleft data is the EUROCAT registry of the Northern Nether-
lands.18 However, cleft rates of the Northern Netherlands are significantly higher than those 
of the Netherlands and can therefore not be used in a national context.19, 20 Additionally, 
international registries show large variations in cleft prevalence without consistent time trends 
1, 21, 22; the worldwide prevalence comes to 15.2 per 10,000 births.21 Unfortunately, comparison 
of our findings with those of other studies is restricted, due particularly to the great differences 
between data sources, times of diagnosis, classifications, inclusion/exclusion criteria, time 
scales, sample sizes, and population characteristics.1, 16, 23
Possible explanations 
Our first hypothesis—that greater prenatal detection of congenital anomalies, including oral 
clefts, has led to more terminations of affected pregnancies—is a plausible explanation for the 
decline in oral clefts among live births in the Netherlands. This hypothesis is supported by our 
findings and additional national data.24 
Since 2007, 2D ultrasound screening in the Netherlands has been routinely performed at 
18-20 weeks gestation. However, the use of prenatal ultrasounds started to increase as early 
as the 1990s, and, before 2007, over 90% of pregnant women residing in the Netherlands 
underwent one or more ultrasound scan.7 As it did elsewhere,9, 22, 25, 26 the subsequent rise 
in prenatally detected anomalies, including oral clefts,7 may have led more affected pregnan-
cies to be terminated in the Netherlands. The rates reported internationally for termination of 
pregnancy (TOP) on the basis of an isolated cleft range from 0 to 92%,26 but TOPs are performed 
more frequently when the cleft is associated with other anomalies.9 Unlike CP, the category 
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CL±P can be detected prenatally using 2D ultrasound,9, 23 which may explain why we found a 
significant decreasing trend for CL±P and no trend for CP.
This hypothesis is also supported by national data on pregnancy terminations.24 In the 
Netherlands, TOP is allowed only under the provision of the Termination of Pregnancy Act; after 
24 weeks gestation it is prohibited.27 Under the terms of this act, all Dutch hospitals or clinics 
licensed to perform TOPs are required to report information relevant to these TOPs. Indica-
tions are not included. The annual reports submitted under this act show that the number of 
second-trimester terminations, especially those performed by the hospitals, have increased 
since 2003. This implies that there has been a rise in the termination of pregnancies affected 
with congenital anomalies, since these are performed mainly by the hospitals.24 
Our second hypothesis—that higher periconceptional use of folic acid has reduced the risk 
of oral clefts in the Netherlands—is also plausible. Several studies have reported a significant 
protective association between periconceptional folic acid and oral cleft risk,28-32 but the evi-
dence on the role of this supplement in cleft etiology is still inconclusive.31, 32 In the Netherlands, 
women are recommended to take 400µg folic acid/day from four weeks before conception 
until eight weeks thereafter, and the frequency of expecting mothers correctly using additional 
folic acid increased gradually over the past decade.8, 33 Our study shows a gradual decline in 
CL±P prevalence, but not in CP prevalence, during approximately the same time frame. These 
findings are consistent with two other studies that investigated the same supplementation 
period,28, 30 while countries with compulsory fortification (United States and Canada) showed a 
decline in both CL±P and CP.31
A possible explanation for these findings is that the recommended period for folic acid 
supplementation does not cover the etiologically relevant time period for CP (8-12 weeks post-
conception).3 This theory is supported by the study of Bakker and colleagues,34 who showed 
that, after discontinuation of folic acid supplementation, the folate concentration (a general 
term for this B-vitamin) in serum immediately decreases and the plasma total homocysteine 
immediately increases. Given that there may be a dose-response relationship between folic 
acid and oral clefts, and that folate may be indirectly associated with clefts through its effects 
on homocysteine metabolism,28, 31, 35 folic acid supplementation until 8 weeks postconception 
might be too short to prevent CP.
Finally, other environmental or lifestyle factors (e.g. dietary patterns) changing over time 
may also account for the decrease in cleft prevalence.1 Specific data on these factors are not 
available for the oral cleft population, but data based on the general Dutch population show 
that maternal smoking and alcohol consumption decreased during the study period.36 Since 
these factors are suggested to be associated with CL±P and CP risk,1 they may play contributory 
roles regarding the decrease in prevalence.
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Possible implications 
Our findings may have several implications for healthcare and policy makers. Firstly, TOP after 
prenatal diagnosis of congenital anomalies raises moral and ethical dilemmas, since most of 
these anomalies are nonlethal (e.g. non-syndromic clefts). If oral clefts are identified prenatally, 
future parents should be counseled by a multidisciplinary cleft palate team that focuses on 
psychosocial support, genetic counseling, education on the management of clefts, and parents’ 
options, TOP being one of them.25, 26, 37, 38 The Netherlands does not yet have a uniform strategy, 
but is developing an evidence-based guideline to optimize prenatal counseling on oral clefts.
Secondly, if folic acid protects against oral clefts, increases in pregnant women’s exposure to 
folic acid and extension of the recommended period to at least 12 weeks postconception ought 
to produce further reductions in prevalence. Since folic acid consumption has been increased 
by food fortification,31, 33 the possible effect on oral clefts is also relevant to the ongoing discus-
sions about fortification. 
Population-based studies including live births and stillbirths could give more insight into 
the causes of the decrease in oral clefts, especially if prenatally diagnosed cases are included. 
Since national data on prenatally diagnosed anomalies and indications of TOP are still lacking, 
uniform registration is needed to evaluate the epidemiological impact of prenatal ultrasound 
screening. Additionally, to further investigate the possible preventive effect of folic acid, future 
studies should focus on timing, duration, dose, and intensity of use of folic acid as well as of 
folic-acid containing supplements.32 Further studies should also differentiate between the 
various cleft types within CL±P and CP, since these are related to different time frames and 
cell biological mechanisms in embryonic development.3, 10, 12 Therefore, a unique case-control 
study has been recently started in the Northern Netherlands, based on detailed data regard-
ing the various cleft types and periconceptional folic acid/multivitamins from the NVSCA and 
Eurocat registries.
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AbSTRACT
The Eurocat registry Northern Netherlands (NNL) has been used in regional context, as well as 
in national/international context, to describe the epidemiology of oral clefts (OC). However, the 
region NNL seems to have prevalence data different from Dutch national registries and certain 
other European areas. This may be due to differences in registration methods or geographical 
variation. To investigate whether the prevalence of OC live births varies regionally in the Neth-
erlands, we established time trends for NNL and the rest of the Netherlands over 1997-2007 
using data from two national registries (the OC Registry and The Netherlands Perinatal Registry) 
and a regional registry (Eurocat NNL). We found that the overall live-birth prevalence—com-
prising cleft lip/alveolus ± cleft palate and cleft palate only—was significantly higher in NNL 
(15.1-21.4 per 10,000) than in the rest of the Netherlands (13.2-16.1 per 10,000). None of the 
registries showed significant trends for NNL, whereas both national registries showed that the 
live-birth prevalence of cleft lip/alveolus ± cleft palate decreased significantly in the rest of 
the Netherlands. Despite some differences in prevalence between the registries, they showed 
similar regional variation in prevalence and trends. In conclusion, the prevalence of OC live 
births varies significantly in the Netherlands, not only between but also within registries. This 
underlines that extrapolation of regional cleft data should be done with caution. To further 
investigate OC etiology and evaluate preventive strategies, future studies should consider 
geographical differences—between and within countries—regarding the various cleft sub-
phenotypes among live births, stillbirths, and pregnancy terminations.
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INTRODuCTION
Oral clefts are one of the most common birth defects in humans. Worldwide, the reported 
prevalence varies from 4.8 to 28.6 per 10,000 live births and stillbirths (with or without termina-
tion of pregnancy)1 with considerable variations associated with gender, ethnicity, socioeco-
nomic status, and geographic region.2-9 Oral clefts are very complex and heterogeneous birth 
defects, being microform/submucous, incomplete, or complete clefts affecting the individual 
structures: lip, alveolus, hard palate, and soft palate including the uvula.10 Classically, they are 
subdivided into two categories: cleft lip/alveolus with or without cleft palate (CL±P) and cleft 
palate only (CP), because of their differences in embryologic development and epidemiol-
ogy.8, 11 Oral clefts may either be isolated or be associated with other congenital anomalies, 
syndromes, or chromosomal defects. Although the etiopathogenesis of non-syndromic oral 
clefts has been widely studied, it is still poorly understood. Many genetic and environmental 
factors, such as smoking, alcohol, and nutrition, have been suggested to contribute to their 
development (OMIM 119530; 119540).8, 11-14 Registration of oral clefts—including their associ-
ated anomalies—and combined epidemiological, fundamental, and clinical approaches may 
enhance our understanding of the causes and pathogenesis of oral clefts.3
Oral clefts in the Netherlands are registered in three registries: 1) National Registry of Com-
mon Oral Clefts (NVSCA);15, 16 2) The Netherlands Perinatal Registry (LVR/LNR);4 and 3) Eurocat 
Northern Netherlands (NNL).17 Internationally, data of Eurocat NNL have been frequently used 
to describe the epidemiology of oral clefts in the region NNL,2, 5, 9, 18 and occasionally, these 
data have been extrapolated to the rest of the Netherlands or used in a European context.7, 19 
It is doubtful, however, whether the region NNL contains a representative sample of the Dutch 
oral cleft population, as its oral cleft prevalence and trends seem to differ from those of Dutch 
national registries.7, 20, 21 These discrepancies may partly be due to differences in registration 
methods, such as ascertainment procedures and inclusion/exclusion criteria. Another possible 
explanation is that the oral cleft prevalence varies within the Netherlands. Since it was found 
previously that the cleft prevalence in NNL was higher than that in certain other European 
regions,2, 5 it might also be higher than that in the rest of the Netherlands. Analysis of regional 
differences in prevalence and time trends—between as well as within populations—is needed, 
as they may reflect differences in risk factors, preventive factors, or genetic predisposition.7, 11
In the present study, we used data from three Dutch registries (NVSCA, LVR/LNR, and Eurocat 
NNL) to establish the prevalence and time trends of oral cleft live births in the region NNL and in 
the rest of the Netherlands from 1997 to 2007, thereby investigating differences between and 
within registries in the Netherlands.
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METHODS
Data sources
The recording methods of the three registries we used have been described elsewhere4, 10, 15-17, 
22 and are summarized here.
The NVSCA registry is an anonymous national registry, which has been maintained by the 
Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA) since 1997. All fifteen 
multidisciplinary cleft palate teams in the Netherlands report their live-born patients with oral 
clefts—irrespective of age—before these patients have an oral cleft operation. These teams 
treat virtually all surviving children with oral clefts who reside in the Netherlands.15, 23 The 
NVSCA uses a unique detailed recording system, which is based on the embryology of the head 
and neck area. All individual anomalies can be described by recording the topography and 
morphology of each anatomical structure (e.g. lip, alveolus, hard palate, and soft palate includ-
ing the uvula). These detailed data can be collapsed to more general diagnoses or codes and 
can be classified in many different ways (e.g., CL±P and CP). Additionally, the NVSCA includes 
general information on infant and parents, and diagnoses of congenital anomalies of other 
organ systems. Note that the recording form is completed during the first visit of the patient to 
the team, which is usually in the postnatal period. No active follow-up of patients takes place. 
To optimize data quality, data are verified on a case-by-case basis, and the cleft palate teams 
perform case-ascertainment activities. Furthermore, the NVSCA registry has been systemati-
cally validated (Rozendaal et al. submitted).10, 16
The LVR/LNR is a linked database of three anonymous national registers, which has been 
maintained by The Netherlands Perinatal Registry since 1995: the National Register of Midwifes 
(LVR1), the National Register of Obstetricians (LVR2), and the National Neonatal Register (LNR). 
The LVR includes information on all pregnancies and births with at least 16 weeks of gestation, 
reported by midwives and obstetricians until the first week of life. The LNR includes information 
on all admissions and re-admissions of newborns to pediatric neonatal departments within 
the first 28 days of life for perinatal problems, reported by pediatricians and neonatologists. 
Besides a large amount of information on pregnancy, delivery, puerperium and neonatal care, 
the LVR/LNR contains information on diagnoses of several congenital anomalies. Oral clefts are 
recorded in the two categories CL±P and CP.4 
Eurocat NNL is a population-based birth defect registry that covers three provinces: Gronin-
gen, Friesland, and Drenthe. This registry is part of a European network of regional and national 
registers, and a WHO Collaborating Centre for the Epidemiologic Surveillance of Congenital 
Anomalies.24 Since 1981, children (until the age of 16 years at notification) and fetuses with 
congenital anomalies diagnosed before or after birth have been reported voluntarily by 
midwives, general practitioners, well-baby clinic doctors, specialists, and parents. In addition, 
various sources, like hospital registries, are searched to find children and pregnancies eligible 
for registration. There is no lower limit for gestational age, and both spontaneous and induced 
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abortions are included. Note that parental informed consent is needed for registration. Euro-
cat includes detailed information on congenital anomalies and risk factors (e.g., medication 
use). Oral clefts (and other congenital anomalies) are coded according to the “International 
Classification of Diseases” (ICD 9th and 10th revision) and subsequently classified into the two 
categories CL±P and CP.17
Study population
The population under study included all infants born alive in the Netherlands from 1997 
through 2007 who had been registered in the NVSCA, LVR/LNR, or Eurocat with an oral cleft 
(with or without additional congenital anomalies). We excluded median and atypical facial 
clefts because of their different pathogenesis.25, 26
Data analysis
To analyze population characteristics of the region NNL and the rest of the Netherlands, the 
NVSCA data on infant/maternal characteristics and additional congenital anomalies were used. 
These data were presented as percentages, medians with interquartile range [IQR], or means 
± 1 standard deviation (SD). Comparisons between the two regions were performed using the 
Chi-square test for categorical variables, the independent t-test for continuous variables having 
a normal distribution, and the Mann-Whitney test for continuous variables having a skewed 
distribution. 
We performed time-trend analyses to estimate the change in live-birth prevalence of all 
oral clefts and of the two cleft categories (CL±P and CP) in the region NNL and in the rest of the 
Netherlands from 1997 to 2007. To analyze the prevalence in NNL, data from all three registries 
were used: a) NVSCA data reported by the cleft palate teams in NNL (extracted by team); b) LVR/
LNR data of patients born in NNL (extracted by zip code); and c) Eurocat NNL data. The preva-
lence in the rest of the Netherlands was analyzed using data from the two national registries 
(NVSCA and LVR/LNR) that remained after extraction of the NNL data. For each data source 
and region, the annual prevalence was determined as the number of registered live-born 
infants with an oral cleft per 10,000 live births in the same region and year. The information on 
the annual numbers of live births in NNL and the rest of the Netherlands was retrieved from 
Statistics Netherlands.27 
We calculated 95% confidence intervals (CI) for the average prevalence, and we used the 
prevalence proportion ratio (PPR) and Chi-square test for analyzing differences between regis-
tries and regional comparisons within registries. Trends in the annual prevalence were analyzed 
by Poisson regression, modeling counts against year. The logarithm of the population size of 
live births was used as an offset. Subsequently, we calculated the estimated annual percentage 
change (EAPC) by fitting a regression line to the natural logarithm of the annual prevalence, 
using calendar year as a regressor variable, i.e., y = b + mx, where y = ln(annual prevalence) and 
x = calendar year. The EAPC was then estimated as 100 * (em – 1). Testing that the EAPC is 0% 
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is equivalent to testing the null hypothesis that the slope of the line in the above equation is 
equal to zero. This was tested by comparing m/SE(m) with a t-distribution with k – 2 degrees 
of freedom, where k is the length of the period. The standard error of m, SE(m), was gener-
ated from the fit of the regression. The calculation assumed that the logarithm of the annual 
prevalence changed at a constant rate over the entire period. The EAPC represents an estimate 
of the year-to-year change in prevalence; negative values represent a declining prevalence and 
positive values represent an increasing prevalence. Statistical significance level for α was set at 
0.05. Statistics were performed using the Statistical Package for Social Sciences (SPSS) version 
17.0 (SPSS Inc., Chicago, IL).
Table 1. Characteristics of the study population of the Northern Netherlands and the rest of the 
Netherlands during 1997-2007, based on data of the NVSCAa
Characteristic Northern
Netherlands
(n = 456)
Rest of the 
Netherlands
(n = 3118)
p Valueb
General information
Boys 258 (56.6) 1841 (59.0) 0.318
Mean birth weight in grams ± SDc 3330 ± 647 3300 ± 655 0.373
Mean gestational age in weeks ± SDd 39 ± 2.1 39 ± 2.2 0.566
Median referral age in months [IQR] 1.9 [1.2-3.0] 0.53 [0.23-1.37] 0.000
Caucasian father 425 (93.2) 2696 (86.5) 0.000
Caucasian mother 433 (95.0) 2731 (87.6) 0.000
Consanguinity 5 (1.1)  76 (2.4) 0.072
Congenital anomalies among relatives 133 (29.2) 840 (26.9) 0.318
Oral clefts among relatives 81 (17.8) 561 (18.0) 0.905
Oral clefts 
CL±P 313 (68.6) 2094 (67.2) 0.528
CP 143 (31.4) 1024 (32.8) 0.528
Additional congenital anomaliese
Other craniofacial anomalies 66 (14.5) 208 (6.7) 0.000
Anomalies other organ systems 67 (14.7) 553 (17.7) 0.109
Syndrome or chromosomal defect 58 (12.7) 300 (9.6) 0.040
NVSCA = Dutch Association for Cleft Palate and Craniofacial Anomalies; n = number; CL±P = cleft lip/alveolus 
with or without cleft palate; CP = cleft palate only; IQR = interquartile range; SD = standard deviation.
a Values are numbers (percentages) unless stated differently.
b p value presents statistical significance level for differences between the two regions: Chi Square test 
for proportions, Mann-Whitney test or independent t-test for continuous variables. p value <0.05 is 
used to determine statistical significance and is presented in bold format.
c Valid cases: Northern Netherlands (n = 443) and rest of the Netherlands (n = 2982).
d Valid cases: Northern Netherlands (n = 450) and rest of the Netherlands (n = 2993).
e Note that the NVSCA has no active follow-up of patients and that associated anomalies detected later 
in infancy are often not included.
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RESuLTS
Study population characteristics
During 1997-2007, a total of 456 and 3118 infants were born alive with oral clefts in the region 
NNL and in the rest of the Netherlands, respectively, and registered in the NVSCA. The charac-
teristics of the study population are presented in Table 1. The median age at cleft palate team 
admission was significantly higher in NNL than in the rest of the Netherlands (difference in 
months: 1.37). The percentage of Caucasian parents was also significantly higher (difference in 
percentage points (pp): 6.7 and 7.4 for Caucasian father and mother, respectively). Finally, oral 
clefts in NNL were more frequently associated with other anomalies of the head and neck area 
(difference in pp: 7.8) and with syndromes or chromosomal defects (difference in pp: 3.1) than 
those in the rest of the Netherlands.
Average prevalence 
During 1997-2007, there were 213,209 live births in the region NNL; the average oral cleft 
prevalence of the NVSCA was 21.4 per 10,000 live births (Table 2). Infants with CL±P accounted 
for 68.6% of the study population, corresponding to a prevalence of 14.7 per 10,000 live births. 
The average prevalence of CP was 6.7 per 10,000 live births. The NVSCA identified 42% (PPR 
= 1.42) more oral clefts than did the LVR/LNR (PPR = 1.47 for CL±P, and PPR = 1.31 for CP). By 
contrast, the NVSCA prevalence was not significantly different from that of Eurocat: all clefts 
(PPR = 1.05), CL±P (PPR = 1.11), and CP (PPR = 0.93).
In the rest of the Netherlands (Table 2), there were 1,938,999 live births during the study 
period. In this region, the NVSCA also identified more oral clefts than did the LVR/LNR: 22% 
(PPR = 1.22) more oral clefts, 24% (PPR = 1.24) more CL±P, and 18% (PPR = 1.18) more CP. When 
comparing both regions within the NVSCA, we found that 33% (PPR = 1.33) more oral clefts 
were identified in NNL than in the rest of the Netherlands (PPR = 1.36 for CL±P, and PPR = 1.26 
for CP)
Time trends
Figure 1A-C displays the annual live-birth prevalence in the region NNL from 1997 through 
2007 for the NVSCA, LVR/LNR, and Eurocat. Although the oral cleft prevalence in NNL seemed 
to decrease in the NVSCA, time-trend analyses showed no significant trends: all clefts (EAPC 
–2.3%; 95% CI: –5.3% to +0.60%), CL±P (EAPC –1.5%; 95% CI: –5.1% to +2.0%), and CP (EAPC 
–4.0%; 95% CI: –9.3 to +1.3%) (Figure 1A). For the LVR/LNR, we observed a small, but not statisti-
cally significant, increase in live-birth prevalence over time: all clefts (EAPC +2.3; 95% CI: –1.2 to 
+5.8), CL±P (EAPC +1.8; 95% CI: –2.5 to +6.1), and CP (EAPC +3.1; 95% CI: –3.0 to +9.1) (Figure 
1B). Like the two national registries, Eurocat showed no significant changes in prevalence over 
time: all clefts (EAPC –0.20%; 95% CI –3.2% to +2.9%), CL±P (EAPC –0.30%; 95% CI: –4.0% to 
+3.5%), and CP (EAPC 0%; 95% CI: –5.1% to +5.1%) (Figure 1C).
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Figure 1. Regional time trends in prevalence of all clefts and the two categories (CL+/-P and CP) per 
10,000 live births in the Netherlands, 1997-2007. Trends in the Northern Netherlands were based on the 
NVSCA (A), LVR/LNR (B), and Eurocat (C). CL+/-P = cleft lip/alveolus with or without cleft palate; CP = cleft 
palate only.
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For the rest of the Netherlands, the annual live-birth prevalence of the NVSCA and LVR/LNR 
is shown in Figure 1D,E. Time-trend analysis of NVSCA data showed that over the 1997-2007 
period, the live-birth prevalence of all clefts in the rest of the Netherlands decreased signifi-
cantly by 1.9% per year (95% CI: –3.1% to –0.80%) (Figure 1D). The prevalence of CL±P showed 
a trend similar to that observed for all clefts; per year, it decreased by a significant 2.2% (95% CI: 
–3.6 to –0.80%). By contrast, no significant trend in CP prevalence was found (EAPC –1.4%; 95% 
CI: –3.4% to +0.60%). For the LVR/LNR, a significant decreasing trend in the rest of the Nether-
lands was detected for CL±P (EAPC –3.0%; 95% CI: –4.6% to –1.5%). However, no evidence for a 
significant trend in all clefts (EAPC –1.3%; 95% CI: –2.5% to 0%) was found. Surprisingly, the CP 
prevalence in the LVR/LNR increased significantly during the study period (EAPC +2.2; 95% CI: 
+0.10% to +4.3%) (Figure 1E).
*
*
*
*
Figure 1. (continued) Trends in the rest of the Netherlands were based on the NVSCA (D) and LVR/LNR (E). 
CL+/-P = cleft lip/alveolus with or without cleft palate; CP = cleft palate only.
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DISCuSSION
This study shows that the live-birth prevalence of oral clefts varies significantly in the Neth-
erlands, not only between registries but also within registries. Specifically, we found that the 
live-birth prevalence of all clefts and of both categories (CL±P and CP) is higher in NNL than 
in the rest of the Netherlands. Furthermore, a significant decreasing trend in CL±P prevalence 
was found for live births in the rest of the Netherlands, but not for those in the region NNL. 
By comparing the average prevalence between registries, we found for both regions that the 
prevalence from the NVSCA is significantly higher than that from the LVR/LNR, while it is similar 
to that of Eurocat.
Strengths and limitations
While the use of three registry databases gave our study its main strength—it allowed us to 
analyze complementary data on oral cleft live births—it also had some limitations. The registries 
have different aims and registration methods, such as ascertainment procedures and inclu-
sion/exclusion criteria, that will always vary. So will the subjectivity that is inevitable among 
personnel who enter the information. For example, the primary aim of the LVR/LNR is to collect 
information on all pregnancies and not solely on congenital anomalies, and data are recorded 
by many different health care providers. As a result, this registry might have more underreport-
ing and misclassification of clefts than do specific congenital anomaly registries.23 This could 
partly explain its significantly lower prevalence for both regions. Another explanation for this 
lower prevalence is that not all health care providers participate in the LVR/LNR yet.22 However, 
the coverage of the LVR/LNR increased during the study period,22 which is probably reflected 
by the increasing CL±P and CP trends in this registry.
Despite various case-ascertainment and validation methods,10, 16, 17 the NVSCA and Eurocat 
also differed somewhat in prevalence, most likely due to selection/survival bias. Eurocat needs 
parental informed consent to record its patients, which might explain its slightly lower oral cleft 
prevalence. Conversely, the NVSCA misses infants with severe associated anomalies who die 
after birth and do not reach the cleft palate teams (mostly being CP patients), which probably 
explains its slightly lower CP prevalence. 
Another weakness of the databases we used is that cases could not be directly matched 
between the registries due to confidentiality constrains and limitations/differences in key infor-
mation. Additionally, we were not able to give complete and reliable national trends according 
to whether clefts were isolated or associated with other anomalies. The NVSCA and LVR/LNR 
have no active follow-up of patients, and therefore, associated anomalies detected after regis-
tration are not included (Rozendaal et al. submitted).4, 28 In preliminary analyses, even low-end 
estimates of isolated and non-isolated clefts did not provide more insight into the causes of 
regional variation in prevalence and trends (personal communication A.M.R.). 
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Finally, the databases do not provide complete and reliable national data on clefts among 
stillbirths and pregnancy terminations, which are essential to gain more insight into the causes 
of the decline in oral clefts. Hopefully, national information on these cases will be available in 
the future, as the Netherlands is developing a national uniform registry for the outcomes of 
prenatal screening, including prenatally diagnosed anomalies and outcomes of pregnancies.29
Possible explanations for regional variation in overall prevalence
Our results for the region NNL are in line with those of Cornel et al.,2 who reported a similar 
prevalence for all clefts and both categories (CL±P and CP) for the period 1981-1988. Hence 
the high prevalence in NNL seems to have already existed for a long time and to be fairly 
constant. This is also consistent with combined international registry data, which showed that 
the prevalence of oral clefts is relatively high in the region NNL.5, 6 Worldwide, the average 
prevalence of oral clefts is 15.2 per 10,000 births,1 and international studies have shown a large 
variation in prevalence between and within countries, without consistent time trends.3, 6, 7, 9, 
11, 18 Unfortunately, comparison of our findings with those of other studies is restricted, due 
particularly to the great differences between data sources, times of diagnosis, classifications, 
inclusion/exclusion criteria, time scales, sample sizes, and population characteristics.3, 6, 8, 9
Regional differences in epidemiological patterns may be due to variations in genetic and 
environmental risk factors, and in gene-environment interactions as well.4, 8, 12, 13 In this study, 
we found some regional variation in population characteristics, which may explain the differ-
ences in prevalence we found within the Netherlands. Firstly, the NNL population included 
relatively more infants with Caucasian parents than that of the rest of the Netherlands. Given 
that Anthony et al.4 described previously that Dutch people have a higher oral cleft risk than 
other ethnic groups, the geographical variation in oral clefts in the Netherlands may be 
explained by ethnic differences. Additionally, the NNL population might have a higher risk on 
genetic predisposition, because many families have lived in this region since ages, and there 
is less immigration in this region than in the rest of the Netherlands.27 This is supported by 
the relatively high cleft prevalence found in Northern European countries, especially Denmark, 
which have until recently homogenous populations and high quality registrations.1, 5, 6, 9, 18 
The fact that patients in NNL had more associated syndromes and chromosomal defects also 
suggests genetic variation between the two study populations, since these syndromic clefts 
are more frequently related to a genetic background than non-syndromic clefts.8 The higher 
proportion of associated defects may on the other hand also be explained by the higher referral 
age we found for NNL patients, since many associated anomalies are diagnosed at a later age 
(Rozendaal et al. submitted).28 
Possible explanations for differences in regional time trends
Our findings of a decline in oral cleft live births in the rest of the Netherlands may be explained 
by several factors that changed during the study period. The first might be the increase in 
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prenatal detection of congenital anomalies (including oral clefts) followed by termination of 
pregnancy (TOP). Abortion in the Netherlands is allowed until the 24th week of pregnancy, only 
under the provision of the Termination of Pregnancy Act (WAZ).30 Since no specific indication 
is needed, TOP is allowed for clefts with associated anomalies as well as for isolated clefts. If 
pregnancies are terminated because of an oral cleft, the prevalence of CL±P will be affected 
most since CL can be detected prenatally using 2D ultrasound, while CP is often not being 
found.3, 31 
Since the 1990s, the performance of prenatal 2D ultrasound examinations has increased 
in the Netherlands, resulting in greater prenatal detection of congenital anomalies, including 
CL±P, in both NNL and the rest of the Netherlands.32, 33 As it did elsewhere,3, 6, 9, 31 this may have 
led more affected pregnancies to be terminated in the Netherlands. However, our findings sug-
gest that this happened only in the rest of the Netherlands, as we found no declining trends in 
NNL. This is supported by Eurocat data showing low and rather stable rates of TOP among clefts 
in NNL;6 all of these were associated with other congenital anomalies, including chromosomal 
defects (personal communication M.K.B.). Additionally, this explanation is also supported by 
national data on TOPs; under the terms of the WAZ, all Dutch hospitals and clinics performing 
TOPs are required to report these terminations (indication not included).34 Annual reports of 
the WAZ have shown that second-trimester terminations have hardly been performed in NNL, 
while they have increased in the rest of the Netherlands since 2003, especially those of 20-24 
weeks of gestation performed by the hospitals. As stated in these reports, this increase implies 
that there has been a rise in termination of pregnancies affected with congenital anomalies, 
because these terminations are mainly performed by the hospitals.34 
Another explanation for the decline in oral cleft live births in the rest of the Netherlands 
might be that increased periconceptional use of folic acid and/or multivitamins has reduced 
the risk of oral clefts. The preventive effects of folic acid/multivitamins have been frequently 
described, but the results are mixed in terms of estimated effects and whether CL±P or CP 
or both are affected.35-37 In a meta-analysis including the most recent observational studies, 
Johnson and Little35 estimated that the risk of CL±P decreased with 18% while using folic acid-
containing supplements and with 23% while using multivitamins. They found no significant 
reduction in CP after supplementation, while compulsory folic acid fortification reduced the 
risk for both CL±P and CP.35
In the Netherlands, women are recommended to take 400 µg folic acid/day from 4 weeks 
before conception until 8 weeks thereafter. Although complete data on the use of folic acid in 
the Netherlands are lacking, several data have shown that the proportion of expecting moth-
ers correctly using folic acid increased from 15-29% in 1996 to about 50% in 2003-2005.38, 39 
Given that most sub-phenotypes of CL±P (complete clefts of the lip/alveolus) develop during 
weeks 4-7 after conception, while incomplete CL±Ps and all sub-phenotypes of CP develop 
during weeks 8-12 after conception (Vermeij-Keers et al., submitted),12 the increase in folic acid 
supplementation until 8 weeks postconception might have mainly affected the prevalence of 
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CL±P.20 This would explain the absence of significant trends for CP in our study, which is in 
line with other studies reporting a reduced risk for only CL±P after the same supplementation 
period (4 weeks before conception until 8 weeks thereafter).40-42 As our effect-measures for 
NNL also indicated decreasing trends, the absence of a significant decline of CL±P in this region 
could solely be due to sample size. 
Finally, other environmental or lifestyle factors (e.g., dietary patterns) changing over time 
may also account for the decrease in prevalence.8 Specific data on these factors are not avail-
able for the Dutch cleft population, but data on the general population have shown that smok-
ing and alcohol consumption decreased among Dutch women of reproductive age during the 
study period.43 Although these changes are certainly too small to account for the complete 
decline in oral clefts, they may have played contributory roles given the causal heterogeneity 
of clefts.8
CONCLuSIONS
In conclusion, this study presents evidence from three Dutch registries that the epidemiologi-
cal pattern of oral clefts varies within the Netherlands. Although the registries showed some 
differences in prevalence, they showed similar results on the regional variation in prevalence as 
well as in time trends of oral cleft live births. Therefore, our findings are unlikely to be explained 
by methodological factors, such as ascertainment methods. 
The findings that the oral cleft prevalence in NNL is not only higher than that in certain other 
European areas but also than that in the rest of the Netherlands may have several implications, 
both nationally and internationally. Although regional data have utility for health services, 
clinicians and researchers in that specific area and can be compared to global means and 
trends, our results underline that extrapolation to a whole country or larger area should be 
made with caution.9 To further investigate environmental and genetic factors that influence the 
risk on oral clefts, future studies should consider the geographical differences in oral clefts—
between and within countries—regarding the various cleft sub-phenotypes among live births, 
stillbirths, and spontaneous/induced abortions. Finally, our results suggest that the decline 
in live-birth prevalence of oral clefts may have been caused by increased prenatal detection 
followed by TOP and/or by increased periconceptional use of folic acid in the Netherlands. This 
would have implications for healthcare and policy makers, as evidence-based guidelines can 
optimize prenatal counseling, and increases in folic acid exposure, including extension of the 
supplementation period, may produce further reductions in prevalence.
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AbSTRACT
Objective: Using the Dutch Oral Cleft Registration, which records the morphology and topogra-
phy of common oral clefts, a new classification based on the (patho)embryology of the primary 
and secondary palates was tested.
Design: Prospective observational study.
Setting: The fifteen cleft palate teams in the Netherlands register patients to the national reg-
istry.
Patients: All unoperated patients with common oral clefts reported between 1997 and 2006 
inclusive were included.
Main outcome measures: The classification is based on the pathoembryological events that 
ultimately result in various sub-phenotypes of common oral clefts. Patients within the three 
categories cleft lip/alveolus (CL/A), cleft lip/alveolus and palate (CL/AP) and cleft palate (CP) 
were divided into three subgroups: fusion defects, differentiation defects, and fusion and dif-
ferentiation defects. A timetable was constructed to relate the type of clefting to the time of 
derailment during embryonic development.
Results: 3512 patients were included. Patients with CL/A showed 22% fusion defects, 75% dif-
ferentiation defects, and 3% fusion and differentiation defects. CL/AP patients and CP patients 
mostly showed fusion defects (70% and 89%, respectively). We were able to relate almost all 
(over 90%) cleft sub-phenotypes to specific weeks in embryonic development.
Conclusions: This classification provides new cleft subgroups that may be used for clinical and 
fundamental research. The sub-phenotypes of these subgroups originate from different time 
frames during embryonic development and different cell biological mechanisms, thereby 
enabling more accurate data for, e.g., gene identification and/or environmental factors.
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INTRODuCTION
Common oral clefts are one of the most frequent congenital anomalies worldwide.1 Ethnic, 
socioeconomic, and geographic variations may partly account for the large multifactorial group 
of nonsyndromic common oral clefts.2-4 A quest for identifying genes and environmental fac-
tors responsible for these anomalies has been done for years. However, only a small part of the 
nonsyndromic common oral clefts have been related to specific genes and/or environmental 
factors, such as MSX1 or smoking.4-8 Within this multifactorial group, huge variations in cleft 
sub-phenotypes exist. These various cleft types originate from different developmental time 
periods (Vermeij-Keers, unpublished data),9 and therefore have different exposures to genes 
and environmental factors.10 If patients with different cleft sub-phenotypes are treated as a 
single group, linkage studies with genes and/or environmental factors may not be as fruitful 
as hoped.8 Therefore, a new classification based on the human embryology of the primary 
and secondary palates was previously introduced (Vermeij-Keers, unpublished data).11, 12 In 
this classification, different sub-phenotypes of common oral clefts are distinguished based 
on different cell biological mechanisms and related to different time periods in embryonic 
development. 
Such a classification can be applied only if detailed phenotype descriptions of the common 
oral clefts are available. In 1997, a new descriptive recording system was developed on behalf 
of the Dutch Association for Cleft Palate and Craniofacial Anomalies (NVSCA).13 This system, the 
NVSCA registry, consistently records all abnormalities of each anatomic structure that form the 
common oral cleft. 
Recently, the feasibility of our new classification was shown for clefts of the primary palate 
using adult unoperated patients from Indonesia (Vermeij-Keers, unpublished data). In addi-
tion, we used this embryological approach to validate NVSCA registry data on the specific 
oral cleft features.11 Previously, we divided broad categories into fusion and/or differentiation 
defects,12 but it is unknown whether this classification is complete and feasible for all cleft sub-
phenotypes of the primary and secondary palates among newborns. 
In this study, we applied the classification to unoperated infants with common oral clefts 
using detailed data of the cleft sub-phenotypes from the NVSCA registry. After considering the 
normal and abnormal development of the primary and secondary palates, their clefts were first 
traditionally classified into three categories: cleft lip/alveolus (CL/A), cleft lip/alveolus and pal-
ate (CL/AP), and cleft palate (CP). Subsequently, we classified the various cleft sub-phenotypes 
within these categories into fusion and/or differentiation defects. Finally, we constructed a 
timetable, relating the various fusion and/or differentiation defects to weeks in embryonic 
development.
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MATERIAL AND METHODS
Patients
In this study, we included all unoperated patients with a common oral cleft that had been 
reported by the 15 multidisciplinary cleft palate teams to the NVSCA registry between 1997 
and 2006 inclusive. After careful examination, the consulting physicians (plastic surgeon, 
orthodontist or pediatrician) recorded these patients using the NVSCA recording form.13 All 
forms were examined for incorrect, inconsistent, or insufficient data by the authors. If additional 
information was needed, it was provided by the cleft palate teams. In addition, the registry data 
were systematically validated.11, 14, 15
In this study, only common oral clefts were included. Median cleft lip and atypical facial 
clefts were excluded for their different pathogenesis.9, 16
Embryological basis of the classification
To place the different sub-phenotypes of oral clefts into the correct time periods and cell 
biological mechanisms during human embryonic development, the normal and abnormal 
development of the primary and secondary palates should be understood and is therefore 
briefly reviewed here.
Normal development of primary and secondary palates: fusion and differentiation
Normal embryonic development of the primary palate (the presumptive lip and alveolus) can 
be divided into early and late embryonic development (i.e., 4 to 7 weeks of development and 7 
to 12 weeks of development [postconception], respectively).9, 10, 17 In contrast, the development 
of the secondary palate (the presumptive hard and soft palates, including the uvula) takes place 
in the late embryonic period (7 to 12 weeks of development). During early development, the 
primary palate is formed in an occipito-frontal direction by fusion of three outgrowing facial 
swellings around each nasal placode (left and right). First, the maxillary process (occipitally) 
and subsequently the lateral nasal process (frontally) adhere and fuse with the medial nasal 
process.9, 17, 18 As a consequence, the lateral and medial nasal processes always surround the 
nasal apertura. During the fusion process, the ectoderm covering the mesenchymal cores of 
the swellings on the fusion side is enclosed and an epithelial plate (the nasal fin) is formed. 
From the occipital part of this plate, the oronasal membrane (i.e., bucconasal membra ne) 
develops and subsequently ruptures by cell death (6 to 7 weeks of development). During the 
same weeks, the epithelial plate gradually disappears by programmed cell death followed by 
epitheliomesenchymal transformation (EMT) and/or migration (Vermeij-Keers, unpublished 
data).17, 19-23 The last location for the epithelial plate to disappear is at the fusion of the pre-
sumptive lip, beneath the nostril.
When late development starts, the mesenchymal cores of the facial swellings have fused 
completely. Subsequently, the primary palate differentiates by (1) outgrowth of the lip and 
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alveolar process in a caudal direction, thereby causing the labial groove, and (2) the develop-
ment of a left and right bone center of the maxilla and two bone centers in each premaxilla.9, 
17 These bone centers approach each other and fuse without forming sutures, except between 
the two premaxillae (the intermaxillary suture). Bony differentiation is accompanied by the 
development of facial musculature.
During the development of the secondary palate, the palatine processes grow out, elevate, 
adhere, and fuse bilaterally with the primary palate and then in the median plane in a fronto-
occipital direction.23-28 They fuse with each other and with the nasal septum. Again, ectoderm 
of the various processes is enclosed during the fusion process, and a Y-shaped epithelial plate 
forms. Subsequently, this plate disappears gradually by programmed cell death followed by 
EMT, and/or migration of epithelial cells towards the nasal side of the plate.9, 23, 24, 29-40 Although 
the cell fate underlying the disappearance of the epithelial plate has been controversial for 
many years, two recent review papers41, 42 showed that none of the three possible cell biologi-
cal mechanisms (programmed cell death, EMT, and migration) can be excluded.
While the palatine processes grow out, the bone centers of the palatine bones develop bilat-
erally. During the fusion process, they approach each other and the bone centers of the maxilla. 
The same holds for the maxilla and premaxillae. In this way, the median and transverse palatine 
sutures develop, as well as the bilateral incisive sutures. In addition, bony differentiation is 
accompanied by muscular differentiation. In conclusion, the primary and secondary palates 
develop in opposite directions: the facial swellings fuse in an occipito-frontal direction, while 
the palatine processes fuse in a fronto-occipital direction.
In view of the above, disturbances during the development of the primary and/or second-
ary palates give rise to fusion and/or differentiation defects. Examples of different cleft sub-
phenotypes in relation to the various developmental periods and cell biological mechanisms 
are discussed below.
Abnormal development of primary and secondary palates: fusion and differentiation defects
Complete cleft lip and alveolus, early embryonic development
This type of clefting represents no fusion at all and is therefore considered a fusion defect, 
because of insufficient outgrowth of the facial swellings, lack of adherence of these swellings, or 
failure of programmed cell death/EMT/migration, that is, the epithelial plate does not develop 
or it remains intact. During the latter situation, further differentiation causes the ectoderm to 
separate again at the fusion site, resulting in a complete cleft lip and alveolus extending to the 
incisive foramen (Figures 1 and 2). As this process is completed before the secondary palate 
starts to fuse, these primary palatal defects are independent of the secondary palatal defects.9 
As a result, complete cleft lip and alveolus can be observed with a normal secondary palate 
(Figure 1b), or with an abnormal secondary palate, such as a complete cleft palate (Figure 2b). 
In the last case, it is readily possible that the palatal shelves could not have reached each other 
because of the width of defect of the primary palate.
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If fusion of the primary palate stops at a certain place along the fusion line, this always gives 
rise to a complete cleft lip combined with an intact alveolar process, or an incomplete cleft of 
the alveolar process. 
Incomplete cleft lip with or without an incomplete cleft alveolus, late embryonic development
After fusion of the maxillary and lateral nasal processes with the medial nasal process, the 
primary palate differentiates by outgrowth of the lip and alveolus into a caudal direction. Since 
the fusion process has been completed at that stage, an incomplete cleft lip always displays a 
tissue bridge below the nostril (Vermeij-Keers, unpublished data).10, 12 Consequently, the left 
1a 1b
Figure 1. A complete left cleft of the lip and alveolus (a); the secondary palate is intact (b).
2a 2b
Figure 2. A complete left cleft of the lip/alveolus (a), hard and soft palate (b).
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incomplete cleft lip and cleft alveolus of the patient in Figure 3a have their origin in incomplete 
caudal outgrowth and/or differentiation of the primary palate during late embryonic develop-
ment (i.e., a differentiation defect). The right side of the same patient shows an incomplete 
cleft lip and a normal alveolus, demonstrating the about same starting point of disruption 
(incomplete outgrowth of the lip during late embryonic development). The presence of incom-
plete outgrowth of the alveolus at one side with normal outgrowth of the contralateral alveolus 
in the same individual might be explained by left/right asymmetry in the timing of the bony 
differentiation. The tissue bridge under de right nostril is larger than at the left side, suggesting 
that the outgrowth of the right lip started earlier than that of the left lip. Likewise, we presume 
that differentiation of the right alveolus preceded the differentiation of the left alveolus. When 
the event of disruption occurred, it is readily possible that differentiation of the right alveolus 
had already been completed, while that of the left alveolus was still differentiating, resulting 
in a normal right alveolus and an incomplete cleft of the left alveolus. A notch in the arch, 
hypoplasia, or a submucous cleft of the alveolar arch can also accompany the incomplete cleft 
lip. It is most likely that the abnormalities of the alveolar arch are the result from insufficient 
outgrowth of the premaxillary bone centers rather than the maxillary centers (Vermeij-Keers, 
unpublished data). 
Incomplete cleft lip and ipsilateral complete cleft alveolus, early and late embryonic development
In an incomplete cleft lip with an ipsilateral complete cleft alveolus (Figures 4a,b and 5a), the 
fusion process of the lip has been completed because a tissue bridge beneath the nostril has 
been formed. It is therefore a differentiation defect of the lip, which arises during late embry-
onic development. In the case of a small tissue bridge combined with an ipsilateral complete 
3a 3b
Figure 3. A bilateral asymmetric incomplete cleft of the lip with a normal right alveolus, and an 
incomplete cleft of the left alveolus (a) combined with a complete cleft of the soft palate (b).
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cleft alveolus (Figure 4b), the term Simonart’s band is used. The alveolar defect is a fusion defect 
that can be explained by a too wide oronasal membrane or a local persistence of the epithelial 
plate in front of the oronasal membrane. This part of the epithelial plate does not disappear 
by programmed cell death/EMT/migration during the early embryonic development (Vermeij-
Keers, unpublished data). As is shown by these two patients, the appearance of the primary 
palate does not predict the appearance of the secondary palate (Figures 4b and 5b).
4a 4b
Figure 4. An incomplete right cleft of the lip, a complete alveolar cleft (a), combined with a complete cleft 
of the hard and soft palate (b).
5a 5b
Figure 5. An incomplete cleft of the right lip and a complete alveolar cleft (a), combined with an 
incomplete cleft of the hard palate and a complete cleft of the soft palate (b).
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Complete cleft hard and soft palate, late embryonic development
If the palatine processes do not grow out or elevate insufficiently, a complete cleft of the hard 
and soft palate will result. This type of cleft can also occur when the palatine processes elevate, 
but do not adhere or fuse with the primary palate, with each other, and with the nasal septum 
(Figures 2b and 4b). These fusion defects develop early in secondary palatogenesis during the 
late embryonic period. 
Incomplete cleft hard palate and complete cleft soft palate, late embryonic development
After elevation of the palatine processes, adhesion/fusion occurs in a fronto-occipital direction. 
If along this fusion line the fusion process is disrupted, various types of cleft palate can be 
observed (i.e., fusion defects). Relative early disruption of this fusion process may result in an 
incomplete cleft of the hard palate and complete cleft of the soft palate (including the uvula; 
Figure 5b). Somewhat later in development the hard palate is fused. If the fusion process stops 
after fusion of the hard palate, an intact hard palate will result, combined with a complete or 
incomplete cleft of the soft palate. Whether there will be a complete or incomplete cleft of the 
soft palate depends on the time of disruption. If disruption occurs later during the fusion pro-
cess, more of the soft palate will be intact (Figure 3b). Therefore, an incomplete cleft of the hard 
palate combined with a complete cleft of the soft palate precedes complete and incomplete 
clefts of the soft palate.
Subclinical features of clefting regarding the primary and/or secondary palates
Milder expression of clefting can also be observed, such as a submucous cleft lip (also known 
as forme fruste, congenital scar, and microform, subsurface or subcutaneous cleft), submucous 
cleft palate, and bifid uvula. Except for the latter cleft type, which results from a fusion defect at 
the end of the fusion process of the secondary palate, these subclinical phenotypes can be con-
sidered as differentiation defects. Submucous clefts result from defective differentiation into 
bone and/or musculature, after completion of the fusion process. Other differentiation defects 
of the secondary palate include: (1) absence (agenesis) of the palatine bone, (2) a palatine bone 
and/or maxilla (palatine part) that is undersized (hypoplasia), or a submucous cleft, and/or (3) 
hypoplastic musculature. 
Furthermore, with our concept of fusion/differentiation defects, special types of human 
cleft sub-phenotypes can be explained, such as an (in)complete cleft of the hard palate com-
bined with an intact soft palate and uvula.43, 44 This type may be the result of local insufficient 
programmed cell death/EMT/migration within the enclosed epithelial plates. Recently, it was 
reported that differential expression of proteins in the developing anterior and posterior sec-
ondary murine palate may cause too short anterior palatal shelves because of diminished cell 
proliferation and increased programmed cell death. The anterior palatal shelves do not reach 
each other, and a cleft of the hard palate remains. At that spot, the epithelium of the palatine 
processes persists, which causes a local fusion defect.45 Another explanation of non-fusion 
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of the anterior palatal shelves was described based on thickened palatal epithelium in Tbx1-
/- mice.46
Classification
In line with recent studies,11, 13, 47, 48 we divided our study population into the three categories 
(CL/A, CL/AP, and CP). As we have shown previously, these categories manifest very heteroge-
neous cleft sub-phenotypes.11, 13 To classify these types, the common oral clefts were divided 
into fusion and/or differentiation defects of the primary palate (lip and alveolus), the secondary 
palate (hard and soft palate, including the uvula), or both. The template for deciding which 
abnormality of the lip, alveolus, and hard and soft palates is a fusion defect or a differentiation 
defect is listed in Table 1. Theoretically, any combination of clefts of the lip, alveolus, hard and/
or soft palates is possible, so each category was subdivided into three subgroups: fusion (F) 
defects, differentiation (D) defects, and fusion and differentiation (FD) defects. 
Table 1. Classification of cleft sub-phenotypes of the primary and secondary palates: division into fusion 
and/or differentiation defects. Any combination of abnormalities of the lip, alveolus, hard and soft palate 
is allowed (adapted from Rozendaal et al.)11
Fusion defects Primary palate Complete cleft lip
Complete cleft alveolus (extending to the foramen 
incisivum)
Incomplete cleft alveolus (only if the lip is normal 
or has a complete cleft)
Secondary palate Complete cleft hard palate
Incomplete cleft hard palate
Complete cleft soft palate
Incomplete cleft soft palate
Complete uvular cleft
Incomplete uvular cleft
Differentiation defects Primary palate Incomplete cleft lip
Submucous cleft lip*
Hypoplastic lip
Incomplete cleft alveolus (only if the lip has an
incompleet or submucous cleft)
Submucous cleft alveolus 
Hypoplastic lip/alveolus
Secondary palate Submucous cleft hard palate
Hypoplastic hard palate
Submucous cleft soft palate (including uvula)
Hypoplastic soft palate (including uvula)
* Synonyms: congenital scar, forme frust, subsurface cleft lip,  subcutaneous cleft lip, and microform cleft 
lip.
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RESuLTS
The national registry recorded 3512 patients with a common oral cleft from 1997 to 2006. 
Twenty-eight percent of all patients showed a CL/A, 39% showed a CL/AP, and 33% exhibited 
a CP. The subdivision of the cleft sub-phenotypes—within these categories—into F defects, D 
defects, and FD defects is presented in Table 2. CL/A patients showed in 22% an F defect, in 75% 
a D defect, and in 3% an FD defect. CL/AP patients showed most frequently F defects (70%) and 
FD defects (29%). The vast majority of the CP patients displayed an F defect (85%).
As FD defects in CL/AP patients (n = 389) may involve F defects and D defects of the primary 
palate as well as of the secondary palate, we divided the study group into F, D, and FD defects 
concerning the primary and secondary palates (Table 3).  The FD defects in CL/AP patients were 
mostly D defects (n = 159, 41%) or FD defects (n = 205, 52%) of the primary palate combined 
with F defects of the secondary palate. Of the 2340 patients with a defect of the primary palate, 
1182 (51%) patients showed an F defect, 914 (39%) patients exhibited a D defect, and 244 (10%) 
patients showed an FD defect. A total of 2535 patients had a defect of the secondary palate and 
Table 2. Classification of the sub-phenotypes within the three cleft categories: division into fusion and/or 
differentiation defects (n = 3512, Dutch Oral Cleft Registry 1997-2006)*
Type Subgroups Total
F D FD
CL/A 213 729 35 977
CL/AP 960 14 389 1363
CP 997 101 74 1172
Total 2170 844 498 3512
* CL/A = cleft lip and/or cleft alveolus, CL/AP = cleft lip and/or cleft alveolus and cleft palate, CP = cleft 
palate, F = fusion defects, D = differentiation defects, FD = fusion and differentiation defects.
Table 3. Classification of all patients with common oral clefts (n = 3512) into fusion and/or differentiation 
defects of the primary and/or secondary palates, based on data from the Dutch Oral Cleft Registry 1997-
2006*
Primary palate Secondary palate Total
No defect F D FD
F 213 960 6 3 1182
D 729 159 14 12 914
FD 35 205 2 2 244
No defect 997 101 74 1172
Total 977 2321 123 91 3512
* F = fusion defects, D = differentiation defects, FD = fusion and differentiation defects.
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an intact primary palate. In 92% of the patients (n = 2321), an F defect was observed, and in the 
remaining 8%, a D defect (n = 123) or FD defect (n = 91) was identified.
Fusion and/or differentiation defects of the primary palate
As shown in Table 4, F defects of the primary palate (n = 1183) mostly were of complete clefts of 
the lip/alveolus (62% in CL/A and 96% in CL/AP patients). Complete cleft lip combined with an 
incomplete cleft alveolus, as well as complete cleft lip, were less frequently observed. Together, 
these three types of clefting accounted for 99% of all F defects of the primary palate.
Ninety-two percent (n = 914) of D defects of the primary palate were incomplete clefts of 
the lip/alveolus (37% CL/A; 69% CL/AP), or incomplete clefts of the lip (51% CL/A; 20% CL/AP), 
or submucous clefts of the lip (5% CL/A; 4% CL/AP). 
FD defects (n = 244) were mainly incomplete clefts of the lip combined with ipsilateral com-
plete clefts of the alveolus (51% CL/A, 42% CL/AP). In 23% of the CL/A patients and in 40% of 
the CL/AP patients, a complete cleft lip/alveolus was observed with a contralateral incomplete 
cleft lip, an incomplete cleft lip/alveolus, or an incomplete cleft lip and complete cleft alveolus. 
Table 4. Distribution of the sub-phenotypes of the primary palate: division of the cleft lip/alveolus 
patients (n = 977) and the cleft lip/alveolus and palate patients (n = 1363) into fusion and/or 
differentiation defects*
CL/A CL/AP
F CCLA 134 932
CCL+ICA 39 9
CCL 37 18
Miscellaneous 3 10
D ICLA 267 128
ICL 374 37
SCL 36 7
Miscellaneous 52 13
FD ICL+CCA 18 88
CCLA; ICL 3 33
CCLA; ICLA 5 27
CCLA; ICL+CCA 0 24
Miscellaneous 9 37
* F = fusion defects, D = differentiation defects, FD = fusion and differentiation defects, CCLA = complete 
cleft lip + complete cleft alveolus, CCL+ICA = complete cleft lip + incomplete cleft alveolus, CCL = 
complete cleft lip, ICLA = incomplete cleft lip + incomplete cleft alveolus, ICL = incomplete cleft lip, SCL 
= submucous cleft lip, ICL+CCA = incomplete cleft lip + complete cleft alveolus (differentiation defect + 
fusion defect), 
CCLA; ICL = complete cleft lip + complete cleft alveolus combined with a contralateral incomplete cleft lip; 
CCLA; ICLA = complete cleft lip + complete cleft alveolus combined with a contralateral incomplete cleft 
lip + incomplete cleft alveolus, CCLA; ICL+CCA = complete cleft lip + complete cleft alveolus combined 
with a contralateral incomplete cleft lip + complete cleft alveolus (differentiation defect + fusion defect).
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Fusion and/or differentiation defects of the secondary palate
Table 5 presents that F defects of the secondary palate (n = 2321) were mostly complete cleft 
palates in CL/AP patients (86%). Complete cleft palate, incomplete cleft of the hard palate 
combined with a complete cleft of the soft palate, and complete cleft of the soft palate were 
observed in 91% of the CP patients. 
D defects (n = 123) were mostly submucous clefts of the hard and/or soft palate (80% CL/
AP, 68% CP). FD defects (n = 91) were predominantly submucous clefts of the hard and/or soft 
palate combined with an (in)complete uvular cleft (71% CL/AP, 69% CP), or submucous cleft of 
the hard palate combined with a complete cleft of the soft palate (12% CL/AP, 26% CP).
Timetable common oral clefts 
As fusion and differentiation defects of the primary and secondary palates originate at different 
time periods, a timetable was constructed, relating the observed defects to weeks of develop-
ment (Figure 6). For FD defects consisting of a fusion defect and a contralateral differentiation 
defect of the primary palate, both defects were considered to originate at different time points 
Table 5. Distribution of the cleft sub-phenotypes of the secondary palate: division of the cleft lip/alveolus 
and palate patients (n = 1363) and cleft palate patients (n = 1172) into fusion and/or differentiation 
defects*
CL/AP CP
F CCP 1142 274
ICHP; CCSP 93 237
CCSP 51 394
ICSP 19 52
I/CCU 17 37
Miscellaneous 2 3
D SCSP 12 55
SCHP+SCSP 6 14
HH/SP 1 29
Miscellaneous 3 3
FD SCH/SP+I/CCU 12 51
SCHP+CCSP 2 19
Miscellaneous 3 4
* F = fusion defects, D = differentiation defects, FD = fusion and differentiation defects, CCP = complete 
cleft palate, CCSP = complete cleft of the soft palate, ICHP = incomplete cleft of the hard palate, ICSP = 
incomplete cleft of the soft palate, I/CCU = (in)complete cleft of the uvula, SCSP = submucous cleft of the 
soft palate, SCHP = submucous cleft of the hard palate, HH/SP = hypoplastic hard and/or soft palate, SCH/
SP = submucous cleft of the hard and/or soft palate.
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(independently). For example, a patient with a complete cleft lip/alveolus combined with a 
contralateral incomplete cleft lip was considered to have sustained two disruptions during 
development. The first disruption was a fusion defect of the primary palate at one side (early 
embryonic development), and the second disruption concerned insufficient outgrowth/dif-
ferentiation of the lip after fusion of the primary palate (late embryonic development). Both 
disruptions were counted in the timetable, once in the F group, and once in the D group (e.g., 3 
CL/A patients and 33 CL/AP patients; Table 4).
DISCuSSION
This study demonstrates that our unique classification system can be applied successfully to 
unoperated newborns/infants having various sub-phenotypes of common oral clefts. Using 
detailed cleft data from the NVSCA registry, we were able to classify all clefts into fusion and/
or differentiation defects.  This was possible because we previously introduced the NVSCA reg-
istry, which describes the individual abnormalities of the common oral cleft.11, 13 Furthermore, 
we were able to construct a timetable expressing fusion and/or differentiation defects in weeks 
of development, based on early and late embryonic development of the primary palate and on 
late embryonic development of the secondary palate.
The main strength of our study was the use of the national validated NVSCA database, which 
allowed us to analyze detailed data on a relatively large sample of patients affected with many 
different cleft sub-phenotypes. The NVSCA registry records all individual abnormalities that 
form the oral cleft, that is, the morphology and side of each anatomic structure (lip, alveolus, 
hard palate, and soft palate including the uvula). These data can be translated to any classifi-
cation, new or old.49 In contrast to this system, most available classification systems interpret 
the observed abnormalities that form the common oral cleft.1 As a consequence, morpho-
logical details such as whether the cleft is complete, incomplete or submucous are lost. As 
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interpretations of these abnormalities will change by increasing knowledge about normal and 
abnormal development, adjustment of previously classified patients to new insights—such as 
a new classification—is often impossible. 
Another strength of our study is that we used morphological sequelae that are more or 
less independent of progress in developmental biology. All parts of the primary and second-
ary palates grow out, adhere and fuse in a given time period, and somewhat later (primary 
palate) or during the same time period (secondary palate) they differentiate into bone and/or 
musculature. Therefore, it seems logical to divide the common oral clefts into fusion defects, 
differentiation defects, or a combination of fusion and differentiation defects (Tables 1 and 2). 
During the last decades, immense progress has been made concerning identification of can-
didate genes and environmental factors with respect to non-syndromic common oral clefts.7, 
10, 20, 50-55 However, elucidating pathways in their development is extremely difficult because 
of the multigenetic influences and their interaction with environmental factors.8, 22, 56, 57 Fur-
thermore, the classification systems that have been used for these studies are interpretations 
of the observed abnormalities. In other words, one does not reckon with the time periods at 
which various common oral clefts are originated. If one could relate groups of cleft types to 
specific time periods, identification of specific known and unknown genes that are expressed 
during these periods may follow. Also, submucous and microform clefts (including orbicularis 
oris muscle defects) are often not registered in other classifications. However, these subclinical 
forms may be just as important for further delineating the pathogenesis, clinical genetics, and 
understanding of the epidemiology.7, 8
As shown by our findings, the pathoembryological sequelae can be described in any indi-
vidual case. Transfer of our data to this classification caused no problems, all patients fitted in 
a subgroup (Table 3). In addition, we constructed a timetable that can be used as a guideline 
for relating the type of clefting to the time period expressed in weeks of development. For 
instance, complete cleft lip/alveolus arises significantly earlier in development than incomplete 
cleft lip (Figure 6). In identifying genes and/or environmental factors, one should therefore 
distinguish these types and restrict the possible/candidate genes and environmental factors 
to the time period involved. 
At the same time, this timetable also had some limitations. First, over 90% of the common 
oral clefts, but not all clefts, fitted in the timetable. Also, some fusion defects of the second-
ary palate were difficult to fit in the table. Theoretically, a complete cleft palate can originate 
from different mechanisms during two different time periods in late embryonic development. 
Complete cleft palate can originate relatively early during late development (7 to 9 weeks of 
development) because of insufficient outgrowth and elevation of the palatal shelves. However, 
lack of adhesion/ programmed cell death and/or EMT and/or migration later during late embry-
onic development (9 to11 weeks of development) may cause the same defect. Arbitrarily, all 
complete cleft palate cases were accumulated and placed in the early period of late embryonic 
development (Figure 6). Because of the possible different cell biological mechanisms and the 
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different originating timeframes, investigating complete cleft palate patients for common 
pathways may be hazardous. If one selects defects of the secondary palate in which a part 
of the hard palate or the whole hard palate has been fused, one can rule out insufficient out-
growth and elevation of the shelves, thereby limiting the number of mechanisms, and relating 
only to one time period. 
In conclusion, our unique classification of common oral clefts provides subgroups reckon-
ing with morphology and underlying cell biological mechanisms, and with the time period 
during which a given common oral cleft evolves. In this way, more accurate data may become 
available for further clinical and fundamental research. For international use of this new clas-
sification adjustment of the ICD-10 cleft coding system (Q35-Q37) is required with regard to 
sub-phenotypes, such as incomplete cleft lip/alveolus and submucous cleft palate.
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AbSTRACT
Background: To improve the outcome of oral clefts and further understand their etiopathogen-
esis, a new embryological cleft classification was previously introduced. We aimed to inves-
tigate whether this classification is complete and feasible for all cleft sub-phenotypes of the 
lip/alveolus, which have rather complex and underexposed patho-embryological mechanisms. 
Additionally, we investigated whether further morphological grading of incomplete cleft lips is 
clinically and embryologically relevant.
Methods: After local announcements, 108 adult unoperated patients from Indonesia with clefts 
of the lip/alveolus only were included. Using color photographs, X-rays, and dental casts, clefts 
were classified—according to their timing and mechanisms in embryogenesis—as fusion 
defects, differentiation defects, or combined defects. We further graded the morphology of 
incomplete cleft lips and analyzed whether these grades were related to the severity of alveolar 
clefts/hypoplasia. Permanent dentition was analyzed to investigate which alveolar part is 
deficient in fusion/differentiation defects.
Results: All sub-phenotypes—comprising 96 unilateral and 12 bilateral clefts—could be classi-
fied into differentiation (79%), fusion (17%), fusion-differentiation (2%), or fusion & differentiation 
(2%) defects. We found that the various morphological grades of cleft lip were not related to 
the associated alveolar clefts/hypoplasia. Additionally, all alveolar and dental deformities were 
located in the premaxillae.
Conclusions: This study demonstrates that this classification is complete and feasible for all 
clefts of the lip/alveolus, that further morphological grading of incomplete cleft lip is neither 
clinically nor embryologically relevant, and that the premaxilla forms the deficient part in 
alveolar deformities. This approach provides new subgroups for clinical/fundamental research 
considering timing and underlying mechanisms in embryogenesis.
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INTRODuCTION
Oral clefts are very complex and heterogeneous birth defects affecting the lip/alveolus/hard 
palate/soft palate including the uvula. Development of these structures entails a complex 
series of embryonic processes, which are related to different time frames and regulated by dif-
ferent cell biological mechanisms and genes in embryogenesis.1-4 In short, the primary palate 
(presumptive lip and alveolus) and secondary palate (presumptive hard and soft palates) are 
formed by subsequent outgrowth, fusion, and differentiation (into bone and musculature) of 
the facial swellings and palatine processes, respectively.1, 4-7 Disruption of any of these tightly 
regulated processes by genetic or environmental factors during different developmental 
periods may result in various cleft sub-phenotypes.4, 8-10 Therefore, accurate and detailed 
phenotyping and subsequent classification of clefts are vital to further understand their etio-
pathogenesis. In other words, the power to detect influencing factors may be weakened when 
heterogeneous cleft groups are treated as a single entity.3 Moreover, it is crucial to help arrive 
at correct diagnosis, thereby improving clinical care and outcome.
Many systems have been developed to classify clefts. Classically, they are divi ded into two 
categories: cleft lip with or without cleft palate; and cleft palate only.11-13 However, recent 
embryological and epidemiological data suggest that clefts affecting the lip only have unique 
genetic and etiologic features and should therefore be distinguished from those affecting both 
the lip and palate.7, 9, 14-18 Besides this broad division, more detailed systems have been devel-
oped. They distinguish the different affected anatomical structures (lip/alveolus/hard palate/
soft palate),19-23 as well as various morphological features (complete/incomplete/submucous 
(subcutaneous) clefts).24-30 However, none of these systems are fully based on the embryology 
of the primary and secondary palates, thereby lacking detailed information needed to gain 
more insight into the causes of clefts.
Therefore, we have developed a new classification that distinguishes the various cleft sub-
phenotypes according to their timing and developmental mechanisms in embryogenesis.4, 7, 10 
More specifically, it allows classifying complete, incomplete, and submucous clefts, as well as 
hypoplasia, of the lip/alveolus and hard/soft palates (including the uvula) into groups of defects 
resulting from defective fusion, differentiation, or both, which are termed as fusion and/or dif-
ferentiation defects. Previously, this classification was successfully applied to broad groups of 
clefts in Dutch newborns.4, 7, 10 However, it is unknown whether this system is complete and 
feasible for all cleft sub-phenotypes, especially for those of the primary palate, which have 
more complex underlying mechanisms. While the embryogenesis of the secondary palate has 
extensively been investigated resulting in general consensus on this topic,12 the developmen-
tal processes of the primary palate have insufficiently been discussed and several questions 
remain unanswered. For example, it is unknown whether further morphological grading of 
incomplete clefts of the lip/alveolus—as has been proposed by several studies24-27, 29, 30—is 
embryologically and clinically relevant. More specifically, it has not been described whether 
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the morphological severity of clefts of the lip is related to that of the associated alveolar clefts/
hypoplasia. Additionally, it remains indefinite which part of the alveolar process—that formed 
by the premaxilla or maxilla—is deficient in these alveolar deformities.
The aim of this study was to investigate whether our new embryological classification is 
complete and feasible for all cleft sub-phenotypes of the primary palate. Using adult unoper-
ated patients from Indonesia with clefts of the primary palate only, we were able to classify sub-
phenotypes that had not been influenced by defective fusion/differentiation of the secondary 
palate. In addition, we analyzed whether the morphological severity of clefts of the lip is related 
to that of associated alveolar deformities, thereby investigating whether further morphological 
grading of incomplete cleft lip is embryologically and clinically relevant and should be added 
to our classification. Finally, we related permanent dentition to the location and morphologi-
cal severity of alveolar deformities in order to investigate which part of the alveolar process is 
deficient in fusion/differentiation defects. 
MATERIAL AND METHODS
Patients and data collection
After local announcement, 350 adult Indonesian patients with oral clefts presented themselves 
for opera tion. To be included, patients had to have clefts of the primary palate only without a 
syndrome diagnosis, previous cleft surgery, or extractions of teeth in the cleft area.31 Median 
cleft lip/alveolus or atypical facial clefts were excluded because of their different pathogenesis.6, 
8, 32 For each patient, cephalograms, standard intraoral and extraoral color photographs, and 
dental casts were made prior to surgery. The principles outlined in the Declaration of Helsinki 
were followed, and details of the patient and data collection have been described elsewhere.31
Embryological classification
To relate the various cleft sub-phenotypes of the lip/alveolus—including further morphological 
grading—to their timing and underlying developmental processes, it is essential to understand 
the normal and abnormal embryological development of the primary and secondary palates, 
which therefore are described first. 
Normal embryonic development of the primary and secondary palates
Fusion processes of the primary and secondary palates and their directions
It is generally accepted that the formation of the secondary palate is based on fusion of the 
palatal shelves (processes).12 However, there is no consensus on the formation of the primary 
palate, which is thought to result from fusion, 2, 33-36 mer ging, 30, 37-40 or a combination of fusion 
and merging of the facial swel lings (prominences or processes) that surround the nasal plac-
ode.21, 41 The formation of both the primary and secondary palates can be subdivided into three 
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pha ses: 1) out growth of the facial swellings or palatal shelves, which are mesenchymal cores 
covered with epithelium; 2) oppo si tion of the swellings/shelves followed by adhesi on of their 
epi the lium and subsequent epithe lial plate (seam) formation; and 3) program med cell death 
(apopto sis) followed by epitheliomesenchymal transformation and migration, resulting in 
disrup tion and subsequent disappearan ce of the epithe lial plate and fusion of the mesenchy-
mal cores of the swellings/shelves. Similar to the secondary palate, all three phases are present 
during formation of the primary palate,5, 6, 33, 42, 43 underlining that the primary palate is formed 
by fusion and not by merging, as the last two phases do not occur in the process of merging.6
Although the fusion processes of the primary and secondary palates are roughly similar, 
there are also some differences. The first is that the facial swellings and palatal shelves fuse 
in opposite directions. The development of the primary palate starts with widely separated 
nasal placodes, which are located at the lateral sides of embryonic head. These placodes are 
transformed into nasal pits, grooves, and tubes, respectively, by the three outgrowing facial 
swellings (medial nasal process, maxillary process, and late ral nasal process) (Figure 1: 1-3). 
These outgrowing facial swellings, which are separated by grooves, adhere from occipital to 
frontal and form an epithelial plate (the nasal fin).36, 43-45 Within this plate, cell death occurs 
before, during, and after formation, which results in a disruption halfway the epithelial plate.6, 
41, 46 Then cell death continues within the remnants of the epithelial plate, the three swellings 
fuse gradually, and the primary palate is formed (human embryos 11-17 mm crown-rump 
length (CRL)).6, 46 The medial nasal process fuses first occipitally with the maxil lary pro cess and 
then frontally with the lateral nasal pro cess.6, 47 As a conse quence, the external nasal aperture 
(nostril) is formed by the medial nasal and lateral nasal processes (Figure 1: 1-3). 
In contrast to the primary palate, the secondary palate is formed from frontal to occipital, 
starting with adherence and fusion of the primary palate to the frontal borders of the palatal 
shelves (Figure 1: 3-6). Note that fusion of the secondary palate occurs after fusion of the primary 
palate; the facial swellings fuse during the early embryonic period, 4-7 weeks of development 
(≤17 mm CRL), while the palatal shelves fuse during the late embryo nic period, 7-12 weeks of 
development (≥17 mm - ≤60 mm CRL).4, 6 
Another difference between the primary and secondary palates is that the formation of the 
primary choanae is based on the development and subsequent rupture of the oronasal mem-
branes (bucconasal membranes), while the secondary choanae are formed by the openings 
into the nasopharynx after formation of the secondary palate. During the development of the 
primary palate, the nasal pits/grooves/tubes have newly formed cavities, which belong in fact 
to the amniotic cavity and not to the stomodeum (oral cavity).36, 44 The floors of these two blind 
ending cavities are formed by the fusing facial swellings, which enclose the epithelial plates. 
From the occipital part of these epithelial plates, the oronasal membranes develop and subse-
quently rupture by cell death, thereby forming the primary choanae (12-17 mm CRL; Figure 1: 
3-4).6, 36, 41 Occipitally, the nasal tubes now open into the stomodeum. Then the secondary pal-
ate develops and the primary choanae are frontally demarcated by the incisive canals. Finally, 
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Figure 1. Embryonic development in successive stages viewed from the oral side: the fusion processes of 
the primary palate (1-3) and secondary palate (3-6), and differentiation of the lip and alveolus (3-6). 
1. The nasal groove surrounded by the facial swellings (a-c) at five weeks; 
2. Outgrowth and fusion of two (a-b) of the three facial swellings in occipito-frontal direction forming 
the nasal tubes at six weeks; 
3. Further outgrowth and fusion of the three swellings (a-c), resulting in the formation of the 
primary palate and the external nasal aperture at about seven weeks (note that the swellings are 
separated by grooves), including the position of the oronasal membrane (om) and the beginning of 
development of the lip (al + bl), alveolus (aa +ba) and the shelves of the secondary palate (bp); 
4. Formation of the primary choanae (pc), outgrowth of the nasal septum (n) and palatal shelves in 
vertical direction, and outgrowth of the lip and alveolus in caudal direction forming the presumptive 
labial groove at eight weeks; 
5. Elevation and outgrowth of the palatal shelves in horizontal position, and start of the fusion of the 
shelves with the primary palate, frontally from the primary choanae (level presumptive incisive 
foramen) at eight to nine weeks; 
6. Completed fusion of the shelves in fronto-occipital direction with the primary palate and nasal 
septum, as well as with each other, and completion of the lip, alveolus, incisive foramen (if ), and 
labial groove (lg) at 10-12 weeks. 
Abbreviations: a = medial nasal process; b = maxillary process; c = lateral nasal process; al = lip developed 
from a; bl = lip developed from b; aa = alveolus (premaxillae) developed from a; ba = alveolus (maxillae) 
developed from b; bp = palatal shelves developed from b; om = oronasal membrane; n = nasal septum; pc 
= primary choana; lg = labial groove; if = incisive foramen.
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the definitive nasal cavities are formed from the nasal tubes and from a part of the stomodeum 
(captured through fusion of the palatal shelves); their openings into the pharynx are formed by 
the secondary choanae.48
Formation of the lip and alveolus & mesenchymal differentiation of the lip, alveolus, hard and soft 
palates
During the late embryonic period, the grooves between the swellings in the embryonic face 
are eliminated by merging.6, 36, 46 The lip and alveolus develop from the primary palate, and the 
mesenchyme of the primary and secondary palates subsequently differentiates into bone cen-
ters and musculature. The presumptive lip and alveolus grow out in caudal direction, resulting 
in formation of the labial groove (Figure 1: 3-6). The first bone centers, which form the alveolus 
and secondary palate, arise in the mesenchyme of each maxillary process, i.e., the presumptive 
maxilla (17 mm CRL). Each maxilla and each palatal bone (anlage at 23 mm CRL) develops from 
a single bone center, while the premaxilla—bearing both incisors—develops from two centers 
in the medial nasal process (the frontal center at 23 mm CRL and occipital center at 50 mm CRL). 
All bone centers grow out and either fuse with each other (the frontal premaxillary center with 
the maxillary center and with the occipital pre maxillary cen ter, respectively) or form a suture 
(that is, the incisive suture be tween the occi pital premaxillary center and maxillary center, and 
the median and transverse palatine sutures between both maxilla ry and palatine centers).6 
Classification
As presented in Table 1, derail ments in the fusion phases of the primary and/or secondary 
palates, including the formation of the primitive choanae, may cause various fusion defects 
along the respective fusion lines. For example, interrupted fusion of the primary palate during 
the early embryonic period (4-7 weeks of development) may result in a complete cleft lip with 
complete/ incomplete cleft alveolus, while defective fusion of the secondary palate during the 
late embryonic period (7-12 weeks of development) may give rise to a complete/incomplete 
hard palate with complete soft palate. Note that differences in anatomical extent and morpho-
logical severity are explained by the fusion direction of the facial swellings (occipito-frontal) 
and palatal shelves (fronto-occipital), and by the development of the primary choanae during 
fusion of the facial swellings.4 If disruption occurs at a later stage during the fusion process, 
more of the primary and secondary palates will be intact. 
Similarly, derailments in the formation of lip/alveolus—after the completed fusion pro-
cess—and in the subsequent mesenchymal differentiation (into bone and musculature) of the 
primary and secondary palates may cause differentiation defects (Table 1). More specifically, 
insufficient merging, outgrowth, or differentiation of the lip/alveolus may result in incomplete 
clefts of the lip and/or alveolus. These sub-phenotypes always show a tissue bridge at the base of 
the nostril, as the fusion process of the lip/alveolus has been completed at this stage.4 Addition-
ally, derailments in the differentiation of musculature and bone anlage and in the out growth, 
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fusion, or suture formation of bone centers may cause bony defects, such as submucous clefts 
or hypoplastic bone/musculature in the primary or secondary palates.
Data analysis
Using patients’ intraoral and extraoral color photographs, we analyzed the morphological 
severity (complete vs. incomplete/submucous (subcutaneous)) of lip defects. Subsequently, 
incomplete clefts of the lip were further graded into three groups: I) vermilion notch; II) cleft 1/3 
to 2/3 lip height; and III) cleft 2/3 lip height to subtotal. Dental casts were used to analyze the 
location and morphological severity of alveolar clefts or hypoplasia; on these casts, we identi-
fied and counted teeth in the premaxilla and maxilla. Absent (agenetic), impacted, or super-
numerary teeth in the cleft area were examined on the corresponding lateral cephalograms. 
To classify the various cleft sub-phenotypes of the lip/alveolus, they were divided into fusion 
and/or differentiation defects of the primary palate (Table 1). Theoretically, more than one 
developmental process can be disturbed during embryogenesis, and therefore any combina-
tion of defects is possible. To be complete and feasible, the system must allow all combinations 
to be grouped into one of the following subgroups: fusion defects, differentiation defects, or 
combined defects (fusion-differentiation defects). An example of the latter group is an incom-
plete cleft lip (differentiation) with complete cleft alveolus (fusion) at the same side, termed as 
Simonart’s band. As a bilateral cleft can consist of a fusion defect at one side and differentiation 
defect at the other side, we presented these defects as fusion & differentiation defects.
RESuLTS
In total, 108 adult patients—comprising 63 males and 45 females, all over 12 years of age—
were included. Table 2 shows the classification of their unilateral (n = 96) and bilateral (n = 12) 
clefts of the primary palate. All sub-phenotypes could be classified into differentiation defects 
(n = 85, 79%), fusion defects (n = 19, 17%), fusion-differentiation defects (n = 2, 2%), or fusion & 
differentiation defects (n = 2, 2%).
Table 2. Classification of the various sub-phenotypes in adult unoperated patients with clefts of the 
primary palate (n = 108) into fusion and/or differentiation defects 
Fusion Defect Differentiation 
Defect
Fusion - Differentiation 
defect*
Fusion & 
Differentiation 
defect†
Total
Unilateral 17 77 2 – 96
Bilateral 2 8 – 2 12
* Combination of a fusion and differentiation defect at one side.
† Fusion defect at one side and differentiation defect at the other side.
Chapter 8158
unilateral clefts
Complete clefts of the lip 
Of the 96 patients with unilateral clefts, 18% (n = 17) showed a complete cleft lip. Table 3 presents 
the different alveolar deformities, including abnormal dentition, found in these patients. 59% 
(n = 10) showed a complete cleft alveolus (extending to the incisive foramen; Figure 2a,b), and 
41% (n = 7) showed an incomplete cleft alveolus along the fusion line between the premaxilla 
and maxilla (Figure 3a,b). All 17 patients showed abnormal dentition at the cleft side and the 
alveolar deformity was located between the central and malformed/hypoplastic lateral incisors 
or at the level of the absent lateral incisor. As all observed clefts result from defective fusion of 
the facial swelling, they were classified as fusion defects (Table 2).
Table 3. Alveolar deformities in unilateral complete (n = 17) and incomplete (n = 79) cleft lip; those with 
abnormal dentition at the cleft sides are presented between parentheses*
Normal 
Alveolus
Complete 
Cleft Alveolus
Incomplete 
Cleft Alveolus
Hypoplastic 
Alveolus
Total
Complete cleft lip – – 10 (10) 7 (7) – – 17 (17)
Incomplete cleft lip 31 (23) 2 (2) 28 (28) 18 (18) 79 (71)
I. Vermilion notch 4 (3) – – 2 (2) 2 (2) 8 (7)
II. Cleft 1/3 to 2/3 lip 
height
17 (12) – – 8 (8) 7 (7) 32 (27)
III. Cleft 2/3 lip height 
to subtotal
10 (8) 2 (2) 18 (18) 9 (9) 39 (37)
* Including absence (agenesis), malformation, or hypoplasia of the lateral incisor, as well as 
supernumerary teeth or a persistent milk canine.
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Incomplete clefts of the lip 
Incomplete cleft lip was diagnosed in 82% (n = 79) of the unilateral cleft patients and further 
divided into three morphological groups (Table 3).
Group I comprised eight patients, with a normal alveolar pro cess in 50% (n = 4; Figure 4a,b), 
incomplete cleft alveolus in 25% (n = 2), and horizon tal or vertical alveolar hypoplasia in 25% 
(n = 2). For the last four patients and for one with a normal alveolar process, the photographs 
indicated that the vermilion notch was accompanied by a submucous (subcutaneous) cleft of 
the lip. Almost all patients (88%, n = 7) showed dental anomalies at the cleft side (Table 3). 
a
b
Figure 2. Unilateral complete cleft lip (a) with 
complete cleft alveolus (extending to the incisive 
foramen) at the level of the absent lateral incisor 
and with rotation of the premaxilla (b).
a
b
Figure 3. Unilateral complete cleft lip (a) with 
incomplete cleft alveolus along the fusion line 
between the premaxilla and maxilla located 
between the central and hypoplastic lateral 
incisors (b)
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Group II comprised 32 patients, with a normal alveolar process in 53% (n = 17), incomplete 
cleft alveolus in 25% (n = 8; Figure 5a,b), and horizontal or vertical alveolar hypoplasia in 22% (n 
= 7). The majority (84%, n = 27) showed dental anomalies at the cleft side.
Group III comprised 39 patients, with a normal alveolar process in 26% (n = 10), incomplete 
cleft alveolus in 46% (n = 18), horizontal or vertical alveolar hypoplasia in 23% (n = 9), and com-
plete cleft alveolus in 5% (n = 2; Figure 6a,b). Almost all (95%, n = 37) showed dental anomalies 
at the cleft side. 
Finally, all complete/incomplete clefts of the alveolus were located between the central and 
malformed/hypoplastic lateral incisors or at the level of the absent lateral incisor, and alveolar 
hypoplasia was always located at the position of the lateral incisor. Patients with a normal 
b
a
Figure 4. Notch of the vermilion (a) with a normal 
alveolus and rotated lateral incisor, persistent milk 
canine, and supernumerary teeth (b).
a
b
Figure 5. Incomplete cleft lip (a) with incomplete 
cleft alveolus between the central and malformed 
lateral incisors (b).
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alveolus, incomplete cleft alveolus, or alveolar hypoplasia (98%, n = 77) were classified as having 
a differentiation defect, because their defects result from defective differentiation. Only two 
patients (3%) showed a complete cleft alveolus, which results from defective fusion, and they 
were therefore classified as fusion-differentiation defects (Table 2). 
bilateral clefts
Complete clefts of the lip 
Of the 12 patients with bilateral clefts, two (17%) showed a bilateral complete cleft lip (Table 4). 
In one of them, this defect was accompanied by a bilateral complete cleft alveolus with absence 
of both lateral incisors. The other patient showed a left-sided complete cleft alveolus at the level 
of the absent lateral inci sor, as well as a right-sided incomplete cleft alveolus in between two 
cone-shaped teeth without a normal lateral incisor. Both patients were classified as bilateral 
fusion defects (Table 2). 
Complete and incomplete clefts of the lip 
Two (17%) of the 12 bilateral cleft cases had a complete cleft lip at one side and incomplete 
cleft lip (1/3 to 2/3 lip height) at the other side (Table 4). One of them also showed a bilateral 
incomplete cleft alveolus between the right central and lateral inci sors and at the level of the left 
absent lateral incisor. The other patient had a left-sided hypo plastic alveo lus with a malformed 
lateral incisor, and a right-sided complete cleft alveolus at the level of the absent lateral incisor. 
Both patients were classified as having a fusion defect at one side and a differentiation defect 
at the other side, that is a fusion & differentiation defect (Table 2).
b
a
Figure 6. Simonart’s band: incomplete (subtotal) 
cleft lip (a) with complete cleft alveolus 
(extending to the incisive foramen) at the level 
of the absent lateral incisor with a persistent milk 
canine and rotation of the premaxilla (b).
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Incomplete clefts of de lip
Eight (67%) of the 12 bilateral cleft cases showed a bilateral incomplete cleft lip extending to 
2/3 lip height to subtotal (Table 4). In 38% (n = 3), a normal alveo lar process was observed at 
both sides. In the other patients, an associated bilateral (50%, n = 4) or unilateral (13%, n = 1) 
incomplete cleft alveolus was observed. While two alveolar defects were located between the 
lateral incisor and a cone shaped extra tooth, the other seven were located between the central 
and malformed/hypoplastic lateral incisors or at the level of the absent lateral incisor. Finally, 
all patients showed abnormalities in dentition and were classified as bilateral differentiation 
defects (Table 2). 
DISCuSSION
This study demonstrates that this new embryological approach is complete and feasible for 
clefts of the primary palate. We were able to classify all observed sub-phenotypes into fusion 
defects, differentiation defects, or combinations of these. By further grading incomplete clefts 
of the lip according to morphological severity, we found that these grades are not related to the 
severity of associated alveolar deformities and thus are neither clinically nor embryologically 
relevant. Finally, we found that all alveolar and dental deformities were located in the premaxil-
lae. 
Strengths and weaknesses 
The main strength of our study is that we used unoperated adult patients with clefts of the pri-
mary palate only, allowing us to evaluate mature sub-phenotypes that had not been influenced 
by defective fusion/differentiation of the secondary palate. Furthermore, their permanent den-
tition was essential to accurately determine the location of the alveolar deformity and which 
part of the alveolar process is deficient in fusion/differentiation defects. However, this design 
also had its limitation. Because only patients who required cleft surgery had presented them-
selves after local announcements in Indonesia, some sub-clinical features—such as isolated 
hypoplasia or submucous (subcutaneous) clefts of the lip—were not included in our study. 
However, these anomalies were recently successfully classified in a study with unoperated 
newborns in the Netherlands.4
Explanations and implications
Classification with embryological basis
Our unique classification is based on normal palatogenesis, thereby fulfilling the criteria 
described by Sandham et al.: “a classification of clefting should be descriptively clear and have 
an embryological ba sis”.49 With regard to the search for causal factors, it is important to divide 
clefts into fusion and/or differentiation defects, because these defects develop in different 
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successive periods and are related to different genes and cell-biological mechanisms.1, 4, 7 For 
example, a complete cleft lip with complete/incomplete cleft alveolus results from defective fusion 
of the facial swellings and consequently develops only during the early embryonic period (4-7 
weeks postconception). By contrast, an incomplete cleft lip results from defective merging/out-
growth/differentiation, after the fusion process during the late embryonic period (7-12 weeks 
postconception; Table 1).1, 4, 7 Whether an incomplete cleft alveolus is a fusion or differentiation 
defect depends on the morphology of the lip (complete vs. incomplete/submucous), and 
therefore the lip should always be evaluated first. 
Furthermore, with our concept of fusion/differentiation defects, special sub-phenotypes—
such as Simonart’s bands (Figure 5)—can also be explained. Previous studies described two 
types of Simonart’s bands: a soft tissue bridge covered with skin and located at the base of 
the nostril, or a mucous tissue bridge located between the segmented alveolar processes.50, 51 
Although the exact developmental mechanisms of these bands have not been identified yet, 
Semb and Shaw described two mechanisms.50 The first is that these abnormalities result from 
incomplete fusion of the lateral and medial nasal processes, and the second is that the defor-
mities are caused by postfusion rupture of tissues. However, based on the earlier-described 
embryology, we believe that the two types of Simonart’s bands may be explained differently. 
Given that the skin covered band at the base of the nostril is formed by normal fusion of the 
lateral and medial nasal processes (i.e., the frontal side of the nasal fin), this Simonart’s band 
can be considered as an incomplete cleft of the lip.47 Therefore, we classified the tissue bridge 
in our two cases with incomplete cleft lip and complete cleft alveolus as a differentiation defect. 
The complete cleft alveolus, however, is a fusion defect, as it is caused by derailments within 
the occipital part of the nasal fin, which is formed by fusion of the medial nasal and maxillary 
processes (the region of the oronasal membrane).6, 36 To explain the complete cleft alveolus in 
case of the Simonart’s band, we have two hypotheses. The first is that if the oronasal membrane 
develops too wide, subsequent rupture of this membrane by cell death may cause a complete 
cleft alveolus in front of the primary choana.4 Although it is well known that persistence of this 
membrane causes choanal atresia,52 this membrane has, to our knowledge, not been related to 
complete cleft alveolus before. Another possible explanation is that the remnant of the nasal fin 
that connects with the oronasal membrane does not disappear by cell death and consequently 
opens again resulting in a complete cleft alveolus.4
Regarding the second type of Simonart’s band, we postulate that the mucous tissue bridge 
between the segmented alveolar processes can be considered as a submucous cleft of the 
alveolus caused by insufficient outgrowth of the bone centers of the premaxilla and maxilla. 
This anomaly can be classified as a differentiation defect of the alveolus combined with fusion 
defect of the lip (complete cleft lip).
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Morphological grading
Our results do not support the suggestion of Jensen et al.25 that the morphological severity of 
the cleft lip can predict the deformity of the alveolar process, and therefore, further morpho-
logical grading of incomplete clefts seems to be neither clinically nor embryologically relevant. 
More specifically, complete cleft lip (extent grade 4, Jensen et al.25) was associated with either 
complete or incomplete cleft alveolus (fusion defects in both combinations), as well as with 
abnormal dentition similar to those in incomplete cleft lip. Additionally, by further grading of 
incomplete cleft lip into three groups of different cleft heights (extent grades 1-3, Jensen et al.25), 
we found that all three groups included patients with normal alveo lar processes and dentition, 
as well as patients with alveolar clefts or hypoplasia. Apart from the complete cleft alveolus in 
the Simonart’s cases (group III, n = 2), all anomalies were classified as differentiation defects. 
Therefore, our results underline that deformities of the lip and alveolus should be evaluated as 
separate entities,22, 24, 28, 29 because of their independent morphological characteristics.
Deficient part alveolar process
Analysis of permanent dentition revealed that all observed alveolar deformities were located 
between the central and lateral incisors, or at the level of the lateral incisor. The latter tooth 
was often absent, hypoplastic, or replaced by one or two malformed teeth. According to Stark 
and Kaplan 53 and Sperber 46, both incisors develop within the premaxilla. This implies that the 
developmental arrest involves the premaxilla, which develops from the medial nasal process 
during early embryonic stages. Our findings are in line with those of Lekkas et al.,54 who did 
not found any missing permanent teeth in the canine-postcanine region of the maxilla in adult 
unoperated Indonesian patients.
Description and registration of clefts
Adequate characterization and description of the individual anomalies that form the various 
cleft sub-phenotypes is critical for both clinical and research purposes, as it helps to arrive at 
correct diagnosis, underlying mechanisms, and causal factors. It is important to also describe 
submucous and microform clefts (including orbicularis oris muscle defects), given that these 
sub-clinical forms have serious clinical implications and may be just as important for further-
ing our understanding of clefts.2, 3 However, in most registration systems,11, 55, 56 subclinical 
features are often not included, and clefs are not described but interpreted and directly coded 
according to clinical diagnosis, which may lead to important information being lost. Therefore, 
the cleft palate teams in the Netherlands have used a different approach, similar to that of 
the current classification. For over 15 years, they have registered oral clefts in the Dutch Oral 
Cleft Registry, using a unique system—based on craniofacial embryology—that records the 
morphology and side of each affected anatomical structure.10, 57, 58 These descriptive data can 
be translated to any classification, new or old, and have enabled clinical, epidemiological, and 
fundamental research and improved clinical care and outcome.4, 7, 9, 13, 16, 17 In line with other 
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recent studies emphasizing the need of accurate and detailed phenotyping,1-3 we encourage 
future studies and registries to use a similar approach to further elucidate the etiopathogenesis 
of clefts. 
CONCLuSIONS
This study demonstrates that this new embryological approach is complete and feasible for 
clefts of the primary palate, as all sub-phenotypes—including Simonart’s bands—could be 
classified into fusion and/or differentiation defects. Whether a cleft lip/alveolus is a fusion or 
differentiation defect depends on the morphology of the lip (complete vs. incomplete/submu-
cous), and therefore the lip should always be evaluated first. Additionally, our study showed that 
further morphological grading of incomplete cleft lip does not predict the severity of alveolar 
deformities and is thus neither clinically nor embryologically relevant. Therefore, the alveolar 
process should always be evaluated separately in order to have complete and accurate diag-
noses and improve outcome and research. Finally, we found that the deficient part in alveolar 
deformities is formed by the premaxilla. This approach provides new subgroups considering 
timing and underlying developmental mechanisms in embryogenesis, thereby enabling more 
accurate clinical and fundamental research. 
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AbSTRACT
Periconceptional folic acid has been associated with a reduced risk of neural tube defects, but 
findings on its effect in oral clefts are largely inconclusive. This case-control study assesses the 
effects of periconceptional folic acid on cleft risk, using complementary data from the Dutch 
Oral Cleft Registry and a population-based birth defects registry (Eurocat) of children and 
fetuses born in the Northern Netherlands between 1997-2009. Cases were live-born infants 
with non-syndromic clefts (n = 367) and controls were infants or fetuses with chromosomal/
syndromal (n = 924) or non-folate related anomalies (n = 2021). We analyzed type/timing/dura-
tion of supplement use related to traditional cleft categories as well as to their timing (early/late 
embryonic periods) and underlying embryological processes (fusion/differentiation defects). 
Consistent supplement use during the etiologically relevant period (weeks 0 -12 postconcep-
tion) was associated with an increased risk of clefts (adjusted odds ratio 1.72, 95% confidence 
interval 1.19 -2.49), especially of cleft lip/alveolus (3.16, 1.69-5.91). Further analysis systemati-
cally showed two - to three-fold increased risks for late differentiation defects—mainly clefts of 
the lip/alveolus—with no significant associations for early/late fusion defects. Effects were 
attributable to folic acid and not to other multivitamin components, and inclusion of partial 
use (not covering the complete etiologically relevant period) generally weakened associations. 
In conclusion, this study presents several lines of evidence indicating that periconceptional 
folic acid in the Northern Netherlands is associated with an increased risk of clefts, in particular 
of cleft lip/alveolus. This association is strengthened by the specificity, consistency, systematic 
pattern, and duration of exposure-response relationship of our findings, underlining the need 
to evaluate public health strategies regarding folic acid and to further investigate potential 
adverse effects.
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INTRODuCTION
There is general consensus that periconceptional folic acid supplementation reduces the risk of 
neural tube defects. However, although the role of folic acid in oral clefts has been investigated 
for over 20 years, evidence for a preventive effect in clefts is still lacking and its role remains 
unresolved.1-3 
Oral clefts—one of the most common congenital anomalies in humans—are complex and 
heterogeneous defects, ranging from mild types to complete clefts affecting the lip, alveolus, 
and palate. While they can occur as part of a broad range of Mendelian, chromosomal, or tera-
togenic syndromes,4, 5 they most commonly occur in isolation. Despite extensive research, the 
etiopathogenesis of these non-syndromic (isolated) forms remains largely unknown. They are 
thought to result from a complex interplay of genetic and environmental factors.4-7 Develop-
ment of the lip, alveolus, and palate entails a complex series of embryological processes, which 
are related to different time frames in embryogenesis and regulated by many different genes 
and cell-biological mechanisms.4, 6-8 Disruption of any of these tightly regulated processes may 
result in various cleft sub-phenotypes.4, 6-10 Therefore, accurate and detailed phenotyping and 
subsequent subdivision according to timing and underlying processes is crucial for furthering 
our understanding of cleft etiology. 
Folate deficiency has been causally related to several congenital anomalies, especially 
neural tube defects. The neural tube and craniofacial region have quite similar developmental 
mechanisms,1, 3 leading to the hypothesis that folate deficiency might also contribute to non-
syndromic clefts. Although multiple (non-randomized) observational studies have suggested 
a beneficial role of folic acid supplements in decreasing cleft risk, the evidence remains largely 
inconclusive, as many studies—including randomized and cohort controlled trials—identified 
no significant effects on clefts.1-3, 11-13 Results are often mixed in terms of estimated effects, 
whether they affect certain or all cleft categories, and whether they are attributable to folic-acid 
containing multivitamins or folic acid alone. This is partly caused by differences in study popu-
lations and designs (including adjustment for confounders).1, 2 Additionally, the composition 
of supplements as well as timing and duration of use varies greatly between studies. Often, 
supplementation is not subdivided by type (folic acid alone or combined with multivitamins) 
and does not completely cover the embryonic period of clefts (4-12 weeks postconception).2, 
6, 8 Another explanation for insufficient evidence might be that heterogeneous cleft groups 
are generally treated as a single entity to reach adequate statistical power. However, this crude 
approach may weaken the power to detect effects, given the etiologic and genetic heterogene-
ity underlying non-syndromic clefts.4, 7 
We conducted a case-control study to assess the effects of periconceptional folic acid 
supplements on the risk of oral clefts relative to other non-folate related congenital anomalies. 
By combining unique complementary data from the Dutch Oral Cleft Registry (NVSCA) and 
a population-based birth defects registry (Eurocat Northern Netherlands), we were able to 
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analyze type, timing, and duration of supplement use in relation to timing and embryological 
mechanisms underlying cleft development. 
METHODS
Study design and population
We used NVSCA and Eurocat data on children/fetuses born in the Northern Netherlands 
between 1997 and 2009 inclusive. 
The NVSCA is a national register maintained by the Dutch Association for Cleft Palate and 
Craniofacial Anomalies. Since 1997, the 15 multidisciplinary cleft palate teams in the Neth-
erlands have reported their anonymous live-born patients with clefts (no age limit), prior to 
cleft surgery. The teams treat virtually all surviving children with clefts who reside in the Neth-
erlands, with a yearly average of 331 new patients, including 40 patients from the Northern 
Netherlands.14 To optimize data quality, data are verified on a case-by-case basis, and the teams 
perform case-ascertainment activities. Additionally, the NVSCA database has been systemati-
cally validated.9 
The population-based Eurocat registry has registered congenital anomalies in the Northern 
Netherlands since 1981 and now monitors about 18,500 births annually. While it has registry-
specific methods for case ascertainment,15 coding and classification are in concordance with 
EUROCAT Central Registry guidelines.16 Children (up to ten years of age at notification) and 
fetuses with congenital anomalies are reported by midwifes, well-baby clinic doctors, and 
specialists. In addition, various sources—mainly hospital registries—are actively searched to 
find children or pregnancies eligible for registration, including spontaneous abortions and 
pregnancies terminated for congenital anomalies. Written parental informed consent is needed 
for registration, and the participation rate is approximately 80%. 
Data collection 
Live-born infants with clefts in the Northern Netherlands are reported to the NVSCA by a plastic 
surgeon during the first patient visit to the team. Using a unique recording system based on the 
embryology of the head and neck area,8-10 the individual cleft anomalies are described in detail 
by recording the affected anatomical structure (lip/alveolus/hard palate/soft palate/uvula), the 
morphology (complete/incomplete/submucous), and the side (left/right/median). Addition-
ally, infant and parental characteristics and diagnoses of associated congenital anomalies are 
recorded. 
In Eurocat, congenital anomalies—including clefts—are coded according to the “Interna-
tional Classification of Diseases” (ninth/tenth revision).16 Once an infant has been reported, 
further information is gathered from the mother. Parents are asked to complete a written 
questionnaire on medical and reproductive history, occupation, demographic characteristics, 
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maternal weight and height, smoking habits, alcohol consumption, and use of medications and 
supplements (with specific questions about folic acid and multivitamins) from three months 
before pregnancy through to delivery. In addition, data on any prescribed medication is 
retrieved from the pharmacy after written parental consent. Subsequently, specific information 
on whether medications have been actually taken, including the period of use, is verified with 
the mother in a telephone interview. 
Definition of cases and controls
We defined cases as live-born infants with non-syndromic clefts, in other words, those not 
associated with other major non-folate related congenital anomalies. Median cleft lip/alveolus 
and atypical facial clefts were not considered to be oral clefts because of their different patho-
genesis.17 For inclusion, cases had to be registered in both databases, which allowed us to com-
bine detailed information on cleft phenotype (NVSCA) with complementary data on maternal 
characteristics and folic acid supplement use (Eurocat). Data linkage was performed using key 
(e.g., date of birth and gender) and cleft information. Discrepancies between registries regard-
ing this information were verified with the cleft palate teams and, if applicable, corrected in the 
study database. Non-matching cases from either registry were similarly verified, and if sufficient 
matching information was found they were added to the database. Using these steps, 91.6% 
(463/505) of the Eurocat and 76.0% (443/583) of the NVSCA cases were matched. The reasons 
why cases could not be matched are displayed in Figure 1. As shown here, the main reason 
that NVSCA cases had not been registered in Eurocat was the lack of permission from parents 
for registration in Eurocat (n = 34). Note that these cases showed a cleft distribution gener-
ally similar to that of the matched cases. Conversely, Eurocat cases were not registered in the 
NVSCA mainly due to postnatal death (n = 31). However, except for 2 cases, all died because of 
syndromal or chromosomal anomalies, and therefore these infants would have been excluded 
from the study anyway. As presented in Figure 1, a total of 474 cases were finally matched, and 
after exclusion of the syndromic (associated) matched cases (n = 48), a total of 426 potential 
cases remained in the study. 
Eurocat does not register non-malformed children, and controls were therefore defined 
as infants or fetuses with chromosomal/syndromal defects or non-folate related congenital 
anomalies. The rationale for choosing chromosomal and syndromal defects is that the origin 
of these disorders is not related to folic acid. The use of malformed controls from birth years 
and geographical areas similar to those of the cases is widely accepted and beneficial with 
regard to internal validity, as it minimizes the potential for differential recall bias and other pos-
sible sources of differential exposure ascertainment compared to controls without congenital 
anomalies.18-22 We excluded infants with anomalies previously associated with folic acid or 
having developmental mechanisms similar to clefts (neural tube defects, n = 213; congenital 
heart defects, n = 1692; hypospadias, n = 472; body wall defects, n = 91; limb reduction defects, 
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n = 157; iris colobomas, n = 16; and diaphragmatic hernias, n = 43),1, 3, 22-24 resulting in a total 
of 3754 potential controls. 
Oral cleft classification
To be consistent with literature,4, 7, 10, 25-27 we first divided cases into three categories: cleft lip/
alveolus only, cleft lip/alveolus and palate, and cleft palate only. Besides this generally accepted 
broad division, cases were also classified according to timing and underlying developmental 
mechanisms.
In short, embryogenesis of the primary palate (presumptive lip and alveolus) and secondary 
palate (presumptive hard and soft palates, including uvula) can be subdivided into an early (4-7 
weeks postconception) and late (7-12 weeks postconception) developmental period. During 
the early embryonic period, the primary palate is formed by outgrowth and fusion of the facial 
swellings. Subsequently—during the late period—the definitive lip and alveolus are formed by 
Selected 
population NVSCA 
(n = 583) 
Remaining cases 
NVSCA (n = 443) 
Excluded: 
• Adopted infants (n = 18) 
• Born outside Eurocat area 
(n = 73) 
No match with Eurocat  
(n = 49): 
• No permission from parents 
for registration (n = 34)a 
• Informed consent from 
parents for registration not 
yet received (n = 6) 
• At this stage, infant too old 
(>10 years of age) for 
registration (n = 7) 
• Untraceable via cleft palate 
teams and hospital registries 
(n = 2) 
Selected 
population Eurocat 
(n = 505) 
Direct match NVSCA-Eurocat  
(n = 432) 
Excluded: 
• Infants having median or 
atypical facial clefts (n = 7) 
No match with NVSCA  
(n = 35): 
• Died in postnatal period and 
therefore did not reach the 
cleft palate teams (n = 31)b 
• Untraceable via cleft palate 
teams and hospital registries  
(n = 4) 
Remaining cases 
Eurocat (n = 463) 
Total match NVSCA-Eurocat  
(n = 474)d 
Additional match with 
NVSCA after veri cation with 
cleft palate teams and 
hospital registries (n = 31) 
Additional match with 
Eurocat after veri cation 
with cleft palate teams and 
hospital registries (n = 11)c 
Figure 1. Flow diagram of selection of cases with oral clefts and matching these cases between the Dutch 
Oral Cleft Registry (NVSCA) and the population-based Eurocat Northern Netherlands. 
a With regard to timing (early or late defects) and underlying embryological processes (fusion and/
or differentiation defects), these infants showed a cleft distribution generally similar to that of the 
matched cases.
b Except 2 infants, all died because of syndromal or chromosomal anomalies, e.g., trisomy 13 or 18.
c At this stage, infants were ≤ 10 years of age and therefore eligible for registration in Eurocat. 
d Including both syndromic and non-syndromic cases.
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outgrowth and differentiation of mesenchyme into bone and musculature. By contrast, the sec-
ondary palate develops only during the latter period by outgrowth and fusion of the palatine 
processes and subsequent differentiation of its mesenchyme into bone and musculature.6, 8, 9
Derailments in fusion and/or differentiation processes may result in various cleft sub-phe-
notypes. For example, interrupted fusion of the primary palate may cause a complete cleft lip/
alveolus, while defective fusion of the secondary palate may give rise to a complete or incomplete 
cleft palate. Additionally, disruptions in differentiation of the primary or secondary palates may 
result in an incomplete or submucous cleft lip/alveolus or submucous cleft palate, respectively. 
Note that more than one of these processes can be disturbed during development, resulting in 
different combinations of defects.6, 8, 9
Based on the early and late embryogenesis described above, cases were first classified into 
early and late defects and then into fusion and/or differentiation defects. Details of this clas-
sification have been described elsewhere.8, 9 
Periconceptional folic acid supplements
To prevent neural tube defects, Dutch women planning a pregnancy are recommended to take 
400μg folic acid/day from four weeks before until eight weeks after conception.28, 29 However, 
this period covers only the early, but not the late, embryonic period for clefts. Therefore, we 
evaluated supplement use during the recommended period, as well as during the early and 
late embryonic periods mentioned above,6, 8, 9 i.e., the etiologically relevant time periods for 
clefts. As for neural tube defects, we included four weeks prior to these embryonic periods 
to reach adequate folate status for prevention, resulting in the following etiologically relevant 
periods: all clefts (0-12 weeks postconception), early defects (0-7 weeks postconception), and 
late defects (3-12 weeks postconception).
Infants were initially excluded from the study if the mothers’ use of folic acid supplements 
was unknown or the period of use was unknown (50 cases, 724 controls). They were also 
excluded if the mother had used folic acid antagonists, which interfere with folate metabo-
lism,18-20 including dihydrofolate reductase inhibitors (methotrexate, sulfasalazine, triamterene, 
pyrimethamine, and trimetroprim) or antiepileptic drugs (5 cases, 47 controls). Additionally, 
infants with reported maternal diabetes mellitus prior to or during pregnancy were excluded (4 
cases, 38 controls), because clefts have been associated with maternal diabetes.30 
Statistical analysis
The following potential confounders were explored using the chi-squared test: year of baby’s 
birth, number of babies/fetuses delivered, number of previous live births, fertility problems, 
maternal age and BMI, mother’s education level, and smoking and alcohol use. To estimate cleft 
risks, we calculated crude and adjusted odds ratios using univariate and multivariate logistic 
regression models, respectively. First, we evaluated the use of any supplement, and if possible, 
we subsequently stratified the analyses into folic acid alone and multivitamins (containing 
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folic acid). Two-tailed values of p < 0.05 and 95% confidence intervals (CI) excluding 1.0 were 
considered statistically significant. Analyses were performed using SPSS software version 19.0. 
RESuLTS
In total, 367 cases and 2945 controls (924 infants with chromosomal defects and 2021 with 
non-folate related anomalies) were included. Apart from the higher proportions of boys 
and previous live births among cases, no further significant differences in infant or maternal 
characteristics were found between cases and controls (Table 1). Generally, mothers who had 
Table 1. Characteristics of cases and non-folate related controls in the Northern Netherlands, based on 
data from Eurocat Northern Netherlands (1997-2009)
Characteristic Cases
(n = 367)
Controls
(n = 2945)
p Valuea
n (%) n (%)
Child sex 0.002
Boy 222 (60.5) 1535 (52.1)
Girl 145 (39.5) 1410 (47.9)
Year of birth 0.22
1997-2000 119 (32.4) 1082 (36.7)
2001-2005 142 (38.7) 1105 (37.5)
2006-2009 106 (28.9) 758 (25.7)
Number of babies/fetuses delivered 0.87
1 348 (95.9) 2821 (96.1)
≥2 15 (4.1) 116 (3.9)
Unknown 4 8
Number of previous live birthsb 0.004
0 146 (40.1) 1411 (48.1)
1 139 (38.2) 1071 (36.5)
2 61 (16.8) 334 (11.4)
≥3 18 (4.9) 118 (4.0)
Unknown 3 11
Fertility problems 0.51
Yes 49 (13.7) 434 (15.0)
No 308 (86.3) 2451 (85.0)
Unknown 10 60
Maternal age at delivery 0.89
15-19 2 (0.5) 26 (0.9)
20-24 30 (8.2) 252 (8.6)
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used supplements had either taken folic acid alone or multivitamins (containing folic acid), at a 
daily dose of 400μg. As presented in Table 2, case mothers reported any periconceptional folic 
acid supplement use more frequently than control mothers. More specifically, consistent use of 
any supplement during the entire recommended period or etiologically relevant cleft periods 
was more frequently reported among cases, while partial use was more frequently reported 
among controls. Stratum analysis revealed similar figures for use of folic acid alone (not as a 
multivitamin). As shown in Table 3, consistent use of any supplement or folic acid alone during 
Table 1. (Continued)
Characteristic Cases
(n = 367)
Controls
(n = 2945)
p Valuea
n (%) n (%)
25-29 120 (33.0) 993 (33.8)
30-34 149 (40.9) 1178 (40.0)
35-39 57 (15.7) 423 (14.4)
≥40 6 (1.6) 70 (2.4)
Unknown 3 3
Body mass index (kg/m2) 0.22
10-18.5 14 (4.0) 95 (3.3)
18.5-25 207 (58.6) 1831 (64.4)
25-30 92 (26.1) 646 (22.7)
>30 40 (11.3) 273 (9.6)
Unknown 14 100
Education level 0.24
Low 83 (23.3) 571 (19.7)
Middle 175 (49.2) 1443 (49.9)
High 98 (27.5) 878 (30.4)
Unknown 11 53
Smoking during pregnancyc 0.59
Yes 92 (25.6) 708 (24.2)
No 268 (74.4) 2212 (75.8)
Unknown 7 25
Alcohol during pregnancyc 0.80
Yes 75 (20.8) 625 (21.4)
No 285 (79.2) 2294 (78.6)
Unknown 7 26
a p value represents statistical significance level for differences between cases and controls (tested two-
sided with χ2 test). p value <0.05 is used to determine statistical significance and is presented in bold 
format.
b Proportions of previous stillbirths or terminated pregnancies did not differ between cases and controls.
c Maternal smoking and alcohol use were considered positive if mothers had reported any use during 
pregnancy, even if they had stopped when they became aware of their pregnancy.
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Table 2. Distribution of timing and duration of periconceptional use of folic acid supplements by 
mothers of case and control infants in the Northern Netherlands, based on data from Eurocat Northern 
Netherlands (1997-2009)
Timing and Duration of Maternal Supplement use Case Mothers
(n = 367)
Control Mothers
(n = 2945)
n (%) n (%)
Any folic acid supplementa
4 weeks before until 8 weeks after conceptionb
Consistent usec 173 (47.1) 1233 (41.9)
Partial used 92 (25.1) 815 (27.7)
No use or use beyond the advised period 102 (27.8) 897 (30.4)
Period of supplement use unknowne 0 (0.0) 0 (0.0)
Weeks 0 to 12 postconceptionf
Consistent usec 100 (27.3) 624 (21.2)
Partial used 173 (47.1) 1484 (50.4)
No use or use beyond the advised period 93 (25.3) 828 (28.1)
Period of supplement use unknowne 1 (0.3) 9 (0.3)
Weeks 0 to 7 postconceptiong
Consistent usec 181 (49.3) 1311 (44.5)
Partial used 84 (22.9) 737 (25.0)
No use or use beyond the advised period 102 (27.8) 897 (30.5)
Period of supplement use unknowne 0 (0.0) 0 (0.0)
Weeks 3 to 12 postconceptionh
Consistent usec 131 (35.7) 887 (30.1)
Partial used 128 (34.9) 1073 (36.4)
No use or use beyond the advised period 97 (26.4) 865 (29.4)
Period of supplement use unknowne 11 (3.0) 120 (4.1)
Specific folic acid supplement
4 weeks before until 8 weeks after conceptionb
Folic acid alone (not as a multivitamin)
Consistent usec 135 (36.8) 991 (33.7)
Partial used 73 (19.9) 654 (22.2)
Multivitamins (containing folic acid)
Consistent usec 21 (5.7) 160 (5.4)
Partial used 23 (6.3) 187 (6.3)
No use or use beyond the advised period 102 (27.8) 897 (30.5)
Type of supplement use unknowne 13 (3.5) 56 (1.9)
Weeks 0 to 12 postconceptionf
Folic acid alone (not as a multivitamin)
Consistent usec 64 (17.4) 383 (13.0)
Partial used 142 (38.7) 1262 (42.9)
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Table 2. (Continued)
Timing and Duration of Maternal Supplement use Case Mothers
(n = 367)
Control Mothers
(n = 2945)
n (%) n (%)
Multivitamins (containing folic acid)
Consistent usec 19 (5.2) 157 (5.3)
Partial used 35 (9.5) 250 (8.5)
No use or use beyond the advised period 93 (25.4) 828 (28.1)
Type or period of supplement use unknowne 14 (3.8) 65 (2.2)
Weeks 0 to 7 postconceptiong
Folic acid alone (not as a multivitamin)
Consistent usec 143 (39.0) 1051 (35.7)
Partial used 65 (17.7) 594 (20.2)
Multivitamins (containing folic acid)
Consistent usec 21 (5.7) 173 (5.9)
Partial used 23 (6.3) 174 (5.9)
No use or use beyond the advised period 102 (27.8) 897 (30.4)
Type of supplement use unknowne 13 (3.5) 56 (1.9)
Weeks 3 to 12 postconceptionh
Folic acid alone (not as a multivitamin)
Consistent usec 83 (22.6) 576 (19.6)
Partial used 113 (30.8) 944 (32.0)
Multivitamins (containing folic acid)
Consistent usec 31 (8.5) 247 (8.4)
Partial used 17 (4.6) 139 (4.7)
No use or use beyond the advised period 97 (26.4) 865 (29.4)
Type or period of supplement use unknowne 26 (7.1) 174 (5.9)
a Total group of folic acid supplements comprising folic acid alone and folic acid-containing 
multivitamins.
b Recommended period for periconceptional use of folic acid supplements in the Netherlands to support 
the prevention of neural tube defects.
c Daily use during the entire above-mentioned period.
d Daily/intermittent use during part of the above-mentioned period.
e If the period of mother’s use of folic acid supplements was not known at all, infants were initially 
(before analysis) excluded from the study and therefore not shown in the current table.  
If the specific type (folic acid alone or multivitamins) or period of use beyond the recommended period 
was unknown when stratified, infants were presented in this table as ‘type or period of supplement use 
unknown’. Note that these infants were excluded from further analysis of the specific stratum.
f Etiologically relevant period for all oral clefts, starting 4 weeks prior to the embryonic development of 
clefts to reach adequate folate status for prevention.
g Etiologically relevant period for early defects, starting 4 weeks prior to the embryonic development of 
early defects to reach adequate folate status for prevention.
h Etiologically relevant period for late defects, starting 4 weeks prior to the embryonic development of 
late defects to reach adequate folate status for prevention.
Chapter 9184
the entire etiologically relevant cleft period (0-12 weeks postconception) was associated with 
a significantly increased risk of all clefts, and in particular of cleft lip/alveolus only. Adjustment 
for potential confounders resulted in about one-and-a-half time higher risks for all clefts and 
three-fold increased risks for cleft lip/alveolus. After inclusion of partial use during the etio-
logically relevant period, the size, but not the direction, of the effects were reduced (except 
for multivitamins, Table 3). Overall, associations were also somewhat weakened by restricting 
analysis of use to the recommended period until 8 weeks, instead of the etiologically relevant 
period until 12 weeks postconception (Table 4). Exploration of a possible genetic background 
revealed that a positive family history for clefts was less frequently reported for cases with cleft 
lip/alveolus (2.5%, 3/120) than cases with other cleft categories (11.4%, 28/245; p = 0.004, data 
not further shown). 
To gain more insight into the detected effects, clefts were also classified according to timing 
and underlying processes in embryogenesis. Table 4 shows that clefts of the lip/alveolus mainly 
consisted of late differentiation defects (70.2%, 85/121). The estimated risks for early and late 
defects—including fusion and/or differentiation defects—are shown in Table 5. Consistent 
supplement use during 0-7 weeks postconception was not significantly associated with higher 
risks of early defects (mainly fusion defects). Similarly, consistent use during 3-12 weeks post-
conception did not significantly increase the risk of late defects. Further subgroup analysis also 
showed no significant crude associations. However, after adjustment for potential confound-
ers, we found two- to three-fold increased risks just for late differentiation defects, regardless 
of supplement type. Similar to the cleft category analysis, inclusion of partial use during the 
etiologically relevant periods reduced the size, but not the direction, of associations (Table 5). 
Finally, if analyses were restricted to only chromosomal defects (n = 924) or only live births (n 
= 2895) as controls, no significant changes in our risk estimates were detected (data not further 
shown).
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Table 4. Classification of cases with various cleft sub-phenotypes in the Northern Netherlands according 
to timing and underlying processes in embryogenesis, based on data from the NVSCA (1997-2009)
Cleft Type Cases
n (%)
Any oral cleft 367
Early defectsa 162 (44.1)
Fusion defects 140 (38.1)
Complete cleft lip/alveolusb 30
Complete cleft lip/alveolus & complete or incomplete cleft palateb 110
Fusion and differentiation defects 22 (6.0)
Incomplete cleft lip & complete cleft alveolusb,c 5
Incomplete cleft lip & complete cleft alveolus & cleft palateb,c 8
Complete cleft lip/alveolus & incomplete or submucous cleft lip/alveolusd,e 1
Complete cleft lip/alveolus & incomplete or submucous cleft lip/alveolus & cleft palated,e 8
Late defectsf 205 (55.9)
Fusion defects 81 (22.1)
Complete or incomplete cleft palate 81
Differentiation defects 104 (28.3)
Incomplete or submucous cleft lip/alveolusb 85
Incomplete or submucous cleft lip/alveolus & submucous cleft palateg 2
Submucous cleft palate 17
Fusion and differentiation defects 20 (5.4)
Incomplete or submucous cleft lip/alveolus & complete or incomplete cleft palateb 14
Incomplete & submucous cleft palate 6
a Embryonic development during 4-7 weeks postconception.
b This category comprised unilateral as well as bilateral clefts.
c Synonym for this phenotype: Simonart’s band.
d This category comprised bilateral clefts only.
e Synonym for submucous cleft lip: microform, subsurface or subcutaneous cleft, forme fruste, and 
congenital scar. 
f Embryonic development during 7-12 weeks postconception.
g This category comprised unilateral clefts only.
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DISCuSSION
This population-based case-control study provides the first evidence that periconceptional 
folic acid supplementation might be associated with elevated risks for certain types of oral 
clefts. Defects of the lip/alveolus—mainly resulting from defective differentiation in develop-
ment—appeared to account for the largest proportion of the risk increase, being associated 
with more than three-fold higher risks after consistent maternal use during the entire etiologi-
cally relevant period. Further analysis systematically showed two- to three-fold increased risks 
for late differentiation defects, with no significant associations for fusion defects. Given that 
stratum analysis revealed similar figures for folic acid alone, effects were attributable to folic 
acid and not to other multivitamin components. Furthermore, a duration of exposure-response 
relationship was shown, as inclusion of partial use generally reduced the size, but not the direc-
tion, of observed associations. 
Strengths and weaknesses
By combining complementary NVSCA and Eurocat data, we were able to investigate type, tim-
ing, and duration of periconceptional folic acid supplement use in relation to traditional cleft 
categories as well as to their timing and underlying embryological processes—an approach 
not used in earlier studies.1, 2 The rationale of this approach was based on the early and late 
embryogenesis, in line with the theoretical basis of the NVSCA system.6, 8-10 The unique data 
combination, allowing us to use a relatively large sample drawn from a well-defined and homog-
enous population, gave our study its main strength. However, there were also some limitations, 
mostly inherent to the observational nature of our study. As information on folic acid supple-
ment use and potential confounders was mainly obtained from retrospective questionnaires, 
recall bias might be a concern. However, although misclassification and measurement errors 
inevitably occur, the use of malformed controls minimized differential recall between cases and 
controls. This is reflected in the equal distribution of other exposures among cases and controls 
for which socially desirable answers could be expected, like maternal smoking and alcohol use. 
Concerns about recall bias were further reduced by the specificity, consistency, and systematic 
character of the observed effects, including the duration of exposure-response relationship. 
Another limitation is that we were not able to investigate dose effects because a fixed dose 
of 400μg is recommended for the periconceptional period in the Netherlands, and high dose 
(5mg) supplements are only prescribed for certain medical indications (e.g., previous pregnancy 
affected with a neural tube defect).  Additionally, exact intake could not be measured because 
we had to rely on information about supplement use from retrospective questionnaires, and 
data on folate concentrations in serum and red blood cells were not available. While verifica-
tion of the products that had been used by cases and controls showed dosages similar to the 
recommended periconceptional dose (400μg), dietary intake was not known, which limited our 
knowledge on folate status. 
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In addition, since parents have to give informed consent for registration in Eurocat, there is a 
possibility of selection bias due to this informed consent. However, we assume that not giving 
the consent is equally distributed among cases and controls, given that both had congenital 
anomalies. Furthermore, the cases with parental refusal showed a cleft distribution generally 
similar to that of the included cases, which suggests that refusal occurred not just in selective 
groups. Conversely, the NVSCA registers only patients who survive long enough to reach a cleft 
palate team. Theoretically, this might also affect results, but in our study, almost all postnatal 
deaths had syndromal or chromosomal anomalies and would therefore have been excluded 
anyway. Another source of selection bias might be the inclusion of pregnancy terminations 
and stillbirths among controls in our study. However, we believe this to be minimal, because 
restricting analyses to live births only did not significantly alter our risk estimates. 
Another weakness might be the presence of unidentified confounding factors. Even though 
we used malformed controls and were well informed about maternal health and lifestyle factors 
as well as use of medications (folic acid antagonists), there may still have been confounding by 
other closely related factors. However, such confounders would have to be strongly related to 
specific cleft defects and folic acid use to produce the observed results. 
Although the use of malformed controls is beneficial with regard to internal validity, it might 
also have its restrictions, as it could lead to risk over- or underestimations if anomalies in the 
control group were also associated with folic acid. However, we assume this to be minimal 
because suspected folate-related anomalies were excluded by design, and further restrictions 
to purely chromosomal anomalies (i.e., excluding the largest subgroup having non-chromo-
somal anomalies) did not substantially change our risk estimates. Additionally, Van Beynum 
and colleagues recently used similar methods and comparable controls drawn from the same 
Eurocat population to demonstrate significant reduced risks for congenital heart defects asso-
ciated with periconceptional folic acid use in the Northern Netherlands.22 As stated by these 
authors, their findings are in line with earlier findings of a Hungarian randomized controlled 
trial12 and other observational studies,22 thereby supporting the validity of malformed controls. 
Moreover, they demonstrated that such controls are representative for the general population, 
as they found overall similar risk estimates using reference groups from the general population. 
Because we investigated supplement use in great detail and considered many potential con-
founders, these reference groups—for which just minimal information on absence or presence 
of folic acid use was available—could not be used in our study. 
Possible explanations
The specificity and systematic pattern in our findings is consistent with recent embryological 
and epidemiological data, suggesting that clefts of the lip/alveolus have unique genetic and 
etiologic features.4, 6, 7, 10, 25-27 However, our results are in contrast with previous studies on the 
effects of periconceptional folic acid in clefts, which showed either preventive or no effects.1-3, 
31 More specifically, one of the first positive effects were reported by Tolarova, who found an 
Chapter 9196
84% reduction in recurrence of cleft lip/alveolus with or without cleft palate after supplemen-
tation of multivitamins and high dose (10 mg) folic acid during 3 months before and after 
pregnancy.32 However, this study was limited by the small number of cases as well as by its 
non-randomized nature. In contrast, the only two intervention trials that considered oral clefts 
and were reported—comprising a randomized controlled trial and cohort-controlled trial from 
Hungary in 1992 and 2004, respectively—showed no reduction or increase in the prevalence of 
cleft lip/alveolus with or without palate or cleft palate alone after supplementation of multivita-
mins with 800μg folic acid.11, 13 This might partly be explained by the low statistical power due 
to limited number of subjects. Among observational studies, the Hungarian case-control study 
of Czeizel and colleagues (1999) indicated a dose-dependent preventive effect of folic acid on 
the risk of clefts.33 Additionally, Li and colleagues recently performed a Chinese prospective 
cohort study, showing a reduced risk for cleft lip with or without palate among women who 
had used periconceptional folic acid in a northern rural region of China with a proven high 
prevalence of folate deficiency.34 However, this reduced risk was mainly attributable to cleft lip 
and palate and not to cleft lip only, the category for which our study showed the most elevated 
risk. Furthermore, no significant effects were found in a more southern region with an overall 
higher socioeconomic status and generally greater availability of fresh vegetables, resulting 
in a better folate status. An important limitation of this study was that folic acid use was not 
randomized, and that women who had taken folic acid may thus have differed systematically 
in other factors that could have influenced the prevalence of clefts. As the authors did not have 
information on risk factors found in our and other studies to be important, such as smoking and 
alcohol,1 they were not able to adjust for these factors.
The mechanisms by which folic acid might prevent certain congenital anomalies remains 
unexplained, but we do know that other aspects surrounding folate metabolism have also been 
shown to deviate for clefts. For example, in some studies, the association with the CT/TT geno-
type of the MTHFR gene appeared to be a protective factor instead of a risk factor for clefts,35-38 
or it appeared to be an even greater risk factor if the mother had used folic acid supplements.38 
Moreover, inhibiting folic acid binding to folate receptor has been shown to reduce the cleft 
risk.39 Finally, some studies have found that increased plasma or erythrocyte folate (a parameter 
for long-term folate status) is associated with elevated, rather than decreased, cleft risks.35, 40, 41 
Given that the Northern Netherlands has a rather homogenous population with relatively 
high cleft rates,14 a higher genetic predisposition might have contributed to our findings. This 
could specifically have affected differentiation defects, as differentiation and fusion processes 
are regulated by different genes and cell-biological processes.4, 6 However, this explanation was 
not supported by our exploratory analysis of relatives with oral clefts, which showed relatively 
low proportions of cleft relatives among cases with these specific defects. 
To our knowledge, our study is the first to report a negative effect of folic acid supplementa-
tion on the risk of an isolated congenital anomaly. However, previous reports have shown com-
parable associations between periconceptional folic acid supplements/multivitamins/cereals 
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and the occurrence of multiple congenital anomalies.42, 43 Furthermore, several animal studies 
have also demonstrated adverse effects linking high folate intake to embryonic delay, growth 
retardation, congenital heart defects.44-46 In humans, folate intake and blood cell concentra-
tions increased significantly due to folate fortification and additional supplementation,47, 48 
but the consequences of long-term high folate intake are not known yet. Recently, it has been 
hypothesized that folic acid intake might lead to changes in epigenetic patterns, thereby alter-
ing gene expression.49-51 This might help to explain different health outcomes (e.g., congenital 
anomalies) among those with similar genetic backgrounds.
Possible implications
Our findings may have implications for healthcare and policy makers. First, oral clefts require 
extensive multidisciplinary treatment and account for substantial morbidity among infants. 
Therefore, higher cleft risks will increase the public health burden in terms of medical costs and 
emotional stress to patients and their families.4, 5, 7 Second, if our findings are correct, it is vital 
to restrict the use of folic acid to the official recommended period of 4 weeks before to 8 weeks 
after conception, that is the etiologically relevant period for neural tube defects.29 Minimizing 
pregnant women’s exposure to folic acid in this way may then reduce cleft prevalence. More 
generally, our study underlines the importance of evaluating public health strategies regarding 
folic acid supplementation, including its timing, duration, and dose, which should be done in the 
light of potential dietary improvements. Together with other emerging studies on the potential 
adverse effects of increased folic acid intake,44-46, 49-51 our findings also underscore the need for 
additional studies on the consequences of increased folic acid intake. Large population-based 
studies using other datasets, but the same approach and methodology as in the current study, 
are needed to confirm or refute our findings. To gain more insight into the role of folic acid in 
the etiology of clefts and other congenital anomalies, future studies should evaluate effects 
according to timing and embryological mechanisms underlying their development.
CONCLuSIONS
This study presents several lines of evidence indicating that periconceptional folic acid in the 
Northern Netherlands is associated with an increased risk of clefts, especially of the lip/alveolus, 
relative to non-folate related malformations. Although detected by an observational study, this 
association is strengthened by the specificity, consistency, systematic pattern, and duration of 
exposure-response relationship of our findings. Ideally, a randomized controlled trial should be 
conducted to confirm or refute our findings, but this would be unethical with the knowledge 
that folic acid can prevent neural tube defects. Therefore, it is advisable to restrict folic acid 
supplementation to the period recommended for neural tube defects until more information 
is available. 
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AbSTRACT
Background: Oral clefts—comprising cleft lip (CL), cleft lip with cleft palate (CLP), and cleft 
palate (CP)—are being diagnosed prenatally more frequently. Consequently, the need for 
accurate information on the risk of associated anomalies and chromosomal defects to aid in 
prenatal counseling is rising. This systematic review was conducted to investigate the prenatal 
and postnatal prevalence of associated anomalies and chromosomal defects related to cleft 
category, thereby providing a basis for prenatal counseling and prenatal invasive diagnostics.
Methods: Online databases were searched for prenatal and postnatal studies on associated 
anomalies and chromosomal defects in clefts. Data from literature were complemented with 
national validated data from the Dutch Oral Cleft Registry.
Results: Twenty studies were included: three providing prenatal data, 13 providing postnatal 
data, and four providing both. Data from prenatal and postnatal studies showed that the 
prevalence of associated anomalies was lowest in CL (0%-20.0% and 7.6%-41.4%, respectively). 
For CLP, higher frequencies were found both prenatally (39.1%-66.0%) and postnatally (21.1%-
61.2%). Although CP was hardly detected by ultrasound, it was the category most frequently 
associated with accompanying defects in postnatal studies (22.2%-78.3%). Chromosomal 
abnormalities were most frequently seen in association with additional anomalies. In absence 
of associated anomalies, chromosomal defects were found prenatally in CLP (3.9%) and postna-
tally in CL (1.8%, 22q11.2 deletions only), CLP (1.0%) and CP (1.6%). 
Conclusion: Prenatal counseling regarding prognosis and risk of chromosomal defects should 
be tailored to cleft category, and more importantly, to the presence/absence of associated 
anomalies. Irrespective of cleft category, clinicians should advise invasive genetic testing if 
associated anomalies are seen prenatally. In absence of associated anomalies, prenatal conven-
tional karyotyping is not recommended in CL, although array-comparative genomic hybridiza-
tion should be considered. In presumed isolated CLP or CP, prenatal invasive testing, preferably 
by array-based methods, is recommended.
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INTRODuCTION
Oral clefts—one of the most common congenital malformations in humans—arise in approxi-
mately 1 of 700 live births.1 It is has been well established that, although clefts can be isolated 
anomalies, they are frequently associated with other congenital anomalies, often as part of a 
syndrome or chromosomal defect. Oral clefts are traditionally subdivided into two categories: 
cleft lip with or without cleft palate (CL±P), and cleft palate only (CP).1 However, recent studies 
have emphasized subdivision into three categories: cleft lip only (CL), cleft lip with cleft palate 
(CLP), and cleft palate only (CP), because of differences concerning embryologic develop-
ment, prevalence, risk factors, and associations with other congenital anomalies.2-5 Although 
many studies have also included median cleft lip or atypical facial clefts as oral clefts,6-8 these 
anomalies should be considered as separate craniofacial anomalies because of their different 
pathogenesis.9, 10
As a result of advances in transabdominal 2D ultrasound technology and its routine use 
in obstetric practice, oral clefts with or without associated anomalies are being diagnosed 
prenatally more frequently.11 Detection rates—predominantly on CL±P—increased from 
approximately 5% in the early 1980s to over 26% in the late 1990s,12 and they are as high 
as 65% today.13 Consequently, there is an increasing need for accurate information to aid in 
prenatal counseling. When informing parents on outcome and prognosis, the category of cleft 
as well as the presence of other congenital anomalies is crucial. Especially the identification 
of an underlying chromosomal defect will influence prenatal counseling and management of 
the pregnancy significantly. However, in clinical practice there is often discussion on whether 
further invasive tests should be performed prenatally to identify chromosomal defects.14 It is 
unknown whether invasive diagnostics should be offered in all identified cleft cases or should 
be limited to specific cleft categories or the presence of associated anomalies.
To allow informed decisions on invasive prenatal diagnostics, clinicians and parents need 
to be informed about the prevalence of associated anomalies and underlying chromosomal 
defects in clefts. However, the reported rates in prenatal cleft populations vary greatly between 
studies.6-8, 13-16 Furthermore, these findings may reflect selection bias,17 as cases that are more 
likely to be diagnosed prenatally tend to be the more severe cases with associated anomalies 
and chromosomal defects.11 Nowadays, increasing numbers of isolated clefts—not accompa-
nied by growth retardation or other prenatal complications—are identified in utero.11 There-
fore, both prenatal and postnatal studies have to be interpreted in order to provide accurate 
information on frequencies of associated anomalies and underlying chromosomal defects for 
future prenatal cleft populations. 
This systematic review presents a comprehensive summary of literature and complemen-
tary Dutch registry data on prenatal and postnatal findings of associated anomalies and 
chromosomal defects related to cleft category. The aim of this study was to provide a basis 
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for prenatal counseling of future parents and to advise on invasive genetic diagnostics in 
prenatally detected oral clefts. 
METHODS
Literature search
In August 2011, the PubMed database was systematically searched using the search string 
“(cleft) AND (abnormalities OR anomalies) AND (chromosomal OR syndrome)”. The search was 
limited to articles published in English after 31 December 1994. This restriction was applied 
because technologies to identify specific syndrome diagnoses and chromosomal abnormalities 
have been developed relatively recent. For example, fluorescence in situ hybridization (FISH) 
was introduced in clinical practice in the early 1990s enabling the detection of specific micro-
deletions.18, 19 Consequently, studies published before 1995 may have reported relatively 
underestimated rates of associated anomalies and chromosomal defects.
The titles and abstracts of the citations were screened independently by two reviewers (MJB 
and WM) to identify potentially relevant papers for which full-text publications were retrieved. 
Additional studies were found by crosschecking references. Studies were included if they 
presented data on oral clefts that were analyzed prenatally and/or postnatally for associated 
anomalies and chromosomal defects, the latter preferably verified by karyotype. To ensure 
the quality and prevent our prenatal analysis from significant underreporting, we excluded 
prenatal studies in which several obvious structural defects (for example anencephaly or holo-
prosencephaly) had been missed by ultrasound. Because of the ethnic variation in prevalence 
of clefts and their associated anomalies,1, 17 studies evaluating non-Caucasian populations (e.g., 
Asian populations) were excluded to keep a homogeneous study population. 
Complementary data
Comparison of the existing literature on congenital anomalies and chromosomal defects asso-
ciated with oral clefts is restricted, particularly due to differences in methodology. For example, 
there is a considerable variation in definitions and classifications of clefts and their accompany-
ing defects, as well as in sample sizes, data sources, methods of data collection, and follow-up 
periods between studies.17 For this reason, we complemented our review of postnatal studies 
with national data from the Dutch Oral Cleft Registry (NVSCA). Since 1997, the 15 Dutch cleft 
palate teams have registered oral clefts and their associated anomalies, using a unique detailed 
recording system based on the embryology of the head and neck area. Because major as well as 
minor anomalies (including dysmorphic features) are recorded in detail, the NVSCA data can be 
fit into any existing classification and are highly applicable for comparison with other studies. 
Moreover, a selection of registry data has recently been validated and completed by review of 
medical data, after a median follow-up period of 5 years.20-22 This selection of validated data 
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was used to complement our analysis on associated anomalies and chromosomal defects in 
postnatally detected clefts.22 In addition, the annual NVSCA reports 1997-2010 were used to 
inventory the different syndromes and chromosomal defects that had been identified postna-
tally.23, 24 The methods of registration and validation have been described in detail elsewhere.5, 
20-22
Data analysis
Data on associated anomalies and chromosomal defects were extracted from the selected 
articles and subdivided according to the three cleft categories: CL, CLP and CP. Also, the vali-
dated and completed NVSCA data were further analyzed according to these three categories.22 
For studies not distinguishing CL and CLP, the category of CL±P was used. Median cleft lip and 
atypical facial clefts were excluded because of their different pathogenesis.9, 10 
For all cleft categories, frequencies of associated congenital anomalies and chromosomal 
defects were deducted from the reported data and presented in numbers and percentages. 
For studies providing karyotype information for isolated and/or associated cases, we calculated 
separate rates of chromosomal defects among isolated (if available) and associated clefts.6-8, 
13-15, 22, 25-27 If studies did not provide numbers of karyotyped cases, but reported routine karyo-
typing of associated clefts (as in daily practice), we assumed that the majority of associated 
clefts were karyotyped.13, 22 Likewise, if chromosomal defects were reported from retrospective 
registry data without information about the presence or absence of associated anomalies, we 
assumed that chromosomal analysis had been performed in associated cases only.16, 26, 28-31 If 
no specific data on chromosomal anomalies was available for the three cleft categories,32-36 
total rates of associated anomalies were calculated. Theoretically, these numbers might also 
include chromosomal anomalies detected in isolated clefts, without other congenital anoma-
lies. Where possible, prevalence data were also subdivided according to unilateral and bilateral 
clefts.6-8, 13, 14, 25 
To specify the detected chromosomal anomalies, we made an inventory of the different 
syndromes and chromosomal defects that had been identified in clefts prenatally and/or post-
natally. Due to great differences in methodology,17 we were not able to perform a meta-analysis 
with these data. To give more information about the reviewed studies and to illustrate the dif-
ferences, we summarized the various study characteristics and designs, including the inclusion 
criteria and definitions of clefts and accompanying defects, as well as the sample sizes, data 
sources, and methods of data collection. 
RESuLTS
The literature search yielded 9,540 citations. Initial screening by title identified 88 potentially rel-
evant abstracts, including 20 studies meeting the inclusion criteria. Subsequently, one of these 
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studies was excluded because obvious structural anomalies (e.g., lobar holoprosencephaly and 
severe congenital heart anomalies) had been missed prenatally, which raised doubts about the 
quality of the performed prenatal ultrasounds.37 
Including the NVSCA study,22 the remaining studies comprised three studies providing 
relevant prenatal data,6-8 13 studies providing relevant postnatal data,22, 25-36 and four studies 
providing both.13-16 All studies with postnatal data had a follow-up period of at least one year. 
Although the studies of Stoll et al.,26 Vallino-Napoli et al.,29 and Walker et al.25 presented both 
prenatal and postnatal data, they were included only in the postnatal analysis for divergent 
reasons. First, the retrospective data of Stoll et al. did not allow extraction of frequencies of 
associated anomalies and chromosomal defects among prenatally detected clefts. Second, 
Vallino-Napoli et al. reported data on pregnancy outcome, but the prenatally detected cleft 
cases could not be identified from their data. Finally, Walker et al. evaluated anomalies that 
could theoretically have been detected by ultrasound instead of those that had actually been 
detected. The latter were not separately discussed in their paper. The various study characteris-
tics and designs of the reviewed studies are presented in Table 1.
Prenatally detected associated anomalies and chromosomal defects
In the seven prenatal studies, a total of 407 fetuses with oral clefts were analysed.6-8, 13-16 The 
prevalence of associated anomalies and chromosomal defects in prenatally detected clefts is 
summarized according to cleft category in Table 2. In the CL category, three out of 23 fetuses 
had associated anomalies, comprising a cardiac defect with a situs inversus,6 an umbilical 
hernia, and a clubfoot.13 One of these three CL cases had a chromosomal defect (trisomy 18).13 
CLP showed the highest prevalence of associated anomalies (54.0%, range 39.1% to 66.0%). 
For studies that grouped CL and CLP together as CL±P, the prevalence was somewhat lower 
(29.9%, range 17.2% to 57.1%). Only one study evaluated prenatally detected CP cases (n = 2); 
both cases had associated anomalies as well as an underlying chromosomal defect.7 In addi-
tion to the three cleft categories, studies distinguishing unilateral and bilateral clefts generally 
found a higher prevalence of associated anomalies and chromosomal defects in bilateral than 
in unilateral CLP or CL±P (Table 3). 
Analysis of chromosomal defects in isolated and associated clefts revealed that almost all 
chromosomal defects were associated with other congenital anomalies or ultrasound markers, 
such as intrauterine growth retardation (97.4%, 74/76; one case with a chromosomal defect 
not included, as information on associated anomalies was not available, Table 2).6 For only 
two cases with chromosomal defects, no accompanying defects were found by ultrasound; 
one case showed a mosaic trisomy 226 and the other had a trisomy 18.13 Consequently, the 
prevalence of chromosomal defects in cases with associated clefts was 50.7% (74/146), while 
it was 0.9 % (2/212) in cases with formerly presumed isolated clefts. In studies specifying the 
detected chromosomal abnormalities, trisomy 13 (56.3%, 36/64) and trisomy 18 (29.7%, 19/64) 
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Table 2. Summary of published prevalence data on associated anomalies and chromosomal defects in prenatally 
and postnatally detected oral clefts
Study Type Associated Anomalies Chromosomal Defects
Isolated clefts* Associated clefts* Total clefts*
% (n) % (n) % (n) % (n)
Prenatal studies
CL
Nyberg 1995† 20.0 (1/5) 0.0 (0/1)‡ 0.0 (0/5)
Berge 2001† 0.0 (0/3) 0.0 (0/3) 0.0 (0/0)  0.0 (0/3)
Maarse 2011† 13.3 (2/15) 50.0 (1/2) 6.7 (1/15)
Total 13.0 (3/23) 0.0 (0/3) 33.3 (1/3) 4.3 (1/23)
CLP
Nyberg 1995† 45.7 (16/35) 5.3 (1/19) 50.0 (8/16) 25.7 (9/35)
Berge 2001† 66.0 (35/53) 0.0 (0/18) 68.6 (24/35) 46.3 (25/54)§
Maarse 2011† 39.1 (9/23) 7.1 (1/14) 66.7 (6/9) 30.4 (7/23)
Total 54.0 (60/111) 3.9 (2/51) 63.3 (38/60) 36.7 (41/112)§
CL±P
Perrotin 2001† 35.7 (20/56) 0.0 (0/36) 55.0 (11/20)‡ 19.6 (11/56)
Offerdal 2008 57.1 (20/35) 40.0 (8/20) 22.9 (8/35)
Russell 2008 51.7 (15/29) 33.3 (5/15)‡|| 17.2 (5/29)
Gillham 2009† 17.2 (26/151) 0.0 (0/122) 34.6 (9/26) 6.0 (9/151)
Total 29.9 (81/271) 0.0 (0/158) 40.7 (33/81) 12.2 (33/271)
CP
Berge 2001† 100.0 (2/2) 100.0 (2/2)‡ 100.0 (2/2)‡
Postnatal studies
CL
Kallen 1996 10.4 (212 /2029) 10.4 (22/212)|| 1.1 (22/2029)
Milerad 1997 8.0 (13/163)¶
Walker 2001** 8.3 (7/84) 14.3 (1/7) 1.2 (1/84)
Calzolari 2007 13.6 (245/1806) 13.1 (32/245)|| 1.8 (32/1806)
Tan 2009 11.9 (8/67) 12.5 (1/8)|| 1.5 (1/67)
Maarse 2011 11.8 (2/17) 0.0 (0/2) 0.0 (0/17)
Rittler 2011 7.6 (9/119) 1.8 (2/110)†† 22.2 (2/9) 3.4 (4/119)
Rozendaal 2012 41.4 (29/70) 0.0 (0/29) 0.0 (0/70)
Total 12.1 (525/4355) 1.8 (2/110) 11.3 (58/512) 1.4 (60/4192)
CLP
Kallen 1996 25.3 (819/3232) 24.5 (201/819)|| 6.2 (201/3232)
Milerad 1997 28.0 (60/214)¶
Walker 2001** 24.6 (44/179) 31.8 (14/44) 7.8 (14/179)
Calzolari 2007 23.8 (693/2913) 22.1 (153/693)|| 5.3 (153/2913)
Tan 2009 23.2 (22/95) 13.6 (3/22)|| 3.2 (3/95)
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Table 2. (Continued)
Study Type Associated Anomalies Chromosomal Defects
Isolated clefts* Associated clefts* Total clefts*
% (n) % (n) % (n) % (n)
Maarse 2011 21.1 (4/19) 25.0 (1/4) 5.3 (1/19)
Rittler 2011 23.5 (93/395) 1.0 (3/302)†† 28.0 (26/93) 7.3 (29/395)
Rozendaal 2012 61.2 (60/98) 5.0 (3/60) 3.1 (3/98)
Total 25.1 (1795/7145) 1.0 (3/302) 23.1 (401/1735) 5.8 (404/6931)
CL±P
Drushel 1996 29.2 (467/1599)¶
DeRoo 2003 22.9 (64/280)¶
Shaw 2004 60.2 (2453/4072)¶ 10.3 (419/4072)
Vallino-Napoli 2006 25.1 (299/1189) 33.8 (101/299)|| 8.5 (101/1189)
Stoll 2007 27.9 (109/390) 33.0 (36/109)|| 9.2 (36/390)
Russell 2008 37.0 (47/127) 34.0 (16/47)|| 12.6 (16/127)
Offerdal 2008 33.3 (22/66) 4.5 (1/22) 1.5 (1/66)
Beriaghi 2009 26.4 (157/595)¶
Gillham 2009 7.2 (16/222) 0.0 (0/206) 6.3 (1/16) 0.5 (1/222)
Total 42.6 (3634/8540) 0.0 (0/206) 31.4 (155/493) 9.5 (574/6066)
CP
Drushel 1996 43.6 (517/1187)¶
Kallen 1996 29.0 (732/2527) 18.3 (134/732)|| 5.3 (134/2527)
Milerad 1997 22.2 (53/239)¶
DeRoo 2003 64.9 (144/222)¶
Shaw 2004 71.1 (1665/2343)¶ 10.6 (249/2343)
Vallino-Napoli 2006 41.7 (347/833) 21.0 (73/347)|| 8.8 (73/833)
Stoll 2007 47.9 (125/261) 14.4 (18/125)|| 6.9 (18/261)
Russell 2008 53.1 (52/98) 11.5 (6/52)|| 6.1 (6/98)
Offerdal 2008 50.0 (10/20) 30.0 (3/10) 15.0 (3/20)
Tan 2009‡‡ 23.1 (27/117) 29.6 (8/27)|| 6.8 (8/117)
Beriaghi 2009 38.7 (206/532)¶
Gillham 2009 26.6 (67/252)
Maarse 2011 52.9 (9/17) 0.0 (0/9) 0.0 (0/17)
Rittler 2011 42.3 (83/196) 0.0 (0/113) 12.0 (10/83) 5.1 (10/196)
Rozendaal 2012 78.3 (54/69) 13.3 (2/15) 16.7 (9/54) 15.9 (11/69)
Total 45.9 (4091/ 8913) 1.6 (2/128) 18.1 (261/1439) 7.9 (512/6481)
221Associated structural and chromosomal defects in oral clefts
CL = cleft lip only; CLP = cleft lip with cleft palate; CL±P = cleft lip with or without cleft palate; CP = cleft 
palate only. Blanc entry: data were not available or could not be deducted.
* Information on karyotype not available for all clefts, unless stated differently (see Table 1). Therefore, 
inclusion of undetected chromosomal defects cannot be ruled out. Null values were given only if 
information about chromosomal analysis was reported.
† Median cleft lip and atypical facial clefts were excluded because of their different pathogenesis.
‡ Karyotype available for all clefts.
§ For one case with a chromosomal defect, data on associated anomalies were not available.
|| Retrospective analysis of data from birth or birth defect registries. Although not specifically 
mentioned whether chromosomal defects were accompanied by additional anomalies, we assumed 
that karyotype analysis had been performed only in associated clefts (as is generally done in clinical 
practice).
¶ No specific data given about type of associated anomalies, including chromosomal defects. Therefore, 
inclusion of chromosomal defects in isolated clefts cannot be ruled out.
** Because of limited data, chromosomal defects among isolated clefts not given.
†† Including deletions 22q11.2 identified by array CGH.
‡‡ Pierre Robin sequence excluded.
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were the most commonly observed defects.6-8, 13, 14 Offerdal et al.15 and Russell et al.16 did not 
specify prenatally identified chromosomal defects in their study (n = 8 and n = 5, respectively). 
Postnatally detected associated anomalies and chromosomal defects
Seventeen studies analyzed a total of 28,953 infants with oral clefts.13-16, 22, 25-36 Table 2 shows 
the prevalence of associated anomalies and chromosomal defects in postnatally detected clefts. 
Similar to the prenatal analysis, postnatal studies showed that CL was less frequently associated 
with accompanying defects than the other two cleft categories. The prevalence of associated 
anomalies in CL was approximately 10%, except for the study of Rozendaal et al. (41.4%).22 For 
CLP and CL±P, most studies showed a prevalence of approximately 25%. However, the studies 
of Shaw et al.35 and Rozendaal et al.22 found a prevalence of about 60%. All studies reported 
that CP was the category most frequently associated with additional anomalies (45.9%; range 
22.2% to 78.3%). When analyzing the underlying chromosomal defects, the prevalence was 
highest in CL±P (9.5%, range 0.5% to 12.6%). The lowest prevalence of chromosomal defects 
was found in CL (1.4%, range 0% to 3.4%). Studies distinguishing unilateral and bilateral clefts 
showed a higher prevalence among bilateral than unilateral CLP (Table 3).
Analysis of chromosomal defects in isolated and associated clefts revealed that almost all 
chromosomal abnormalities were found in association with additional anomalies. Only two 
studies found chromosomal defects in isolated clefts. In the study of Rittler et al.,27 informa-
tion was available for 58% (108/185) of the isolated cleft cases (Table 1). They found diagnostic 
evidence for chromosomal defects in 1.8% (2/110) of the CL cases (both having a deletion 
22q11.2), and for 1.0% (3/302) of the CLP cases. The latter three cases showed a deletion 
22q11.2, a 46,X,del(X)(q1.3), and a 46,XY,add(15)(p11). As the 22q11.2 deletions were identi-
fied with array-comparative genomic hybridization (array CGH) during follow-up, the rate of 
chromosomal defects detected by standard karyotyping was 0% (0/110) and 0.7% (2/302) for 
CL and CLP, respectively. Although the rate of karyotyped cases was not known in the study of 
Rozendaal et al.,22 they found that two out of 15 isolated CP cases had chromosomal defects 
(trisomy 21 and 46,XY,add(14)(p), respectively). In both cases, the identification of the chromo-
somal abnormality was delayed due to absence of additional congenital anomalies. An inven-
tory of the reported chromosomal defects, non-chromosomal syndromes, and other diagnoses 
associated with prenatally and/or postnatally detected clefts is provided in Table 4.
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Table 4. Observed chromosomal defects and non-chromosomal syndromes associated with oral clefts in 
prenatal and/or postnatal populations
 
Studies
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Chromosomal defect
Trisomy 6 X
Trisomy 9p X
Trisomy 13 X X X X X X X X X X X X
Trisomy 16p X
Trisomy 18 X X X X X X X X X X X X
Trisomy 21 X X X X X X
Trisomy 22 X
Triploidy 69 X
Monosomy 21 X
Mosaic trisomy 22 X
Mosaic tetrasomy 12p X
Partial autosomal trisomy X X
Translocation X X
Deletion 2q X
Deletion 4p X X X
Deletion 4q X
Deletion 5p14.3p14.1 X
Deletion 5q21.1q23.3 X
Deletion 13q X X
Deletion 22q11.2 X X X
46,XY,der(3)del(p26)inv 
dup(3)(p24p25) X
46,XX, der(6)t(2;6)(q37;q27)
pat X
dup(11)(p11.1p15.5)pat X
46,XY,der(14)t(14;16)
(p11;p12.3) X
46,XY,add(15)(p11) X
46,XX,del(16)(q22.3q22.3) X
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Table 4. (Continued)
 
Studies
Prenatal Prenatal-
Postnatal
Postnatal
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46,XY,der(18)t(16;18)
(q24;q23)pat X
46,XY,del(18)(q21.3) X
47,XX,+inv dup (22)(q11q11) X
dup(22)(q11q11) X
Partial autosomal deletion X X X
Sex chromosomal 
abnormalities X X X X X
Other chromosomal 
abnormalities X X
Non-chromosomal syndrome
Adams-Oliver syndrome X
Amniotic band association X X
Anti-epileptic drugs X
Apert syndrome X X X X
Beckwith-Wiedeman 
syndrome X X X
Branchio-oculo-facial 
syndrome X
Bohring-Opitz syndrome X
Caudal Regression 
syndrome X
CHARGE syndrome X X X
Chondrodystrophy X
Cornelia de Lange syndrome X X X X
Crouzon syndrome X X
DiGeorge syndrome X X
Duane retraction syndrome X
Ectrodactyly-ectodermal 
dysplasia-clefting syndrome X X X
Encephalocele-clefting 
syndrome X
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Table 4. (Continued)
 
Studies
Prenatal Prenatal-
Postnatal
Postnatal
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Fetal alcohol syndrome X
Fraser syndrome X
Fryns syndrome X
Goldenhar syndrome X X X X X
Gordon syndrome X
Gorlin syndrome X
Greig syndrome X
Hay-Wells (AEC) syndrome X
Holoprosencephaly X
Ivemark syndrome X
Jeune syndrome X
Kabuki syndrome
Kartagener syndrome† X
Klippel-Feil syndrome X X X
Larsen syndrome X X
Loeys-Dietz syndrome X
Meckel-Gruber syndrome X
Meckel syndrome X X
Moebius syndrome X X X
Mohr syndrome X
Multiple epifysial dysplasia† X
Multiple pterygium 
syndrome X
Nager syndrome X X
Noonan syndrome X
Omenn 
reticuloendotheliosis† X
Opitz-Frias syndrome X
Opitz G/BBB X X
Oro-facio-digital syndrome X X X
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Table 4. (Continued)
 
Studies
Prenatal Prenatal-
Postnatal
Postnatal
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Osler-Weber syndrome† X
Osteogenesis imperfecta† X
Osteopathia striata with 
cranial sclerosis X
Oto-palato-digital syndrome X X X
Pentalogy of Cantrell 
(Thoraco-abdominal 
syndrome) X
Poland syndrome† X
Popliteal pterygium 
syndrome X X
Rieger syndrome X
Roberts syndrome X
Robinow syndrome X
Rubinstein-Taybi syndrome† X X X
Smith-Lemli-Opitz syndrome X X X X
Stickler syndrome X X X X X X X
Treacher-Collins syndrome X X X X X
VACTERL X
Van der Woude syndrome X X X X X X
VATER association X
VCF syndrome§ X
X-linked hydrocephalus† X
Other diagnosis
Neonatal Abstinence 
syndrome X
Pierre Robin sequence X X X X X X
Sebaceus Nevus syndrome X
* Annual reports 1997-2010 of the Dutch Association for Cleft Palate and Craniofacial anomalies, 
comprising data without follow-up.
† Diagnosis uncertain.
§ Clinical diagnosis, not confirmed by karyotype.
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DISCuSSION
This systematic review assessed the association of prenatally and postnatally detected oral 
clefts with other congenital anomalies and underlying chromosomal defects, thereby providing 
a basis for prenatal counseling and well-informed decisions on invasive prenatal diagnostics in 
clefts. We demonstrated that the prevalence of associated structural and chromosomal defects 
is evidently related to cleft category. Although varying in study characteristics and designs, 
both prenatal and postnatal studies showed a higher frequency of associated anomalies and 
chromosomal defects in CLP and CP than in CL. For all cleft categories, chromosomal defects 
were almost always seen in association with additional congenital anomalies. Therefore, the 
presence of additional anomalies on ultrasound is the most important predictor of underlying 
chromosomal defects in fetuses with oral clefts.
Methodological issues
The use of both prenatal and postnatal studies—including detailed Dutch registry data—gave 
our study its main strength. It allowed us to provide a more reliable and representative basis 
for prenatal counseling and genetic testing than when only prenatal studies were evaluated. 
As the proportion of detected isolated clefts in prenatal populations is rising, previous prenatal 
studies may not have provided representative samples of current/future prenatal cleft popula-
tions. Overall, prenatal rates of associated anomalies and chromosomal defects may have been 
too high, because associated clefts are more likely to be detected by ultrasound than isolated 
clefts,11 and some prenatal cases never reach term due to lethal anomalies or termination of 
pregnancy (TOP).16, 25, 26, 29 Another advantage of our evaluation of postnatal studies is that 
congenital anomalies not detected by ultrasound were also included. Especially studies with 
a longer follow-up allowed us to consider minor anomalies and features that become more 
evident later in life.22 For example, individuals with the velo-cardio-facial (VCF) syndrome 
(22q11.2 deletion) are often diagnosed at school age when speech and learning difficulties 
become evident, unless a cardiac defect manifests earlier.38 Our study was also strengthened 
by its focus on clinical genetic aspects. If provided, karyotype information was evaluated and 
separate rates of chromosomal defects among isolated (if available) and associated clefts were 
calculated. Besides these prevalence rates, we also composed an inventory of the different 
syndromes and chromosomal defects in prenatally and/or postnatally detected clefts reported 
by the reviewed studies and complemented with Dutch registry data, thereby specifying the 
detected anomalies (Table 4). 
However, combining results from different studies also had its limitations, mainly due to 
methodological issues. As summarized in Table 1, we found many differences in study charac-
teristics and designs between the reviewed studies, which are in line with those reported by 
Wyszynski et al.17 The most important issue was non-uniform subdivision of oral clefts. Some 
studies distinguished CL and CLP,6, 7, 13, 25, 27, 28, 30, 31, 33 while others grouped them as CL±P.8, 14-16, 
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26, 29, 32, 34-36 Together with previous studies,2-5 our results stress the need of accurate prenatal 
subdivision into three categories (CL, CLP and CP). Obviously, analyzing CL and CLP as one 
group will result in different frequencies of associated anomalies and chromosomal defects 
than when they are analyzed separately. Unfortunately, prenatal distinction between CL and 
CLP can be limited because prenatal identification of involvement of the palate is still chal-
lenging.11, 14 For this reason, data on prenatally detected CP were limited in the current study. 
However, there is evidence of improvements in imaging, as well as in experience in detection 
and interpretation of subtle signs on ultrasound,39, 40 which will progressively reduce the lower 
limits for detection. 
Another important factor was that associated anomalies were differently defined and clas-
sified in the evaluated studies, which partly explains the wide variation in the reported rates 
of associated anomalies.17 The definitions in the reviewed studies ranged from only major 
(structural) non-facial congenital anomalies to all anomalies, including minor congenital 
anomalies and ultrasound markers, such as intrauterine growth retardation (Table 1). This 
might explain, at least partially, the relatively high rates of associated anomalies reported by 
Rozendaal et al., 22 who also included minor and dysmorphic features in their analysis. Although 
these minimal defects are hardly detected prenatally, they may be recognizable components of 
specific syndromes or chromosomal defects in postnatally detected clefts.17 Similarly, the high 
prevalence of Shaw et al.35 could also partly be due to the inclusion of minor defects, as they 
used diagnostic codes with low specificity, including the malformation groups “ear, face, neck” 
and “upper alimentary tract”. Another source of variation is the inconsistent definition of Pierre 
Robin sequence applied in clinical practice and consequently its over or underreporting.41 
Some of the reviewed studies classified this condition—being CP combined with micrognathia, 
glossoptosis and airway compromise—as isolated CP,26, 27, 33 while other studies considered it 
as a separate category28, 31 or as associated CP.11, 14, 16, 22, 29
The reviewed studies also varied considerably in their reporting of karyotypic information 
(Table 1). While some studies provided explicit information about the number of karyotyped 
cases and their detected associated and chromosomal defects,6-8, 13-15, 22, 25, 27 others reported 
only abnormal karyotypes, but not their associated anomalies,16, 26, 28-31 or they did not give 
any specific data at all.32-36 As a consequence, separate and complete rates of chromosomal 
defects could not always be obtained. Furthermore, in studies providing explicit informa-
tion, chromosomal analysis was mostly performed in associated clefts only, which explains 
why almost all reported chromosomal defects were accompanied by additional anomalies. 
It is important to realize that most of these studies obtained chromosome results for just a 
part—and not all—of the clefts, and that the inclusion of cases with undetected chromosomal 
defects in their rates therefore cannot be ruled out. Besides karyotype analysis, most studies did 
also not report whether FISH analysis had been performed and whether microdeletions were 
included in the presented data. Only the studies of Tan et al.31, Rittler et al.27, and Rozendaal 
et al.22 reported the inclusion of microdeletions or duplications, while Stoll et al.26 included 
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the results of FISH22q11 screening as from 1994. In contrast, Kallen et al.28 reported not to 
have included microdeletions, which might have led to an underestimation of the frequency of 
underlying chromosomal defects. On the other hand, some studies may have overrepresented 
chromosomal defects in association with oral clefts due to the inclusion of sex chromosome 
abnormalities. For example, Stoll et al.26 showed that 12 out of 54 abnormal karyotypes con-
cerned abnormalities of sex chromosomes, which may be coincidental findings and not related 
to clefts. From literature, no convincing evidence is provided that the most frequently detected 
sex chromosomal anomalies (e.g., 47,XXX; and 47,XXY) are actually related to clefts.
Differences in study settings and data sources between studies (Table 1) may also have 
accounted for the variation in the prevalence of associated anomalies and are possible sources 
of selection bias. For example, some studies were performed with data from prenatal cen-
tres,6-8, 13, 15 while others were retrospectively conducted via the so-called ‘cleft palate teams’.14, 
16 Consequently, the retrospective cleft-team studies did not include the fetuses that were not 
born alive and were thus not referred to the cleft palate teams, thereby inducing selection bias. 
Additionally, according to Wyszynski et al.,17 information obtained from vital records (e.g., birth 
certificates) is neither complete nor accurate in detail due to passive ascertainment methods 
(i.e., data submitted by data sources and not actively collected by registry staff searching data 
sources for eligible cases) and lack of follow-up. Conversely, studies having active ascertain-
ment methods or long follow-up periods, such as that of Rozendaal et al. (median follow-up 5 
years),22 may result in relatively high rates of associated anomalies. Also, the value of information 
depends on the interest and skills of the person who records the anomalies. This is in line with 
the study of Tan et al.,31 who reported higher frequencies of associated anomalies in patients 
recruited for a clinical study than in cases derived from a birth defect register. They suggested 
this was explained by a combination of ascertainment bias and more complete diagnosis by 
detailed clinical assessment in the clinical study. 
Nevertheless, despite the above-mentioned issues, we found unambiguous evidence that 
the three cleft categories are differently associated with structural and chromosomal defects. 
Due to the inclusion of large numbers of cases from both prenatal and postnatal populations, 
we were able to provide a rather reliable basis for clinicians and future parents, thereby allow-
ing accurate counseling and informed decisions on whether to have invasive diagnostics if an 
oral cleft is detected prenatally. 
Prenatal counseling and genetic testing
When counseling future parents regarding prognosis and risk of associated chromosomal 
defects, it is vital to tailor the discussion according to cleft category. As our results showed, CLP 
and CP are more frequently associated with additional anomalies and chromosomal defects 
than CL. Moreover, these frequencies are higher in bilateral than in unilateral CLP or CL±P. This 
emphasizes the need for accurate prenatal subdivision of clefts. However, accurate detection 
of additional anomalies appears to be even more significant to outcome. As we found, the 
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presence of other congenital anomalies is a strong predictor for chromosomal defects. For all 
cleft categories, both prenatal and postnatal studies showed that chromosomal abnormalities 
are almost always seen in association with other congenital anomalies. Therefore, invasive pre-
natal testing to identify chromosomal abnormalities in combination with genetic counseling 
should be offered in all cases with associated anomalies, irrespective of cleft category.
It should be realized, however, that the absence of associated anomalies does not exclude 
the possibility of the presence of an underlying chromosomal defect. As mentioned above, 
chromosomal analysis was often not performed in isolated cases, and therefore undetected 
chromosomal defects might have been included in our rates of isolated clefts. The few studies 
that reported chromosomal defects in isolated clefts showed that the prevalence differed by 
category. As standard karyotyping did not reveal any chromosomal defect, cases with isolated 
CL have the most favorable prognosis when it comes to chromosomal anomalies with a poor 
outcome. Therefore, if confident in ultrasound findings, conventional karyotyping is not recom-
mended in isolated CL. However, based on the findings of Rittler et al.27, array CGH to detect 
deletion 22q11.2 should be considered. 
For CLP, prenatal studies together showed chromosomal defects in 3.9% of the presumed 
isolated cases, while just one postnatal study addressed this issue showing defects in 1.0%. In 
the latter study,27 standard karyotyping revealed chromosomal defects in 0.7% of the isolated 
CLP cases, while array CGH during follow-up revealed a deletion 22q11.2 for one more case. 
Based on these data, it is recommended to inform future parents about the possible association 
of a chromosomal defect and to consider invasive prenatal testing in these cases, preferably by 
array-based methods. However, if not confident in ultrasound findings regarding cleft category, 
it should be noted that the overall prevalence in presumed isolated clefts (CP excluded) was 
0.8% (7/830). Furthermore, when considering invasive testing, the baseline risk of complica-
tions (1%) should be weighed against the potential benefits.42 Another concern might be the 
detection of unexpected or unclassified variants with array-based methods, which should be 
discussed with future parents.
Regarding CP, especially isolated CP, prenatal identification is still challenging, which has 
resulted in limited prenatal information on their underlying chromosomal defects. However, 
postnatal karyotyping of isolated CP cases revealed a chromosomal defect in 1.6%. Especially in 
this category, specific syndromes, such as VCF (22q11.2 deletion), Treacher-Collins, and Stickler, 
have to be considered. As presented in Table 4, these syndrome diagnoses were frequently 
reported in the evaluated literature. Therefore, until more information on chromosomal defects 
in prenatally presumed isolated CP is available, we advise to consider invasive genetic test-
ing and consultation by a clinical geneticist if an isolated CP is detected prenatally. A prenatal 
diagnostic algorithm according to cleft category is presented in Figure 1.
Based on the above findings, more accurate prenatal ultrasound screening will improve 
counseling, especially regarding palatal involvement. Therefore, we advise to refer pregnant 
women with a fetus suspected of an oral cleft to a tertiary care centre where more specific 
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ultrasound screening can be performed. In addition, if a normal karyotype is confirmed or inva-
sive testing is declined, future parents should be counseled by a multidisciplinary cleft palate 
team that focuses on psychosocial support, education on management of clefts, and parents’ 
options, TOP being one of them.43-46 Finally, it is crucial to distinguish median clefts and atypical 
facial clefts from oral clefts. These different craniofacial anomalies are associated with other 
congenital anomalies and have a different prognosis, and should therefore be referred to and 
treated by specialized multidisciplinary craniofacial teams.
Future studies
The use of array CGH in clinical practice is rising, and it is expected that it will be implemented 
as standard prenatal diagnostics in the near future. Compared to conventional karyotyping, 
Oral cleft 
detected 
prenatally on US 
Associated 
anomalies on US 
Invasive prenatal 
testing, preferably 
by array CGH 
Standard prenatal 
consulting of 
clinical geneticist 
Prenatal 
consulting of cleft 
palate team* 
Isolated oral cleft 
on US 
CL 
Karyotyping not 
recommended; 
consider array CGH 
Prenatal 
consulting of cleft 
palate team 
Postnatal 
consulting of 
clinical geneticist 
CLP 
Consider invasive 
prenatal testing, 
preferably by array 
CGH 
Consider prenatal 
consulting of 
clinical geneticist 
Prenatal 
consulting of cleft 
palate team* 
CP 
Consider invasive 
prenatal testing, 
preferably by array 
CGH 
Consider prenatal 
consulting of 
clinical geneticist 
Prenatal 
consulting of cleft 
palate team* 
Figure 1. Algorithm for invasive genetic testing according to oral cleft category. CL = cleft lip only; CLP = 
cleft lip with cleft palate; CP = cleft palate only; US = ultrasound; array CGH = array-comparative genomic 
hybridization. * If a normal karyotype is confirmed or invasive genetic testing is declined.
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array CGH can detect smaller chromosome deletions and duplications. To gain more insight 
in the yield of array CGH in cases with clefts, it would be interesting to perform array CGH in 
a large cohort of cases with prenatally and postnatally detected clefts. This would also give us 
more information about the proportion and types of chromosomal defects that are missed 
in cases that have not been karyotyped or studied by array-based methods. Especially with 
regard to prenatally presumed isolated clefts, this is essential to reach consensus on the role of 
invasive genetic testing in these cases. As was demonstrated by the NVSCA data,23, 24 clefts can 
be associated with various microdeletions and duplications. This implies that array CGH should 
be the standard technique to identify chromosomal defects in children with oral clefts. 
Finally, follow-up studies are needed to gain more insight into additional abnormalities 
and chromosomal anomalies identified after birth. This can aid in more optimal counseling of 
future parents, especially with regard to unexpected anomalies in presumed isolated clefts, and 
timely treatment of children with clefts.
CONCLuSIONS
This systematic review presents unambiguous evidence that the different cleft categories 
are variously associated with additional congenital anomalies and underlying chromosomal 
defects. This emphasizes the need of accurate subdivision of CL, CLP and CP for both ultrasound 
screening and postnatal follow-up. However, the most important predictor of chromosomal 
abnormalities is the presence of associated anomalies, and we urge clinicians to advise invasive 
testing in these cases. In absence of associated anomalies, cases with CL have the most favor-
able prognosis and do not require conventional karyotyping. In presumed isolated CLP and CP, 
professionals should explain the possible association of a chromosomal defect and consider 
invasive genetic testing, preferably by array-based methods. In all cleft categories, an associa-
tion with deletion 22q11.2 should be considered.
Accurate prenatal diagnosis by ultrasound is essential in the quality of counseling, especially 
with regard to palatal involvement and associated anomalies. Therefore, pregnant woman—
with a fetus suspected of an oral cleft—should be referred to a tertiary care centre where more 
specific ultrasound screening can be performed. Finally, follow-up studies, including array CGH, 
are needed to gain more insight in additional abnormalities and chromosomal defects missed 
in associated and presumed isolated clefts. This would aid in more optimal counseling and 
timely treatment of children with oral clefts. 
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AbSTRACT
Orofacial clefts are being diagnosed prenatally more frequently. They comprise various sub-
phenotypes that have different underlying embryological processes and vary in accompanying 
structural and chromosomal defects, and thus have a different prognosis. Therefore, accurate 
and detailed phenotyping and subsequent classification of clefts is essential to further under-
stand their etiopathogenesis. Furthermore, it is crucial to help arrive at correct diagnosis, thereby 
improving clinical care and outcome. This is especially important in the prenatal setting, as it 
will influence counseling and management of the pregnancy significantly. While many systems 
have been developed to record or classify clefts, most are intended for the postnatal setting 
only, and those designed for fetal clefts do not incorporate the latest scientific insights and 
are not designed for modern ultrasound technologies. Therefore, we propose a new prenatal 
ultrasound classification for orofacial clefts based on their patho-embryology, recent epide-
miological insights, and advances in ultrasound technology to aid in prenatal counseling, care, 
and research. In short, this paper discusses why oral clefts (i.e., unilateral or bilateral clefts of the 
lip/alveolus or palate) should be distinguished from midline and atypical facial clefts, and why 
the latter should be considered as craniofacial clefts based on their patho-embryogenesis and 
accompanying defects. Subsequently, both groups are further divided according to their spe-
cific underlying embryological processes as well as their accompanying defects, prognosis, and 
outcome. Finally, our system is discussed in relation to the only previously published—purely 
prenatal—cleft classification, the Nyberg classification.
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INTRODuCTION
Orofacial clefts are complex and heterogeneous birth defects affecting various facial structures, 
including the lip, alveolus, and palate. Normal development of these structures entails a com-
plex series of embryonic processes, which are related to different time frames and regulated by 
different cell biological mechanisms and genes.1-4 Disruption of any of these tightly regulated 
processes may result in various cleft sub-phenotypes.2-8 Therefore, accurate and detailed phe-
notyping and subsequent classification of clefts is crucial to further understand their etiopatho-
genesis. Furthermore, it is essential to help arrive at correct diagnosis and improve clinical care 
and outcome. Different cleft types are variously associated with accompanying structural and 
chromosomal defects and thus have a different prognosis.9 Especially in the prenatal setting, 
early detection of these anomalies is of paramount importance, as it will influence counseling 
and management of the pregnancy significantly.
Clinically, it is crucial to distinguish oral clefts (often termed orofacial clefts and comprising 
unilateral or bilateral clefts of the lip/alveolus/palate) from midline and atypical facial clefts. 
While the latter anomalies should be considered as craniofacial clefts given their patho-
embryogenesis, accompanying defects, and outcome,5, 6, 10, 11 they are often interpreted as 
oral clefts.12-20 Consequently, great discrepancies with regard to cleft definition and classifica-
tion exist. Although many systems have been developed to record or classify clefts, most are 
intended for the postnatal setting only,7, 8, 12, 14, 18, 21-28 and just a few have been specifically 
designed for fetal clefts. The first prenatal diagnosis of oral clefts was reported in the early 80s,29 
and Nyberg et al.30 presented an ultrasound classification based on the embryology of the face 
in 1995. Later on, Sommerlad et al.31 demonstrated the use of Kernahan’s postnatal ‘striped 
Y’ model to record oral clefts detected with both two- and three-dimensional (2D and 3D) 
ultrasound. While these systems have brought structure in the prenatal diagnosis of clefts, they 
do not incorporate the latest insights into the embryonic and genetic mechanisms underlying 
clefts,2-4, 32 and they have not been designed for modern ultrasound technologies. Because 
of the technical advances in prenatal imaging, as well as in the experience in detection and 
interpretation of subtle signs, fetal anomalies of the head and neck area are being diagnosed 
in detail more frequently.20, 31, 33-38 Although prenatal detection rates for oral clefts by 2D ultra-
sound have historically been poor, recent studies have reported rates of over 75% for clefts of 
the lip/alveolus (with or without cleft palate).39 Because prenatal identification of involvement 
of the palate by 2D is still challenging, detection rates for clefts of the palate only have been 
considerably lower (0%-22%).39 However, there is evidence of improvements in imaging and 
detecting subtle signs that will progressively increase the prenatal detection of cleft palate.37, 40, 
41 Besides oral clefts, craniofacial clefts and their syndromes, such as frontonasal dysplasia, are 
also being diagnosed prenatally more frequently.34, 42 As a consequence, there is an increasing 
demand for accurate and updated information and classification of clefts to aid in prenatal 
counseling and further research.
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In this article, we propose a new prenatal classification of oral and craniofacial clefts based 
on their underlying embryological processes as well as on recent insights in their epidemiology 
(including accompanying defects and prognosis) and advances in ultrasound technology. To 
explain the rationale behind this classification, the epidemiology, registration and embryology 
of both oral and craniofacial clefts are outlined before introducing this new system. Finally, our 
system is compared with Nyberg’s ultrasound classification and the differences are discussed. 
EPIDEMIOLOGy AND REGISTRATION OF CLEFTS
Oral clefts
Oral clefts are among the most common congenital anomalies in humans, ranging from minor 
(subcutaneous or submucous) types to complete clefts of the lip, alveolus, and hard and soft 
palates (including the uvula).4, 8 Worldwide, the prevalence varies from 4.8 to 28.6 per 10,000 
births,43 with considerable variations in ethnicity and geographic regions. Oral clefts may either 
be isolated or be associated with other congenital anomalies, often as part of a syndrome or 
chromosomal defect.2, 9, 44, 45 Many genetic and environmental factors—such as maternal smok-
ing, alcohol use, and nutrition—have been suggested to contribute to their development.1, 44 
To gain more insight into the epidemiology and causes of congenital anomalies—including 
oral clefts—and to optimize their outcome and prevention, various birth defect registries have 
been established using different postnatal recording and classification systems. Classically, 
oral clefts are divided into two categories: cleft lip with or without cleft palate, and cleft palate 
only.44, 46, 47 However, more recent epidemiological studies have also distinguished cleft lip 
only from those that affect both the lip and palate, because these categories may have unique 
embryological and etiological features.7, 9, 28, 48, 49 To further classify oral clefts, many registries 
use the International Classification of Diseases (ICD) or its extensions.46, 50, 51 Using these clas-
sifications, oral clefts are not described, but interpreted and directly coded according to clinical 
diagnosis. Because this approach may lead to important anatomical and morphological details 
being lost, more specific systems have been developed. These comprehensive systems incor-
porate the anatomical extent by distinguishing the different affected structures (lip, alveolus, 
hard palate, and soft palate including the uvula),13, 21, 23, 25, 52 as well as the morphological sever-
ity (complete, incomplete, and submucous clefts).12, 18, 24, 27 Although these systems seem to 
be clinically sufficient, none of them has been fully based on craniofacial embryology, thereby 
lacking detailed information needed to gain more insight into the causes of clefts. Therefore, 
the Dutch Oral Cleft Registry (NVSCA) has developed a unique descriptive system—based 
on the embryology of the head and neck area—to record craniofacial congenital anomalies 
(including oral clefts) in the postnatal setting. This system records all individual anomalies that 
form the craniofacial defect by describing the morphology and side of each affected anatomi-
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cal structure, thereby expressing the various embryonic mechanisms underlying the various 
sub-phenotypes.4, 7, 8, 28, 45
Craniofacial clefts
In contrast to oral clefts, craniofacial clefts are rare congenital anomalies affecting the face and 
cranium in a great variety of sub-phenotypes, including midline cleft lip and palate or atypical 
facial clefts, such as hemifacial microsomia (Tessier 7) and Treacher-Collins (Tessier 6, 7, 8).53 Dif-
ferent facial parts and tissue layers can be involved with various degrees of severity on clinical 
presentation. Rare craniofacial clefts can present themselves unilaterally or bilaterally, in the 
midline of the face, or in paramedian or oblique directions.5, 6 Their low frequency has made 
their study and classification difficult. Consequently, little is known about their epidemiology, 
as most reports are based on small groups from various ethnic and geographic regions. In 
a review, Kawamoto reported a prevalence ranging from 1.4 to 4.9 per 100,000 live births.54 
Craniofacial clefts are almost always associated with other congenital anomalies and frequently 
part of a syndrome or chromosomal defect.55
Because craniofacial clefts are rare, just a few recording systems have specifically been 
designed for craniofacial clefts. In 1976, Tessier introduced a new comprehensive classification 
of craniofacial clefts and their syndromes. Using an anatomical cleft numbering system, he 
described the various sub-phenotypes of craniofacial clefts, but oral clefts were also included.53 
In contrast to this system, Van der Meulen et al.5, 6 developed an embryological system clas-
sifying both oral and craniofacial clefts as well as other craniofacial malformations, such as 
craniosynostosis. This system is based on the underlying developmental processes of the head 
and neck area, similar to the above-described NVSCA system. 
EMbRyOLOGy OF THE HEAD AND NECk AREA
From a clinical point of view, it is essential to prenatally distinguish between embryologically 
different cleft anomalies, because they have specific accompanying defects, outcome, and 
prognosis. Additionally, with regard to the search for causal factors, it is even more crucial to 
group clefts according to their timing and underlying mechanisms in embryogenesis, as the 
power to detect effects may be weakened when heterogenous cleft groups are treated as a 
single entity or divided in a too simplistic way.3 To classify according to abnormal embryonic 
processes that result in various cleft deformities, normal craniofacial development need to 
be understand first. The embryogenesis of the various head and neck structures has been 
described elsewhere (Vermeij-Keers et al., submitted)1, 4, 10, 11 and is summarized here. 
The craniofacial region develops during two main successive periods. The first is the early 
embryonic period from 4 to 9 weeks gestation (1-17 mm Crown-Rump Length (CRL), starting 
with the development of the forebrain (prosencephalon) and early face, followed by formation 
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of the nose and primary palate. During the second period, which is the late embryonic period 
from 9 to 14 weeks gestation (17- 60 mm CRL), the lip and alveolus, secondary palate, and facial 
skull are formed. 
Development of the forebrain and early face (4-6.5 weeks gestation)
It is important to realize that the ultimate width of the face is determined by the width of the 
forebrain (prosencephalon). In short, its development involves the following steps. The initial 
morphological structures of the developing prosencephalon are formed by the cephalic or 
neural folds (walls), which caudally continue as the neural plate (1.5 mm CRL).56 These neural 
walls grow out in a lateral direction and are then transformed into the prosencephalon of the 
neural tube due to fusion of the walls in the midline. During this outgrowth process, the optic 
primordia develop bilaterally by a local thickening of both neural walls. Within both primordia, 
a progressively deepening groove, called the optic sulcus, is formed.57 As both sulci expand, 
the fusion of the neural walls is completed and the sulci are transformed into optic vesicles. 
The final point of neural wall closure—the rostral neuropore—is located between two areas of 
specific surface ectoderm (epithelium) covering the prosencephalon, i.e., the nasal fields.56, 58 
Within each laterally located nasal field, a lens placode (optic primordium) and nasal placode 
develop during 6-7 weeks gestation (5-6.5 mm CRL).58-60 
Development of the nose and primary palate (6.5-9 weeks gestation)
After closure of the rostral neuropore, the development of the nose holds a key position with 
regard to facial morphogenesis. The nose develops from two widely separated nasal placodes, 
with the interplacodal area in between (6.5 weeks gestation; 6.5 mm CRL).10 Therefore, the 
presumptive nose can be considered as two separate organs, which can develop asymmetri-
cally. First, the three facial swellings (processes) around each placode grow out (the maxillary 
process and lateral nasal process at the lateral side, and medial nasal process at the medial 
side), resulting in nasal grooves and tubes, respectively (Figure 1:1-3).10, 11, 59 Subsequently, the 
three facial swellings fuse in an occipito-frontal direction, resulting in the formation of the pri-
mary palate, i.e., the presumptive lip and alveolus (9 weeks gestation, 17 mm CRL). Figure 1:1-3 
demonstrates that the fusion process starts with adherence and fusion of the most occipital 
parts of the maxillary process and medial nasal process, and that it ends with fusion of the most 
frontal parts of the lateral and medial nasal processes. As a consequence, both nasal processes 
surround the nostril. Figure 1:3-4 shows the residual shallow grooves on the fusion lines of the 
primary palate. 
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Figure 1. The six successive stages of facial embryonic development viewed from the oral side: the 
respective fusion processes of the primary palate (1-3) and secondary palate (3-6), and outgrowth of the 
lip and alveolus (3-6; Adapted from Ten Donkelaar et al.76). 
1. Two nasal grooves, widely separated, surrounded by the facial processes/swellings (a-c) at seven 
weeks gestation; 
2. Outgrowth and fusion of two (a-b) of the three facial swellings in occipito-frontal direction forming 
the nasal tubes at eight weeks; 
3. Further outgrowth and fusion of the three swellings (a-c), resulting in the formation of the primary 
palate and the nostril at about nine weeks (note that the swellings are separated by grooves), 
and the beginning of outgrowth of the lip (al+bl), alveolus (aa+ba) and processes/shelves of the 
secondary palate; these swellings and shelves exist of mesenchyme covered by ectoderm;
4. Outgrowth of the nasal septum and palatal shelves in fronto-caudal and vertical direction, 
respectively, and further outgrowth of the lip and alveolus in caudal direction forming the 
presumptive labial groove at ten weeks; 
5. Elevation and outgrowth of the palatal shelves in horizontal position, and start of the fusion of the 
shelves with the primary palate at 10-11 weeks; 
6. Completed fusion of the shelves with the primary palate and nasal septum, as well as with each 
other, and completion of the lip, alveolus and labial groove at 12-14 weeks. The fusion lines of the 
primary and secondary palates are striped (3-6).
Abbreviations: a = medial nasal process; b = maxillary process; c = lateral nasal process; al = lip developed 
from a (prolabium); bl = lip developed from b; aa = alveolus (premaxillae) developed from a; ba = alveolus 
developed from b; bp = palatal shelves developed from b; if = incisive foramen; lg = labial groove; n = 
nasal septum; * = Internasal groove.
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Development of the lip/alveolus and secondary palate (9-14 weeks gestation)
After fusion of the facial swellings, the residual grooves between the swellings are eliminated 
by a process called merging.11, 59 The internasal groove disappears by outgrowth of the pre-
sumptive nasal septum in a fronto-caudal direction (17-27 mm CRL; Figure 1:4-6), and not—as 
is frequently assumed—by fusion of the medial nasal processes in the midline.11, 59 As a result, 
the tip and dorsum of the nose, and the nasal septum, columella, and prolabium/philtrum are 
formed, and the distance between the nostrils/presumptive nasal cavities and between the 
presumptive eyes/orbits decreases relatively. Simultaneously, the lip and alveolar process of the 
upper jaw grow out in a caudal direction, thereby forming the labial sulcus (groove) between 
the lip and alveolus (Figure 1:3-6). During the same period, the palatal shelves (processes) grow 
out in the oral cavity at either side of the tongue (27-30 mm CRL). Subsequently, they shift from 
a vertical into a horizontal position above the tongue and fuse with the primary palate, with 
each other, and with the nasal septum in a fronto-occipital direction. As a result, the secondary 
palate (the presumptive hard and soft palates including the uvula) is formed (30-50 mm CRL; 
Figure 1:3-6).11, 59 
Development of the facial skull (9-14 weeks gestation)
During the late embryonic period, the mesenchyme of the fused facial swellings and palatal 
shelves differentiates into musculature and bones of the facial skull, starting with the forma-
tion of the maxillary bone center in the maxillary process (9 weeks gestation, 17 mm CRL). The 
number of bone centers developing within one bone, the timing of their development, and the 
outgrowth of these bone centers followed by fusion or suture formation are crucial factors that 
determine skull development.11 In the context of oral and craniofacial clefts, the formation of 
the premaxillae, maxillae, and palatine bones are explained. Initially, each half of the upper jaw 
is formed out of three separate bone centers: two centers of the premaxilla (development at 
23 and 50 mm CRL) developing within the medial nasal process and bearing two incisor teeth, 
and one single maxillary bone center. These bone centers grow out and fuse with each other at 
the original fusion line of the medial nasal and maxillary processes, thereby forming the defini-
tive maxilla, including the alveolar process; the intermaxillary suture develops in the midline, 
between both halves of the upper jaw. The hard palate develops from the maxillary bone center 
and palatine bone center at either side. These bilateral bone centers grow out to each other and 
to those of the premaxilla, thereby forming the incisive, medial, and transverse palatine sutures. 
Besides these “normal” sutures, additional sutures have been found in the above-mentioned 
bones and other facial/skull bones (e.g., zygomatic or occipital bone) in adult normal skulls,10, 
11, 32 indicating that the number of bone centers might vary. 
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NEw uLTRASOuND CLASSIFICATION OF ORAL AND CRANIOFACIAL CLEFTS 
To be feasible for clinical as well as research purposes, prenatal classification of clefts should 
be based on recent scientific insights as well as on modern ultrasound techniques. Due to a 
more focused and routine approach using high-resolution ultrasound techniques, complete 
and incomplete clefts of the lip, alveolus (located between the premaxilla and maxilla), and 
hard and soft palates (including the uvula) can be properly detected nowadays.31, 37, 41, 61-63 
With regard to craniofacial clefts, routine ultrasound can identify agenesis (absence) of the 
prolabium and premaxilla, hypertelorism, hypotelorism, and atypical clefts.30, 33-35, 64 However, 
subtle features—such as subcutaneous and submucous clefts or hypoplasia—can not be visu-
alized prenatally. Additionally, the outcome and prognosis of the various cleft sub-phenotypes 
may differ from the postnatal setting, as cases that are more likely to be prenatally diagnosed 
tend to be the more severe cases with associated defects.39 As a consequence, most postnatal 
recording and classification systems may not be sufficient and properly applied in the prenatal 
setting. Therefore, we have developed a new prenatal ultrasound classification of oral and 
craniofacial clefts (Figure 2). 
Oral clefts
Prenatally, it is important to subdivide oral clefts into three main categories: I) cleft lip/alveolus 
only, II) cleft lip/alveolus and palate, and III) cleft palate only (Figure 2:I-III). Besides their different 
embryological and etiological features,2, 3, 7, 48 these categories are differently associated with 
accompanying defects,9, 49 and therefore have a different prognosis. As was recently reported,9 
clefts with palatal involvement (II and III) are more frequently associated with additional struc-
tural anomalies and underlying chromosomal defects. For example, clefts of the palate only (III) 
are often seen in association with specific syndromes, such as Treacher-Collins, Stickler, and the 
velo-cardio-facial syndrome (22q11.2 deletion). Consequently, they require specific prenatal 
management, including genetic counseling and invasive genetic testing (preferably by array-
comparative genomic hybridization, array CGH).9 By contrast, clefts of the lip/alveolus only (I) 
are less frequently associated with additional anomalies, and thus have the most favorable 
prognosis. These cases should be counseled by specialized multidisciplinary cleft palate teams, 
and prenatal genetic counseling and testing is recommended only when associated anomalies 
are found.9 
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Figure 3 presents the various sub-phenotypes within the three oral cleft categories and 
Figure 4 shows the categories on 2D ultrasound scan. The most common type within the first 
category (I) is the unilateral incomplete cleft lip/alveolus (Figures 3:I and 4:I),7 which results from 
defective outgrowth of the lip/alveolus or from disturbed differentiation of its mesenchyme 
into bone and musculature (9-14 weeks gestation, ≥17 mm CRL).1, 4 As the fusion process of 
the primary palate is completed at this stage, the incomplete cleft lip/alveolus always shows a 
tissue bridge at the base of the nostril (Figure 2:I and 4:I; Vermeij-Keers et al. submitted).1, 4 In 
the second category (II), the unilateral or bilateral complete cleft lip/alveolus and palate (Figures 
3:II and 4:IIa and IIb) is the most frequently observed sub-phenotype.7 This type is caused by 
defective fusion of the facial swellings (6.5-9 weeks gestation, ≤17 mm CRL) and subsequent 
defective fusion of the palatal shelves (9-14 weeks gestation, ≥17 mm CRL).1, 4, 11 In contrast 
to the incomplete cleft lip/alveolus (I), these complete sub-phenotypes do not show a tissue 
Figure 2. Ultrasound classification of oral (I-III) and craniofacial clefts (IV-VI) in fetuses of 20 weeks 
gestation. The most frequent sub-phenotypes are underlined within the categories: 
I. Unilateral or bilateral complete or incomplete cleft lip/alveolus; 
IIa. Unilateral complete or incomplete cleft lip/alveolus and palate (including bifid uvula, not shown); 
IIb. Bilateral complete or incomplete cleft lip/alveolus and palate (including bifid uvula; and if complete, 
with protrusion of the prolabium and premaxillae);
III. Complete or incomplete cleft palate including bifid uvula;
IV. Complete median cleft lip and palate with hypotelorism (that is, agenesis of the premaxillae, 
prolabium, and nasal septum combined with holoprosencephaly; these cases are always 
microcephalic); 
V. Incomplete median cleft lip (alveolus) with or without hypertelorism (combined with a flat bifid 
nose, and the alveolar cleft is located at the absent intermaxillary suture);
VI. Atypical facial clefts (located at extra sutures of facial bones, such as the maxilla; in these cases, the 
nose is normal and not affected by the cleft). 
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Figure 3. Various cleft sub-phenotypes within the three oral cleft categories: I. cleft lip/alveolus only, II. 
cleft lip/alveolus and palate, and III. cleft palate only, viewed from the oral side (based on Van der Meulen 
et al., 1990).6 The most frequent sub-phenotypes are underlined. From left to right: 
I. Unilateral complete or incomplete cleft lip; unilateral complete or incomplete cleft lip with 
incomplete cleft alveolus; unilateral complete cleft lip and alveolus; bilateral complete cleft lip and 
alveolus (with protrusion of the prolabium and premaxillae);
II. Unilateral complete cleft lip and alveolus with complete cleft soft palate (including a bifid uvula); 
unilateral complete cleft lip, alveolus, hard palate, and soft palate; unilateral complete cleft lip, 
alveolus, hard palate, and soft palate with contra-lateral incomplete cleft hard palate; bilateral 
complete cleft lip, alveolus, hard palate, and soft palate (with protrusion of the prolabium and 
premaxillae);
III. Complete cleft soft palate (including a bifid uvula; the dotted line indicates the border between the 
hard and soft palates); complete cleft soft palate with incomplete cleft hard palate; complete cleft 
soft and hard palates.
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bridge at the base of the nostril and the alveolar deformity generally extends to the incisive 
foramen (Vermeij-Keers et al. submitted).4, 11 Although the unilateral and bilateral forms of this 
cleft type result from similar embryonic processes, it is clinically relevant to further distinguish 
them (Figure 2:IIa and IIb), because the bilateral forms are more frequently associated with 
other anomalies than unilateral forms.9 In the third main category (III), the complete cleft soft 
palate and complete cleft hard and soft (including the uvula; Figure 3:III) are most commonly 
observed.7 Both sub-phenotypes result from disrupted fusion of the palatal shelves. As these 
shelves fuse in a fronto-occipital direction, starting at the incisive foramen and ending at the 
uvula, the time of disruption determines whether there will be a complete or incomplete cleft 
of the hard and/or soft palate including the uvula (Vermeij-Keers et al. submitted).4 In other 
words, if the fusion process is disrupted at a later stage, more of the hard/soft palate will be 
intact. Consequently, a complete cleft hard and soft palate precedes a complete/incomplete 
cleft of the soft palate only. Furthermore, palatal clefts always show a bifid uvula (Figure 3:III).4, 
6 Using this latter structure, Wilhelm and Borgers37 recently developed a new technique to 
improve the prenatal detection of isolated cleft palates. They found that an intact uvula can 
be visualized as the ‘equals sign’ and that absence of this typical presentation indicates a cleft 
palate. 
Craniofacial clefts
With respect to prenatal outcome and counseling, it is crucial to distinguish craniofacial clefts 
from oral clefts, because they are associated with other (more severe) congenital anomalies 
and almost always have underlying chromosomal abnormalities, and thus have a different 
prognosis.19, 30 Consequently, these cases require invasive prenatal testing and specific coun-
seling, focusing on parent’s options, termination of pregnancy being one of them. Based on 
their different underlying embryonic mechanisms and associations with other anomalies, 
craniofacial clefts should be further divided into three categories: IV) complete median cleft 
lip and palate with hypotelorism, V) incomplete median cleft lip (alveolus) with or without hyper-
telorism, and VI) atypical facial cleft (Figure 2:IV-VI). The first category (IV) is the most commonly 
described craniofacial cleft and is also known as ‘midline cleft lip and palate’, which is part of 
the holoprosencephaly series.33, 58, 65 This craniofacial anomaly is prenatally characterized by 
microcephaly as well as agenesis of both premaxillae, the prolabium, and the nasal septum 
combined with cleft palate and hypotelorism (Figures 2:IV and 4:IV) and originates from early 
embryological stages (4-5.5 weeks gestation, 1-3 mm CRL). Holoprosencephaly in category 
IV concerns the semilobar or incomplete form and is caused by insufficient outgrowth of the 
neural walls and consequently of the telencephalic hemispheres,66 leading to agenesis of the 
olfactory bulbs, agenesis or hypoplasia of the corpus callosum, and undivided thalami in later 
developmental stages.58 Additionally, both medial nasal processes do not develop and there is 
no interplacodal area. In the embryonic face, both nasal placodes fuse to one single placode.10, 
11, 58 It is important to realize that these cases always have associated anomalies (chromosomal 
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Figure 4. Two-dimensional (2D) ultrasound images of fetuses showing the different categories of oral (I-III) 
and craniofacial (IV-VI) clefts according to the new ultrasound classification. U = upper lip; L = lower lip; N 
= nose; BN = bifid nose; O = orbit.
I. Right-sided unilateral incomplete cleft lip and alveolus with deviation of the nasal septum to the 
contra-lateral side (coronal view) at 20 weeks, 3 days of gestation;
IIa. Right-sided unilateral complete cleft lip, alveolus, and palate with deviation of the nasal septum to 
the contra-lateral side (coronal view) at 23 weeks, 6 days of gestation; 
IIb. Bilateral complete cleft lip, alveolus, and palate with protrusion of the prolabium and premaxillae 
(coronal view) at 19 weeks, 6 days of gestation;
III. Because detection of isolated cleft palate by 2D ultrasound is still challenging and generally done by 
3D ultrasound, 2D images were not available for this category;
IV. Complete median cleft lip and palate with absent prolabium, premaxillae, and nasal septum as well 
as hypotelorism (coronal view) at 22 weeks, 1 day of gestation;
V.1. Incomplete median cleft lip and alveolus (coronal view) combined with 2. a flat bifid nose without 
hypertelorism (coronal/axial view) at 24 weeks, 3 days of gestation;
VI. Atypical facial clefts are very rare, and consequently an ultrasound image of this category could not 
be provided.
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defects in 61%-82%), resulting in 100% mortality.19, 30 Therefore, future parents require specific 
prenatal counseling and care, including termination of the pregnancy. 
The incomplete median cleft lip with or without hypertelorism (Figures 2:V and 4:V) is a rare 
malformation and also known as ‘median cleft face syndrome’, ‘frontonasal dysplasia or mal-
formation’, ‘bifid nose with median cleft lip’, or cleft no. 0.5, 6, 34, 42, 53 Note that this incomplete 
cleft condition is a normal feature in rhodents.67 In case of hypertelorism, the ultrasound shows 
a bony distance between the orbits that is too wide,34 which is caused by insufficient fronto-
caudal outgrowth of the nasal septum during embryogenesis (9-14 weeks gestation, ≥17 
mm CRL). The bifid nose and median cleft lip can be considered as remnants of the internasal 
groove that has not fully disappeared, and the cleft between both premaxillae, if present, as 
absence of the intermaxillary suture.11 While these cases are mentally less affected compared to 
those of category IV, mental retardation may be present, especially in cases with agenesis of the 
corpus callosum.34, 42 Besides the frequent association with anomalies of the central nervous 
system, various other accompanying defects and related syndromes have been described.34, 42 
However, due to its rarity, exact numbers on associated findings are not available. Nevertheless, 
awareness of these associated anomalies is vital for optimal prenatal care, which should include 
genetic counseling as well as consultation of a specialized multidisciplinary craniofacial team.
The final category (VI) comprises the various atypical facial clefts (Figure 2:VI), which also 
are very rare malformations.5, 6, 35, 53, 68 Most of these atypical clefts are caused during late 
embryogenesis (9-14 weeks gestation) due to the development of additional bone centers and 
consequently extra sutures.11 These additional centers can develop within the maxilla and have 
also been found within other bones of the facial skeleton, such as the zygomatic bone (bipartite 
os zygomaticum).6, 10, 11, 68 While most of the skulls with extra bone centers and sutures develop 
normally, defective differentiation at these extra sutures can rarely result in atypical facial clefts. 
It should be realized that in cases with atypical clefts, the nose is not affected by the cleft, which 
makes them easy to distinguish from oral clefts. Similar to category V, these cases should be 
counseled prenatally by specialized multidisciplinary craniofacial teams. 
Compared to Nyberg’s classification
In several aspects, this new classification is different from Nyberg’s ultrasound classification of 
facial clefts (Table 1).30 First, oral clefts are distinguished from craniofacial clefts, while Nyberg 
et al. considered them to be all facial clefts. Second, the alveolus is not described in their classifi-
cation. From an embryological point of view, however, it is essential to analyze and describe the 
alveolus separately,31 as its deformity is not related to that of the lip and has unique underlying 
embryonic processes (Vermeij-Keers et al., submitted). Another important point missing is 
that, although displayed, the differences between complete and incomplete clefts of the lip/
alveolus are not explained by Nyberg et al. Prenatally, it is important to distinguish these two 
groups, given that—in contrast to complete cleft lip—the palate is significantly less involved in 
incomplete clefts of the lip,7 and the latter thus has a more favorable prognosis, especially when 
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it comes to associated defects.9 Another difference is that Nyberg et al. did not include clefts of 
the palate only, as this category was hardly prenatally detected at that time. However, because 
of recent and future advances in ultrasound techniques and experience,37, 41 an update is 
needed and therefore, this category is included in our classification. With regard to craniofacial 
clefts, Nyberg et al. did not describe or include the incomplete median cleft lip (alveolus) with 
or without hypertelorism (category V). Given its different patho-embryogenesis and associated 
anomalies,5, 6, 10, 11 this craniofacial anomaly should be distinguished from complete median 
cleft lip and palate with hypotelorism (category IV). Finally, Nyberg et al. presented atypical 
facial clefts as anomalies associated with amniotic bands or the limb-body-wall complex. How-
ever, in line with previous studies,5, 6, 11, 35, 68, 69 these anomalies should be explained differently 
and not by amniotic bands. Therefore, these bands were not included in our classification. 
CONCLuSIONS
With regard to prenatal care and future research, it is vital to differentiate between oral and 
craniofacial clefts and between their embryologically different sub-categories, given their 
varying etiopathological features and accompanying defects, resulting in a different prognosis 
and clinical outcome. Clefts of the lip/alveolus without palatal involvement—mainly being 
unilateral incomplete clefts —have the most favorable prognosis because of their relatively 
low rates of associated structural and chromosomal defects. In contrast, complete clefts of the 
Table 1. New ultrasound classification of oral and craniofacial clefts versus Nyberg’s ultrasound 
classification of facial clefts
New Prenatal ultrasound Classification* Nyberg Classification30
Oral clefts Facial clefts
Category I Unilateral or bilateral complete or 
incomplete cleft lip/alveolus
Type 1 Cleft lip without cleft palate
Category IIa Unilateral complete or incomplete 
cleft lip/alveolus and palate
Type 2 Unilateral cleft lip and palate
Category IIb Bilateral complete or incomplete 
cleft lip/alveolus and palate
Type 3
3a
3b
Bilateral cleft lip and palate
with premaxillary protrusion
with hypoplastic midface
Category III Cleft palate only —
Craniofacial clefts
Category IV Complete median cleft lip and  
palate with hypotelorism
Type 4 Midline cleft lip and palate
Category V Incomplete median cleft lip (alveolus)  
with or without hypertelorism
—
Category VI Atypical facial clefts Type 5 Facial cleft associated with amniotic 
bands or limb-body-wall complex
* The most commonly observed morphologic features are underlined
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lip/alveolus have significantly higher risks of palatal involvement, and thus of accompanying 
defects. The bilateral complete clefts are more frequently associated with other anomalies 
than unilateral clefts. Therefore prenatal ultrasound screening should be more focused on 
the morphological severity of the lip/alveolus. When the palate is involved, specific prenatal 
management, including genetic counseling and invasive genetic testing, is recommended. In 
case of craniofacial clefts, prenatal management should always include invasive genetic testing 
given the frequent association of (more severe) congenital and chromosomal anomalies, and 
parents’ options, including termination of pregnancy, should be discussed. Additionally, referral 
of future parents to a specialized multidisciplinary cleft palate team or craniofacial team for 
counseling is advised. 
Finally, it is crucial to obtain further clinical experience with new ultrasound techniques, 
such as the ‘equal sign’ marker, and other more sophisticated 3D techniques or fetal MRI. 
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General discussion
Oral clefts impose a large burden on the health, quality of life, and socio-economic well-being 
of affected individuals and their families. They also represent a significant public health burden 
in terms of immediate and long-term medical costs.1 Although access to care has increased 
around the world in recent years, the quality of care still varies substantially.2 Prevention is 
the ultimate objective for these anomalies, and understanding of their causes is a condition 
sine qua non for this aim. However, despite extensive research representing a wide variation of 
designs, methods, and data, the causal factors and mechanisms underlying oral clefts remain 
largely unrevealed. This thesis is aimed at defining a prenatal and postnatal approach to further 
our understanding of these factors and mechanisms and to optimize the overall management 
of oral clefts. 
MAIN FINDINGS, LIMITATIONS, AND POSSIbLE ExPLANATIONS 
Part I. Descriptive registration and validation
To enable clinical, epidemiological, and fundamental research, the Dutch cleft palate teams—
united in the “Dutch Association for Cleft Palate and Craniofacial Anomalies” (NVSCA)—have 
reported their new patients to the NVSCA registry for over 15 years, with an average of 351 
patients per year.3 Among the objectives are surveillance for changes in frequencies and distri-
butions of specific cleft phenotypes as well as of their influencing factors.4, 5 Additionally, con-
sistent description is vital to evaluate any treatment strategies, to compare with other registries 
and studies, and to improve interdisciplinary and inter-center communication. To meet these 
requirements in an non-time consuming way, the NVSCA uses a unique recording system that 
easily allows description of all individual anomalies that form the oral cleft.3, 6 
To investigate the feasibility of this system and ensure that the data provided are valid, a 
national validation project was conducted. We assessed the quality of registered data from 
all Dutch teams through extensive medical data review over a 7-year period (1997-2003). The 
main strengths of this project are the national distribution of the sampling frame—including 
large urban teaching hospitals and regional ones—as well as the successful retrieval of medical 
records (96%). Additionally, the postnatal follow-up (median of 5 years) allowed us to include 
associated anomalies detected later in infancy. However, the use of medical data also has its 
limitations, as their quality varied by team. Consequently, these data can never be 100% equal 
to the presentation in the outpatient clinical setting. As described in Chapter 2, our project 
showed that, while the quality of general infant and parental information varied by item, data 
were accurate and complete for the three commonly studied cleft categories (CL, CLP, and 
CP), making the NVSCA data highly suitable for comparison with other registries and studies. 
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Analysis of the anatomical structures and morphological severity revealed that the data quality 
of the various sub-phenotypes within these categories was generally satisfactory, supporting 
the clinical feasibility of this descriptive system (Chapter 3). However, externally visible (lip/
alveolus) and severe (complete) clefts were generally more adequately diagnosed and recorded 
than less recognizable (hard and soft palate including the uvula) and mild (incomplete or 
subcutaneous/submucous) defects. These results might be explained by incomplete clinical 
examination. As reported earlier, this has mainly been a problem in newborn routine examina-
tion,7-9 but it might also happen among the more experienced examiners.8 Another possible 
explanation for the underreporting of mild features is that greater severity might encourage 
physicians to report better. 
With regard to associated congenital anomalies, the proportion of individuals affected 
with these anomalies varies greatly between studies and appears to be related to the time of 
registration and how data have been collected.10 Not all anomalies are detectable at birth or 
in the neonatal period, and early registration might cause underreporting of these anomalies, 
in particular of those that require specific diagnostic procedures (e.g., chromosomal defects 
or developmental disorders).10, 11 In Chapter 4 we evaluated both major and minor (minimal) 
congenital anomalies, resulting in a relatively high proportion of cases with associated anoma-
lies (61%) compared to other studies (3% to 63%).10, 12-15 Craniofacial anomalies were most 
frequently diagnosed, followed by defects of the central nervous system, skin, upper limbs, and 
lower limbs. Subsequent validation showed that—in contrast to the oral cleft features—the 
data quality on associated anomalies is moderate to poor according to Landis and Koch’s 
classification.16 Given that cases could have more than one associated anomaly, we found 
an underreporting of approximately 80% of the defects in cases with additional craniofacial 
anomalies or with additional anomalies of other organ systems, and 54% of the final diagnoses. 
Two-phased medical data review revealed that underreporting was caused rather equally by 
delayed diagnoses and deficient recording. Our rates are consistent with those of other stud-
ies evaluating underreporting of congenital anomalies during the neonatal period (37% to 
86%),11, 17-20 while registration after longer follow-up periods showed considerably lower rates 
(7% to 21%).21-24 In line with this contrast, we assume that a part of the delayed diagnoses are 
explained by the early registration in the NVSCA. However, our results also show that obvious 
external defects (such as craniofacial and limb anomalies) were missed during intake. This 
might partly have been caused by the fact that patients are initially seen and recorded by plastic 
surgeons, orthodontists, or pediatricians, who are usually not fully trained in dysmorphology 
and syndromology. 
Part II. Prevalence in the Netherlands
Since 2003, the number of new oral cleft patients reported to the NVSCA has fallen.4, 5 This 
decline is unlikely to be explained by underreporting or misclassification, as these factors were 
minimized by standard and extra case-ascertainment activities. Therefore, other influencing 
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factors were searched, especially in the field of primary prevention, such as periconceptional 
folic acid supplementation, and the “so called” secondary prevention by prenatal screening.25 
As a result we hypothesized that the prevalence might have been affected by the increased 
correct periconceptional use of folic acid supplements among expecting Dutch mothers after a 
government-sponsored mass media campaign in 1995 and the proactive intervention by Dutch 
pharmacies since 2004.26-28 In the Netherlands, folic acid supplement use is recommended 
from 4 weeks before conception until 8 weeks after it.26, 27, 29 Because this recommended period 
covers only the developmental period of most CL±P sub-phenotypes and not of CP,6, 30-32 more 
adequate use during this periconceptional period might have mainly affected CL±P. This theory 
is supported by findings that, after discontinuation of supplementation, the folate concentra-
tion in serum immediately decreases and the plasma total homocysteine level immediately 
increases.33 Given the possible dose-response relationship between folic acid and clefts as 
well as the possible indirect effects through homocysteine metabolism,34-36 supplementation 
until 8 weeks postconception might be too short to prevent CP. Although the evidence on the 
role of folic acid in oral clefts is largely inconclusive, our hypothesis would be consistent with 
several studies reporting that folic acid or multivitamin use during the same periconceptional 
supplementation period is associated with a decreased CL±P risk only,37-40 while countries with 
compulsory fortification (United States and Canada) have shown a decline in both CL±P and 
CP.35
Another influencing factor might be the greater prenatal detection of oral clefts and their 
associated anomalies in the Netherlands. While routine ultrasound screening during 18-22 
weeks of gestation was nationally implemented in 2007, the performance of 2D ultrasound 
scans during this gestational period started to increase as early as the 1990s.41 As it did else-
where,42-46 the rise in prenatally detected anomalies may have led more affected pregnancies 
to be terminated. This is supported by national data on TOP provided by the annual reports of 
the Dutch Termination of Pregnancy Act (WAZ). They have shown that the number of second-
trimester terminations, especially those performed in the hospitals, have increased since 
2003, implying a rise in TOP affected with congenital anomalies.47, 48 If pregnancies have been 
terminated because of the presence of an oral cleft with or without associated anomalies, again 
the CL±P prevalence would have been affected most. Unlike CP, this category can be easily 
detected by routine 2D ultrasound.45, 49, 50 
In Chapter 5 we used NVSCA data to establish the rates of oral clefts among live births in the 
Netherlands from 1997 to 2006, resulting in an average oral cleft prevalence of 16.8 per 10,000 
live births. Time-trend analyses showed that the live-birth prevalence decreased significantly 
during this period. Additionally, stratification revealed a similar trend for CL±P, while no signifi-
cant trend for CP was found, supporting that the higher periconceptional folic acid use and/
or the greater prenatal detection of clefts and their associated anomalies might have caused 
the decline in prevalence. As stillbirths and neonatal deaths were not included in our analysis, 
a change in perinatal or neonatal mortality could theoretically also have affected our rates. 
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However, we assume this is of minor importance, given that the Dutch perinatal and neonatal 
mortality decreased during this specific period.51 Moreover, this would have mainly affected 
CP, as this category is more frequently associated with severe further defects than CL±P.2, 10 
Other environmental or lifestyle factors changing over time may also account for the decrease 
in cleft prevalence. While specific data on these factors are not available for oral clefts in the 
Netherlands, data based on the general Dutch population have shown a decrease in maternal 
smoking and alcohol consumption during the study period.52 Given their suggested associa-
tion with cleft risk,2, 53 these factors may have played contributory roles in the detected trends 
of oral clefts.
Unfortunately, comparison of our findings with those of other studies is restricted, particu-
larly due to the great differences between data sources, sample sizes, inclusion and exclusion 
criteria, times of diagnosis, classifications, and population characteristics.2, 10, 46, 54, 55 Regional 
Eurocat data have often been used to describe clefts from the Netherlands in a European or 
international context,55-58 and they have occasionally been extrapolated to the whole of the 
Netherlands.59 However, as its cleft prevalence seems to differ from national (LVR/LNR)60 and 
other European registries,56, 58 the Northern Netherlands might not contain a representative 
sample of the Dutch oral cleft population. Therefore, NVSCA data over 1997-2007 were com-
pared with national data from the LVR/LNR and regional data from Eurocat, thereby verifying the 
detected decreasing trends and investigating whether the prevalence varies within the Neth-
erlands (Chapter 6). We found that the overall live-birth prevalence of oral clefts is significantly 
higher in the Northern Netherlands (15.1 to 21.4 per 10,000) than in the rest of the Netherlands 
(13.2 to 16.1 per 10,000). Additionally, time-trend analyses confirmed the significant decreasing 
trend in CL±P for the rest of the Netherlands, but not for the Northern Netherlands. By compar-
ing the rates between registries, we found that the NVSCA and Eurocat have rather similar rates 
for the Northern Netherlands, while the LVR/LNR has significantly lower rates for both regions, 
most possibly due to its incomplete coverage.61 Unfortunately, none of the registries could 
give complete and reliable national data on associated anomalies, stillbirths, and pregnancy 
terminations to provide more insight into the causes of regional differences and trends.
Our results of relatively high rates for the Northern Netherlands are in line with previous 
findings46, 56, 58 and thus seem to have already existed for a long time and to be fairly constant. 
Regional differences in epidemiological patterns may be due to variations in genetic and 
environmental risk factors, and in gene-environment interactions as well.2, 32, 62 For example, 
our Northern population consisted of more Caucasian infants than the rest of the Netherlands. 
As populations of Dutch origin have higher cleft risks than other ethnic groups,62 our findings 
may be partly explained by ethnic differences. Additionally, there may be a greater genetic 
predisposition in the Northern Netherlands due to a lower migration compared to the rest 
of the Netherlands.63 This is supported by the higher cleft prevalence in Northern European 
countries that have relatively homogeneous populations and high quality registrations.46, 55, 
57, 58, 64 The regional differences in trends might be explained by differences in the impact of 
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prenatal ultrasound screening. While the rise in prenatally detected anomalies may have led 
more affected pregnancies to be terminated in the rest of the Netherlands, several data sug-
gest that this did not affect the region Northern Netherlands. Eurocat data have shown rather 
low and stable rates of TOP among clefts in the Northern Netherlands,44, 46 and all terminated 
pregnancies affected with clefts were associated with additional anomalies, including chromo-
somal defects (personal communication M.K. Bakker). Furthermore, in contrast to the rest of 
the Netherlands, second-trimester terminations have hardly been performed in the Northern 
hospitals and abortion clinics.47, 48 It is unknown whether the regional differences in trends can 
be explained by differences in periconceptional folic acid use, as complete national data on 
this subject are not available. However, it should be realized that our effect-measures for the 
Northern Netherlands also indicated decreasing trends and that the absence of a significant 
effect in the Northern Netherlands could solely be due to sample size. 
Part III. Postnatal classification
After complete and detailed description of the various sub-phenotypes of oral clefts, subse-
quent adequate subdivision according to their related time periods and underlying processes 
in development is needed to allow linkage to specific cell-biological mechanisms, genes, 
and environmental factors that are expressed during these periods. Although many systems 
have been developed to classify clefts,65-73 none of them are fully based on human embryol-
ogy of the nose and oral cavity, and infrequent or subclinical features are often not included. 
Therefore, a new postnatal classification of oral clefts was proposed, dividing broad groups of 
oral clefts into defects resulting from defective fusion, differentiation, or both.6 This approach 
reflects the different underlying patho-embryological processes and timing in development of 
the primary and secondary palates, and its rationale is in line with the theoretical basis of the 
NVSCA registry.3, 6, 30-32, 74-76 After discussing its embryological basis, we tested this new clas-
sification on all sub-phenotypes among Dutch newborns registered in the NVSCA (Chapter 7). 
The descriptive data allowed us to classify all different sub-phenotypes—including subclinical 
features—within the three cleft categories (CL, CLP, and CP) into fusion and/or differentiation 
defects. In addition, we were able to construct a timetable relating the various observed defects 
to weeks in embryonic development. For example, a complete cleft of the lip/alveolus arises 
significantly earlier (by disrupted fusion of the primary palate in the early embryonic period) 
than an incomplete cleft of the lip/alveolus (by disrupted differentiation of the primary palate 
during the late embryonic period).6, 30-32, 75, 76 However, our timetable has some limitations, 
because over 90% of the observed defects, but not all clefts, could be fitted in. More specifically, 
some fusion defects of the secondary palate were difficult to place in time. Theoretically, a com-
plete cleft palate can develop relatively early during the late embryonic period (7-9 weeks of 
development) because of insufficient outgrowth and elevation of the palatal shelves. However, 
lack of adhesion, apoptosis, or epithelio-mesenchymal transformation (EMT) during the second 
part of the late embryonic period (9-11 weeks of development) may cause a similar defect.6, 
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30-32, 75, 76 Only when a minimal part or more of the hard palate is fused, insufficient outgrowth 
and elevation of the palatal shelves can be excluded as underlying mechanisms, and the cleft 
palate can then be related to one specific timeframe.
While there is general consensus on the embryogenesis of the secondary palate,2 the devel-
opmental processes of the primary palate are complex and have been rather underexposed. 
Therefore, we tested our classification on adult unoperated patients from Indonesia with clefts 
of the primary palate only (Chapter 8). We were able to classify all their sub-phenotypes—not 
being influenced by defective development of the secondary palate—into fusion and/or 
differentiation defects. Additionally, we showed that further morphological grading of incom-
plete clefts of the lip, as has been proposed by several studies, is not related to the severity of 
associated alveolar deformities. Analysis of the permanent dentition of these patients revealed 
that all observed alveolar deformities were located between the central incisor and—often 
malformed or absent—lateral incisor. As both incisors develop within the premaxilla,77, 78 our 
findings imply that the developmental arrest involves the premaxilla.
Part IV. Effects of periconceptional folic acid supplementation
Although multiple (non-randomized) observational studies have suggested a beneficial role 
of folic acid in supplements in decreasing cleft risk,35, 79, 80 the evidence remains inconclusive, 
as many studies—including randomized and cohort controlled trials—identified no significant 
effects on clefts.35, 79-83 Results are often mixed in terms of estimated effects, whether they affect 
certain or all cleft categories, and whether they are attributable to folic acid or other multivita-
min components. One of the factors hampering our insights might be that supplementation is 
often not subdivided by type (folic acid alone or combined with multivitamins) and does not 
completely cover the embryonic periods of clefts.35 Also, most studies evaluate heterogeneous 
cleft groups to reach adequate power, but given their etiologic and genetic heterogeneity this 
crude approach may just weaken the power to detect effects.53, 84 Therefore, we analyzed the 
type, timing, and duration of periconceptional folic acid supplementation in relation to the tim-
ing and embryological mechanisms underlying cleft development (Chapter 9). This was done 
by applying our new postnatal classification to combined complementary NVSCA and Eurocat 
data in a population-based case-control study. By assessing effects on oral clefts relative to 
other non-folate related congenital anomalies, we unexpectedly found the first evidence that 
periconceptional folic acid supplementation might be associated with elevated risks for certain 
types of oral clefts. Defects of the lip/alveolus—mainly resulting from defective differentiation 
in development—appeared to account for the largest proportion of risk increase, being associ-
ated with more than three-fold higher risks. Further analysis systematically revealed two- to 
three-fold increased risks for differentiation defects developing during the late embryological 
period, with no associations for fusion defects. Stratum analysis showed similar figures for 
supplements consisting of folic acid alone, and effects were therefore attributable to folic acid 
and not to other multivitamin components. 
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Although our use of malformed controls is widely accepted and beneficial with regard to 
internal validity,85-88 some limitations inherent to the observational nature of this study, such as 
recall/selection bias and confounding, are not completely avoidable. However, our findings are 
strengthened by their specificity, consistency, systematic pattern, and duration of exposure-
response relationship. The deviation of our results from other studies might be explained by our 
unique design, including the subdivision according to specific supplement and cleft features—
an approach not used in earlier studies.35, 79 Because mechanisms by which folic acid might pre-
vent certain anomalies remains unexplained,79 a meaningful explanation for our unexpected 
risk pattern cannot be provided. However, we do know that other aspects surrounding folate 
metabolism (such as MTHFR gene polymorphisms, folate receptors, and plasma/erythrocyte 
folate), have also been shown to deviate for clefts.89-95 Additionally, comparable associations 
between folate intake and the occurrence of multiple congenital anomalies have been found.96, 
97 Moreover, adverse effects of high folate intake have been established in animal studies.98-100 
In humans, folate fortification and additional supplementation have increased folate intake and 
blood cell concentrations significantly,101, 102 but the consequences of long-term high intake 
are not known yet. Recently, it has been hypothesized that folic acid might lead to changes in 
epigenetic patterns, thereby altering gene expression.103-105 This might be an explanation for 
different health outcomes among those with similar genetic backgrounds. 
Part V. Prenatal diagnosis and classification
Oral clefts are being diagnosed prenatally more frequently. Detection rates—predominantly 
on CL±P—increased from approximately 5% in the early 1980s to over 26% in the late 1990s,106 
and they are as high as 65% today.107 Consequently, the need for accurate information on the 
risk of associated anomalies and underlying chromosomal defects is rising to aid in decisions 
on invasive diagnostics and informing future parents on outcome and prognosis. In Chapter 
10 the frequencies of associated congenital anomalies and chromosomal defects among 
prenatally and postnatally detected oral clefts were assessed from literature and NVSCA data, 
providing an inventory of the various detected syndromes and chromosomal defects as well as 
an algorithm for prenatal diagnostics. We demonstrated that the prevalence of these defects 
is evidently related to cleft category. Although strongly varying in study characteristics and 
designs, both prenatal and postnatal studies showed a higher frequency of associated defects 
in CLP (21% to 66%) and CP (22% to 78%) than in CL (0% to 41%). Furthermore, these frequen-
cies were higher in bilateral (23% to 79%) than in unilateral (16% to 52%) CLP or CL±P. For 
all categories, chromosomal defects were almost always seen in association with additional 
congenital anomalies. In the absence of associated anomalies, chromosomal defects were 
found prenatally in CLP (3.9%), and postnatally in CL (1.8%, 22q11.2 deletions only), CLP (1.0%), 
and CP (1.6%). However, these results are limited by the great variation in designs and meth-
odologies of the evaluated studies. In line with previous findings,10 the most important issues 
were the non-uniform subdivision of oral clefts and the different definitions and classifications 
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of associated anomalies among studies. Furthermore, chromosomal analysis was mostly per-
formed in associated clefts only, which explains why almost all reported chromosomal defects 
were accompanied by additional anomalies. As a consequence, the risk of chromosomal 
anomalies in isolated clefts may be underestimated.
Because the various cleft categories are differently associated with additional anomalies 
and thus have a different prognosis and outcome, accurate prenatal ultrasound screening 
and subsequent subdivision of oral clefts will improve counseling and management of the 
pregnancy significantly. Moreover, it is vital to prenatally distinguish oral clefts from midline 
and atypical facial clefts. While the latter are often considered to be oral clefts,65, 67, 70, 108-113 
they should be classified as craniofacial clefts given their different patho-embryogenesis and 
accompanying defects.30, 31, 114, 115 To classify clefts prenatally, the system of Nyberg is most 
generally used.116 While this system has brought structure in the prenatal diagnosis of clefts, it 
does not incorporate the latest embryological and genetic insights,30, 31, 53, 74, 84, 114, 115, 117 and 
it has not been designed for modern ultrasound technologies.118-129 Therefore, we have devel-
oped a new prenatal ultrasound classification of oral and craniofacial clefts considering their 
underlying embryological processes and associated congenital anomalies as well as advances 
in ultrasound technology (Chapter 11). In contrast to Nyberg et al,116 we distinguish oral clefts 
(categories I-III) from craniofacial clefts (categories IV-VI), instead of considering them to be 
all facial clefts. Another difference is that we have described the alveolus separately because 
of its unique underlying embryological processes,6, 31, 32, 75, 76 and we have included clefts of 
the palate only as these are prenatally detectable nowadays.123, 125, 126, 128 Besides grouping 
oral clefts into the three main categories (categories I-III), it is essential to prenatally differen-
tiate between incomplete and complete clefts of the lip/alveolus, because the palate is less 
frequently involved in incomplete clefts3, resulting in a better prognosis, especially when it 
comes to associated defects (chapter 10). Although unilateral and bilateral forms of CLP result 
from similar embryological processes, it is clinically relevant to distinguish them prenatally, 
because unilateral forms (category IIa) are less frequently associated with additional anomalies 
than bilateral (category IIb) forms (chapter 10). With regard to craniofacial clefts, Nyberg et al.116 
described just one type of midline cleft. However, based on difference in embryological pro-
cesses30, 31, 75, 76, 114, 115, 130 and associated anomalies,112, 119, 120, 122, 131, 132 we included two forms 
in our classification: complete median cleft lip and palate (with absent premaxillae, prolabium, 
and nasal septum) and hypotelorism (category IV), and incomplete median cleft lip (alveolus) 
with or without hypertelorism (category V). Furthermore, atypical facial clefts (category VI) are 
not explained by amniotic bands—as believed by Nyberg et al.116— but by different embryo-
logical processes.31, 114, 115, 121, 133, 134
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IMPLICATIONS AND RECOMMENDATIONS
Postnatal management 
Clinical outcome and prognosis of patients with oral clefts depend largely on the timely and 
accurate diagnosis of their cleft phenotype as well as their associated congenital anomalies, 
including underlying syndromes and chromosomal defects.2, 10 We found that less visible and 
mild cleft features are less adequately reported to the NVSCA, possibly due to incomplete 
examination, and that a considerable part of the associated anomalies, including externally 
visible anomalies, are missed during the first consultations with the cleft palate teams (Chap-
ters 3 and 4). These findings emphasize the need for early and thorough evaluation of patients 
with oral clefts. Adequate diagnosis of involvement of the palate is important, not only with 
regard to associated feeding difficulties, but also because of their relatively high association 
with additional congenital anomalies.2, 10 In addition, cleft team members should be trained 
and focused on the postnatal detection of co-occurring anomalies, especially such as Pierre 
Robin sequence and cardiovascular/urogenital anomalies. These anomalies are frequently 
missed during intake (chapter 4) and will change treatment policy as well as the prognosis and 
clinical outcome of patients. Furthermore, minor defects should also be correctly identified, 
because they may be recognizable components of specific syndromes or chromosomal defects 
that significantly affect cleft management.10 Early genetic counseling seems warranted in most 
cases to maximize the ascertainment of associated anomalies. Besides the postnatal detection, 
cleft team members should be more aware of prenatal findings, as a considerable amount of 
associated anomalies are detected prenatally nowadays.41, 50, 135
Postnatal registration
Valid description of cleft sub-phenotypes is vital to investigate their causal factors, evaluate any 
treatment and preventive strategies, compare with other registries and studies, and improve 
interdisciplinary and inter-center communication.53, 84 Despite some challenges described 
(Chapters 2-4), the NVSCA provides such consistent descriptive data. We demonstrated that the 
unique NVSCA recording system is clinically feasible and generates overall valid data. However, 
information on morphologically severe clefts can be interpreted with higher confidence than 
those on morphologically mild clefts. As these mild (subclinical) features may represent specific 
genetic or environmental characteristics,53, 84, 136-138 one should be aware that these character-
istics might be underestimated in registry-based studies. The underrepresentation of associ-
ated anomalies restricts the use of NVSCA data for research on these anomalies and underlines 
the need for postnatal follow-up and reregistration at a later age. However, these data can 
still be valuable, for example in providing low-end estimates of rates, as long as one remains 
cognizant of the limitations.19 After these findings, several strategies have been undertaken by 
the NVSCA Registration working group to improve the completeness of NVSCA registry data. 
First, the registry form was converted to a digital form in 2008, thereby eliminating paperwork, 
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reducing transfer errors from paper to database, and allowing obligatory fields for key informa-
tion.5 Second, a reregister project has recently been started for 1997 and will be implemented 
for the subsequent years to complete anomalies and final diagnoses diagnosed after the first 
cleft palate team consultations.
In contrast to other systems, such as ICD-based registries,44, 46, 139, 140 the NVSCA data can be 
fitted into any classification, old or new (Chapters 7 and 9), thereby providing a solid basis—
complementary to other registries—for clinical, epidemiological, and fundamental research. 
Internationally, there is growing awareness that coding oral clefts in a too simplistic way could 
potentially lead to important information being lost,53, 84 as well as weakening of the power to 
detect effects. In line with these studies, registries and future studies should be encouraged to 
accurately phenotype oral clefts according to standard protocols with data-sharing activities. 
As many registries and studies are ICD-based, we believe that adjustment of the ICD-10 cleft 
coding system (Q35-Q37)141 is required with regard to the anatomical and morphological cleft 
features, including subcutaneous, incomplete, and complete cleft lip/alveolus and submucous 
cleft palate. In this way, more accurate international data may become available to facilitate the 
ongoing identification of causal factors as well as the improvement of overall cleft manage-
ment.
Postnatal classification
To enable grouping of the detailed descriptive NVSCA data, we have provided a new postnatal 
classification that is complete and feasible for all sub-phenotypes of the primary and/or second-
ary palates, including subclinical features (Chapters 6 and 7). Furthermore, with our concept of 
fusion/differentiation defects, special sub-phenotypes—such as Simonart’s bands—can also 
be explained. Two types of bands have been described: the skin-covered soft tissue bridge 
located at the base of the nostril with an ipsilateral complete cleft alveolus, and the mucous 
tissue bridge located between the segmented alveolar process with an ipsilateral complete 
cleft lip.142, 143 Although a few mechanisms have been described,142 the exact developmental 
processes of these bands have not been identified yet. Our hypothesized mechanisms based 
on the patho-embryology of the primary palate6, 31, 144, 145 may contribute to the understanding 
of such complicated phenotypes. In addition, we demonstrated that whether an incomplete 
cleft alveolus is a fusion or differentiation defect depends on the morphology of the lip (com-
plete vs. incomplete/subcutaneous cleft), and that the lip should therefore always be evaluated 
first. As further morphological grading of incomplete cleft lip does not predict the severity of 
the alveolar deformity, these grades have no therapeutic consequences and thus are neither 
clinically nor embryologically relevant. These results underline that the lip and alveolar process 
have independent morphological characteristics and should therefore be evaluated separately 
in order to have a complete and accurate diagnosis. Our timetable relating the type of clefting 
to timeframes in development (Chapter 6) can be used as a guideline in research, provided that 
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one is aware of the limitation that complete clefts of the hard palate have various underlying 
embryological mechanisms during different specific timeframes in the late embryonic period. 
Primary and secondary prevention in the Netherlands
The NVSCA data have shown that the prevalence of oral clefts and its trends among live births 
varies within the Netherlands (Chapters 5 and 6). Consistent with its deviation from other 
European regions,56, 58 the prevalence in the Northern Netherlands is significantly higher than 
that in the rest of the Netherlands, possibly due to differences in ethnic and genetic population 
characteristics. Therefore, this region does not contain a representative sample of the overall 
Dutch oral cleft population. Although regional data have utility for health services, clinicians, 
and researchers in that specific area and can be compared by global means and trends, our 
findings underline that extrapolation of regional data to a whole country or larger areas should 
be made with caution.55 Further studies investigating etiology and evaluating preventive 
strategies should consider these geographical differences in cleft sub-phenotypes among live 
births, stillbirths, and spontaneous/induced abortions, between and within countries, as they 
may reveal clues to the causal factors of oral clefts. 
The detected significant decreasing trend of CL±P among live births in the rest of the Neth-
erlands (Chapters 5 and 6) may have several implications for healthcare and policy makers, 
partially lying in the possible effects of primary and secondary preventive factors. Firstly, the 
average 1.9% reduction per year in live-birth prevalence (2.2% for CL±P) we estimate will reduce 
the psychological burden on patients and their families, as well as the costs associated with the 
medical care of these patients. The second implication lies in the moral and ethical dilemmas 
raised by the possible increase in terminations of pregnancies affected with congenital anoma-
lies, since a considerable part of these cases might be non-lethal. Therefore, if oral clefts are 
detected prenatally, future parents should be counseled by a multidisciplinary cleft palate team 
that focuses on psychosocial support, genetic counseling, education on cleft management, and 
parent’s options, TOP being one of them.42, 43, 146, 147 Recently, an evidence-based guideline was 
developed providing a uniform strategy for prenatal counseling and management of oral clefts 
in the Netherlands.148 Future population-based studies also including stillbirths and terminated 
pregnancies can give more insight into the impact of prenatal screening, especially if prenatal 
diagnoses are known. However, complete and reliable national data on prenatally diagnosed 
anomalies and indications of TOP are still lacking. Therefore, uniform national registration of 
prenatal outcomes as well as implementation of indications for TOP in the WAZ47, 48 are essen-
tial to further evaluate the impact of prenatal screening in the Netherlands. In order to increase 
our insights, we have conducted an anonymous retrospective (1997-2007) and prospective 
registration since 2008 to record the number and outcome of prenatally detected oral clefts 
counseled by the Dutch cleft palate teams. To enable the prospective registration, the NVSCA 
registry has been expanded with an anonymous digital prenatal form that allows matching to 
the postnatal form. Although this registration does not provide complete data on prenatally 
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diagnosed cleft cases, our preliminary data indicate that termination of the pregnancy occurs 
before and after counseling and in case of additional anomalies, but also when isolated clefts 
are diagnosed.
With regard to folic acid, it is unknown whether differences in periconceptional supple-
ment use have accounted for the detected regional differences in trends and prevalence, as 
national data on this topic are lacking and its role in oral cleft risk remains unrevealed.1, 35, 80 
Therefore, future studies should focus on the type, timing, and duration of periconceptional 
folic acid supplementation35, 79 in relation to the various cleft sub-phenotypes. This was done 
with population-based data from the Northern Netherlands in chapter 9. In contrast to our 
expectations, we found several lines of evidence indicating that periconceptional folic acid use 
in this region is associated with an increased, instead of decreased, risk of oral clefts, especially 
of those resulting from defective differentiation during 7-12 weeks of development. Although 
detected by an observational study, this association is strengthened by the specificity, con-
sistency, systematic pattern, and duration of exposure-response relationship of our findings. 
Therefore, it is vital to restrict the use of folic acid supplements to the official recommended 
period for neural tube defects, which is 4 weeks before to 8 weeks after conception. Given 
the demonstrated duration of exposure-response relationship, minimizing pregnant women’s 
exposure in this way may then reduce the cleft prevalence. In addition, the effect of folic acid on 
oral clefts is relevant to the ongoing discussions about food fortification, as the folic acid intake 
and folate blood cell concentrations have been increased significantly by food fortification.28, 35, 
101, 102 Our unexpected results underline the importance of evaluating public health strategies 
regarding folic acid supplementation, including its timing, duration, and dose, which should be 
done in the light of potential dietary improvements. Together with other preliminary findings 
on the potential adverse effects of increased folic acid intake,98-100, 103-105 our results underscore 
the need for additional studies on the consequences of increased intake. Large population-
based studies using other datasets, but the same approach and methodology, are needed to 
confirm or refute our findings.   
Prenatal counseling and genetic testing
Prenatally, it is crucial to distinguish craniofacial clefts from oral clefts, because they have a dif-
ferent pathogenesis and are associated with other (more severe) congenital anomalies. There-
fore, parents expecting a child with a craniofacial cleft require specific prenatal counseling and 
care, and they should be referred to specialized multidisciplinary craniofacial teams. In case of 
a complete median cleft lip and palate and hypotelorism—which have high risks of underlying 
chromosomal defects (61% to 82%) and 100% mortality due to their microcephaly112, 116—the 
option of terminating the pregnancy should be discussed (chapter 11). 
With regard to oral clefts, prenatal counseling on the prognosis and risk of chromosomal 
defects should be tailored to cleft category, and more importantly to the presence or absence 
of associated anomalies (chapter 10). The demonstrated differences in associations with other 
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structural anomalies stress the need of accurate prenatal subdivision into three categories (CL, 
CLP, and CP), and further subdivision of unilateral and bilateral CLP. However, accurate detec-
tion of additional anomalies appears to be even more significant to outcome, as the presence 
of these anomalies is the most important predictor for underlying chromosomal defects. Irre-
spective of cleft category, clinicians should therefore advise invasive genetic testing to identify 
chromosomal defects if associated anomalies are seen prenatally. In absence of associated 
anomalies, CL has the most favorable prognosis when it comes to chromosomal anomalies 
with a poor outcome. Therefore, if confident in ultrasound findings, prenatal conventional 
karyotyping is not recommended in CL, but given the few reported 22q11.2 deletions,149 array 
comparative genomic hybridization (array CGH) may be considered. In presumed isolated 
CLP and CP, however, prenatal genetic counseling and invasive testing (preferably by array-
based methods) should be considered given their higher risks on underlying chromosomal 
defects. Especially CP can be associated with specific syndromes, such as the velo-cardio-facial 
syndrome (VCF, 22q11.2 deletion), Treacher-Collins, and Stickler (Chapter 10). However, when 
considering invasive testing, the baseline risk of complications (1%) should be weighed against 
the potential benefits.150 Additionally, one should be aware of the detection of unexpected or 
unclassified variants with array-based methods, which should be discussed with future parents.
Because complete clefts of the lip/alveolus have considerably higher risks of palatal involve-
ment than incomplete clefts of the lip/alveolus, they have a less favorable prognosis, especially 
when it comes to associated defects. Therefore, prenatal ultrasound screening should be more 
focused on the morphological severity of the lip/alveolus. Furthermore, it is crucial to obtain 
further clinical experience with new ultrasound techniques, such as the ‘equal sign’ marker to 
detect cleft palate,128 as well as other more sophisticated 3D techniques or fetal MRI.125 With 
regard to associated structural and chromosomal defects, follow-up studies are needed to 
acquire more accurate data on their prevalence and risk factors in prenatal and postnatal oral 
cleft populations. As array CGH can detect smaller chromosome deletions and duplications 
compared to conventional karyotyping, performing array CGH in large cohorts of prenatally 
and postnatally detected clefts would also give us more information about the proportions 
and types of chromosomal defects that are missed when cases are not genetically tested. This is 
essential to reach consensus on the role of invasive genetic testing in prenatally detected clefts. 
CONCLuDING FuTuRE PERSPECTIVES
In this thesis, we demonstrated that adequate and complete description, registration, and sub-
sequent classification are essential in order to further understand oral clefts. When the primary 
palate is affected, the alveolus should be evaluated and described separately in order to have a 
complete and accurate diagnosis, as its morphology is not related to that of the lip. Therefore, 
the commonly used cleft categories should include the alveolus as a separate anatomical 
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structure, resulting in cleft lip/alveolus (CL/A), cleft lip/alveolus and palate (CL/AP), or cleft lip/
alveolus with or without cleft palate (CL/A±P). Furthermore, frequently used classifications, 
such as the ICD-10 cleft coding system, should be adjusted and also incorporate the different 
morphological cleft features, thereby generating data on a large scale that can be subdivided 
according to timing and underlying mechanisms in embryogenesis. The NVSCA recording 
system provides such detailed data on all sub-phenotypes, which can be fitted into any clas-
sification. However, to optimize its quality and value, cleft team members need to be trained 
and more focused on less visible and mild cleft features as well as on additional congenital 
anomalies. Furthermore, genetic counseling is warranted in most cases, and reregistration at a 
later age is strongly recommended to also include certain anomalies that can be detected only 
later in infancy. 
In the prenatal setting, more accurate ultrasound screening will improve counseling, 
especially regarding palatal involvement. Therefore, pregnant women with a fetus suspected 
of having an oral cleft should be referred to a tertiary center where more specific ultrasound 
screening can be performed. Also, it is important to obtain further clinical experience with new 
ultrasound techniques or fetal MRI. As different cleft categories are variously associated with 
additional structural and chromosomal anomalies and thus require different approaches in 
counseling, testing, and management, broad implementation of a uniform prenatal subdivi-
sion of clefts is vital. Additionally, follow-up studies, including array CGH, are needed to gain 
more insight into the proportions and types of structural and chromosomal anomalies missed 
in associated and presumed isolated clefts and into their risk factors.
Finally, to gain more insight into cleft etiology and effects of primary and secondary preven-
tive strategies, future studies should consider geographical differences in cleft sub-phenotypes 
and include live births and stillbirths as well as spontaneous and induced abortions. Extrapo-
lation of regional data to larger areas should be made with caution. To evaluate the impact 
of prenatal screening strategies in the Netherlands, uniform national registration of prenatal 
screening outcomes as well as implementation of indications for TOP in the WAZ are needed. 
With regard to folic acid, the increased risk we found for specific sub-phenotypes of oral clefts 
by an observational study is systematic and specific enough to warrant further evaluation, 
especially in the light of increased intake due to dietary improvements. Ideally, a randomized 
controlled trial should be conducted to confirm or refute our findings, but this would be unethi-
cal with the knowledge that folic acid can prevent neural tube defects. Therefore, future studies 
should focus on the type, timing, dose, and duration of folic acid supplementation in relation 
to embryologically different sub-phenotypes. Until more information is available, prudence 
is needed and we advise restricting supplementation to the periconceptional period recom-
mended to protect against neural tube defects.
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Summary
Oral clefts—one of the most common congenital anomalies among humans—comprise a wide 
range of sub-phenotypes affecting the lip, alveolus, and hard and soft palates. While they are 
often diagnosed immediately after birth, they are increasingly being diagnosed during preg-
nancy by routine two-dimensional (2D) ultrasonography. Oral clefts may either be isolated or 
be associated with other congenital anomalies, often as part of a syndrome or chromosomal 
defect. Although their etiopathogenesis has been widely studied, it is still poorly understood. 
This thesis is aimed at describing and classifying the various sub-phenotypes of clefts as well 
as their associated anomalies in both the prenatal and postnatal setting, thereby providing an 
approach and basis to further understand their etiopathogenesis and optimize their prenatal 
and postnatal outcome and prognosis. 
PART I Descriptive registration and validation
In chapter 2 we describe the study design and first results of a national validation project 
evaluating the quality of data recorded in the Dutch registry of patients with oral clefts and 
craniofacial anomalies, maintained by the Dutch Association of Cleft Palate and Craniofacial 
Anomalies (NVSCA). We drew a random sample of 250 patients registered with oral clefts in 
the national NVSCA database from 1997 through 2003 by the Dutch cleft palate teams using a 
unique descriptive recording system based on the embryology of the head and neck area; of 
these patients, 13 were excluded because of lacking medical data. After linking registry data 
to clinical data derived from medical record review, we found that the three cleft categories 
that are used nowadays to study oral clefts (cleft lip/alveolus = CL, cleft lip/alveolus and palate 
= CLP, and cleft palate = CP) had been accurately and completely recorded in the NVSCA. All 
categories showed near-perfect inter-database agreement with a kappa (κ) value of 0.89 and 
over, a sensitivity of 90% and over, and a specificity of 97% and over. Data quality on associated 
infant and parental characteristics was reasonable to satisfying, with ranging κ values (0.20 to 
0.76), sensitivity (25% to 97%), and specificity (35% to 93%). These findings show that NVSCA 
data are highly suitable for comparison with other studies and registries.
In chapter 3 the quality of NVSCA data was further evaluated by analyzing whether the 
specific features (topography and morphology) of the various sub-phenotypes within the three 
cleft categories are adequately recorded in clinical practice. Medical data review revealed that 
the data quality of the various sub-phenotypes was generally satisfactory, but appeared to be 
related to anatomical location and morphological severity. The topographic anatomical struc-
tures (lip, alveolus, and hard and soft palates) showed near-perfect inter-database agreement 
with a κ value ranging from 0.82 to 0.98, sensitivity of over 87%, and specificity of over 95%. 
However, when analyzing the morphology of these structures, validity decreased, especially for 
morphologically mild features. This association was most evident for anomalies of the hard and 
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soft palates. For example, inter-database agreement was higher for complete/incomplete cleft 
soft palate (κ value of 0.91 and sensitivity of 96%) than for submucous cleft hard/soft palate (κ 
value of 0.77 and sensitivity of 69%). Our results support the clinical feasibility of the descriptive 
NVSCA system and underline its additional value—compared to other registry systems—for 
fundamental, epidemiological, and clinical research. However, morphologically severe clefts 
can be interpreted with higher confidence than mild clefts, which might have implications for 
research on these features and for guidelines on routine neonatal examination.
In chapter 4 NVSCA data on congenital anomalies, syndromes, and chromosomal defects 
associated with oral clefts were validated. Through two-phased medical data review, we inves-
tigated whether these anomalies are accurately diagnosed and subsequently recorded. We 
found that the quality on associated anomalies was moderate to poor, with a κ value ranging 
from 0.59 to 0. Seventy-seven percent of the craniofacial anomalies were underreported in the 
NVSCA: 30% due to delayed diagnosis and 47% due to deficient recording. Additionally, 80% 
of the associated anomalies of other organ systems were underreported: 52% due to delayed 
diagnosis and 28% due to deficient recording. The reporting of final diagnoses was somewhat 
better; however, 54% were still underreported (24% delayed diagnosis and 30% deficient 
recording). The rate of overreporting was 1.6% or lower. These results emphasize the need for 
routine and thorough examination of patients with clefts. Clinicians should be more focused 
on co-occurring anomalies, and early genetic counseling seems warranted in most cases. 
Additionally, our findings underline the need for postnatal follow-up and ongoing registration 
of associated anomalies; reregistration in the NVSCA at a later age is recommended. 
PART II Prevalence in the Netherlands
In chapter 5 we present trends in prevalence of oral cleft live births in the Netherlands over 
1997 -2006. We performed time-trend analyses on NVSCA data of Dutch infants born alive with 
oral clefts during the study period. Prevalence rates and the estimated annual percentage 
change (EAPC) were calculated and stratified into CL±P and CP in order to investigate whether 
the higher periconceptional use of folic acid supplements or the greater prenatal detection of 
oral clefts (with or without associated anomalies) followed by pregnancy termination might 
have affected the prevalence. Both factors would mainly affect CL±P. Unlike CP, this category 
develops during the period recommended for folic acid use and can be detected prenatally by 
2D ultrasound. In the 1997-2006 period, 3,308 infants out of 1,970,872 live births had oral clefts, 
resulting in an overall prevalence per 10,000 live births of 16.8 (CL±P 11.3; CP 5.5). Time-trend 
analysis showed that the prevalence of all oral clefts decreased (EAPC –1.8%; 95% confidence 
interval (CI): –3.0% to –0.6%), as did the CL±P prevalence (EAPC –2.3%; 95% CI: –3.8% to 
–0.9%). No significant trends were found for the CP prevalence. These findings demonstrate 
that because the live-birth prevalence of CL±P decreased, that of all oral clefts decreased, sug-
gesting that higher periconceptional folic acid use or greater prenatal detection followed by 
pregnancy termination might have accounted for the observed decline. While this may have 
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implications for prenatal counseling and folic acid policy, further studies on these topics are 
needed first. 
In chapter 6 we compared NVSCA prevalence data over 1997-2007 with national data from 
the combined National Obstetric and Neonatal Registries (LVR/LNR) and regional data from 
the population-based registry of Eurocat Northern Netherlands, thereby verifying the detected 
decreasing trends and investigating whether the prevalence varies within the Netherlands. We 
found that the overall live-birth prevalence of oral clefts is significantly higher in the Northern 
Netherlands (15.1 to 21.4 per 10,000) than in the rest of the Netherlands (13.2 to 16.1 per 10,000). 
Time-trend analyses of both national registries confirmed the significant decreasing trend in 
CL±P for the rest of the Netherlands, while none of the registries showed significant trends 
for the Northern Netherlands. Despite some differences in prevalence between registries, they 
showed similar regional variation in prevalence and trends. In conclusion, our findings show 
that the prevalence of oral cleft live births varies significantly within the Netherlands, not only 
between but also within registries. This underlines that extrapolation of regional cleft data 
should be done with caution. Further studies investigating etiology and evaluating preventive 
strategies should consider these geographical differences in cleft sub-phenotypes among live 
births, stillbirths, and spontaneous/induced abortions, between and within countries, as they 
may reveal clues to the causal factors of oral clefts.
PART III Postnatal classification 
In chapter 7 a new postnatal classification of oral clefts based on the patho-embryology of 
the primary and secondary palates is described and tested on all sub-phenotypes among 
Dutch newborns. All unoperated infants registered in the national NVSCA database from 
1997 through 2003 were included. Using their descriptive data, we divided the different sub-
phenotypes—including subclinical features—within the three cleft categories (CL, CLP, and CP) 
into fusion defects, differentiation defects, or combinations of these, thereby classifying them 
according to their underlying patho-embryological processes. In total, 3.512 patients were 
included, showing a CL in 28%, CLP in 39%, and CP in 33%. Patients with CL showed 22% fusion 
defects, 75% differentiation defects, and 3% combined fusion and differentiation defects. CLP 
and CP patients most frequently had fusion defects (70% and 89%, respectively). We were able 
to construct an embryonic timetable relating almost all observed sub-phenotypes (over 90%) 
to specific weeks in development. This approach—considering timing and underlying mecha-
nisms in embryogenesis—provides new feasible subgroups for further clinical, epidemiologi-
cal, and fundamental research.
In chapter 8 we analyzed adult unoperated patients from Indonesia with clefts of the lip/
alveolus only to investigate whether our new classification is complete and feasible for all 
cleft sub-phenotypes of the primary palate. Compared to the secondary palate, the primary 
palate has rather complex and underexposed underlying patho-embryological mechanisms. 
Additionally, we investigate whether further morphological grading of incomplete cleft lips 
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is clinically and embryologically relevant and should be added to this classification. After 
local announcements, 108 adult unoperated patients with clefts of the lip/alveolus only were 
included. Using color photographs, X-rays, and dental casts, clefts were classified as fusion 
defects, differentiation defects, or combined defects. We further graded the morphology of 
incomplete cleft lips and analyzed whether these grades were related to the severity of alveolar 
clefts/hypoplasia. Permanent dentition was analyzed to investigate which alveolar part is 
deficient in fusion/differentiation defects. All sub-phenotypes—comprising 96 unilateral and 
12 bilateral clefts—could be classified into fusion defects (17%), differentiation defects (79%), 
unilateral fusion-differentiation defects (2%), or bilateral fusion & differentation (2%) defects. 
We found that the various morphological grades of cleft lip were not related to the associated 
alveolar clefts/hypoplasia. Additionally, all alveolar and dental deformities were located in the 
premaxillae. This study demonstrates that this classification is complete and feasible for all 
clefts of primary palate, that further morphological grading of incomplete cleft lip is neither 
clinically nor embryologically relevant, and that the premaxilla forms the deficient part in 
alveolar deformities. 
PART IV Effects of periconceptional folic acid supplementation
In chapter 9 the effects of periconceptional folic acid supplements on the risk of oral clefts rela-
tive to other non-folate related congenital anomalies was assessed in a population-based case-
control study, using complementary data from the NVSCA and Eurocat databases of children 
and fetuses born in the Northern Netherlands between 1997 and 2009 inclusive. Cases were 
live-born infants with non-syndromic clefts (n = 367) and controls were infants or fetuses with 
chromosomal/syndromal (n = 924) or non-folate related anomalies (n = 2021). We analyzed 
type, timing, and duration of supplement use related to the three cleft categories as well as to 
their timing (early/late embryonic periods) and underlying embryological processes (fusion/
differentiation defects). Consistent supplement use during the etiologically relevant period 
(weeks 0 to 12 postconception) was associated with an increased risk of clefts (adjusted odds 
ratio 1.72, 95% CI 1.19 to 2.49), especially of cleft lip/alveolus (3.16, 1.69 to 5.91). Further analysis 
systematically showed two- to three-fold increased risks for late differentiation defects—mainly 
clefts of the lip/alveolus—with no significant associations for early/late fusion defects. Effects 
were attributable to folic acid and not to other multivitamin components, and inclusion of 
partial use (not covering the complete etiologically relevant period) generally weakened asso-
ciations. This study presents several lines of evidence indicating that periconceptional folic acid 
in the Northern Netherlands might be associated with an increased risk of clefts, in particular 
of cleft lip/alveolus. This association is strengthened by the specificity, consistency, systematic 
pattern, and duration of exposure-response relationship of our findings, underlining the need 
to evaluate public health strategies regarding folic acid and to further investigate potential 
adverse effects.
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PART V Prenatal diagnosis and classification 
In chapter 10 we give an overview of literature and complementary validated NVSCA data on 
the type and frequency of associated structural and chromosomal anomalies related to oral 
cleft category in prenatal and postnatal populations. The aim of this study was to provide a 
basis for prenatal counseling and decisions on prenatal invasive diagnostics. Twenty studies 
were included: 3 providing prenatal data, 13 providing postnatal data, and 4 providing both. 
Data from prenatal and postnatal studies showed that the prevalence of associated anomalies 
is lowest in CL (0 to 20% and 8 to 41%, respectively). For CLP, higher frequencies were found 
both prenatally (39% to 66%) and postnatally (21% to 61%). Although CP was barely detectable 
by ultrasound, it was the category most frequently associated with accompanying defects in 
postnatal studies (22% to 78%). Chromosomal abnormalities were most frequently seen in 
association with additional anomalies. In the absence of associated anomalies, chromosomal 
defects were found prenatally in CLP (3.9%) and postnatally in CL (1.8%, 22q11.2 deletions 
only), in CLP (1.0%), and in CP (1.6%). These findings underline that prenatal counseling regard-
ing prognosis and risk of chromosomal defects should be tailored to cleft category, and more 
importantly to the presence or absence of associated anomalies. Irrespective of cleft category, 
clinicians should advise invasive genetic testing if associated anomalies are seen prenatally. In 
the absence of associated anomalies, prenatal conventional karyotyping is not recommended 
in CL, although array comparative genomic hybridization should be considered. In presumed 
isolated CLP or CP, prenatal invasive testing, preferably by array-based methods, is recom-
mended.
In chapter 11 we present a new prenatal ultrasound classification of oral and craniofacial 
clefts to aid in prenatal counseling, care, and research. This system is designed for modern 
ultrasound technologies and subdivides clefts according to their patho-embryological 
processes, associated congenital anomalies, and recent epidemiological insights. In contrast 
to most other systems, oral clefts (categories I-III) are distinguished from midline and atypical 
facial clefts (categories IV-VI), as the latter should be considered as craniofacial clefts because 
of their different patho-embryogenesis and accompanying defects. Additionally, the alveolus 
is described separately because of its unique underlying embryological processes, and clefts 
of the palate only are included as these are prenatally detectable nowadays. Besides grouping 
oral clefts into the three main categories (categories I-III), it is essential to prenatally differen-
tiate between incomplete and complete clefts of the lip/alveolus, because the palate is less 
frequently involved in incomplete clefts, resulting in a better prognosis, especially when it 
comes to associated defects. Although unilateral and bilateral forms of CLP result from similar 
embryological processes, it is clinically relevant to distinguish them prenatally, because unilat-
eral forms (category IIa) are less frequently associated with additional anomalies than bilateral 
forms (category IIb). With regard to craniofacial clefts, we distinguish two types of midline clefts 
based on differences in embryological processes and associated anomalies: complete median 
cleft lip and palate with hypotelorism (category IV), and incomplete median cleft lip (alveolus) 
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with or without hypertelorism (category V). The latter category (VI) of our classification com-
prises atypical facial clefts that are—in contrast to what is generally stated in literature—not 
explained by amniotic bands, but by different embryological processes.
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Schisis is één van de meest voorkomende aangeboren afwijkingen. Er zijn veel verschillende 
subfenotypen te onderscheiden en afhankelijk van de lokalisatie spreekt men van een lip-, 
kaak-, of gehemeltespleet, of een combinatie hiervan. Meestal worden deze afwijkingen direct 
na de geboorte ontdekt, maar door de verbetering in het structurele tweedimensionale (2D) 
echoscopisch onderzoek worden met name de lip/kaakspleten met of zonder gehemeltesple-
ten toenemend tijdens de zwangerschap gediagnosticeerd. Schisis komt als een geïsoleerde 
afwijking voor, maar ook met bijkomende aangeboren afwijkingen, meestal als onderdeel van 
een syndroom of chromosomale afwijking. De ontstaanswijze en oorzakelijke factoren van 
schisis zijn wereldwijd gedurende vele decennia onderzocht, maar ondanks het grote aantal 
studies is er nog relatief weinig over bekend. Het doel van dit proefschrift is om zowel de 
verschillende subfenotypen van schisis en de daarbij voorkomende congenitale afwijkingen te 
beschrijven en te classificeren, zowel in de prenatale en postnatale setting, om zo een aanpak 
en basis te bieden voor het verkrijgen van meer kennis over de etiopathogenese van schisis en 
het optimaliseren van de prenatale en postnatale uitkomst en prognose.
DEEL I beschrijvende registratie en validatie
In hoofdstuk 2 hebben we de studieopzet en eerste resultaten beschreven van een nationaal 
validatieproject waarin de kwaliteit van gegevens werd onderzocht opgenomen in de registra-
tie van patiënten met schisis en craniofaciale afwijkingen van de Nederlandse Vereniging voor 
Schisis en Craniofaciale Afwijkingen (NVSCA). Hiervoor werd uit de nationale NVSCA-database 
een random sample genomen van 250 patiënten die gedurende de periode 1997-2003 met 
een schisis werden geregistreerd door de Nederlandse schisisteams met behulp van een uniek 
gedetailleerd registratiesysteem gebaseerd op de embryologie van het hoofd/halsgebied; van 
deze patiënten werden er 13 geëxcludeerd vanwege onvoldoende medische gegevens. Om de 
kwaliteit van de registratiegegevens te kunnen beoordelen werden deze gegevens vergeleken 
met een herregistratie van de klinische gegevens verkregen uit de medische status van de des-
betreffende patiënten. Hieruit bleek dat de drie grove categorieën die tegenwoordig gebruikt 
worden om schisis te onderzoeken (lip/kaakspleten = CL, lip/kaak en gehemeltespleten = CLP, 
en gehemeltespleten = CP), accuraat en compleet worden geregistreerd in de NVSCA. Voor 
alle categorieën werd een goede inter-database overeenkomst gevonden met een kappa (κ) 
waarde van 0,89 en hoger, een sensitiviteit van 90% en hoger, en een specificiteit van 97% 
en hoger. De gegevens met betrekking tot de algemene karakteristieken van het kind en de 
ouders bleken minder, maar redelijk valide te zijn en toonden een variërende κ-waarde (0,20-
0,76), sensitiviteit (25%-97%), en specificiteit (35%-93%). Tezamen laten deze bevindingen zien 
dat de NVSCA-gegevens uitermate geschikt zijn voor vergelijking en onderzoek met andere 
studies en registraties van aangeboren afwijkingen, waaronder schisis. 
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In hoofdstuk 3 werd de kwaliteit van de NVSCA-gegevens verder geanalyseerd door te 
onderzoeken of de specifieke kenmerken (topografie en morfologie) van de verschillende 
subfenotypen binnen de drie schisiscategorieën adequaat zijn geregistreerd in de klinische 
praktijk. Uit vergelijking van deze gegevens met de herregistratie bleek dat de kwaliteit over 
het algemeen acceptabel is, maar dat deze varieert met de anatomische lokalisatie en de 
morfologische ernst van de afwijkingen. De topografische-anatomische structuren (lip, kaak, 
harde en zachte palatum) toonden een goede inter-database overeenkomst met een κ-waarde 
variërend van 0,82 tot 0,98, een sensitiviteit van hoger dan 87% en een specificiteit van hoger 
dan 95%. De validiteit daalde echter bij het analyseren van de morfologie van deze structuren, 
voornamelijk voor de morfologisch milde kenmerken. Voor het harde en zachte palatum was 
deze associatie het duidelijkst aanwezig. Zo was bijvoorbeeld de overeenkomst hoger voor 
de complete/incomplete spleten van het zachte palatum (κ-waarde 0,91 en sensitiviteit 96%) 
dan voor de submuceuze spleten van het harde/zachte palatum (κ-waarde 0,77 en sensitiviteit 
69%). Onze resultaten laten zien dat het unieke NVSCA-registratiesysteem valide en klinisch 
toepasbaar is en onderstrepen de aanvullende waarde – ten opzichte van andere registratie-
systemen – voor verder fundamenteel, epidemiologisch en klinisch onderzoek. De data voor 
morfologisch ernstigere spleten zijn echter betrouwbaarder dan die voor morfologisch mildere 
afwijkingen. Dit heeft mogelijk implicaties voor onderzoek naar deze kenmerken alsook voor 
het verbeteren van richtlijnen op het gebied van routine neonataal onderzoek.
In hoofdstuk 4 valideerden we de NVSCA-gegevens met betrekking tot geassocieerde con-
genitale afwijkingen, syndromen en chromosomale defecten. Door middel van herregistratie in 
twee fasen (eenmaal gebaseerd op de medische gegevens die beschikbaar waren op het oor-
spronkelijke moment van registratie in de NVSCA, en eenmaal gebaseerd op alle gegevens die 
beschikbaar waren op het moment van dit onderzoek, dus inclusief postnatale follow-up) werd 
onderzocht of deze afwijkingen adequaat gediagnosticeerd zijn tijdens het eerste bezoek aan 
de schisisteams en of ze vervolgens goed geregistreerd zijn. De kwaliteit voor geassocieerde 
afwijkingen bleek middelmatig tot slecht te zijn, met een κ-waarde variërend van 0,59 tot 0. 
Van de craniofaciale afwijkingen ontbrak 77% in de NVSCA: 30% door verlate diagnose en 47% 
door deficiënte registratie. Van de afwijkingen betreffende andere orgaansystemen was 80% 
niet geregistreerd: 52% door verlate diagnose en 28% door deficiënte registratie. De registratie 
van de uiteindelijke diagnose (zoals syndromen of chromosomale defecten) was beter, maar 
nog niet acceptabel, met een onderrapportage van 54%: 24% door verlate diagnose en 30% 
door deficiënte registratie. De overrapportage was slechts 1,6% of lager. Deze bevindingen 
benadrukken het belang van uitvoerig routineonderzoek van patiënten met schisis. Hierbij 
moet meer gefocust worden op bijkomende afwijkingen, en vroege genetische counseling lijkt 
op zijn plaats in de meeste gevallen. Daarnaast onderstrepen onze resultaten het nut van post-
natale follow-up en continue registratie, en herregistratie in de NVSCA op een latere leeftijd 
wordt dan ook aanbevolen.
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DEEL II Prevalentie in Nederland
In hoofdstuk 5 presenteren we de trends in prevalentie van schisis onder levendgeborenen in 
Nederland over 1997-2006. Hiervoor verrichtten we tijdtrendanalyses met NVSCA-gegevens 
van kinderen met schisis die levend geboren werden in Nederland tijdens de studieperiode. 
De prevalenties en het geschatte percentage jaarlijkse verandering (EAPC) van de prevalen-
ties werden berekend en vervolgens gestratificeerd naar: lip/kaak- met of zonder gehemel-
tespleten (CL±P); en gehemeltespleten zonder lip/kaakspleten (CP). Op deze manier werd 
onderzocht of het toegenomen periconceptioneel gebruik van foliumzuursupplementen en/
of de toegenomen prenatale detectie van schisis (met of zonder geassocieerde afwijkingen) 
gevolgd door zwangerschapsafbreking de prevalentie van schisis mogelijk beïnvloed zouden 
kunnen hebben. Beide factoren zijn voornamelijk van toepassing op CL±P, omdat deze, anders 
dan CP, ontstaan tijdens de periode die aanbevolen is voor foliumzuurgebruik en deze via de 
2D-echoscopisch onderzoek prenataal gediagnosticeerd kunnen worden. Gedurende 1997-
2006 hadden 3.308 van de 1.970.872 levend geboren kinderen een schisis, met als resultaat 
een totale prevalentie per 10.000 levendgeborenen van 16,8 (CL±P 11,3; CP 5,5). Tijdens de 
studieperiode daalde de prevalentie van schisis significant met 1.8% per jaar (95% betrouw-
baarheidsinterval (BI): –3,0% tot –0,6%) doordat de prevalentie van CL±P daalde (EAPC –2,3%; 
95% BI: –3,8% tot –0,9%). Er werden geen significante trends voor CP gevonden. Concluderend 
tonen onze resultaten dat de prevalentiedaling in schisis veroorzaakt is door een daling in CL±P. 
Deze specifieke daling suggereert dat het toegenomen periconceptioneel foliumzuurgebruik 
en/of de toegenomen prenatale detectie gevolgd door zwangerschapsafbreking mogelijke 
oorzaken zouden kunnen zijn. Alhoewel dit implicaties zou moeten hebben voor prenatale 
counseling en het foliumzuurbeleid, is verder onderzoek naar deze factoren vereist. 
 In hoofdstuk 6 worden de prevalentiegegevens van de NVSCA over 1997-2007 vergeleken 
met de nationale gegevens van de Landelijke Verloskunde en Neonatale Registraties (LVR/LNR) 
en de regionale gegevens van de Eurocat-registratie in Noord-Nederland. Het doel hiervan was 
om de gedetecteerde dalende trends te verifiëren en om te onderzoeken of de prevalentie 
varieert binnen Nederland. Deze vergelijking toonde dat de totale prevalentie van schisis 
onder levendgeborenen significant hoger is in Noord-Nederland (15,1 tot 21,4 per 10.000) dan 
in de rest van Nederland (13,2 tot 16,1 per 10.000). Tijdtrendanalyse van beide nationale regis-
traties bevestigden de significant dalende trend in CL±P voor de rest van Nederland, terwijl 
geen van de registraties significante trends voor Noord-Nederland vertoonde. Ondanks enige 
verschillen in prevalentie tussen de registraties, lieten ze een vergelijkbare regionale variatie 
in prevalentie en trends binnen Nederland zien. Concluderend varieert de prevalentie van 
schisis onder levendgeborenen significant in Nederland, niet alleen tussen maar ook binnen 
registraties. Dit onderstreept dat men zeer voorzichtig dient te zijn met het extrapoleren van 
regionale schisisgegevens. Het is van belang dat verdere studies naar de etiologie en naar het 
effect van preventieve maatregelen rekening houden met geografische verschillen in subfe-
notypen van schisis onder levend- en doodgeborenen alsmede spontane en geïnduceerde 
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zwangerschapsafbrekingen, omdat dit kan leiden tot meer inzicht in the oorzakelijke factoren 
van schisis.
DEEL III Postnatale classificatie
In hoofdstuk 7 wordt een nieuwe postnatale classificatie van schisis – gebaseerd op de patho-
embryologie van het primaire en secundaire palatum – beschreven en getest op alle subfe-
notypen onder Nederlandse pasgeborenen. Alle ongeopereerde kinderen die geregistreerd 
werden in de nationale NVSCA-database van 1997 tot en met 2003 werden geïncludeerd. Met 
behulp van de beschrijvende gegevens van deze kinderen werden de verschillende subfeno-
typen, inclusief subklinische kenmerken, binnen de drie schisiscategorieën (CL, CLP en CP) 
ingedeeld in fusiedefecten, differentiatiedefecten, of combinaties hiervan. Op deze manier 
werden de subfenotypen ingedeeld naar onderliggende patho-embryologische processen. 
In totaal werden 3.512 patiënten geïncludeerd, waarvan 28% een CL had, 39% een CLP en 
33% een CP. Patiënten met CL hadden in 22% van de gevallen een fusiedefect, in 75% een 
differentiatiedefect en in 3% een gecombineerd fusie-differentiatiedefect. Onder de patiënten 
met CLP en CP werd in de meeste gevallen een fusiedefect gediagnosticeerd (respectievelijk 
in 70% en 89%). Daarnaast was het mogelijk om een embryologische tijdstabel te construeren 
waarbij bijna alle subfenotypen (> 90%) gerelateerd kon worden aan specifieke weken in de 
ontwikkeling. Deze nieuwe aanpak, waarbij schisis ingedeeld wordt naar de timing en onder-
liggende mechanismen in embryogenese, is goed toepasbaar en biedt nieuwe subgroepen 
voor klinisch, epidemiologisch en fundamenteel onderzoek.
In hoofdstuk 8 hebben we volwassen ongeopereerde patiënten uit Indonesië met een 
spleet van alleen de lip en/of kaak geanalyseerd om te onderzoeken of de nieuwe postnatale 
classificatie compleet en toepasbaar is voor alle subfenotypen van het primaire palatum. Ver-
geleken met die van het secundaire palatum, zijn de onderliggende embryologische processen 
van het primaire palatum namelijk zeer complex en onderbelicht in de literatuur. Daarnaast 
onderzochten we of verdere morfologische gradering van incomplete lipspleten zowel klinisch 
als embryologisch relevant is en toegevoegd dient te worden aan de classificatie. Na lokale 
aankondigingen van de mogelijkheid tot klinische behandeling, werden 108 volwassen 
ongeopereerde patiënten met spleten van alleen de lip en/of kaak geïncludeerd. Met behulp 
van kleurenfoto’s, röntgenfoto’s en kaakmodellen, classificeerden we de subfenotypen als 
fusiedefect, differentiatiedefect, of als gecombineerd defect. Vervolgens werden de incomplete 
lipspleten morfologisch verder gegradeerd en onderzochten we of deze te relateren waren aan 
de ernst van de geassocieerde alveolaire afwijkingen (spleten of hypoplasie). De permanente 
dentitie werd geanalyseerd om te onderzoeken welk deel van de alveolus deficiënt is in fusie- 
en/of differentiatiedefecten. Zesennegentig patiënten toonden een unilaterale en 12 patiënten 
een bilaterale schisis. Het was mogelijk om alle subfenotypen te classificeren, wat resulteerde 
in 17% fusiedefecten, 79% differentiatiedefecten, 2% unilaterale fusie-differentiatiedefecten en 
2% bilaterale fusie- & differentiatiedefecten. De morfologische gradering van lipspleten bleek 
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niet gerelateerd te zijn aan de geassocieerde alveolairspleten of -hypoplasie. Daarnaast waren 
alle alveolaire en dentale afwijkingen gelokaliseerd in de premaxillae. Deze studie demon-
streert dat onze nieuwe classificatie compleet en toepasbaar is voor spleten van het primaire 
palatum, dat verdere morfologische gradering van incomplete lipspleten noch klinisch noch 
embryologisch relevant is, en dat het deficiënte deel in alveolaire afwijkingen de premaxilla 
betreft. 
DEEL IV Effect van periconceptionele foliumzuursuppletie
In hoofdstuk 9 onderzochten we de effecten van periconceptionele foliumzuursupplementen 
op het risico van schisis ten opzichte van andere niet-foliumzuur gerelateerde aangeboren 
afwijkingen in een populatie-gebaseerde case-controle studie. Hiervoor werden de comple-
mentaire gegevens van de NVSCA en Eurocat gebruikt voor kinderen en foetussen geboren 
in Noord-Nederland van 1997 tot en met 2009. Als cases includeerden we levend geboren 
kinderen met non-syndromale schisis (n = 367) en als controles kinderen en foetussen met 
chromosomale of syndromale afwijkingen (n = 924) of met niet-foliumzuur gerelateerde 
aangeboren afwijkingen (n = 2021). Het type, de timing en de duur van supplementgebruik 
werd geanalyseerd in relatie tot de drie schisiscategorieën alsook tot de timing (vroege en 
late embryonale periodes) en onderliggende processen (fusie/differentiatiedefecten) in de 
embryogenese. Consistent gebruik van supplementen tijdens de etiologisch relevante periode 
(week 0 tot en met 12 na de conceptie) bleek geassocieerd te zijn met een verhoogd risico 
voor schisis (aangepaste odds ratio 1,72; 95% BI 1,19  tot 2,49), en in het bijzonder voor lip/
kaakspleten (3,16; 95% BI 1,69 tot 5,91). Meer specifiekere analyse toonde twee- tot driemaal 
verhoogde risico’s voor late differentiatiedefecten, welke voornamelijk spleten van de lip/kaak 
betroffen, zonder significante associaties voor vroege en late fusiedefecten. Effecten waren 
toe te schrijven aan foliumzuur en niet aan andere componenten van multivitaminen en 
werden zwakker na inclusie van gedeeltelijk gebruik (gedurende een deel van de etiologisch 
relevante periode). Deze studie presenteert verschillende lijnen van bewijs die suggereren dat 
periconceptioneel gebruik van foliumzuur in Noord-Nederland geassocieerd zou kunnen zijn 
met een verhoogd risico voor schisis, voornamelijk voor lip/kaakspleten. Deze associatie wordt 
ondersteund door de specificiteit, de consistentie, het systematische patroon, en de ‘duur van 
blootstelling-respons relatie’ in onze resultaten. Dit onderstreept dat de evaluatie van ‘public 
health’ strategieën en onderzoek naar de potentiële nadelige effecten van foliumzuur nood-
zakelijk is.
DEEL V Prenatale diagnose en classificatie
In hoofdstuk 10 geven we een overzicht van literatuur en complementaire gevalideerde 
NVSCA-gegevens voor het type en de frequentie van geassocieerde structurele en chromoso-
male afwijkingen in relatie tot de categorieën schisis in prenatale en postnatale populaties. Het 
doel hiervan is om een basis te bieden voor prenatale counseling en voor beslissingen op het 
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gebied van prenatale invasieve diagnostiek. Twintig studies werden geïncludeerd: 3 met prena-
tale gegevens, 13 met postnatale gegevens en 4 met prenatale en postnatale gegevens. Zowel 
prenatale als postnatale studies toonden dat de prevalentie van geassocieerde afwijkingen het 
laagste is in CL (respectievelijk 0 tot 20% en 8 tot 41%). Voor CLP werden hogere frequenties 
gevonden in prenatale (39% tot 66%) en postnatale (21% tot 61%) studies. CP werd nauwelijks 
gedetecteerd met het 2D-echoscopisch onderzoek, maar de postnatale studies lieten zien dat 
deze categorie het vaakst geassocieerd is met bijkomende afwijkingen (22% tot 78%). Chro-
mosomale afwijkingen werden het meest gezien wanneer er sprake was van geassocieerde 
afwijkingen. In de afwezigheid van geassocieerde afwijkingen werden chromosomale defecten 
prenataal gediagnosticeerd in alleen CLP (3,9%) en postnataal in CL (1,8%, alleen 22q11.2 dele-
ties), in CLP (1,0%) en in CP (1,6%). Deze bevindingen benadrukken dat prenatale counseling 
met betrekking tot prognose en het risico op chromosomale afwijkingen zou moeten worden 
afgestemd op de schisiscategorie, en in nog hogere mate op de aan- of afwezigheid van geas-
socieerde afwijkingen. Daarnaast wordt in het geval van prenatale geassocieerde afwijkingen 
invasief genetisch onderzoek geadviseerd. Bij de afwezigheid van geassocieerde afwijkingen in 
CL wordt prenatale conventionele karyotypering niet aanbevolen, maar zou “array comparative 
genomic hybridization” overwogen kunnen worden. Indien verondersteld wordt dat CLP of CP 
geïsoleerd voorkomt, is prenataal invasief onderzoek aan te bevelen, bij voorkeur met array-
gebaseerde methoden.
In hoofdstuk 11 presenteren we een nieuwe prenatale echoclassificatie van schisis en 
craniofaciale spleten met als doel prenatale counseling, zorg en onderzoek te optimaliseren. 
Dit systeem is ontwikkeld voor moderne echotechnieken en deelt de afwijkingen in volgens 
onderliggende patho-embryologische processen, bijkomende congenitale afwijkingen en 
recente epidemiologische inzichten. In tegenstelling tot de meeste systemen, onderscheiden 
wij schisis (categorieën I-III) van mediane en atypische aangezichtsspleten (categorieën IV-VI). 
Deze laatste groepen dienen beschouwd te worden als craniofaciale spleten vanwege de andere 
patho-embryogenese en bijkomende defecten. Daarnaast wordt de alveolus apart beschreven 
gezien de unieke onderliggende embryologische processen, en zijn de gehemeltespleten 
zonder lip/kaakspleten ook opgenomen in de classificatie omdat deze steeds beter prenataal 
te diagnosticeren zijn. Naast de groepering van schisis in drie categorieën is het belangrijk 
om incomplete van complete lip/kaakspleten te onderscheiden, omdat het palatum minder 
vaak is aangedaan bij incomplete spleten, wat resulteert in een betere prognose, voorname-
lijk als het gaat om geassocieerde afwijkingen. Hoewel unilaterale en bilaterale lip/kaak- en 
gehemeltespleten dezelfde onderliggende embryologische processen hebben, is het klinisch 
relevant om deze groepen te onderscheiden omdat unilaterale vormen (categorie IIa) minder 
vaak geassocieerd zijn met bijkomende afwijkingen dan bilaterale vormen (categorie IIb). Wat 
betreft de craniofaciale spleten zijn er twee aparte categorieën mediane aangezichtsspleten 
te onderscheiden gezien hun verschillen in embryologische processen en bijkomende afwij-
kingen: complete mediane lip/kaak- en gehemeltespleet met hypotelorisme (categorie IV) en 
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incomplete mediane lip(kaak)spleet met of zonder hypertelorisme (categorie V). De laatste 
categorie (VI) van de classificatie bestaat uit atypische aangezichtsspleten die – in tegenstelling 
tot wat over het algemeen beweerd wordt in de literatuur – niet verklaard kunnen worden door 
amnionstrengen, maar door andere embryologische processen.
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Abbreviations
2D two-dimensional
3D three-dimensional
array CGH array-comparative genomic hybridization
BI betrouwbaarheids interval
BPA British Pediatric Association Classification of Diseases
CCL complete cleft lip 
CCLA complete cleft lip + complete cleft alveolus
CCL+ICA complete cleft lip + incomplete cleft alveolus
CCLA;ICL complete cleft lip + complete cleft alveolus combined with a 
contralateral incomplete cleft lip
CCLA;ICLA complete cleft lip + complete cleft alveolus combined with a 
contralateral incomplete cleft lip + incomplete cleft alveolus
CCLA; ICL+CCA complete cleft lip + complete cleft alveolus combined with a 
contralateral incomplete cleft lip + complete cleft alveolus
CCP complete cleft palate
CCSP complete cleft of the soft palate
CI confidence interval
CL cleft lip
CL/A cleft lip/alveolus
CL/AP cleft lip/alveolus and palate
CL/A±P cleft lip/alveolus with or without cleft palate 
CLP cleft lip and palate
CL±P cleft lip with or without cleft palate
CP cleft palate
CRL crown-rump length
D differentiation defect
EAPC estimated annual percentage change
ECLAM Latin American Collaborative Study of Congenital Malformations
EMT epitheliomesenchymal transformation
EUROCAT European Registry of Congenital Anomalies and Twins 
F fusion defect
FD fusion and differentiation defect
FISH fluorescence in situ hybridization
Fro. os frontale
HH/SP hypoplastic hard and/or soft palate
ICD International Classification of Diseases
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ICHP incomplete cleft of the hard palate
ICL incomplete cleft lip
ICLA incomplete cleft lip + incomplete cleft alveolus
ICL+CCA incomplete cleft lip + complete cleft alveolus 
ICSP incomplete cleft of the soft palate
I.o.d. interorbital distance
IQR interquartile range
IUCR intrauterine growth retardation
I/CCU (in)complete cleft of the uvula
Κ kappa
LNR Landelijke Neonatologie Registratie (National Neonatal Registry)
LVR Landelijke Verloskunde Registratie (National Obstetric Registry)
Mand. mandible
Max. maxilla
MCA multiple congenital anomalies
Nas. os nasale
NNL Northern Netherlands
NVSCA Nederlandse Vereniging voor Schisis en Craniofaciale Afwijkingen 
(Dutch Association for Cleft Palate and Craniofacial Anomalies)
OC common oral cleft
Occ. os occipitale 
Pal.dur. palatum durum
Pal.mol. palatum molle
Par. os parietale
PPR prevalence proportion ratio
Pre. premaxilla
Pre./Max. premaxilla – maxilla
PRS Pierre Robin Sequence
SCHP submucous cleft of the hard palate
SCH/SP submucous cleft of the hard and/or soft palate
SCL submucous cleft lip
SCSP submucous cleft of the soft palate
SD standard deviation
Temp. os temporale
Ton. tongue
TOP termination of pregnancy
US ultrasound
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VCF velo-cardio-facial syndrome (22q11.2 deletion)
WAZ Wet Afbreking Zwangerschap
(Termination of Pregnancy Act)
Zyg. zygoma
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Summary of PhD Training and Teaching Activities
Name PhD student: 
Erasmus MC Department: 
PhD period: 
Promotor: 
Supervisor: 
Annemarie Rozendaal
Plastic and Reconstructive Surgery
2008 – 2012
Prof. dr. S.E.R. Hovius
Dr. C. Vermeij-Keers
Year Workload
(Hours/
ECTS)
1. PhD training
General academic skills 
- 
- 
English Course Proficiency A 
Biomedical English Writing and Communication
2008
2009
30 hours 
4 ECTS
Research skills
- 
- 
Principles of Research in Medicine and Epidemiology, NIHES 
Biostatistics for Clinicians, NIHES
2008
2009
0.7 ECTS
1 ECTS
In-depth courses (e.g. medical training)
- Microsurgery training
Skillslab, Erasmus MC Rotterdam
2008 & 2009 150 hours
Oral presentations
-  Validatie van de NVSCA-registratie Schisis: studieopzet en eerste 
resultaten. 23e Wetenschappelijke Vergadering NVSCA. Nijmegen, 
Nederland
2008 1 ECTS
-  Drie registraties: prevalentie van schisis in Nederland en Noord-
Nederland, een nationale daling 1997-2006. Commissie Registratie 
Aangeboren Afwijkingen, Ministerie van Volksgezondheid, Welzijn en 
Sport. Den Haag, Nederland
2009 1 ECTS
-  Validation of the NVSCA Registry Common Oral Clefts: study design 
and first results. 11th International Congress on Cleft lip and Palate and 
Related Craniofacial Anomalies. Fortaleza, Brazil
2009 1 ECTS
-  Ten years registration of common oral clefts: decrease of prevalence in 
the Netherlands, 1997-2006. 11th International Congress on Cleft lip and 
Palate and Related Craniofacial Anomalies. Fortaleza, Brazil
2009 1 ECTS
-  Tien jaar schisisregistratie: daling prevalentie van schisis in Nederland, 
1997-2006. 24e Wetenschappelijke Vergadering NVSCA. Tilburg, 
Nederland
2009 1 ECTS
-  Validatie van de NVSCA-registratie Schisis: kwaliteit van registratie van 
de individuele schisisafwijkingen. 25e Wetenschappelijke Vergadering 
NVSCA. Den Haag, Nederland
2010 1 ECTS
-  Regionale verschillen in de prevalentie van schisis onder 
levendgeborenen in Nederland 1997-2007: trendanalyse van gegevens 
uit drie Nederlandse registraties. 25e Wetenschappelijke Vergadering 
NVSCA. Den Haag, Nederland
2010 1 ECTS
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-  Oral Clefts: Registration, classification, and epidemiology of prenatal and 
postnatal phenotypes. PhD-weekend afdeling Dermatologie – Erasmus 
MC Rotterdam. Zuid-Limburg, Nederland
2012 1 ECTS
International and national conferences
- Symposium Perinatologie in beeld. Rotterdam, Nederland 2008 1 ECTS
- 23e Wetenschappelijke Vergadering NVSCA. Nijmegen, Nederland 2008 1 ECTS
-  Voorjaarsvergadering Nederlandse Vereniging voor Plastische Chirurgie. 
Utrecht, Nederland
2009 1 ECTS
-  11th International Congress on Cleft Lip and Palate and Related 
Craniofacial Anomalies. Fortaleza, Brazil
2009 1 ECTS
- 24e Wetenschappelijke Vergadering NVSCA. Tilburg, Nederland 2009 1 ECTS
- 25e Wetenschappelijke Vergadering NVSCA. Den Haag, Nederland 2010 1 ECTS
Seminars and workshops
- Kortjakje, Zondagsschool voor Plastische Chirurgie. Zeist, Nederland 2008 7 hours
-  Training in hechttechnieken zenuwen, pezen en flexoren, Skillslab, 
Erasmus MC Rotterdam, Rotterdam, Nederland
2008 20 hours
-  PhD-weekend afdeling Dermatologie – Erasmus MC Rotterdam. Zuid-
Limburg, Nederland
2012 48 hours
Other
-  Session chair “Junior Investigations”. 11th International Congress on Cleft 
lip and Palate and Related Craniofacial Anomalies. Fortaleza, Brazil
2009
- Member Working Group NVSCA registry 2008 – 2012 120 hours
- Member Working Group NVSCA website 2008 – 2012 120 hours
Awards
- “ The best Junior Investigation – Dr. Cassio M. Raposo do Amaral Award” 
11th International Congress on Cleft Lip and Palate and Related 
Craniofacial Anomalies. Fortaleza, Brazil
2009
2. Teaching activities
Lecturing
-  Vierdejaars vaardigheidsonderwijs anatomie en functie van de hand, 
curriculum geneeskunde, Erasmus Universiteit Rotterdam (EUR), 
Nederland
2008 6 hours
-  Keuzeonderwijs craniofaciale chirurgie, embryologie en 
registratie van schisis en andere hoofd/halsafwijkingen, 3e jaars 
keuzeonderwijsstudenten, EUR, Nederland
2009 & 2010 20 hours
-  Seminar embryologie en registratie van schisis en andere hoofd/
halsafwijkingen, orthodontisten in opleiding, Academisch Centrum 
Tandheelkunde Amsterdam (ACTA)
2009 & 2011 10 hours
Supervising practicals and excursions
- Supervisie Microchirurgiecursus voor AIOS Obstetrie en Gynaecologie, 
Skillslab, Erasmus MC Rotterdam, Nederland 2008 5 hours
- Supervisie Microchirurgiecursus voor specialisten en specialisten in 
opleiding, Skillslab, Erasmus MC Rotterdam, Nederland
2008 & 2009 28 hours
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Curriculum Vitae
Annemarie Rozendaal werd op 11 december 1981 geboren in Rotterdam. Zij doorliep het lager 
onderwijs op de Rehobothschool te Ridderkerk. In dezelfde plaats behaalde zij in 2000 haar 
VWO-diploma aan het Farel College. Aansluitend begon zij haar studie Geneeskunde aan de 
Erasmus Universiteit te Rotterdam. Tijdens deze studie was zij actief bij de Medische Faculteits 
Vereniging Rotterdam (MFVR), onder andere als bestuurslid en als voorzitter van de Facultaire 
Introductie Commissie. Daarnaast was zij werkzaam in het Studententeam Thoraxchirurgie 
van het Erasmus MC Rotterdam. In 2004-2005 verrichtte zij in dit ziekenhuis haar afstudeer-
onderzoek op de afdelingen Plastische en Reconstructieve Chirurgie en Orthodontie. Hiervoor 
deed zij – onder supervisie van Dr. C. Vermeij-Keers en Dr. J.W. van Neck – onderzoek naar de 
betrouwbaarheid en toepasbaarheid van het landelijk registratiesysteem van de Nederlandse 
Vereniging voor Schisis en Craniofaciale Afwijkingen (NVSCA) voor patiënten met schisis 
met of zonder geassocieerde afwijkingen. Als student-assistent continueerde zij tijdens haar 
co-assistentschappen deze onderzoeksactiviteiten en ontstond de basis voor dit proefschrift. 
Na haar keuze- en oudste co-assistentschap verricht te hebben op dezelfde afdeling behaalde 
zij haar artsexamen in 2008. Hierna werd zij als arts-onderzoeker op de afdelingen Plastische 
en Reconstructieve Chirurgie en Orthodontie aangesteld, onder supervisie van Prof. Dr. S.E.R. 
Hovius en Dr. C. Vermeij-Keers, met dit proefschrift als resultaat. Tijdens haar promotietraject 
deed zij tevens diensten in de kliniek en volgde zij trainingen microchirurgie. In 2011 besloot zij 
zich te specialiseren in de Dermatologie en Venerologie. Ter voorbereiding op deze opleiding 
volgde zij gedurende 4 maanden een klinische meeloopstage op de afdeling Dermatologie van 
het Sint Fransiscus Gasthuis te Rotterdam (Dr. M.C.G. van Praag en Drs. D.G.C.T.M. Snels). Hierna 
werd zij aangenomen voor de opleiding tot dermatoloog in het Erasmus MC (Prof. H.A.M. 
Neumann en Dr. B.H. Thio), waarmee zij in juli 2012 begon. Gedurende het eerste half jaar liep 
zij een perifere stage in het Catharina Ziekenhuis te Eindhoven (Dr. G.A.M. Krekels) en per 1 
juli 2013 is ze gestart met een tweede perifere stage van een jaar in het Amphia Ziekenhuis te 
Breda (Dr. A. Erceg).
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Met een zeer voldaan gevoel schrijf ik het laatste deel van dit proefschrift, het dankwoord. Het 
was een zeer onvoorspelbare, afwisselende en soms zware weg, maar het is klaar, de olifant is 
op!! Zonder de inzet, steun, expertise en bijdrage van veel mensen was het nooit geworden 
wat het nu is. Graag wil ik iedereen die dit proefschrift mogelijk heeft gemaakt heel hartelijk 
danken, waarbij ik er een aantal bij naam wil noemen.
In de eerste plaats wil ik graag mijn co-promotor, dr. C. Vermeij-Keers, bedanken. Christl, zonder 
jouw uitgebreide wetenschappelijke kennis, ervaring en expertise op embryologisch gebied 
en je inspanningen voor de landelijke NVSCA-registratie Schisis had dit promotieonderzoek 
nooit plaats kunnen vinden. Je bevlogenheid, uithoudingsvermogen en precisie zijn bewonde-
renswaardig. We hebben heel intensief samengewerkt, en ik ben je dan ook bijzonder dankbaar 
voor al je tijd en energie. Geen vraag was je te veel, en je was altijd bereid om op korte termijn 
stukken te beoordelen. Ik heb je kritische blik en volhardendheid zeer gewaardeerd en ontzet-
tend veel geleerd van onze discussies en je manier van denken. Bedankt voor het vertrouwen 
dat je in me hebt gehad. 
Prof. dr. S.E.R. Hovius, mijn promotor, hartelijk dank voor de mogelijkheid om onderzoek te doen 
op uw afdeling. Uw betrokkenheid, adviezen en visie heb ik als zeer waardevol ervaren.
De leden van de kleine commissie, Prof. dr. E.B. Wolvius, Prof. dr. D. Oepkes en Prof. dr. D. Lindhout, 
ben ik zeer erkentelijk voor het beoordelen van mijn proefschrift en voor het waardevolle com-
mentaar.
Ook wil ik graag Prof. dr. R.P.M. Steegers-Theunissen, Prof. dr. H.A.M. Neumann en Prof. dr. C.M.A.M. 
van der Horst hartelijk danken voor het plaatsnemen in de grote commissie. Professor Neu-
mann, zeer veel dank voor de mogelijkheden die ik tijdens mijn opleiding dermatologie op uw 
afdeling heb gekregen om dit werk af te ronden.
Dr. E.M. Ongkosuwito wil ik bedanken voor zijn bereidheid om als deskundige plaats te nemen in 
de promotiecommissie. Beste Edwin, als onervaren en groene keuzeonderzoekster kreeg ik in 
het 4e jaar van mijn geneeskundeopleiding deels op jouw afdeling de gelegenheid om de basis 
te leggen voor dit onderzoek. Je leerde mij de klinische “ins and outs” over schisis en andere 
craniofaciale afwijkingen, waarna je tot en met de afronding van dit proefschrift betrokken 
bent gebleven. Ik ben je zeer dankbaar voor de mogelijkheden die je mij – als afdelingshoofd 
van de afdeling Orthodontie – geboden hebt voor het vervolgen van dit onderzoek en het te 
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laten worden tot wat het nu is. Je hebt me altijd gesteund en ik kon altijd bij je terecht, ook 
gewoon voor de gezelligheid of voor je orthodontische skills.
Daarnaast wil ik ook mijn waardering uitspreken naar jouw voorgangster, Prof. dr. B. Prahl-
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graag bedanken voor hun bijdrage. 
Mw. C. Oostdijk, beste Carin, super bedankt voor je strakke organisatie en hulp! Dat was echt 
onmisbaar tijdens zo’n laatste promotiefase.
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hartelijke bedanken voor hun interesse, steun en ruimte die ik heb gehad voor het afronden 
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Lieve vrienden, ook jullie wil ik super bedanken! Niet voor de bijdrage aan dit boekje, maar voor 
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Oral clefts are one of the most common congenital anomalies among humans, comprising a wide 
range of sub-phenotypes affecting the lip, alveolus, and 
hard and soft palates. They may either be isolated or be 
associated with other congenital anomalies, often as part 
of a syndrome or chromosomal defect. Although their 
etiopathogenesis has been widely studied, it is still poorly 
understood. 
This thesis is aimed at describing and classifying the 
various sub-phenotypes of oral clefts as well as their 
associated anomalies in both the prenatal and postnatal 
setting, thereby providing an approach and basis to 
further understand their etiopathogenesis and optimize 
their outcome and prognosis. In part I of this thesis, we 
validate a unique recording system of oral clefts, based on 
the embryology of the head and neck area. In part II, the 
prevalence of oral clefts in the Netherlands, including its 
differences between regions and registries, is investigated. 
Part III describes a new postnatal embryological 
classification of oral clefts, providing subgroups related 
to specific time periods and underlying embryological 
processes in development. In the case-control study of 
part IV, we assess the effects of periconceptional folic 
acid supplement use on the risk of oral clefts. Finally in 
part V, we analyze the type and prevalence of associated 
structural anomalies and chromosomal defects in prenatal 
and postnatal oral cleft populations and present a new 
prenatal ultrasound classification of clefts aiding in prenatal 
counseling and care.
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